User Image Cart Icon 0 Search Image
  • Home > Blog > Aldosterone & Obesity/hypertension

Aldosterone & Obesity/hypertension

  1. Aldosteroneย inย obesity
  2. Resistantย hypertension,ย obesity, sleep apnea, andย Aldosterone: theory and therapy
  3. The role ofย Aldosteroneย inย obesity-relatedย hypertension
  4. Visceralย obesityย and insulin resistance are associated with plasmaย Aldosteroneย levels in women
  5. obesity,ย hypertensionย andย Aldosterone: is leptin the link?
  6. Aldosteroneย antagonism attenuatesย obesity-inducedย hypertensionย and glomerular hyperfiltration
  7. Aldosteroneย production and signaling dysregulation inย obesity
  8. Fibrosis and cardiac function inย obesity: a randomised controlled trial ofย Aldosteroneย blockade
  9. Plasmaย Aldosterone, plasma lipoproteins,ย obesityย and insulin resistance in humans
  10. The role of the renin-angiotensin-Aldosteroneย system inย obesity-related renal diseases
  11. Adipocytes produceย Aldosteroneย through calcineurin-dependent signaling pathways: implications in diabetes mellitusโ€“associatedย obesityย and vascular dysfunction
  12. Adipocytes,ย Aldosteroneย andย obesity-relatedย hypertension
  13. The link between the renin-angiotensin-Aldosteroneย system and renal injury inย obesityย and the metabolic syndrome
  14. Leptin-Aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people withย obesity
  15. The reninโ€“angiotensinโ€“Aldosteroneย system as a link betweenย obesityย and coronavirus disease 2019 severity
  16. obesity, sleep apnea,ย Aldosterone, andย hypertension
  17. Morbidย obesity, hypertensive disease and the renin-angiotensin-Aldosteroneย axis
  18. Vasculometabolic and Inflammatory Effects ofย Aldosteroneย inย obesity
  19. A critical review of the evidence supportingย Aldosteroneย in the etiology and its blockade in the treatment ofย obesity-associatedย hypertension
  20. The regulation ofย Aldosteroneย secretion by leptin: implications inย obesity-related cardiovascular disease
  21. The renin angiotensinย Aldosteroneย system inย obesityย andย hypertension: roles in the cardiorenal metabolic syndrome
  22. obesity-related heart failure with a preserved ejection fraction: the mechanistic rationale for combining inhibitors ofย Aldosterone, neprilysin, and sodium-glucose โ€ฆ
  23. The association ofย Aldosteroneย withย obesity-relatedย hypertensionย and the metabolic syndrome
  24. The link between adipose tissue renin-angiotensin-Aldosteroneย system signaling andย obesity-associatedย hypertension
  25. The involvement ofย Aldosteroneย on vascular insulin resistance: implications inย obesityย and type 2 diabetes
  26. Interaction ofย Aldosteroneย and extracellular volume in the pathogenesis ofย obesity-associated kidney disease: a narrative review
  27. Fat cells may be theย obesityโ€“hypertensionย link: human adipogenic factors stimulateย Aldosteroneย secretion from adrenocortical cells
  28. obesityย and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-Aldosteroneย system
  29. Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity andย Aldosteroneย levels in morbidย obesity
  30. Role of mineralocorticoid receptor and reninโ€“angiotensinโ€“Aldosteroneย system in adipocyte dysfunction andย obesity
  31. Aldosteroneย deficiency in mice burdens respiration and accentuates diet-induced hyperinsulinemia andย obesity
  32. obesity-inducedย hypertensionย develops in young rats independently of the renin-angiotensin-Aldosteroneย system
  33. Differential effects of reninโ€“angiotensinโ€“Aldosteroneย system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure inย obesityย โ€ฆ
  34. Role of renin-angiotensin-Aldosteroneย system in metabolic syndrome andย obesity-relatedย hypertension
  35. Relationship betweenย obesity,ย hypertension, andย Aldosteroneย production in postmenopausal African American women: a pilot study
  36. Response to โ€˜renal injury in extremeย obesity: the important role ofย Aldosteroneโ€˜
  37. Increasedย Aldosterone: mechanism ofย hypertensionย inย obesity
  38. Changes in serumย Aldosteroneย are associated with changes inย obesity-related factors in normotensive overweight and obese young adults
  39. Aldosteroneย is involved in the pathogenesis ofย obesity-related glomerulopathy through activation of Wnt/ฮฒ-catenin signaling in podocytes
  40. Impact ofย obesityย on the association of active renin and plasmaย Aldosteroneย concentrations, andย Aldosterone-to-renin ratio with preeclampsia
  41. Reviving the use ofย Aldosteroneย inhibitors in treatingย hypertensionย inย obesity
  42. Race,ย obesity, and the renin-angiotensin-Aldosteroneย system: treatment response in children with primaryย hypertension
  43. obesityย and the reninโ€“angiotensinโ€“Aldosteroneย system
  44. PS 08-85 ASSOCIATION OFย Aldosteroneย SYNTHASE (CYP11B2) GENE POLYMORPHISMS WITHย obesityย IN ESSENTIAL HYPERTENSIVE CHILDREN AND โ€ฆ
  45. Beneficial long-term effect ofย Aldosteroneย antagonist added to a traditional blockade of the reninโ€“angiotensinโ€“Aldosteroneย system among patients withย obesityย โ€ฆ
  46. Changes inย Aldosteroneย andย obesity-related cardiometabolic risk factors with a 1-year weight loss intervention in normotensive overweight and obese young โ€ฆ
  47. Insulin resistance and the renin-angiotensin-Aldosteroneย system in metabolic syndrome andย obesity-relatedย hypertension
  48. The renin, angiotensin,ย Aldosterone, andย obesityย connection
  49. The renin-angiotensin-Aldosteroneย system (RAAS) and its relation with calcium homeostasis in maleย obesity
  50. The Relationship betweenย obesity, insulin resistance andย Aldosteroneย levels
  51. Emerging role ofย Aldosteroneย in mediating the vicious cycle ofย obesity, insulin resistance and metabolic syndrome
  52. Distribution of genotypes and alleles of theย Aldosterone-synthase gene in patients with abdominalย obesity
  53. Targeting the Renin-Angiotensin-Aldosteroneย System inย obesity
  54. Altered circadian plasma cortisol andย Aldosteroneย group rhythms in Cushingโ€™s syndrome versusย obesityย and health.
  55. Characteristics of the Renin-Angiotensin-Aldosteroneย System in Carriers of Polymorphic Variants of the VDR Gene With Arterialย hypertensionย andย obesity
  56. obesity-stimulatedย Aldosteroneย release is not related to an S1P-dependent mechanism
  57. ARTERIAL STIFFNESS,ย Aldosterone, CRP AND DIASTOLIC DYSFUNCTION IN PATIENTS WITHย hypertension,ย obesityย AND ATRIAL FIBRILLATION
  58. RENIN-ANGIOTENSIN-Aldosteroneย SYSTEM IN PATIENTS WITH ABDOMINALย obesityย AND ARTERIALย hypertension
  59. Changes in excretion ofย Aldosteroneย in urine during absolute starvation in essentialย obesity.
  60. The Renin-Angiotensin-Aldosteroneย System as a Link Betweenย obesityย and Coronavirus Disease 2019 Severity
  61. Effect ofย Aldosteroneย receptor antagonist onย obesity-related glomerulonephropathy
  62. Aldosteroneย Production and Signaling Dysregulation inย obesity
  63. Adipocyte-derivedย Aldosteroneย And Cortisol Are Nox1/4 Dependent: Implications Inย obesity-associated Vascular Dysfunction.
  64. โ€ฆ efficacy and safety of dual blockage of the renin-angiotensin-Aldosteroneย system in patients with type 2 diabetes,ย hypertensionย andย obesityย without renal dysfunction
  65. Role ofย Aldosteroneย inย obesity-induced endothelial dysfunction
  66. Aldosteroneย synthase gene polymorphism in alimentaryย obesity, metabolic syndrome components, some secondary forms of arterialย hypertension, pathology of the โ€ฆ
  67. RELATIONSHIP BETWEENย obesityย AND PLASMAย Aldosteroneย IN ESSENTIALย hypertension: INFLUENCE OF GENDER: PP. 34.372
  68. Possible Interactions Among Fatty Acids, Other Lipids, andย Aldosteroneย in theย hypertensionย ofย obesity
  69. Influence of Race andย obesityย on the Renin-Angiotensin-Aldosteroneย System in Adolescents Born Preterm
  70. Does Reninโ€Angiotensinโ€Aldosteroneย System Inhibition Impactย obesityย as a Coโ€“Risk Factor?
  71. P658Left ventricular function improvement byย Aldosteroneย blockade inย obesity: contribution of beneficial changes in collagen turnover
  72. BAS/BSCR35 Effects ofย Aldosteroneย andย obesityย on the anticontractile properties of perivascular adipose tissue in rat aortic rings
  73. Abstract MP009: Changes inย Aldosteroneย are Associated With Changes inย obesity-Related Factors in Normotensive Overweight/Obese Young Adults Undergoing โ€ฆ
  74. RENIN-ANGIOTENSIN-Aldosterone-SYSTEM IN PATIENTS WITH ABDOMINALย obesityย ANDย hypertension: PP. 26.334
  75. The relationship between renin-Aldosteroneย system andย obesityย in non-insulin dependent diabetes mellitus (NIDDM).
  76. Role of the adipose-tissue renin-angiotensin-Aldosteroneย system inย obesityย andย obesity-associatedย hypertension.
  77. obesity, adipocytes, and the renin-angiotensin-Aldosteroneย axis.
  78. โ€ฆ ofย Aldosterone, Plasma Renin Activity (PRA) and Superoxide Dismutase (SOD) with Inflammation and Insulin Resistance in Adult Men with Centralย obesity
  79. Effect ofย obesityย on Activation of the Renin Angiotensin-Aldosteroneย system in Patients with Moderate to Advanced Heart Failure
  80. Differential aspects of the dynamics of the renin-angiotensin-Aldosteroneย system inย obesityย with and withoutย hypertensionย and in essential arterialย hypertension
  81. โ€ฆ receptor agonists and antagonists ofย Aldosteroneย on the performance of daily blood pressure monitoring in patients withย hypertensionย and concomitantย obesity
  82. Hyperinsulinemia Leads the Elevation of Plasmaย Aldosteroneย Concentration Independently withย obesity, Dyslipidemia, and Insulin Resistance in Patients with Type 2 โ€ฆ
  83. Function of the adrenal cortex inย obesity. 6.ย Aldosteroneย secretion and excretion of its metabolites during some dynamic tests.
  84. Abstract A39: Gene-environment interactions between SNPs in the renin-angiotensin-Aldosteroneย system andย hypertension,ย obesity, and blood pressure-related โ€ฆ
  85. Function of the adrenal cortex inย obesity. 5. Daily secretion ofย Aldosterone.
  86. โ€ฆ : C-344Tย Aldosterone-SYNTHASE GENE POLYMORPHISM AND RENIN-ANGIOTENSIN-Aldosteroneย SYSTEM IN PATIENTS WITH ABDOMINALย obesity
  87. โ€ฆ growth factor-23โ€”klothoโ€”vitamin D 3 axis and the reninโ€”angiotensinโ€”Aldosteroneย axis in the development and progression ofย obesity-related kidney disease
  88. PS 04-15 MICE LACKINGย Aldosteroneย SYNTHASE OR TREATED WITH EPLERENONE ARE RESISTANT TO DIET-INDUCEDย obesity
  89. Role of NADPH oxidase (Nox) 1/4 in adipocyte-derivedย Aldosteroneย production and in inflammation and fibrosis inย obesity
  90. 6.1ย hypertensionย Associated withย obesityย or Overweight: a Role forย Aldosterone?
  91. The reninโ€“angiotensinโ€“Aldosteroneย system, glucose metabolism and diabetes
  92. Plasmaย Aldosteroneย concentration in the patient with diabetes mellitus Rapid Communication
  93. Aldosteroneย and angiotensin: Role in diabetes and cardiovascular diseases
  94. Local renalย Aldosteroneย system and its regulation by salt, diabetes, and angiotensin II type 1 receptor
  95. Aldosteroneย function in diabetes mellitus: effects on cardiovascular and renal disease
  96. Reninโ€angiotensinโ€Aldosteroneย system in diabetes andย hypertension
  97. Diabetes mellitus, the renin-angiotensin-Aldosteroneย system, and the heart
  98. The role of the renin-angiotensin-Aldosteroneย system in diabetes and its vascular complications
  99. Selectiveย Aldosteroneย blockade with eplerenone reduces albuminuria in patients with type 2 diabetes
  100. Reninโ€angiotensinโ€Aldosteroneย system, glucose metabolism and incident type 2 diabetes mellitus: MESA
  101. โ€ฆ role for sodium in the pathogenesis of blood pressure changes independent of angiotensin,ย Aldosteroneย and catecholamines in type 1 (insulin-dependent) diabetes โ€ฆ
  102. Blockade of the reninโ€“angiotensinโ€“Aldosteroneย system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes
  103. Sodium, renin,ย Aldosterone, catecholamines, and blood pressure in diabetes mellitus
  104. Diabetes and reninangiotensin-Aldosteroneย system: implications for COVID-19 patients with diabetes treatment management
  105. Evidence for renoprotection by blockade of the reninโ€“angiotensinโ€“Aldosteroneย system inย hypertensionย and diabetes
  106. Aldosteroneย and myocardial extracellular matrix expansion in type 2 diabetes mellitus
  107. The crosstalk between insulin and renin-angiotensin-Aldosteroneย signaling systems and its effect on glucose metabolism and diabetes prevention
  108. Effect of SGLT2 inhibitors on body composition, fluid status and reninโ€“angiotensinโ€“Aldosteroneย system in type 2 diabetes: a prospective study using โ€ฆ
  109. Aldosteroneย breakthrough during angiotensin II receptor blockade in hypertensive patients with diabetes mellitus
  110. Aldosteroneย blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic โ€ฆ
  111. Aldosterone, renin, and diabetes mellitus in African Americans: the Jackson Heart Study
  112. A systematic review of the role of renin angiotensinย Aldosteroneย system genes in diabetes mellitus, diabetic retinopathy and diabetic neuropathy
  113. Increasedย Aldosteroneย levels in a model of type 2 diabetes mellitus
  114. Aldosteroneย increases urine production and decreases apical AQP2 expression in rats with diabetes insipidus
  115. Renin-angiotensin-Aldosteroneย system activation in long-standing type 1 diabetes
  116. Impact of the renin-angiotensin-Aldosterone-system on cardiovascular and renal complications in diabetes mellitus
  117. The renin-angiotensin-Aldosteroneย system and the eye in diabetes
  118. Big renin and biosynthetic defect ofย Aldosteroneย in diabetes mellitus
  119. The state and responsiveness of the renin-angiotensin-Aldosteroneย system in patients with type II diabetes mellitus
  120. Aldosteroneย and type 2 diabetes mellitus
  121. Renin-angiotensin-Aldosteroneย system blockade is associated with higher risk of contrast-induced acute kidney injury in patients with diabetes
  122. Renin angiotensinย Aldosteroneย system blockade and renal disease in patients with type 2 diabetes: an Asian perspective from the RENAAL study
  123. Blocking the renin-angiotensin-Aldosteroneย system to prevent diabetes mellitus
  124. Aldosteroneย responsiveness in patients with diabetes mellitus
  125. miR-196b-5p-enriched extracellular vesicles from tubular epithelial cells mediatedย Aldosterone-induced renal fibrosis in mice with diabetes
  126. Renin-angiotensin-Aldosteroneย system in diabetes mellitus.
  127. Effect of reninโ€“angiotensinโ€“Aldosteroneย system blockade in adults with diabetes mellitus and advanced chronic kidney disease not on dialysis: a systematic review โ€ฆ
  128. Diabetes impairs the vascular effects ofย Aldosteroneย mediated by G protein-coupled estrogen receptor activation
  129. The renin-angiotensin-Aldosteroneย system is suppressed in adults with type 1 diabetes
  130. Determinants and changes associated withย Aldosteroneย breakthrough after angiotensin II receptor blockade in patients with type 2 diabetes with overt nephropathy
  131. Cardiacย Aldosteroneย overexpression prevents harmful effects of diabetes in the mouse heart by preserving capillary density
  132. The role of reninโ€“angiotensinโ€“Aldosteroneย systemโ€based therapy in diabetes prevention and cardiovascular and renal protection
  133. The role ofย Aldosteroneย in cardiovascular disease in people with diabetes andย hypertension: an update
  134. Aldosteroneย induces Vasoconstriction in Individuals with Type 2 Diabetes: Effect of Acute Antioxidant administration
  135. Reninโ€“angiotensinโ€“Aldosteroneย system genotypes and haplotypes affect the susceptibility to nephropathy in type 2 diabetes patients
  136. Higher screeningย Aldosteroneย to renin ratio in primary aldosteronism patients with diabetes mellitus
  137. Eplerenone reduces proteinuria in type II diabetes mellitus: implications forย Aldosteroneย involvement in the pathogenesis of renal dysfunction
  138. The tissue renin-angiotensin-Aldosteroneย system in diabetes mellitus
  139. Impact of aliskiren treatment on urinaryย Aldosteroneย levels in patients with type 2 diabetes and nephropathy: an AVOID substudy
  140. Genetic variant of the renin-angiotensin system and prevalence of type 2 diabetes mellitus: a modest but significant effect ofย Aldosteroneย synthase
  141. The study of reninโ€“angiotensinโ€“Aldosteroneย in experimental diabetes mellitus
  142. Renin-angiotensin-Aldosteroneย system, electrolyte homeostasis and blood pressure in alloxan diabetes.
  143. The role of the tissue renin-angiotensin-Aldosteroneย system in the development of metabolic syndrome, diabetes mellitus and itsvascular complications
  144. Serum potassium is a predictor of incident diabetes in African Americans with normalย Aldosterone: the Jackson Heart Study
  145. Renin angiotensinย Aldosteroneย system (RAAS) inhibitors in the prevention of early renal disease in diabetes
  146. Effect of renin-angiotensin-Aldosteroneย system inhibitors on all-cause mortality and major cardiovascular events in patients with diabetes: A meta-analysis focusing on โ€ฆ
  147. Renin angiotensinย Aldosteroneย system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL study
  148. Responsiveness of plasma renin andย Aldosteroneย in diabetes mellitus
  149. Glucose-induced hyperkalemia with normalย Aldosteroneย levels: Studies in a patient with diabetes mellitus
  150. โ€ฆ between urinary sodium excretion and serumย Aldosteroneย in patients with diabetes in the presence and absence of modifiers of the reninโ€“angiotensinโ€“Aldosteroneย โ€ฆ
  151. Low plasmaย Aldosteroneย despite normal plasma renin activity in uncomplicated type 1 diabetes mellitus: effects of RAAS stimulation
  152. Ongoing treatment with renin-angiotensin-Aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population
  153. Associations between glycaemic control and activation of the renin-angiotensin-Aldosteroneย system in participants with type 2 diabetes mellitus andย hypertension
  154. Individual variability in response to renin angiotensinย Aldosteroneย system inhibition predicts cardiovascular outcome in patients with type 2 diabetes: A primary care โ€ฆ
  155. Endocrinological aspects of proteinuria and podocytopathy in diabetes: role of theย Aldosterone/mineralocorticoid receptor system
  156. Decreases in renin andย Aldosteroneย secretion in alloxan diabetes: an effect of insulin deficiency
  157. The reninโ€Aldosteroneย axis in patients with diabetes insipidus
  158. Aldosteroneย receptor antagonism in patients with diabetes and chronic kidney disease: new promises and old problems
  159. Aldosterone-mediated apical targeting of ENaC subunits is blunted in rats with streptozotocin-induced diabetes mellitus
  160. The potential benefits ofย Aldosteroneย antagonism in Type 2 diabetes mellitus
  161. Renin-angiotensin-Aldosteroneย system blockade in diabetes: role of direct renin inhibitors
  162. Mechanistic and clinical aspects of renin-angiotensin-Aldosteroneย system blockade in the prevention of diabetes mellitus and cardiovascular disease
  163. Reduced plasmaย Aldosteroneย concentrations in randomly selected patients with insulinโ€dependent diabetes mellitus
  164. Increased integrated concentration of norepinephrine, epinephrine,ย Aldosterone, and growth hormone in patients with uncontrolled juvenile diabetes mellitus
  165. Effect of sodium glucose co-transporter-2 inhibition on theย Aldosterone/renin ratio in type 2 diabetes mellitus
  166. Changes ofย Aldosteroneย levels in patients with type 2 diabetes complicated by moderate to severe obstructive sleep apneaโ€“hypopnea syndrome before and after โ€ฆ
  167. Effects of SGLT2 Inhibitors on Renin-Aldosteroneย System for One Month and Six Months in Type 2 Diabetes
  168. Reninโ€“angiotensinโ€“Aldosteroneโ€“blockade is associated with decreased use of antidepressant therapy in patients with type 1 diabetes and diabetic nephropathy
  169. โ€ฆ of the antihypertensive and antialbuminuric response to higher doses of reninโ€“angiotensinโ€“Aldosteroneย system blockade in albuminuric hypertensive type 2 diabetes โ€ฆ
  170. Effect of acute hyperglycaemia on plasma potassium andย Aldosteroneย levels in type 2 (non-insulin-dependent) diabetes
  171. Atrial natriuretic peptide and renin-angiotensin-Aldosteroneย system in non-insulin-dependent diabetes mellitus.
  172. Dissociation of renin andย Aldosteroneย during dehydration: studies in a case of diabetes insipidus and adipsia
  173. Responsiveness of plasmaย Aldosteroneย to angiotensin II in patients with diabetes mellitus
  174. Aldosteroneย responses to angiotensin II, adrenocorticotropin, and potassium in chronic experimental diabetes mellitus in rats
  175. RU28318, anย Aldosteroneย antagonist, in combination with an ACE inhibitor and angiotensin receptor blocker attenuates cardiac dysfunction in diabetes
  176. Renin angiotensin-Aldosteroneย system (RAAS) blockers usage among type II diabetes mellitus patientsโ€”A Retrospective Study
  177. Add-on antihypertensive medications to angiotensin-Aldosteroneย system blockers in diabetes: a comparative effectiveness study
  178. Renin-Aldosteroneย responsiveness in uncomplicated juvenile-type diabetes mellitus
  179. Renin-Aldosteroneย axis in normoalbuminuric insulin-dependent diabetes mellitus patients with glomerular hyperfiltration
  180. โ€ฆ Renal Association clinical guidelines:ย hypertensionย management and renin-angiotensin-Aldosteroneย system blockade in patients with diabetes, nephropathy and/or โ€ฆ
  181. โ€ฆ of cilnidipine on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes mellitus: association with BNP andย Aldosteroneย โ€ฆ
  182. Blockade of the renin-angiotensin-Aldosteroneย system and renal protection in diabetes mellitus
  183. Reninโ€Angiotensinโ€Aldosteroneย System Blockers in Elderly Adults with Chronic Kidney Disease without Diabetes Mellitus or Proteinuria
  184. Altered relation of the renin-Aldosteroneย system and vasoactive peptides in type 2 diabetes: the KORA F4 study
  185. Renin-angiotensin-Aldosteroneย system antagonists and the prevention of type 2 diabetes mellitus
  186. Advanced glycation of high-density lipoprotein and the functionality ofย Aldosteroneย release in type 2 diabetes
  187. Renin angiotensinย Aldosteroneย system altered in resistantย hypertensionย in Sub-Saharan African diabetes patients without evidence of primary hyperaldosteronism
  188. Responsiveness of plasma 18-hydroxycorticosterone andย Aldosteroneย to angiotensin II or corticotropin in nonazotemic diabetes mellitus
  189. Production ofย Aldosteroneย in male rats with inherited diabetes insipidus (Brattleboro strain)
  190. โ€ฆ โ€“Aldosteroneย system before and during submaximal bicycle exercise in relation to circulatory catecholamines in patients with Type 1 (insulin-dependent) diabetes โ€ฆ
  191. THE RENINโ€Aldosteroneย SYSTEM IN NEPHROGENIC DIABETES INSIPIDUS AND THE INFLUENCE OF HYDROCHLOROTHIAZIDE AND INDOMETHACIN
  192. Recurrent hyperkalemic renal tubular acidosis and hyponatremia in diabetes mellitus due toย Aldosteroneย resistance
  193. Renin-Angiotensin-Aldosteroneย system inhibition in prevention of diabetes mellitus.
  194. P153 Modulation of renin-angiotensin-Aldosteroneย system reverses adverse left atrial remodelling in type 2 diabetes
  195. Renoprotective effects of reninโ€“angiotensinโ€“Aldosteroneย system blockers in type 2 diabetes: demystifying multiple treatment comparisons in a network meta-analysis
  196. Relationships between renin,ย Aldosterone, blood pressure and renal function in hypertensive insulin-dependent diabetes mellitus
  197. Aldosteroneย responsiveness to an acute potassium load in diabetes mellitus and chronic renal insufficiency
  198. Diabetes Mellitus and Risks of Dual Blockade of the Renin-angiotensin-Aldosteroneย System
  199. Effects of amiloride on oral glucose loading, serum potassium, renin, andย Aldosteroneย in dietโ€controlled diabetes
  200. Glomerular hyperfiltration in insulin-dependent diabetes mellitus: no evidence for enhanced activity of the renin-angiotensin-Aldosteroneย system
  201. Reninโ€“angiotensinโ€“Aldosteroneย system blockade and urinary albumin excretion in communityโ€based patients with Type 2 diabetes: The Fremantle Diabetes Study
  202. Genetic polymorphism of renin-angiotensin-Aldosteroneย system in type 2 diabetes and in combination with arterialย hypertensionย among Dagestan inhabitants
  203. The function ofย Aldosteroneย in patients with diabetes
  204. Renin-angiotensin-Aldosteroneย system in diabetes insipidus
  205. Diabetes insipidus after surgery of intracranial arterial aneurysmsโ€“with special reference to the human ADH andย Aldosteroneย secretion (authorโ€™s transl)
  206. โ€ฆ angiotensin converting enzyme (ACE) insertion/deletion andย Aldosteroneย synthase (CYP11B2)-344C/T polymorphisms in relation to type 2 diabetes mellitus risk in โ€ฆ
  207. The Role ofย Aldosteroneย in Diabetes-Related Vascular Disease: A New Therapeutic Target?
  208. Plasma renin andย Aldosteroneย in youngsters with insulin-dependent diabetes mellitus
  209. The efficacy and safety of dual blockage of the renin-angiotensin-Aldosteroneย system in patients with type 2 diabetes,ย hypertensionย andย obesityย without renal โ€ฆ
  210. Azelnidipine Decreased Plasmaย Aldosteroneย andPlasminogen Activator Inhibitor Type 1 Levelsin the Hypertensive Patients with Type 2 Diabetes Mellitusโ€•the Jikei โ€ฆ
  211. Relationship betweenย Aldosteroneย and diabetes mellitus and its chronic complications
  212. Correlation Betweenย Aldosteroneย and Gestational Diabetes Mellitus.
  213. Effects ofย Aldosterone, methylprednisolone and triiodothyronine on the response to water loading in the conscious hypothyroid rat with diabetes insipidus.
  214. Aldosteroneย excess: a rare non-nephrophathic cause ofย hypertensionย in type I diabetes.
  215. 538-P: Copeptin and Renin Angiotensinย Aldosteroneย System (RAAS) Activation in Long-Standing Type 1 Diabetes (T1D)
  216. The potential benefits ofย Aldosteroneย antagonism in Type 2 diabetes mellitus
  217. Mineralocorticoid receptor and diabetes: in favour of other corticosteroids thanย Aldosterone
  218. Aldosteroneย prevents deleterious effects of diabetes in mouse hearts
  219. The effect of rosiglitazone combined with insulin on plasmaย Aldosteroneย in diabetes patients
  220. Aldosteroneย and Protein Disulfide Isomerase Activity in Diabetes
  221. Aldosteroneย Prevents Deleterious Effects of Diabetes in Mouse Hearts by a Proangiogenic Effect
  222. hypertensionย management and renin-angiotensin-Aldosteroneย system blockade in patients with diabetes, nephropathy and/or chronic kidney disease
  223. โ€ฆ , May 15, 10: 00 AM-12.00 PM: Rationale forย Aldosteroneย receptor blockade in the treatment of cardiovascular diseases*:ย Aldosteroneย receptor antagonists in diabetes โ€ฆ
  224. Pancreatic Reninโ€Angiotensinโ€Aldosteroneย System in the Cardiometabolic Syndrome and Type 2 Diabetes Mellitus
  225. โ€ฆ of acid-releasing renal function of rats in the dynamics of experimental diabetes mellitus with underlying pharmacological blockade of renin-angiotensin-Aldosteroneย โ€ฆ
  226. Cardiovascular Complications in Diabetes: Role ofย Aldosteroneย and Mineralocorticoid Receptors
  227. Acuteย Aldosteroneย Administration Increases Vascular Resistance in Patients with Type 2 Diabetes
  228. The Increase of Plasmaย Aldosteroneย Concentrations Were Correlated with Insulin Resistance in Patients with Type 2 Diabetes Mellitus.
  229. Aldosteroneย antagonism in type 2 diabetes mellitusโ€”a new therapeutic approach to diabetic macrovascular disease?
  230. Nโ€Acetylcysteine Attenuatesย Aldosteroneย induced Vasoconstriction in Individuals with Type 2 Diabetes
  231. Relationship Between Circulatingย Aldosteroneย and Adipocytokines or Oxidative Stress in Patients With Type 2 Diabetes
  232. Renin Angiotensinย Aldosteroneย System (RAAS) Activation and Diabetic Nephropathy (DN) Resistor Status in Longstanding Type 1 Diabetes
  233. โ€ฆ Usage of Renin-Angiotensin-Aldosteroneย System Blocking Agents on Incidence of Contrast-Induced Nephropathy in Patients with Diabetes Mellitus and Renal โ€ฆ
  234. Comparison of the morphological changes in the capillaries and the state of the renin-angiotensin-Aldosteroneย system in diabetes mellitus
  235. RENIN-ANGIOTENSIN-Aldosteroneย SYSTEM IN DIABETES MELLITUS
  236. H003 Cardiacย Aldosteroneย overexpression prevents harmful effects of diabetes in mouse heart by preserving capillary density
  237. Correlation between insulin resistance and renin-angiotensin-Aldosteroneย system in newly diagnosed type 2 diabetes mellitus
  238. Plasma and Urinaryย Aldosteroneย Levels in Rats with Non-Insulin Dependent Diabetes Mellitus-Association with Myocardial Fibrosis
  239. The role of the renin-angiotensin-Aldosteroneย system blockade in preventing type 2 diabetes
  240. G Protein-coupled Estrogen Receptor Contributes To The Vascular Effects Ofย Aldosteroneย And Type Two Diabetes-associated Vascular Dysfunction
  241. Ednit effects on activity of renin-angiotensin-Aldosteroneย system and renal function in hypertensive subjects with diabetes mellitus
  242. Effects of atenolol add-on treatment on plasma renin activity (PRA) andย Aldosteroneย escape in hypertensive patients with diabetes receiving valsartan
  243. Are renin angiotensinย Aldosteroneย system gene polymorphisms risk factors forย hypertensionย and diabetes? A literature review report from Malaysia
  244. โ€ฆ ADHERENCE TO RENIN-ANGIOTENSIN-Aldosterone-SYSTEM (RAAS) INHIBITORS AND RENAL FUNCTION AMONG PATIENTS WITH TYPE 2 DIABETES: A โ€ฆ
  245. Orthostatic hypotension in complicated diabetes mellitus: study of the renin-angiotensin-Aldosteroneย system (authorโ€™s transl)
  246. Diabetes mellitus type-II relatedย hypertensionย and cardiovascular diseases: involvement of impaired regulatory renin-angiotensin-Aldosteroneย system
  247. Abstract P632: Nlrp3/inflammasome Activation Contributes Toย Aldosterone-induced Vascular Dysfunction In Type 2 Diabetes.
  248. โ€ฆ autonomousย Aldosteroneย secretion in patients with type 2 Diabetes Mellitus and arterialย hypertension. The effect of SGLT2 inhibitors on renin-angiotensin-Aldosteroneย โ€ฆ
  249. Effect of sodium depletion on the renin-angiotensin-Aldosteroneย system and prostaglandins in patients with insulin-dependent diabetes mellitus
  250. Impaired Sodium Excretion during Water Immersion in Diabetes Mellitus: Observations on the Renin-Aldosteroneย System
  251. Reninโ€angiotensinโ€Aldosteroneย system blockade ameliorates myocardial and ventricular function of rats with diabetes mellitus
  252. โ€ฆ Leads the Elevation of Plasmaย Aldosteroneย Concentration Independently withย obesity, Dyslipidemia, and Insulin Resistance in Patients with Type 2 Diabetes Mellitus
  253. Renin-Angiotensin-Aldosteroneย System of Local Organizations and Chronic Complications of Type 2 Diabetes
  254. Aldosterone, Not Leptin, is Correlated With High Sympathetic Activity in Resistantย hypertensionย With or Without Type 2 Diabetes
  255. โ€ฆ with angiotensin converting enzyme inhibitor andย Aldosteroneย antagonist on insulin sensitivity and serum leptin concentration in patients with type 2 diabetes โ€ฆ
  256. โ€ฆ NITRIC OXIDE SYNTHASE, ANGIOTENSINOGEN ANDย Aldosteroneย SYNTHASE GENE POLYMORPHISMS IN TYPE 2 DIABETES MELLITUS AND THEIR โ€ฆ
  258. The kidney in diabetes mellitus: urinary transfer in excretion,ย hypertension, the Renin-Angiotensin-Aldosteroneย system, and the role of angiotensin converting enzyme โ€ฆ
  259. PP. 09.11: ASSOCIATION OF PLASMAย Aldosteroneย CONCENTRATION WITH PREVALENCE OF DIABETES MELLITUS IN SUSPECTED PRIMARY โ€ฆ
  260. CMS and Type 2 Diabetes Mellitus: Bound Together by the Renin Angiotensinย Aldosteroneย System
  261. โ€ฆ irbesartan, and perindopril plus irbesartan on blood pressure, renal hemodynamics, proteinuria, renin angiotesin-Aldosteroneย system, and TGF-B1, in type 2 diabetes โ€ฆ
  262. A Nox4 Inhibitor, GKT 137831, Decreasesย Aldosteroneย Synthesis, Adiposity and Vascular Contractility in a Murine Model of Diabetes.
  263. Effect of 5-month guanfacine treatment on the renin-angiotensin-Aldosteroneย system and some metabolic factors in patients with diabetes mellitus type II and โ€ฆ
  264. S-423 Plasmaย Aldosteroneย level and its metabolic implications in patients with type 2 diabetes
  265. โ€ฆ CILNIDIPINE ON SYMPATHETIC NERVOUS SYSTEM AND PLASMAย Aldosteroneย CONCENTRATION IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES โ€ฆ
  266. โ€ฆ OF THE RENIN-ANGIOTENSIN SYSTEM AND PREVALENCE OF TYPE 2 DIABETES MELLITUS. A MODEST BUT SIGNIFICANT EFFECT OFย Aldosteroneย โ€ฆ
  267. Aldosteroneย and arterialย hypertension
  268. Mechanisms ofย hypertension: the expanding role ofย Aldosterone
  269. Serumย Aldosteroneย and the incidence ofย hypertensionย in nonhypertensive persons
  270. Structural analysis and evaluation of theย Aldosteroneย synthase gene inย hypertension
  271. Genetic determination of plasmaย Aldosteroneย levels in essentialย hypertension
  272. Essentialย hypertension: renin andย Aldosterone, heart attack and stroke
  273. Role ofย Aldosteroneย in left ventricular hypertrophy inย hypertension
  274. hypertension: reninโ€“angiotensinโ€“Aldosteroneย system alterations
  275. Narrative review: the emerging clinical implications of the role ofย Aldosteroneย in the metabolic syndrome and resistantย hypertension
  276. Aldosterone-receptor antagonism inย hypertension
  277. Global-and renal-specific sympathoinhibition inย Aldosteroneย hypertension
  278. Aldosterone,ย hypertension, and cardiovascular disease: an endless story
  279. Saline suppression of plasmaย Aldosteroneย inย hypertension
  280. Plasmaย Aldosteroneย is related to severity of obstructive sleep apnea in subjects with resistantย hypertension
  281. Aldosterone: role in the cardiometabolic syndrome and resistantย hypertension
  282. The renin-angiotensin-Aldosteroneย system: a specific target forย hypertensionย management
  283. Vasoconstriction-volume analysis for understanding and treatingย hypertension: the use of renin andย Aldosteroneย profiles
  284. ICV infusion of corticosterone antagonizes ICV-Aldosteroneย hypertension
  285. hypertension, increasedย Aldosteroneย secretion and low plasma renin activity relieved by dexamethasone
  286. Aldosteroneย Excretion Rate and Blood Pressure in Essentialย hypertensionย Are Related to Polymorphic Differences in theย Aldosteroneย Synthase Gene CYP11B2
  287. Resistantย hypertension, obstructive sleep apnoea andย Aldosterone
  288. Aldosteroneย and the risk ofย hypertension
  289. Somatic mutations in ATP1A1 and ATP2B3 lead toย Aldosterone-producing adenomas and secondaryย hypertension
  290. Aldosterone-to-renin ratio, arterial stiffness, and the response toย Aldosteroneย antagonism in essentialย hypertension
  291. Intracerebroventricular infusion ofย Aldosteroneย inducesย hypertensionย in rats
  292. Aldosterone: role in edematous disorders,ย hypertension, chronic renal failure, and metabolic syndrome
  293. Aldosteroneย and the vasculature: mechanisms mediating resistantย hypertension
  294. Association between increased plasma levels ofย Aldosteroneย and decreased systemic arterial compliance in subjects with essentialย hypertension
  295. Aldosteroneย excretion among subjects with resistantย hypertensionย and symptoms of sleep apnea
  296. Aldosterone, inflammation, immune system, andย hypertension
  297. Characterization of resistantย hypertension: association between resistantย hypertension,ย Aldosterone, and persistent intravascular volume expansion
  298. Severity of obstructive sleep apnea is related toย Aldosteroneย status in subjects with resistantย hypertension
  299. Central interactions ofย Aldosteroneย and angiotensin II inย Aldosterone-and angiotensin II-inducedย hypertension
  300. Eplerenone, a selectiveย Aldosteroneย blocker, in mild-to-moderateย hypertension
  301. A chimaeric llฮฒ-hydroxylase/Aldosteroneย synthase gene causes glucocorticoid-remediable aldosteronism and humanย hypertension
  302. Influence of arterial blood pressure andย Aldosteroneย on left ventricular hypertrophy in moderate essentialย hypertension
  303. Association of the Cโˆ’ 344Tย Aldosteroneย synthase gene variant with essentialย hypertension: a meta-analysis
  304. Increased cardiac types I and III collagen mRNAs inย Aldosterone-saltย hypertension.
  305. A new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-Aldosteroneย hypertension
  306. Hereditaryย hypertensionย caused by chimaeric gene duplications and ectopic expression ofย Aldosteroneย synthase
  307. Arterial pressure, left ventricular mass, andย Aldosteroneย in essentialย hypertension
  308. Vascular complications in patients withย Aldosteroneย producing adenoma in Japan: comparative study with essentialย hypertension
  309. Effects of the selectiveย Aldosteroneย blocker eplerenone versus the calcium antagonist amlodipine in systolicย hypertension
  310. Aldosteroneย is produced from ventricles in patients with essentialย hypertension
  311. Aldosteroneย antagonists inย hypertensionย and heart failure.
  312. Aldosteroneย antagonist improves diastolic function in essentialย hypertension
  313. Molecular basis of salt sensitivity in humanย hypertension: evaluation of renin-angiotensin-Aldosteroneย system gene polymorphisms
  314. Aldosteroneย secretion and primary and malignantย hypertension
  315. Experimentalย Aldosteroneย hypertensionย in the dog.
  316. Intracerebroventricular infusion of RU28318 blocksย Aldosterone-saltย hypertension
  317. Influence of antihypertensive medication onย Aldosteroneย and renin concentration in the differential diagnosis of essentialย hypertensionย and primary aldosteronism
  318. Variation at theย Aldosteroneย synthase (CYP11B2) locus contributes toย hypertensionย in subjects with a raisedย Aldosterone-to-renin ratio
  319. Renin-Aldosteroneย Relationships in Pregnancy-Inducedย hypertension: An Alternative Viewpoint
  320. Molecular genetics of the renin-angiotensin-Aldosteroneย system in humanย hypertension.
  321. Comparison of surgery and prolonged spironolactone therapy in patients withย hypertension,ย Aldosteroneย excess, and low plasma renin
  322. hypertensionย and severe hyperkalaemia associated with suppression of renin andย Aldosteroneย and completely reversed by dietary sodium restriction
  323. Genetic variants in the epithelial sodium channel in relation toย Aldosteroneย and potassium excretion and risk forย hypertension
  324. Plasma renin activity and angiotensin I andย Aldosteroneย concentrations in cats withย hypertensionย associated with chronic renal disease.
  325. hypertensionย and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-Aldosteroneย systems.
  326. Myocardial ultrasonic backscatter inย hypertension: relation toย Aldosteroneย and endothelin
  327. Immunoreactive endogenous ouabain in primary aldosteronism and essentialย hypertension: relationship with plasma renin,ย Aldosteroneย and blood pressure levels.
  328. Brain sodium channels and ouabainlike compounds mediate centralย Aldosterone-inducedย hypertension
  329. โ€ฆ of congestive heart failure: vasopressin,ย Aldosterone, and angiotensin II: further evidence for renal-adrenal interaction from studies inย hypertensionย and in cirrhosis
  330. โ€ฆ -responsiveย Aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essentialย hypertension.
  331. Investigation of the role ofย Aldosteroneย inย hypertensionย associated with spontaneous pituitaryโ€dependent hyperadrenocorticism in dogs
  332. Ratio of serumย Aldosteroneย to plasma renin concentration in essentialย hypertensionย and primary aldosteronism
  333. Assessment of the novel selectiveย Aldosteroneย blocker eplerenone using ambulatory and clinical blood pressure in patients with systemicย hypertension
  334. Genetic polymorphism of the reninโ€“angiotensinโ€“Aldosteroneย system and arterialย hypertensionย in the Italian population: the GENIPER Project
  335. Long-term safety and efficacy of the selectiveย Aldosteroneย blocker eplerenone in patients with essentialย hypertension
  336. Haplotype analysis ofย Aldosteroneย synthase gene (CYP11B2) polymorphisms shows association with essentialย hypertension
  337. Can the genetic factors influence the treatment of systemicย hypertension? The case of the renin-angiotensin-Aldosteroneย system
  338. Incidence of primary aldosteronism uncomplicated essentialย hypertension: a prospective study with elevatedย Aldosteroneย secretion and suppressed plasma renin โ€ฆ
  339. Non-genomic actions ofย Aldosterone: role inย hypertension
  340. Aldosterone-producing adenoma withoutย hypertension: a report of two cases
  341. The control ofย Aldosteroneย secretion in normal and hypertensive man: abnormal renin-Aldosteroneย patterns in low reninย hypertension
  342. Relation of renin, angiotensin II, and experimental renalย hypertensionย toย Aldosteroneย secretion
  343. Aldosteroneย receptor antagonism normalizes vascular function in liquorice-inducedย hypertension
  344. An abnormal sodium metabolism in Japanese patients with essentialย hypertension, judged by serum sodium distribution, renal function and the renin-Aldosteroneย โ€ฆ
  345. Left ventricular mass and geometry before and after etiologic treatment in renovascularย hypertension,ย Aldosterone-producing adenoma, and pheochromocytoma
  346. Age versus urinary sodium for judging renin,ย Aldosterone, and catecholamine levels: studies in normal subjects and patients with essentialย hypertension
  347. Systemicย hypertensionย after cardiac transplantation: effect of cyclosporine on the renin-angiotensin-Aldosteroneย system
  348. Angiotensin,ย Aldosteroneย and human arterialย hypertension
  349. Isย Aldosteroneย the missing link in refractoryย hypertension?:ย Aldosterone-to-renin ratio as a marker of inappropriateย Aldosteroneย activity
  350. Effect of chronic diuretic treatment on the plasma reninโ€angiotensinโ€Aldosteroneย system in essentialย hypertension.
  351. > VI. RENIN,ย Aldosterone, ANDย hypertension: The Intercurrentย hypertensionย of Primary Aldosteronism
  352. Contrasting associations betweenย Aldosteroneย synthase gene polymorphisms and essentialย hypertensionย in blacks and in whites
  353. Renin andย Aldosteroneย levels andย hypertensionย following envenomation in humans by the yellow scorpion Leiurus quinquestriatus
  354. Importance of the renin-angiotensin-Aldosteroneย system (RAS) in the physiology and pathology ofย hypertension
  355. Plasmaย Aldosteroneย response to ACTH in primary aldosteronism and in patients with low reninย hypertension
  356. Plasmaย Aldosterone-renin interrelationships in various forms of essentialย hypertension: studies using a rapid assay of plasmaย Aldosterone
  357. Production of experimentalย hypertensionย byย Aldosterone
  358. hypertensionย and hypersalimentation. 1.ย Aldosteroneย hypertension.
  359. Renin,ย Aldosterone, body fluid volumes, and the baroreceptor reflex in the development and reversal of Goldblattย hypertensionย in conscious dogs
  360. Familial hyperpotassemia andย hypertensionย accompanied by normal plasmaย Aldosteroneย levels: possible hereditary cell membrane defect
  361. Renin-angiotensin-Aldosteroneย system gene polymorphisms andย hypertensionย in Hong Kong Chinese
  362. Abnormally sustainedย Aldosteroneย secretion during salt loading in patients with various forms of benignย hypertension; relation to plasma renin activity
  363. Essentialย hypertensionย andย Aldosterone
  364. โ€ฆ ofย Aldosteroneย in man: Evidence for regulation of electrolyte balance and arterial pressure by a renal-adrenal system which may be involved in malignantย hypertension
  365. Serumย Aldosteroneย level in patients withย hypertensionย during treatment by acupuncture
  366. VI. RENIN,ย Aldosterone, ANDย hypertension: The Relationship Between Plasma Renin andย Aldosteroneย in Normal Man
  367. Aldosteroneย metabolites and possibleย Aldosteroneย precursors inย hypertension
  368. Aldosteroneย synthase (CYP11B2)โˆ’ 344 C/T polymorphism is associated with left ventricular structure in human arterialย hypertension
  369. Influence of plasmaย Aldosteroneย on left ventricular geometry and diastolic function in treated essentialย hypertension
  370. Effect of fructose-inducedย hypertensionย on the renin-angiotensin-Aldosteroneย system and atrial natriuretic factor
  371. Further studies on urinaryย Aldosteroneย in human arterialย hypertension.
  372. The cardiac structure-function relationship and the renin-angiotensin-Aldosteroneย system inย hypertensionย and heart failure
  373. Impact of renin-angiotensin-Aldosteroneย system gene variants on the severity ofย hypertensionย in patients with newly diagnosedย hypertension
  374. Effect of thiazide diuretics on plasma volume, body electrolytes, and excretion ofย Aldosteroneย inย hypertension
  375. Familial hyperkalemia,ย hypertension, and hyporeninemia with normalย Aldosteroneย levels: A tubular defect in potassium handling
  376. Effects of amlodipine on urinary sodium excretion, renin-angiotensin-Aldosteroneย system, atrial natriuretic peptide and blood pressure in essentialย hypertension.
  377. Eplerenone: a selectiveย Aldosteroneย receptor antagonist forย hypertensionย and heart failure.
  378. Disparate patterns ofย Aldosteroneย response during diuretic treatment ofย hypertension
  379. Effect of atrial natriuretic factor on blood pressure, renin, andย Aldosteroneย in Goldblattย hypertension.
  380. Results of adrenal surgery in patients withย hypertension,ย Aldosteroneย excess, and low plasma renin concentration.
  381. Alterations inย Aldosteroneย secretion and metabolism in low reninย hypertension
  382. Regulation of cardiac output duringย Aldosterone-inducedย hypertension.
  383. Renin-Aldosteroneย profiling inย hypertension
  384. Aldosteroneย studies in obese patients withย hypertension
  385. Left ventricular hypertrophy in asymptomatic essentialย hypertension: its relationship withย Aldosteroneย and the increase in sodium-proton exchanger activity.
  386. Reversal of cardiovascular structural changes when treating essentialย hypertension: the importance of the renin-angiotensin-Aldosteroneย system
  387. Combining renin-angiotensin-Aldosteroneย system blockade with diuretic therapy for treatment ofย hypertension
  388. Functional derangements in the regulation ofย Aldosteroneย secretion inย hypertension.
  389. Role of renin-angiotensin-Aldosteroneย system in salt-sensitiveย hypertensionย induced by sensory denervation
  390. Endothelin receptor blockade lowers plasmaย Aldosteroneย levels via different mechanisms in primary aldosteronism and high-to-normal reninย hypertension
  391. Aldosteroneย and specificย Aldosteroneย receptor antagonists inย hypertensionย and cardiovascular disease
  392. Possible mechanism of action forย Aldosterone-inducedย hypertension
  393. Aldosteroneย antagonists in the treatment ofย hypertensionย and target organ damage
  394. Effect of nifedipine on plasma renin,ย Aldosteroneย and catecholamines in arterialย hypertension
  395. Enhancedย Aldosteroneย response to angiotensin II in humanย hypertension.
  396. Aldosteroneย and renin in essentialย hypertension.
  397. Role of theย Aldosteroneย system in the salt-sensitivity of patients with benign essentialย hypertension
  398. Symptoms and the distress they cause: comparison of anย Aldosteroneย antagonist and a calcium channel blocking agent in patients with systolicย hypertension
  399. Renin-angiotensin-Aldosteroneย andย hypertension
  400. Electrolyte metabolism andย Aldosteroneย secretion in benign and malignantย hypertension
  401. Alterations of calcium, magnesium, and zinc in essentialย hypertension: their relation to the renin-angiotensin-Aldosteroneย system
  402. Aldosteroneย excretion in essentialย hypertension
  403. Calcium metabolism and the renin-Aldosteroneย system in essentialย hypertension.
  404. Does the renin-angiotensin-Aldosteroneย system modify cardiac structure and function in essentialย hypertension?
  405. The steroid content of adrenal adenomas and measurements ofย Aldosteroneย production in patients with essentialย hypertensionย and primary aldosteronism
  406. The role ofย Aldosteroneย in the development ofย hypertensionย in spontaneously hypertensive rats
  407. Malignantย hypertensionย due to anย Aldosteroneย producing adrenal adenoma
  408. Effect of corticotropin onย Aldosteroneย excretion and plasma renin in normal subjects, in essentialย hypertensionย and in primary aldosteronism
  409. Role of renin andย Aldosteroneย inย hypertensionย due to a renin-secreting tumor
  410. Studies onย Aldosterone: II.ย hypertensionย as a cumulative effect ofย Aldosteroneย administration
  411. Unexpected pressor responses to propranolol in essentialย hypertension: an interaction between renin,ย Aldosteroneย and sympathetic activity
  412. Low-renin, low-Aldosteroneย hypertensionย and abnormal cortisol metabolism in a 19-month-old child
  413. The role of the renin-angiotensin-Aldosteroneย system in circulatory control andย hypertension.
  414. Regression of left ventricular hypertrophy in patients withย hypertension: blockade of the renin-angiotensin-Aldosteroneย system
  415. Influence of sodium intake on hydrochlorothiazideโ€induced changes in blood pressure, serum electrolytes, renin andย Aldosteroneย in essentialย hypertension
  416. Malignantย hypertension: effect of therapy on renin andย Aldosterone
  417. Role ofย Aldosteroneย in angiotensin II-inducedย hypertensionย in rats
  418. Effects of losartan on the renin-angiotensin-Aldosteroneย axis in essentialย hypertension.
  419. The influence of a heparin-like compound onย hypertension, electrolytes andย Aldosteroneย in man
  420. hypertensionย withย Aldosteroneย excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour
  421. Renin-angiotensin-Aldosteroneย system and G-protein beta-3 subunit gene polymorphisms in salt-sensitive essentialย hypertension
  422. Aldosteroneย diagnosis inย hypertension: comparative evaluation of radioimmunoassays for urinaryย Aldosteroneย and 18-OH-corticosterone
  423. Reninโ€“Angiotensinโ€“Aldosteroneย System Loci and Multilocus Interactions in Youngโ€Onset Essentialย hypertension
  424. Effects of glucocorticoid administration onย Aldosteroneย excretion and plasma renin in normal subjects, in essentialย hypertensionย and in primary aldosteronism
  425. hypertensionย corrected andย Aldosteroneย responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible โ€ฆ
  426. Serumย Aldosteroneย changes during hyperinsulinemia are correlated to body mass index and insulin sensitivity in patients with essentialย hypertension
  427. Renin,ย Aldosterone, sodium andย hypertension
  428. Molecular variants in the P450c11AS gene as determinants ofย Aldosteroneย synthase activity in the Dahl rat model ofย hypertension
  429. Gene polymorphisms of the renin-angiotensin-Aldosteroneย system and essential arterialย hypertensionย in childhood.
  430. Abnormal responsiveness of the reninย Aldosteroneย system to acute stimulation in patients with essentialย hypertension
  431. hypertensionย induced by oral contraceptives containing estrogen and gestagen: effects on plasma renin activity andย Aldosteroneย excretion
  432. Aldosteroneย secretion inย hypertension
  433. Effects of biobehaviorally-assisted relaxation training on blood pressure, plasma renin, cortisol, andย Aldosteroneย levels in borderline essentialย hypertension.
  434. Renin-angiotensin-Aldosteroneย system for blood pressure and electrolyte homeostasis and its involvement inย hypertension, in congestive heart failure and in โ€ฆ
  435. A decreased metabolic clearance rate ofย Aldosteroneย in benign essentialย hypertension
  436. Plasma renin activity and plasmaย Aldosteroneย concentrations in untreated Nigerians with essentialย hypertension.
  437. Adrenal sensitivity to angiotensin II and undiscoveredย Aldosteroneย stimulating factors inย hypertension
  438. Renin-angiotensin-Aldosteroneย system and sodium balance in experimental renalย hypertension
  439. Interaction betweenย Aldosteroneย secretion, sodium and potassium balance, and angiotensin activity in man: studies inย hypertensionย and cirrhosis
  440. Coronary microvascular fluid flux and permeability: influence of angiotensin II,ย Aldosterone, and acute arterialย hypertension
  441. Sodium sensitivity in essentialย hypertension: role of the renin-angiotensin-Aldosteroneย system and predictive value of an intravenous frusemide test.
  442. Altered renin-angiotensin-Aldosteroneย relationships in normal renin essentialย hypertension.
  443. Maternalย hypertensionย and progeny blood pressure: role ofย Aldosteroneย and 11ฮฒ-HSD
  444. Dysregulation ofย Aldosteroneย secretion and its relationship to the pathogenesis of essentialย hypertension
  445. Artificial mutations in P450c11AS (Aldosteroneย synthase) can increase enzymatic activity: a model for low-reninย hypertension?
  446. Estrogens andย hypertension: effect of discontinuing estrogens on blood pressure, exchangeable sodium, and the renin-Aldosteroneย system
  447. Systemic systolicย hypertensionย in the elderly: correlation of hemodynamics, plasma volume, renin,ย Aldosterone, urinary metanephrines and response to thiazide โ€ฆ
  448. Renin-angiotensin-Aldosteroneย system during chronic thiazide therapy of benignย hypertension
  449. Angiotensin andย Aldosteroneย in renovascularย hypertension
  450. Studies of the renin-angiotensin-Aldosteroneย system in patients withย hypertensionย and in normal subjects
  451. Metabolic cardiovascular risk factors and the renin-Aldosteroneย system in essentialย hypertension.
  452. Acromegaly andย hypertension: prevalence and relationship to the renin-angiotensin-Aldosteroneย system
  453. Effects of angiotensin infusions onย Aldosteroneย and electrolyte excretion in normal subjects and patients withย hypertensionย and adrenocortical disorders
  454. Response ofย Aldosteroneย and 18-hydroxycorticosterone to angiotensin II in normal subjects and patients with essentialย hypertension, Connโ€™s syndrome, and โ€ฆ
  455. Contribution of endothelin-1 to renal activator protein-1 activation and macrophage infiltration inย Aldosterone-inducedย hypertension
  456. Calcium sensitivity of isometric force in intact and chemically skinned aortas during the development ofย Aldosterone-saltย hypertensionย in the rat.
  457. Effect of posture on the plasma concentrations ofย Aldosteroneย inย hypertensionย and primary hyperaldosteronism
  458. Alteredย Aldosteroneย response to salt intake and angiotensin II infusion in young normotensive men with parental history of arterialย hypertension
  459. Aldosteroneย receptor antagonists forย hypertension
  460. โ€ฆ of angiotensin converting enzyme inhibitors in essential and renalย hypertension: effects of captopril and enalapril on renin-angiotensin-Aldosterone, renal function and โ€ฆ
  461. The role of ACTH in the episodic release ofย Aldosteroneย in patients with idiopathic adrenal hyperplasia,ย hypertension, and hyperaldosteronism
  462. Low renin,โ€œnormalโ€ย Aldosteroneย andย hypertension: Circadian rhythm of renin,ย Aldosterone, Cortisol and growth hormone
  463. Vascular responsiveness in rats resistant toย Aldosterone-saltย hypertension.
  464. hypertensionย withย Aldosteroneย excess.
  465. Acute effects of the calcium antagonist, nifedipine, on blood pressure, pulse rate, and the renin-angiotensin-Aldosteroneย system in patients with essentialย hypertension
  466. The promise of selectiveย Aldosteroneย receptor antagonists for the treatment ofย hypertensionย and congestive heart failure
  467. Long-term effects of irbesartan and atenolol on the renin-angiotensin-Aldosteroneย system in human primaryย hypertension: the Swedish Irbesartan Left Ventricular โ€ฆ
  468. hypertensionย caused by anย Aldosterone-secreting adenoma: occurrence in a 7-year-old child
  469. A delayed suppression of the renin-Aldosteroneย axis following saline infusion in humanย hypertension.
  470. The effect of low and high sodium diets on plasma atrial natriuretic factor, the reninโ€Aldosteroneย system and blood pressure in subjects with essentialย hypertension
  471. Renin-angiotensin-Aldosteroneย system in pregnancy-inducedย hypertension
  472. Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasmaย Aldosteroneย in essentialย hypertension
  473. Plasma renin activity (PRA) andย Aldosteroneย (PA) in patients with chronic glomerulonephritis (GN) andย hypertension.
  474. The reninโ€”angiotensinโ€”Aldosteroneย system and carotid artery disease in mild-to-moderate primaryย hypertension
  475. Renin-angiotensin-Aldosteroneย system, RR interval, and blood pressure variability during postural changes in borderline arterialย hypertension
  476. Adenovirus-mediated human prostasin gene delivery is linked to increasedย Aldosteroneย production andย hypertensionย in rats
  477. Aldosteroneย and corticosterone secretion rates in rats with experimental renalย hypertension
  478. Aldosteroneย in sustained essentialย hypertension
  479. Rhythm characteristics of plasma renin,ย Aldosteroneย and cortisol in five subtypes of mesor-hypertension
  480. Triamterene-Induced Changes inย Aldosteroneย and Renin Values in Essentialย hypertension: Evidence of a Role forย Aldosteroneย in Preventing Blood Pressure โ€ฆ
  481. Renin andย Aldosteroneย in essentialย hypertension
  482. Aldosteroneย and electrolyte balance in humanย hypertension
  483. Quadric analysis in the preoperative distinction between patients with and without adrenocortical tumors inย hypertensionย withย Aldosteroneย excess and low plasma โ€ฆ
  484. Body fluid volumes and the response of renin andย Aldosteroneย to shortโ€and longโ€term thiazide therapy of essentialย hypertension
  485. Aldosterone, the adrenal cortex, andย hypertension
  486. hypertensionย andย Aldosteroneย overproduction without renin suppression in Cushingโ€™s syndrome from an adrenal adenoma
  487. Circadian changes in plasma renin activity and plasmaย Aldosteroneย concentration in two-kidneyย hypertensionย rats.
  488. Aldosterone-related genetic effects inย hypertension
  489. Heritable abnormalities of the renin-angiotensin-Aldosteroneย system in essentialย hypertension.
  490. โ€ฆย hypertensionย with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinaryย Aldosteroneย โ€ฆ
  491. Regulation ofย Aldosteroneย receptors inย hypertension
  492. Plasma Renin Activity and in vitro Synthesis ofย Aldosteroneย by the Adrenal Glands of Rats with Spontaneous, Renal, or Pinealectomyโ€Inducedย hypertension
  493. Use of the converting enzyme inhibitor enalapril in renovascularย hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-Aldosteroneย system.
  494. Influence ofย Aldosteroneย vs endothelin receptor antagonism on renovascular function in liquoriceโ€inducedย hypertension
  495. Controlled study of circadian rhythm of blood pressure in patients withย Aldosterone-producing adenoma compared with those with essentialย hypertension
  496. Different regulation of cardiac and renal corticosteroid receptors inย Aldosterone-salt treated rats: effect ofย hypertensionย and glucocorticoids
  497. Theย Aldosteroneย to renin ratio in secondaryย hypertension
  498. Plasma deoxycorticosterone andย Aldosteroneย in essentialย hypertension
  499. Urinaryย Aldosteroneย andย hypertension
  500. Changes in the renin-angiotensin-Aldosteroneย system and in sodium and potassium balance during development of renalย hypertensionย in rats
  501. Experimentalย Aldosteroneย hypertensionย in the rat
  502. The renin-angiotensin-Aldosteroneย system: focus on its distinct role in arterialย hypertensionย and its various inhibitors as a therapeutic strategy to effectively lower blood โ€ฆ
  503. Activity of renin-angiotensin-Aldosteroneย system (RAAS) and vasopressin level in patients with primary pulmonaryย hypertension
  504. โ€ฆ evidence on blocking the reninโ€“angiotensinโ€“Aldosteroneย system in cardiovascular disease and the long-term treatment ofย hypertension: data from recent โ€ฆ
  505. Aldosteroneย metabolic clearance is normal in low-renin essentialย hypertension
  506. Role ofย Aldosteroneย in the pathogenesis ofย hypertension
  507. Development ofย hypertensionย in rats treated withย Aldosteroneย acetate
  508. Bluntedย Aldosteroneย responsiveness to angiotensin II in normotensive subjects with familial predisposition to essentialย hypertension.
  509. Relation between plasma renin activity, angiotensin, andย Aldosteroneย and blood pressure in mild untreatedย hypertension.
  510. In vivo left ventricular function and collagen expression inย Aldosterone/salt-inducedย hypertension
  511. Effects of long-term enalapril and losartan therapy ofย hypertensionย on cardiovascularย Aldosterone
  512. Unilateral Page kidneyย hypertensionย in man: Studies of the renin-angiotensin-Aldosteroneย system before and after nephrectomy
  513. Captopril inย hypertensionย with renal artery stenosis and in intractableย hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I โ€ฆ
  514. โ€ฆ and calcium channel-blocking drugs on plasmaย Aldosteroneย responses to infusion of angiotensin II in normal subjects and patients with essentialย hypertension
  515. hypertensionย and hypokalemic alkalosis associated with underproduction ofย Aldosterone
  516. Perspectives on the renin-angiotensin-Aldosteroneย system inย hypertension
  517. Aldosteroneย suppression with dopamine infusion in low-reninย hypertension.
  518. Dissociation of plasma renin activity andย Aldosteroneย in essentialย hypertension
  519. The relationship ofย Aldosteroneย synthase gene polymorphism withย hypertensionย and left ventricular hypertrophy
  520. Plasma immunoreactive gamma melanotropin in patients with idiopathic hyperaldosteronism,ย Aldosterone-producing adenomas, and essentialย hypertension.
  521. Modifications of myocardial Na+,K+-ATPase isoforms and Na+/Ca2+ exchanger inย Aldosterone/salt-inducedย hypertensionย in guinea pigs
  522. Nomograms relatingย Aldosteroneย excretion to urinary sodium and potassium in the pediatric population: Their application to the study of childhoodย hypertension
  523. Characteristics of adrenal-regeneration andย Aldosteroneย hypertension.
  524. Reninโ€“angiotensinโ€“Aldosteroneย system polymorphisms and essentialย hypertension: where are we?
  525. Failure of chronicย Aldosteroneย infusion to increase arterial pressure in dogs with angiotensin-inducedย hypertension.
  526. Renin-angiotensin-Aldosteroneย system in experimental renalย hypertensionย in the rabbit
  527. Relationship of plasma renin activity andย Aldosteroneย levels with hemodynamic functions in essentialย hypertension
  528. The renin-Aldosteroneย system in pre-eclampsia, essential and transientย hypertensionย during pregnancy, and normotensive pregnant and non-pregnant control โ€ฆ
  529. Acute effects of captopril on cardiopulmonary hemodynamics and renin-angiotensin-Aldosteroneย and bradykinin profile inย hypertension
  530. A study of urinary and intracellular sodium and potassium, renin,ย Aldosterone, andย hypertensionย in blacks and Indians in Natal
  531. Dynamicย Aldosteroneย and 18-hydroxydeoxycorticosterone studies in labile and stable benign essentialย hypertension
  532. Opposite associations of circulatingย Aldosteroneย and atrial natriuretic peptide with left ventricular diastolic function in essentialย hypertension
  533. Catecholamines and the renin-angiotensin-Aldosteroneย system during treatment with felodipine ER or hydrochlorothiazide in essentialย hypertension.
  534. Urinaryย Aldosteroneย andย hypertension
  535. Effect of blood pressure angiotensin II andย Aldosteroneย concentrations during treatment of severeย hypertensionย with intravenous labetalol: comparison with โ€ฆ
  536. The Role of Urinary PGE2 and Renin-Angiotensin-Aldosteroneย System in the Pathogenesis of Essentialย hypertension
  537. Dissociation in the excretion of differentย Aldosteroneย metabolites and unmetabolized (โ€˜freeโ€™)ย Aldosteroneย inย hypertension
  538. The Yucatan miniature swine: an improved pig model for the study of desoxycorticosterone-acetate (DOCA) andย Aldosteroneย hypertension
  539. Relationship between plasmaย Aldosteroneย concentration and plasma potassium in patients with essentialย hypertensionย during alprenolol treatment
  540. hypertensionย with inappropriateย Aldosteroneย stimulation: a syndrome
  541. The integrated concentration of plasma renin activity andย Aldosteroneย in essentialย hypertension.
  542. Reducedย Aldosteroneย metabolites inย hypertension
  543. Relations between renin,ย Aldosteroneย and experimentalย hypertensionย in rats
  544. The gerontological decline of the renin-Aldosteroneย system: a chronobiological approach extended to essentialย hypertension
  545. Circulatory volume in essentialย hypertension. Relationships with age, blood pressure, exchangeable sodium, renin,ย Aldosteroneย and catecholamines.
  546. Abnormal urinary kallikrein inย hypertensionย is not related toย Aldosteroneย or plasma renin activity.
  547. Shortโ€term effects of atenolol and nifedipine on atrial natriuretic peptide, plasma renin activity, and plasmaย Aldosteroneย in patients with essentialย hypertension
  548. โ€ฆ Renin Activity Ratio in Hypertensive Patients with Increases of 11-Deoxycorticosterone and 18-Hydroxy-ll-Deoxycorticosterone: A Subtype of Essentialย hypertension?
  549. Renal function, body fluid volumes, renin,ย Aldosterone, and noradrenaline during treatment ofย hypertensionย with pindolol.
  550. The adrenal cortex andย hypertension: some observations on a possible role for mineralocorticoids other thanย Aldosterone
  551. Suppression of plasma renin andย Aldosteroneย in stress-saltย hypertensionย in dogs
  552. Suppression of the Reninโ€”Aldosteroneย System in Mild Essentialย hypertension
  553. Response of plasmaย Aldosteroneย to fludrocortisone in primary hyperaldosteronism and other forms ofย hypertension
  554. Dopaminergic regulation of circadian rhythms of blood pressure, renin andย Aldosteroneย in essentialย hypertension
  555. The prevalence ofย hypertensionย in an unselected population, and the frequency of abnormalities of potassium, angiotensin II andย Aldosteroneย in hypertensive subjects
  556. Antihypertensive andย Aldosterone-lowering effects of synthetic atrial natriuretic factor in renin-dependent renovascularย hypertension.
  557. The Reninโ€Aldosteroneย System and Renal Hemodynamics in Patients with Posttransplantย hypertension
  558. Aldosteroneย acts on the kidney, not the brain, to cause mineralocorticoidย hypertensionย in sheep
  559. High-renin malignantย hypertensionย secondary to anย Aldosterone-producing adenoma
  560. Sodium balance, plasma renin, andย Aldosteroneย inย hypertension.
  561. Effects of enalapril maleate on blood pressure, renin-angiotensin-Aldosteroneย system, and peripheral sympathetic activity in essentialย hypertension.
  562. Aldosteroneย and magnesium in essential arterialย hypertension.
  563. The effects of sodium loading and deprivation on plasma renin and plasma and urinaryย Aldosteroneย inย hypertension
  564. hypertensionย due to coexisting pheochromocytoma andย Aldosterone-producing adrenal cortical adenoma
  565. The renin-angiotensin-Aldosteroneย system andย hypertensionย in primary hyperparathyroidism
  566. Altered Ca-dependent fluxes of 42K in rat aorta duringย Aldosterone-saltย hypertension.
  567. Effects of ACTH and posture onย Aldosteroneย metabolism in essentialย hypertension
  568. โ€ฆ and indirect measurement of urinary kallikrein excretion in patients with essentialย hypertensionย and normotensives: relation to age and plasma renin andย Aldosteroneย โ€ฆ
  569. Aldosteroneย secretion by dogs during the developmental phase of Goldblattย hypertension
  570. Effect of chlorothiazide uponย Aldosteroneย excretion and sodium and potassium balance in essentialย hypertension
  571. Effect of verapamil on renal plasma flow, glomerular filtration rate and plasma angiotensin II,ย Aldosteroneย and arginine vasopressin in essentialย hypertension
  572. Aldosteroneย in primaryย hypertensionย relationship to plasma renin activity and urinary electrolytes and a comparison with normotensive subjects
  573. The renin-Aldosteroneย system and thiazide-induced depletion of total body potassium in essentialย hypertension
  574. โ€ฆ enzyme inhibition on blood pressure, plasma renin activity (PRA) and plasmaย Aldosteroneย in hypertensive diabetics compared to patients with essentialย hypertension.
  575. The renin-Aldosteroneย system in exaggerated natriuresis of essentialย hypertension
  576. Role ofย Aldosteroneย in the antihypertensive effect of spironolactone in essentialย hypertension
  577. Central and renal circulation, renin andย Aldosteroneย in plasma during prazosin treatment in essentialย hypertension
  578. Plasmaย Aldosteroneย in essentialย hypertensionย with low renin activity
  579. โ€ฆ of nicardipine, a calciumโ€entry blocker: Effects on renal function, plasma renin activity, andย Aldosteroneย concentration in mildโ€toโ€moderate essentialย hypertension
  580. The effect of indomethacin on plasma renin activity and urinaryย Aldosteroneย of patients with essentialย hypertension
  581. Effect of anย Aldosteroneย antagonist on electrolytes and juxtaglomerular granularity in adrenal regenerationย hypertension
  582. Candesartan cilexetil inย hypertension: Effects of six weeksโ€™ treatment on haemodynamics, baroreceptor sensitivity and the renin-angiotensin-Aldosteroneย system
  583. The metabolic clearance ofย Aldosteroneย decreases similarly during infusion of angiotensin II in patients with essentialย hypertensionย and in normal subjects
  584. Malignantย hypertensionย andย Aldosteroneย secretion: Influence of reversal and progression of the syndrome in two cases
  585. Prostanoids andย Aldosterone-induced mild experimentalย hypertensionย in rats.
  586. โ€ฆ paper: the renin-angiotensin-Aldosteroneย system for blood pressure regulation and for subdividing patients to reveal and analyze different forms ofย hypertension
  587. Differences in adrenal cholesterol, ascorbic acid, circulating corticosterone andย Aldosteroneย during the onset ofย hypertensionย in SHR vs WKy rats
  588. Responses of plasma catecholamines, renin-angiotensin-Aldosteroneย system, and atrial natriuretic peptide to exercise in patients with essentialย hypertension
  589. Efficacy of nicardipine slow release (SR) onย hypertension, potassium balance and plasmaย Aldosteroneย in idiopathic aldosteronism.
  590. โ€ฆ beta adrenergic blockade with orally administered labetalol inย hypertension: Studies on blood volume, plasma renin andย Aldosteroneย and catecholamine excretion
  591. Effects of the selective mineralocorticoid receptor antagonist, eplerenone, in a model ofย Aldosterone-inducedย hypertensionย and cardiac fibrosis
  592. Renin, angiotensin II,ย Aldosterone, catecholamines, prostaglandins and vasopressin. The importance of pressor and depressor factors forย hypertensionย in pregnancy
  593. The characterization of low reninย hypertensionย by plasma renin activity and plasmaย Aldosteroneย concentration
  594. Plasmaย Aldosteroneย Response to Angiotensin II in Sodiumโ€Restricted Elderly Subjects with Essentialย hypertension
  595. Left ventricular hypertrophy and remodelling of resistance arteries: the role of activation of the reninโ€“angiotensinโ€“Aldosteroneย system inย hypertension
  596. Blood volume andย Aldosteroneย secretion inย hypertensionย and primary aldosteronism.
  597. Solitary kidney and ageing as causes of low renin andย Aldosteroneย concentrations: relevance to โ€˜low-reninโ€™essentialย hypertension
  598. Effect of indapamide on the reninโ€Aldosteroneย system, and urinary excretion of potassium and calcium in essentialย hypertension.
  599. Renin-Aldosteroneย system suppression during water immersion in renovascularย hypertension.
  600. Relationships between sodium clearance, plasma renin activity, plasmaย Aldosterone, renal hemodynamics and blood pressure in essentialย hypertension
  601. An association between mineral metabolism and the renin-Aldosteroneย system in humanย hypertension.
  602. Dexamethasone-responsiveย hypertensionย in young women with suppressed renin andย Aldosterone
  603. Abnormal vasopressin andย Aldosteroneย response to furosemide in essentialย hypertension
  604. Effects of intravenous labetalol on blood pressure, angiotensin II andย Aldosteroneย inย hypertension: comparison with propranolol
  605. Circadian rhythm of renin andย Aldosteroneย in unilateral renovascularย hypertension: pre-and post-operative studies
  606. โ€ฆ between plasmaย Aldosteroneย and angiotensin II before and after noradrenergic inhibition in normal subjects and patients with mild essentialย hypertension
  607. Factors for postoperative persistentย hypertensionย in patients withย Aldosterone-producing adenoma
  608. Effects of experimental renalย hypertensionย onย Aldosteroneย biosynthesis by rat adrenal tissue
  609. Biochemical correction in the syndrome ofย hypertensionย and hyperkalaemia by severe dietary salt restriction suggests reninโ€Aldosteroneย suppression critical in โ€ฆ
  610. Abnormal norepinephrine andย Aldosteroneย responses to upright posture in nonmodulatingย hypertension
  611. โ€ฆ plasma renin activity and plasmaย Aldosteroneย concentration to long-term administration of captopril in patients with severe, treatment-resistant malignantย hypertension
  612. Aldosterone-Inducedย hypertension: Effects of a Kininase Inhibitor
  613. Mechanism of inhibition ofย Aldosteroneย secretion by a Ca2+ channel blocker in patients with essentialย hypertensionย and patients with primary aldosteronism
  614. hypertensionย and mineralocorticoids. Usefulness of renin andย Aldosteroneย measurements
  615. Hypotensive and natriuretic effects of nifedipine in essentialย hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-Aldosteroneย systems.
  616. Captopril,ย Aldosteroneย and urinary kallikrein in primaryย hypertension
  617. Age-and sex-related differences in plasmaย Aldosteroneย in essentialย hypertension. Relationship to plasma renin activity
  618. The Renin-Angiotensin-Aldosteroneย System inย hypertension.
  619. STRUCTUREโ€FUNCTION RELATIONSHIPS OFย Aldosteroneย SYNTHASE AND 11ฮฒโ€HYDROXYLASE ENZYMES: IMPLICATIONS FOR HUMANย hypertension
  620. Effect of enalapril on renin, angiotensin converting enzyme activity,ย Aldosteroneย and prostaglandins in patients withย hypertension.
  621. Aldosteroneย antagonism andย hypertension
  622. The substitutive role of ACTH in supportingย Aldosteroneย response to head-up tilt during acute renin suppression in patients with essentialย hypertension.
  623. Effect of a new mineralocorticoid antagonist mespirenone onย Aldosterone-inducedย hypertension
  624. Functional aspects of the reninโ€“angiotensinโ€“Aldosteroneย system and angiotensin II receptor AT1 blockers in arterialย hypertension
  625. Essential arterialย hypertension: plasma and urinaryย Aldosteroneย alterations.
  626. Aldosteroneย responsiveness to angiotensin II after sodium restriction in subjects with low renin essentialย hypertension
  627. Renin-angiotension-Aldosteroneย system, urinary prostaglandins and kallikrein in pregnancy-inducedย hypertension: evidence for a dysregulation of the renin โ€ฆ
  628. Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-Aldosteroneย system, and blood pressure in essentialย hypertension.
  629. Aldosteroneย response to prolonged ACTH infusion in juvenileย hypertension
  630. Adrenal Cortex,ย Aldosterone, andย hypertension: Report of an International Workshop
  631. The role ofย Aldosteroneย in the response to treatment of primaryย hypertension
  632. Metabolism ofย Aldosteroneย in dogs with renovascularย hypertension
  633. Renin-angiotensin-Aldosteroneย system in arterialย hypertension.
  634. Effect of propranolol therapy onย Aldosteroneย responses to angiotensin II and adrenocorticotropic hormone in essentialย hypertension
  635. Renin-angiotensin andย Aldosteroneย in Experimentalย hypertension
  636. Effects of the Calcium Antagonist Felodipine on the Sympathetic and Reninโ€Angiotensinโ€Aldosteroneย Systems in Essentialย hypertension
  637. Primary aldosteronism due toย Aldosteroneย producing adenoma withoutย hypertension
  638. The Acute and Chronic Effects of Betaxolol on Blood Pressure, Reninโ€Aldosterone, and Renal Function in Essentialย hypertension
  639. Renin-hyporesponsiveness in essentialย hypertensionย dissociation between plasma renin and catecholamines orย Aldosteroneย following furosemide
  640. Effects of nisoldipine on sympathetic activity, the renin-angiotensin-Aldosteroneย system, and water-sodium-calcium metabolism in patients with essentialย hypertension.
  641. Effect of angiotensin converting-enzyme inhibition on potassium-mediatedย Aldosteroneย secretion in essentialย hypertension
  642. โ€ฆ haemodynamics and the renin-angiotensin-Aldosteroneย system in normotensive subjects with a familial predisposition toย hypertension: changes during increased salt โ€ฆ
  643. CAPTOPRIL IN PRIMARYย hypertension: Effects related to the reninโ€angiotensinโ€Aldosteroneย and kallikreinโ€kinin systems.
  644. โ€ฆ reducesย Aldosteroneย and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-reninย hypertensionย and idiopathic hyperaldosteronism
  645. Perinephritisย hypertensionย in Macaca fascicularis (cynomolgus monkey): studies of the renin-angiotensin-Aldosteroneย axis and renal hemodynamic function.
  646. โ€ฆ -angiotensin-Aldosterone, and cardiovascular response during exercise following acute and long-term calcium antagonism with felodipine in essentialย hypertension.
  647. Urinary excretion of renal prostaglandins, kallikrein, vasopressin andย Aldosteroneย in essentialย hypertension
  648. Severeย hypertensionย in a ten-year-old boy secondary to anย Aldosterone-producing tumour identified by adrenal sonography.
  649. Aldosterone: clinical implications in essentialย hypertension
  650. Role ofย Aldosteroneย in the initial stage of two forms of experimental vasorenalย hypertension
  651. The renin-angiotensin-Aldosteroneย system and arterialย hypertensionย in patients with rheumatoid arthritis
  652. โ€ฆ forโ€ย Aldosteroneโ€ andโ€ 18-hydroxycorticosteroneโ€ in unprocessed urine, and their use in screening to distinguish primary aldosteronism fromย hypertension.
  653. hypertension, angiotensin II,ย Aldosterone, and race
  654. Jejunal permeability to water and electrolytes in patients with chronic intrahepaticย hypertension: evidence for a role ofย Aldosterone.
  655. Treatment of drug-resistantย hypertensionย with minoxidil or angiotensin-converting enzyme inhibitor: blood pressure, renin,ย Aldosterone, and electrolyte responses.
  656. Aldosteroneย regulation in essentialย hypertension: altered adrenal responsiveness to angiotensin II.
  657. Aldosteroneย metabolism in the isolated perfused liver of R and Sย hypertension-prone Dahl rats
  658. The relationship ofย Aldosteroneย to mild essentialย hypertension.
  659. Effect of oral labetalol on plasma catecholamines, renin andย Aldosteroneย in patients with severe arterialย hypertension
  660. Urinary sodium andย Aldosteroneย excretion following portocaval shunts for cirrhosis of liver and portalย hypertension: effect of end-to-side and side-to-side anastomoses โ€ฆ
  661. Three cases of malignantย hypertension: the roles of endothelin-1 and the renin-angiotensin-Aldosteroneย system.
  662. Dopaminergic regulation ofย Aldosteroneย secretion: assessment in different subtypes of primary aldosteronism and in essentialย hypertension
  663. Aldosteroneย andย hypertension
  664. Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin andย Aldosteroneย in essentialย hypertension
  665. Responsiveness of the reninโ€Aldosteroneย system during exercise in young patients with essentialย hypertension
  666. A simple method for definition of incomplete suppression ofย Aldosteroneย and its association withย hypertensionย and hypokalaemia in man
  667. Remikiren (Ro 42-5892)โ€”An orally active renin inhibitor in essentialย hypertensionย Effects on blood pressure and the renin-angiotensin-Aldosteroneย system
  668. hypertension, oedema, and suppressed reninย Aldosteroneย system due to unsupervised salt administration.
  669. Low-Renin Essentialย hypertension: Diminution ofย Aldosteroneย Suppression?
  670. Angiotensin II in primaryย hypertension, relationship to plasma renin activity,ย Aldosteroneย and urinary electrolytes
  671. Effect of coffee on blood pressure and activity renin-angiotensin-Aldosteroneย system and catecholamines concentration in patients with essentialย hypertension
  672. Effect of one year of thiazide therapy on plasma volume, renin,ย Aldosterone, lipids and urinary metanephrines in systolicย hypertensionย of elderly patients
  673. Renalย hypertensionย with Elevatedย Aldosterone: Case Due to Muscular Hypertrophy Cured by Nephrectomy with Decline ofย Aldosteroneย Levels to Normal
  674. Aldosterone: possible roles in sustaining essentialย hypertensionย and in determining response to antihypertensive treatment
  675. โ€ฆ ON BLOOD PRESSURE, RENAL FUNCTION, PLASMA RENIN ACTIVITY, AND PLASMAย Aldosteroneย IN MILDโ€TOโ€MODERATE ESSENTIALย hypertension
  676. Captopril in the long-term treatment of essentialย hypertension: changes in the renin-angiotensin-Aldosteroneย system
  677. Humoral mechanisms in the pathogenesis of arterialย hypertensionย with emphasis on the renin-angiotensin-Aldosteroneย system and natriuretic substances
  678. Does industrial environment influence the prevalence of arterialย hypertension, plasma cholesterol and uric acid concentration and activity of the renin-Aldosteroneย โ€ฆ
  679. Abnormalities in the reninโ€“angiotensinโ€“Aldosteroneย system in normotensive subjects with a positive family history ofย hypertension
  680. Verapamil sustained-release in renal parenchymalย hypertension: effect on blood pressure, kidney function, angiotensin II,ย Aldosterone, arginine vasopressin, atrial โ€ฆ
  681. On the Role ofย Aldosteroneย toย hypertension; Especially an Extent of Its Participation
  682. โ€ฆ effects of angiotensin II infusion and variations in salt intake on plasmaย Aldosteroneย levels in normal subjects, patients with essentialย hypertensionย and patients with โ€ฆ
  683. Role of renin-angiotensin-Aldosteroneย system and of sympathetic activity in arterialย hypertensionย associated with autosomal dominant polycystic kidney disease
  684. โ€ฆ of low-reninย hypertension:ย Aldosteroneย response to sodium restriction and upright posture, angiotensin II, ACTH and potassium in patients withย hypertension
  685. โ€ฆ pressure,ย Aldosteroneย and body fluids during enalapril treatment: a doubleโ€blind randomized study vs hydrochlorothiazide plus propranolol in essentialย hypertension
  686. An Apraisal of the Role ofย Aldosteroneย and the Sympathetic Nervous System in Essentialย hypertension
  687. Effect of chronic beta-adrenergic blockade on blood pressure and release of renin,ย Aldosteroneย and cortisol in essentialย hypertensionย (authorโ€™s transl)
  688. Relationship between Plasma Renin-Angiotensin-Aldosteroneย and ANF Levels in Primaryย hypertension
  689. Morphological signs of hyperactivity of the renin-Aldosteroneย system in cadmium-induced experimentalย hypertension.
  690. Interrelations between plasma renin activity,ย Aldosterone, and sympathetic nervous system activity in essentialย hypertension.
  691. PLASMA RENIN ACTIVITY ANDย Aldosteroneย SECRETION RATE INย hypertension: The Distinction between Primary and Secondary Hyperaldosteronism
  692. hypertensionย due to a giantย Aldosterone-secreting adenoma
  693. โ€ฆ โ€“Aldosteroneย system in essential arterialย hypertensionย in clinical practice. Activity of the renin-angiotensin-Aldosteroneย system during treatment ofย hypertensionย with โ€ฆ
  694. Aldosteroneย excess and essentialย hypertension
  695. The influence of a heparin-like compound onย hypertension, electrolytes andย Aldosteroneย in man.
  696. Relationship between vasopressin and the renin-angiotensin-Aldosteroneย system in essentialย hypertension: effect of converting enzyme inhibitor on plasma โ€ฆ
  697. Correlation between propranolol in plasma and urine, renin-Aldosteroneย system and blood pressure in essentialย hypertension
  698. โ€ฆ Effects of Dopamine on the Renin-Angiotensin-Aldosteroneย System in Conscious Rats: THE 10th CONFERENCE ON THE PATHOGENESIS OFย hypertension
  699. Enhanced response of plasmaย Aldosteroneย to metoclopramide in essentialย hypertension.
  700. โ€ฆ 52: Comparison of selectiveย Aldosteroneย blockade versus calcium antagonism on blood pressure, vascular compliance, and microalbuminuria in systolicย hypertensionย โ€ฆ
  701. Effects of celiprolol on plasma renin,ย Aldosterone, norepinephrine and epinephrine in primaryย hypertension
  702. Inhibitory effect of enalapril on serumย Aldosteroneย in essentialย hypertension
  703. Effects ofย Aldosteroneย on intralymphocytic sodium and potassium in patients with essentialย hypertension
  704. โ€ฆ metabolism, plasma renin activity and serumย Aldosterone: a double-blind pilot comparison against hydrochlorothiazide in patients with essentialย hypertension.
  705. Relation between somatostatin, atrial natriuretic peptide, beta-endorphin,ย Aldosteroneย and pregnancy inducedย hypertension
  706. Renin/angiotensin/Aldosteroneย system in malignantย hypertension
  707. Effects of corticotropin-releasing factor (CRF) onย Aldosteroneย and 18-hydroxycorticosterone in essentialย hypertensionย and primary aldosteronism
  708. The renin-angiotensin-Aldosteroneย system in primary and secondaryย hypertension
  709. Molecular genetics of the renin-angiotensin-Aldosteroneย system in humanย hypertension
  710. Aldosterone, sodium and potassium in essentialย hypertension
  711. The state of the renin-angiotensin-Aldosteroneย system in various clinical forms ofย hypertensionย in aging
  712. Aldosterone-binding globulin-inducedย hypertensionย in the rat. A new experimental model.
  713. Hypotensive effect of intensifyingย Aldosteroneย metabolism in dogs with vasorenalย hypertension
  714. The renin-angiotensin system andย Aldosteroneย inย hypertension: a brief review of some aspects.
  715. Plasma human atrial natriuretic peptide, endothelin-1,ย Aldosteroneย and plasma-renin activity in pregnancy-inducedย hypertension
  716. Changes in renin activity,ย Aldosteroneย level and electrolytes in pregnancy-inducedย hypertension.
  717. Daily profiles ofย Aldosteroneย levels during normal, high and low sodium intake in patients with essentialย hypertension
  718. Renin-Angiotensin-Aldosteroneย System of a Woman with Bartterโ€™s Syndrome: Juxtaglomerular Cell Hyperplasia withoutย hypertension
  719. Plasma catecholamines, renin andย Aldosteroneย during combined alpha-and beta-adrenoceptor blockade in patients with severe arterialย hypertension.
  720. Circadian variation ofย Aldosteroneย urinary excretion in idiopathicย hypertension.
  721. Effect of pressor agents on blood pressure, plasma renin activity and plasmaย Aldosteroneย concentration in essentialย hypertension
  722. Studies on Plasma Renin andย Aldosteroneย in Essentialย hypertension
  723. Plasma concentration ofย Aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-reninย hypertension
  724. Reduced response of plasmaย Aldosteroneย to acute ACTH stimulation during long-term treatment with spironolactone in essentialย hypertension
  725. Physiopathology of arterialย hypertension. Significance of the renin-angiotensin-Aldosteroneย system and structural changes
  726. โ€ฆ agonist cianergoline on blood pressure, the renin-angiotensin-Aldosteroneย axis and the sympathetic nervous system in patients with essentialย hypertension
  727. Hyperplastic changes andย Aldosteroneย content in the adrenal cortex in essentialย hypertensionย and primary aldosteronism
  728. Molecular genetics of the renin angiotensinย Aldosteroneย system in humanย hypertension
  729. Role of the renin-angiotensjon-Aldosteroneย system in the pathogenesis of arterialย hypertension
  730. โ€ฆ traditional Chinese medicine differential types and plasma levels of renin, angiotension II,ย Aldosterone, atrial natriuretic factor in patients with essentialย hypertension
  731. โ€ฆ -relationship of sympathetic nervous system and renin-angiotensin-Aldosteroneย system in three renin subgroups of borderline and persistent essentialย hypertension
  732. Regulation ofย Aldosteroneย Secretion by a Newย Aldosteroneย Stimulating Factor: THE 11th CONFERENCE ON THE PATHOGENESIS OFย hypertension
  733. Behavior of the renin-angiotensin-Aldosteroneย system and vasopressin secretion in patients with renovascularย hypertensionย or small kidney
  734. Isolation of a polarย Aldosterone-like substance from the urine and adrenal incubates of patients with arterialย hypertension
  735. P-70: The selectiveย Aldosteroneย blocker eplerenone is safe and efficacious for the long-term treatment of mild-to-moderateย hypertension
  736. Renin-angiotensin-Aldosteroneย system in essentialย hypertension. Inappropriately high plasmaย Aldosteroneย in young patients with severeย hypertensionย and in older โ€ฆ
  737. Significance of the renin-angiotensin-Aldosteroneย system for pathogenesis and early diagnosis of pregnancy-inducedย hypertensionย with special reference to โ€ฆ
  738. The Relationship between the Upright Serumย Aldosteroneย Level and the Left Ventricular Geometry in Essentioalย hypertension
  739. The changes of serum-ACE, plasma renin activity andย Aldosteroneย in the diabetics withย hypertension
  740. Association betweenย Aldosteroneย synthase gene polymorphism and primaryย hypertensionย in Chinese Han population [J]
  741. Arterialย hypertensionย in acromegaly: altered dopaminergic control ofย Aldosteroneย secretion
  742. Effect of captopril on renal haemodynamics and the renin-angiotensin-Aldosteroneย and osmoregulatory systems in essentialย hypertension
  743. Altered coupling between aortic adrenergic-receptors and inositol phosphate accumulation inย Aldosteroneย hypertension
  744. Restructuring of the collagen network inย hypertension: role of the angiotensin-Aldosteroneย system
  745. โ€ฆ factor in high-altitude pulmonaryย hypertension: the influence of acute hypoxia on plasma atrial natriuretic factor, renin, andย Aldosteroneย concentrations in highlanders โ€ฆ
  746. The acute effect of nicardipine on the renin-angiotensin-Aldosteroneย system in salt-sensitive essentialย hypertension
  747. Chronobiological evidence for an uncoupling of the Na, K-ATPase toย Aldosteroneย in normal reninย hypertension
  748. Selected components of the kallikrein-kinin system and of the renin-angiotensin-Aldosteroneย system in offspring of parents withย hypertension
  749. Renal kallikrein-kinin system and prostaglandin inย hypertension: their relation to renin-angiotensin-Aldosteroneย system.
  750. Essentialย hypertensionย andย Aldosterone
  751. Aldosteroneย metabolism after prolonged ACTH administration in juvenileย hypertension
  752. Dissociated Reninโ€“Aldosteroneย Response to Acute Sodium Depletion in Patients with a Previous History of Pregnancyโ€“Associatedย hypertension
  753. The level of plasma renin and plasmaย Aldosteroneย activity in normotensive women and in pregnancy-induced arterialย hypertensionย in a group of women from โ€ฆ
  754. Effect of penbutolol on circadian blood pressure, and renin,ย Aldosteroneย and cortisol levels in patients with essentialย hypertension.
  755. Blood pressure, catecholamines, renin andย Aldosteroneย during short and long-term treatnent of essentialย hypertensionย with verapamil
  756. Role of renin-angiotensin-Aldosteroneย system in pathogenesis of arterialย hypertensionย in chronic renal failure
  757. Human salivary or plasmaย Aldosterone-and dehydroepiandrosterone-binding glycoprotein inducesย hypertensionย in the rat.
  758. Beta-adrenergic regulation of circadian rhythmicity of the renin-angiotensin-Aldosteroneย system in five subtypes of essentialย hypertension.
  759. The Role ofย Aldosteroneย in Pathogenesis of Artenalย hypertension
  760. 14C-Aldosteroneย binding by plasma proteins in adolescents with primary arterialย hypertension
  761. Genetic aspects of plasmaย Aldosteroneย binding globulins in families of patients with essentialย hypertension, including isolation of novel thermostable homologues from โ€ฆ
  762. Considerations of the renin-angiotensinย Aldosteroneย system in the pathogenesis ofย hypertensionย in infancy
  763. hypertensionย with defectiveย Aldosteroneย stimulation by sodium restriction: a new syndrome
  764. Aldosteroneย Receptors and Effector Mechanisms in Mononuclear Leukocytes in Different Forms ofย hypertension
  765. New frontiers inย Aldosterone/mineralocorticoid biology: A reemerging force in target organ damage andย hypertension
  766. Vasopressin and renin-Aldosteroneย system in patients with arterialย hypertension
  767. Effects of losartan on the renin-angiotensin-Aldosteroneย system and erythrocytosis in patients with chronic obstructive pulmonary disease and systemicย hypertension
  768. Changes in reactivity of the renin-angiotensin-Aldosteroneย system in old age as a risk factor in the development ofย hypertension
  769. Role ofย Aldosteroneย in the pathogenesis ofย hypertension
  770. Aldosteroneย secretion rate and electrolyte balance studies on three patients withย hypertension: Influence of guanethidine, hydralazine and methyclothiazide
  771. Post-renal-transplantย hypertensionย Urine volume, free water clearance and plasma concentrations of arginine vasopressin, angiotensin II andย Aldosteroneย before and โ€ฆ
  772. Plasma renin activity,ย Aldosteroneย and cortisol levels during physical exercise in essentialย hypertension.
  773. Polymorphism ofย Aldosteroneย synthase gene CYP11B2 inย hypertensionย in China
  774. Effects of various doses of captopril on plasmaย Aldosteroneย concentrations in patients with essentialย hypertension
  775. The renin-angiotensin-Aldosteroneย system and serum lipoproteins in patients with essentialย hypertension
  776. Role ofย Aldosteroneย in potassium secretion in chronic renal failure associated withย hypertensionย (transtubular potassium gradient)
  777. Effect of Ac-SDKP on Cardiac and Renal Collagen Deposition inย Aldosterone-Saltย hypertension
  778. Determination of plasma atrial natriuretic peptide, angiotensin II,ย Aldosteroneย and efficacy of benazepril in patients with salt sensitive essentialย hypertension
  779. Role of steroids inย hypertension: evaluation of plasma mineralocorticoid activity withย Aldosteroneย receptors
  780. hypertensionย following subcutaneous and intraperitoneal injections of polyvinyl alcohol and the effect ofย Aldosterone
  781. The renin-angiotensin-Aldosteroneย system inย hypertensionย of hypothalamic origin
  782. โ€ฆ on blood pressure, weight, plasma volume, the renin-angiotensin-Aldosteroneย system, and the renal kallikrein-kinin system in patients with essentialย hypertension.
  783. Renin-angiotensin-Aldosteroneย system and pulmonary hemodynamics in patients with pulmonary arteryย hypertension
  784. Urinary excretion ofย Aldosteroneย in patients withย hypertension
  785. Aldosterone, Angiotensin, andย hypertension
  786. Mineralocorticoid receptor activation byย Aldosteroneย or corticosterone inducesย hypertension, myocardial infarction and proteinuria
  787. Deviation of plasmaticย Aldosteroneย and significance of the stimulating (ACTH-cortrosyn) and inhibitory (propranolol) effects inย hypertensionย and cardiovascular โ€ฆ
  788. โ€ฆ pressure, heart rate, working capacity, plasma renin activity, plasma angiotensin II, urinary catecholamines andย Aldosteroneย in patients with essentialย hypertension.
  789. Changes of the renin-angiotensin-Aldosteroneย system under contraceptive steroids. Contribution to the etiology ofย hypertensionย under hormonal contraceptives
  790. The renin-angiotensin-Aldosteroneย system and the adrenergic system in normal pregnancy andย hypertensionย induced by pregnancy
  791. Correlation of atrial natriuretic factor and renin-Aldosteroneย system with chronic pulmonaryย hypertensionย among residents in a high altitude
  792. Differential Effects of Acute and Chronic ฮฒ-Adrenoreceptor Blockade on Blood Pressure and the Reninโ€”Angiotensinโ€”Aldosteroneย System in Essentialย hypertension
  793. Changes in the renin-Aldosteroneย system after unilateral portalization of adrenal and renal blood in patients with arterialย hypertension
  794. Plasmaย Aldosteroneย and plasma renin activity in patients with essential and renalย hypertensionย under acute stimulation with saline depletion and acute suppression โ€ฆ
  795. Development of a mouseย hypertensionย model induced byย Aldosteroneย excess
  796. The renin-Aldosteroneย profile inย hypertension
  797. โ€ฆ central and peripheral sympathetic nervous system and the renin-Aldosteroneย system on the onset and maintenance of high blood pressure in essentialย hypertension
  798. The Relationship ofย Aldosteroneย to Mild Essentialย hypertension
  799. โ€ฆ BETWEENย Aldosteroneย SECRETION, SODIUM AND POTASSIUM BALANCE, AND ANGIOTENSIN ACTIVITY IN MAN: STUDIES INย hypertensionย AND โ€ฆ
  800. The renin-angiotensin-Aldosteroneย system and antidiuretic hormone secretion during plasmapheresis in patients with high arterialย hypertensionย refractory to drug โ€ฆ
  801. Essentialย hypertensionย and left ventricular hypertrophy in cardiovascular disease: beyond overactivity of the reninโ€“angiotensinโ€“Aldosteroneโ€“sodium system
  802. Plasmaย Aldosteroneย concentration and vascular reactivity inย hypertension
  803. Role ofย Aldosteroneย and theย Aldosteroneย binding globulin in experimental and spontaneousย hypertension
  804. Strategy for studying mineralocorticoids other thanย Aldosteroneย in arterialย hypertensionย of hormonal origin
  805. Concentration of adrenocorticotrophic hormone andย Aldosteroneย secretion in essentialย hypertensionย and hyperaldosteronism
  806. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin andย Aldosteroneย inย hypertension.
  807. โ€ฆ on plasma renin activity, plasmaย Aldosteroneย concentration, urinary prostaglandin E excretion and blood pressure in patients with essentialย hypertension
  808. โ€ฆ increase of mineralocorticoids after furosemide in low-renin essentialย hypertension: Evidence for 18-hydroxycorticosterone to be a better marker thanย Aldosterone
  809. Erythrocyte cation transport in arterialย hypertension: interrelation with the renin-angiotensin-Aldosteroneย system and the atrial natriuretic factor
  810. Role ofย Aldosteroneย in the initial stage of 2 forms of experimental vasorenalย hypertension
  811. The kallikrein-kinin system in primaryย hypertension: dynamics of circulating components of the kallikrein-kinin system in relation to the renin-angiotensin-Aldosteroneย โ€ฆ
  812. Studies on kallikrein-kinin system in essentialย hypertension: urinary kallikrein-kinin system and renin-angiotensin-Aldosteroneย system (authorโ€™s transl)
  813. Kallikrein-kinin, enkephalin, renin-Aldosteroneย and catecholamine systems in the vanadate (as vanadyl)-induced arterialย hypertension.
  814. The Relationship between the Upright Serumย Aldosteroneย Level and the Left Ventricular Geometry in Essentioalย hypertension.
  815. Plasma Renin andย Aldosteroneย Profiles in Essentialย hypertension.
  816. โ€ฆ in peripheral venous distensibility and blood pressure modifications in borderlineย hypertension: evidence against a primary role for the renin-angiotensin-Aldosteroneย โ€ฆ
  817. Radioimmunologic determination ofย Aldosteroneย and renin in the blood in the diagnosis of different forms of arterialย hypertension
  818. VI. RENIN,ย Aldosterone, ANDย hypertension: The Hepatic Metabolism of Renin andย Aldosterone
  819. โ€ฆ renin-angiotensin-Aldosteroneย system and kinin system in hypertensive and normotensive youngsters with or without a family history of essential arterialย hypertension
  820. Renin angiotensinย Aldosteroneย system, urinary prostaglandins and kallikrein in pregnancy inducedย hypertension. Evidence for a disregulation of the renin-angiotensin โ€ฆ
  821. Negative noxiousness ofย Aldosteroneย analogue-inducedย hypertensionย and inhibition ofย Aldosteroneย by silver spike point electrical stimulation
  822. Effects of acebutolol on the renin-Aldosteroneย system in essential arterialย hypertension
  823. Human Essentialย hypertension: Role of the Genes of the Renin-Aldosteroneย System
  824. The development and maintenance of experimentalย Aldosteroneย hypertensionย in the rat: evidence for a mechanism other than peripheral vascular โ€ฆ
  825. Radioimmunologic analysis of the state of the renin-angiotensin-Aldosterone-system in arterialย hypertension
  826. Radioimmunologic analysis of the state of the renin-angiotensin-Aldosteroneย system in arterialย hypertension
  827. Role ofย Aldosteroneย in essential arterialย hypertensionย complicated by chronic renal insufficiency
  828. Factors for postoperative persistentย hypertensionย in patients withย Aldosteroneย producing adenoma
  829. hypertension: the role of renin, angiotensin andย Aldosterone
  830. Plasma renin activity andย Aldosteroneย in patients with essentialย hypertension
  831. Aldosteroneย reduces baroreceptor discharge in the dog.ย hypertension
  832. Aldosteroneย response to modulation of potassium in patients on dialysis or with essentialย hypertension.
  833. Rectal electrical potential difference and plasmaย Aldosteroneย in hyperaldosteronism and low-, normal-and high-reninย hypertension
  834. Plasma renin activity and plasmaย Aldosteroneย in essentialย hypertension: effect of age and diastolic blood pressure
  835. Adrenal cancer withย hypertensionย but low plasma renin andย Aldosterone.
  836. Relationship between plasmaย Aldosteroneย and left ventricular structure and function in patients with essentialย hypertension
  837. Changes of Atrial Natriuretic Peptide andย Aldosteroneย in Pregnancy-inducedย hypertensionย and Normal Pregnancy
  838. hypertensionย and the Renin-Angiotensin-Aldosteroneย Axis
  839. Saralasin-induced changes of blood pressure, renin andย Aldosteroneย in essential and renalย hypertensionย (authorโ€™s transl)
  840. Plasma renin activity,ย Aldosteroneย and adrenergic activity in patients withย hypertensionย and in normotensives with a family history ofย hypertension
  841. Possible Implication of the Renin-Angiotensin-Aldosteroneย System in theย hypertensionย of Phaeochromocytoma
  842. Hypotensive effect of intensification ofย Aldosteroneย metabolism in dogs with vasorenalย hypertension
  843. Aldosteroneย Receptor Antagonism Normalizes Vascular Function in 11ฮฒ-Hydroxysteroid Dehydrogenase Deficientย hypertension
  844. The Renin-Angiotensin-Aldosteroneย System inย hypertensionย its Biochemistry and Applications
  845. Plasma mineralocorticoidsโ€“Aldosteroneย and desoxycorticosteroneโ€“in patients withโ€ low-reninโ€ arterialย hypertension
  846. Renin-angiotensin-Aldosteroneย system inย hypertensionย patients who have had a cerebral stroke
  847. Changes in the renin-angiotensin-Aldosteroneย system in the development ofย hypertensionย in aging. 2
  848. Effects ofย Aldosteroneย antagonism on cardiac fibrosis in patients with essentialย hypertension
  849. Preliminary study on relationship between renin-angiotensin-Aldosteroneย system andย hypertensionย in coal miners
  850. โ€ฆ de Recherche et dโ€™Etudes sur les Genomes (GREG). Genetic determination of plasmaย Aldosteroneย levels in essentialย hypertension-comparison between urban and โ€ฆ
  851. P-489: Plasma renin activity andย Aldosteroneย level in patients with essentialย hypertension
  852. Relations between blood insulin concentration, renin-angiotensin-Aldosteroneย system and clinical picture ofย hypertension
  853. Changes of the renin-angiotensin-Aldosteroneย system and immunologic parameters in essential and symptomatic arterialย hypertension
  854. Alcohol andย hypertensionย in sudden cardiac death, features of the status of the renin-angiotensin-Aldosteroneย system
  855. Renin-Aldosteroneย system in secretion of cortisol in patients with arterialย hypertensionย in European North
  856. Low Reninย hypertension: A State of Inappropriate Secretion ofย Aldosterone.
  857. The value of stimulation of the renin-angiotensin-Aldosteroneย system as a screening test forย hypertensionย (authorโ€™s transl)
  858. A study on the serum angiotensin I angiotensin II atrial natriureticfactor andย Aldosteroneย levels in essentialย hypertension
  859. Body fluid compartments,ย hypertensionย and the renin-angio-tensin-Aldosteroneย system (RAAS) in hemodialysed patients
  860. The effect of long-term treatment of arterialย hypertensionย with Ca antagonists on the renin-angiotensin-Aldosteroneย system in diabetics. Hyporeninemic โ€ฆ
  861. VI. RENIN,ย Aldosterone, ANDย hypertension: Pseudo-primary Aldosteronism
  862. Effect of obzidan on hemodynamic indices and the renin andย Aldosteroneย levels of the blood plasma in patients with juvenileย hypertension
  863. Low renin variant ofย hypertension: functional relations of the renin-Aldosteroneย pressor system
  864. Aldosteroneย precursors and arterialย hypertensionย with adrenal nodules not caused by aldosteronism
  865. Is there a relation between the renin-angiotensin-Aldosteroneย system and vasopressin secretion in essentialย hypertension?
  866. Levels of catecholamines and activity of the renin-Aldosteroneย system in women withย hypertensionย in the period before and after menopause
  867. Essentialโ€™hypertensionย with hypokalemia: Caused byย Aldosterone-secreting adrenal adenoma
  868. โ€ฆ โ€“Aldosteroneย system in essentialย hypertensionโ€“hypotensive action of beta adrenergic blocking agents and variation of the renin-Aldosteroneย system (authorโ€™s transl)
  869. EVALUATION OF PRESSOR ASSAY, PLASMA RENIN ACTIVITY, ANDย Aldosteroneย EXCRETION IN RENAL VASCULARย hypertension.
  870. Behavior of the plasma renin activity andย Aldosteroneย after salt restriction and upright posture in essentialย hypertension
  871. The renin-angiotensin-Aldosteroneย system in children and adolescents with nephrogenicย hypertension
  872. Dopaminergic control ofย Aldosteroneย secretion is not mediated by atrial natriuretic factor in patients with essentialย hypertension.
  873. Observation of the Plasma Renin-Angiotensin-Aldosteroneย System and Prostaglandin System in Essentialย hypertension
  874. The renin-angiotensin-Aldosteroneย system in the diagnosis of renovascular arterialย hypertension
  875. Clinical significance of renin-angiotensin-Aldosteroneย system, endothelin and nitric oxide in renalย hypertensionย and adrenocorticoadenomas
  876. Basal and reactive renin andย Aldosteroneย secretion in arterialย hypertensionย of insulin dependent diabetics
  877. Continuous long-term treatment with diuretics ofย hypertensionย and the status of the renin-angiotensin-Aldosteroneย system
  878. Measurement and Significance of Calcitonin Gene-related Peptide. Neuropeptide Y andย Aldosteroneย in Portalย hypertension
  879. The correlation of atrial natriuretic peptide values with those of renin, angiotensin andย Aldosteroneย inย hypertensionย patients below and above 50
  880. Diazoxide test in the diagnosis of arterialย hypertension: modifications in the levels of renin andย Aldosteroneย in blood of patients with various restrains of the renal โ€ฆ
  881. The effects of capoten and nifedipine on plasma endothelin, renin activity, an-giotensin andย Aldosteroneย in patients with essentialย hypertension
  882. Effect of inhibition of converting enzyme by captopril on arterial pressure, renin andย Aldosteroneย in essentialย hypertension
  883. 163 ROLE OF THE RENIN-Aldosteroneย SYSTEM INย hypertensionย COARCTATION OF THE AORTA
  884. โ€ฆ cardiopulmonary hematic centralization (by immersion in water) on hydrosaline elimination and on the renin-angiotensin-Aldosteroneย system in essentialย hypertension
  885. Atrial natriuretic peptide inhibits theย Aldosteroneย response to metoclopramide in patients with glomerular disease and essentialย hypertension
  886. The renin-angiotensin-Aldosteroneย system in hypertensive subjects. III-The use of beta-blockers in reno-vascularย hypertensionย (authorโ€™s transl)
  887. Relation of myocardial fibrosis to circulatingย Aldosteroneย and endothelin in primary and secondary humanย hypertension: an ultrasonic study by acoustic densitometry
  888. A study of urinary and intracellular sodium and potassium, renin,ย Aldosteroneย andย hypertensionย in Africans and Indians in Natal.
  889. Effect of nifedipine treatment on the renin-Aldosteroneย system and secretion of cortisol and growth hormone in patients with essentialย hypertension
  890. Plasma renin activity andย Aldosteroneย excretion in patients with essentialย hypertension, withย hypertensionย in bilateral adrenal cortex hyperplasia and withย Aldosteroneย โ€ฆ
  891. Renin-angiotensin-Aldosteroneย system in the treatment of essentialย hypertensionย with a beta-adrenergic blocker: sotalol
  892. Acute combined alpha-and beta-adrenergic blockade in essentialย hypertension: effects on blood pressure, renal function, renin, andย Aldosterone
  893. Adenovirus-mediated Human Prostasin Gene Delivery is Associated with Increasedย Aldosteroneย Production andย hypertensionย in Rats
  894. The role of the kallikrein-kinin and renin-angiotensin-Aldosteroneย systems in the development ofย hypertensionย in glomerulonephritis
  895. Renin, Angiotensin andย Aldosteroneย in Relation to Electrolyte Metabolism [Abridged]ย hypertensionย and Hyperaldosteronism with Low Plasma Renin โ€ฆ
  896. Inhibition of the renin-angiotensin-Aldosteroneย axis by low dose intravenous captopril as a treatment for accelerated phaseย hypertension.
  897. Blood level of free serotonin, catecholamines and the renin-angiotensin-Aldosteroneย system in patients with primaryย hypertension
  898. Behavior ofย Aldosteroneย and plasma renin activity after ACTH administration and insulin-induced hypoglycemia in patients with essential arterialย hypertension
  899. Renin-Angiotensin-Aldosteroneย System and Adrenergic System inย hypertensionย Induced by Pregnancy: Critical Role of the Stimulative Conditions and of the Lability โ€ฆ
  900. โ€ฆ -release nicardipine on blood pressure, renal function and the renin-angiotensin-Aldosteroneย system in patients with mild-to-moderate essential arterialย hypertension
  901. Renin-Aldosteroneย and kallikrein-kinin systems in the patients with arterialย hypertensionย who took part in elimination of aftereffects of the accident at Chernobyl Atomic โ€ฆ
  902. Atrial natriuretic peptide, left ventricular mass and renin-angiotensin-Aldosteroneย system in essential arterialย hypertensionย of a mild or moderate degree
  903. โ€ฆ between atrial natriuretic factor and the renin-angiotensin-Aldosteroneย system in the renal reaction to acute volume loading in patients with essentialย hypertension
  904. Effects of pharmacological modulation of the renin-angiotensin-Aldosteroneย system on salt sensitivity in patients with borderlineย hypertension
  905. โ€ฆ of gene polymorphism ofย Aldosteroneย synthese gene CYP11B2 (-344T/C) on antihypertensive response to Valsartan in Han nationality essentialย hypertensionย โ€ฆ
  906. โ€ฆ โ€“Aldosteroneย system, blood volume, serum uric acid and urinary excretion of prostaglandins and kallikrein in the arterialย hypertensionย induced by pregnancy
  907. โ€ฆ /hypertension/Congestive Heart Failure: Angiotensin-Converting Enzyme Gene Polymorphism Has No Influence on the Circulating Renin-Angiotensin-Aldosteroneย โ€ฆ
  908. OR-78: White coatย hypertension, microalbuminuria and renin-angiotensin-Aldosteroneย system gene variants in adolescents
  909. โ€ฆ , serum levels of sodium, potassium,ย Aldosterone, total catecholamines, 6-keto-PGF2alpha and plasma renin activity in patients with primary arterialย hypertensionย โ€ฆ
  910. โ€ฆ to 9: 00 AMย Aldosterone-A Common Link in Cardiac and Vascular Disorders*: Ability to selectively interfere with the effects ofย Aldosteroneย in patients withย hypertensionย โ€ฆ
  911. โ€ฆ โ€“Aldosteroneย system, sympathetic-adrenal system and the level of the 6-keto-PGF1 alpha metabolite of prostacyclin in patients with primary arterialย hypertension
  912. โ€ฆ action by decreasing the production of angiotensin II andย Aldosterone, are being extensively prescribed for the treatment ofย hypertensionย and congestive heart โ€ฆ
  913. P-243: Assessment of the novel selectiveย Aldosteroneย blocker eplerenone using ambulatory and clinic BP in 400 patients with systemicย hypertension: results from a โ€ฆ
  914. Case 39-1972:ย hypertension, Hypokalemia and Elevated Urinaryย Aldosteroneย Level
  915. (Supplementary) 19-Hydroxyandrostenedione, A New Amplifier of the Action ofย Aldosterone, in Low Renin Essentialย hypertension
  916. P-669: Screening for primaryย Aldosteroneย in older patients withย hypertension
  917. P-392: Ultrasound tissue characterization in patients with primary and secondaryย hypertension: influence of the renin-angiotensin-Aldosteroneย system
  918. P-525: An interaction of insulin and renin-Aldosteroneย system responsible for left ventricular hypertrophy in patients with essentialย hypertension
  919. 736 Vascular hypertrophy and the renin-angiotensin-Aldosteroneย system in the initiation ofย hypertensionย caused by inhibition of nitric oxide synthesis
  920. 4. On the Role of Renin-Angiotensin System with Special Relation toย Aldosteroneย for the Etiology ofย hypertension
  921. โ€ฆ of 5-month guanfacine treatment on the renin-angiotensin-Aldosteroneย system and some metabolic factors in patients with diabetes mellitus type II andย hypertension
  922. P-387: Twenty-four hour pulse pressure, left ventricular mass, risk factors andย Aldosteroneย in untreated essentialย hypertension
  923. Effect of a Single Dose of Ramipril (HOE 498) on the Renin Angiotensin-Aldosteroneย System in Essential Arterialย hypertension
  924. 10 Dopaminergic Control ofย Aldosteroneย in Essentialย hypertension
  925. โ€ฆ OF NIFEDIPINE ON PLASMA RENIN ACTIVITY, PLASMAย Aldosteroneย & CORTISOL CONCENTRATIONS IN PATIENTS WITH ESSENTIALย hypertension
  926. K+ channel mutations in adrenalย Aldosterone-producing adenomas and hereditaryย hypertension
  927. Predictors of hyperkalemia risk followingย hypertensionย control withย Aldosteroneย blockade
  928. Aldosteroneย in salt-sensitiveย hypertensionย and metabolic syndrome
  929. hypertensionย in blacks: individualized therapy based on renin/Aldosteroneย phenotyping
  930. Dysregulated reninโ€“angiotensinโ€“Aldosteroneย system contributes to pulmonary arterialย hypertension
  931. Resistantย hypertensionย andย Aldosterone: an update
  932. Pathogenesis ofย hypertension: interactions among sodium, potassium, andย Aldosterone
  933. The renin angiotensinย Aldosteroneย system inย hypertension: roles of insulin resistance and oxidative stress
  934. Aldosteroneย synthase inhibitors inย hypertension: current status and future possibilities
  935. Sleep apnea,ย Aldosterone, and resistantย hypertension
  936. Association of kidney function with residualย hypertensionย after treatment ofย Aldosterone-producing adenoma
  937. Effects of a novelย Aldosteroneย synthase inhibitor for treatment of primaryย hypertension: results of a randomized, double-blind, placebo-and active-controlled phase 2 โ€ฆ
  938. Aldosterone,ย hypertension, and beyond
  939. The central role of the brainย Aldosteroneโ€“โ€œouabainโ€ pathway in salt-sensitiveย hypertension
  940. The effects ofย Aldosteroneย antagonists in patients with resistantย hypertension: a meta-analysis of randomized and nonrandomized studies
  941. High prevalence of autonomousย Aldosteroneย secretion among patients with essentialย hypertension
  942. Effectiveness of the selectiveย Aldosteroneย blocker, eplerenone, in patients with resistantย hypertension
  943. Therapeutic perspectives inย hypertension: novel means for reninโ€“angiotensinโ€“Aldosteroneย system modulation and emerging device-based approaches
  944. โ€ฆ -angiotensin-Aldosteroneย system beyond blood pressure regulation: molecular and cellular mechanisms involved in end-organ damage during arterialย hypertension
  945. hypertension, reninโ€“angiotensinโ€“Aldosteroneย system inhibition, and COVID-19
  946. Actions of circulating angiotensin II andย Aldosteroneย in the brain contributing toย hypertension
  947. Sex differences in angiotensin II-andย Aldosterone-inducedย hypertension: the central protective effects of estrogen
  948. Role of brainย Aldosteroneย and mineralocorticoid receptors inย Aldosterone-saltย hypertensionย in rats
  949. Stress-inducedย Aldosteroneย hyper-secretion in a substantial subset of patients with essentialย hypertension
  950. Recent update of renin-angiotensin-Aldosteroneย system in the pathogenesis ofย hypertension
  951. Aldosteroneย synthesis in the brain contributes to Dahl saltโ€sensitive ratย hypertension
  952. Aldosteroneย mediates cardiac fibrosis in the setting ofย hypertension
  953. Leptin inducesย hypertensionย and endothelial dysfunction viaย Aldosterone-dependent mechanisms in obese female mice
  954. The role of the renin-angiotensin-Aldosteroneย system in the pathobiology of pulmonary arterialย hypertensionย (2013 Grover Conference series)
  955. Aldosterone,ย hypertensionย and heart failure: insights from clinical trials
  956. Plasmaย Aldosteroneย levels are elevated in patients with pulmonary arterialย hypertensionย in the absence of left ventricular heart failure: a pilot study
  957. Use ofย Aldosteroneย antagonists for treatment of uncontrolled resistantย hypertension
  958. โ€ฆ enzyme inhibitors reduce mortality inย hypertension: a meta-analysis of randomized clinical trials of reninโ€“angiotensinโ€“Aldosteroneย system inhibitors involving 158 998 โ€ฆ
  959. Aldosterone, oxidative stress, and NF-ฮบB activation inย hypertension-related cardiovascular and renal diseases
  960. Study ofย Aldosteroneย synthase inhibition as an addโ€on therapy in resistantย hypertension
  961. Aldosteroneย induces electrical remodeling independent ofย hypertension
  962. Spironolactone, eplerenone and the newย Aldosteroneย blockers in endocrine and primaryย hypertension
  963. hypertensionย and renin-angiotensin-Aldosteroneย system inhibitors in patients with Covid-19
  964. Hypoadiponectinemia andย Aldosteroneย excess are associated with lack of blood pressure control in subjects with resistantย hypertension
  965. The renin-angiotensin-Aldosteroneย system: a crossroad from arterialย hypertensionย to heart failure
  966. Renal volume, renin-angiotensin-Aldosteroneย system,ย hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease
  967. Long-term effects ofย Aldosteroneย blockade in resistantย hypertensionย associated with chronic kidney disease
  968. Aldosteroneย acting through the central nervous system sensitizes angiotensin II-inducedย hypertension
  969. Relation of dietary salt andย Aldosteroneย to urinary protein excretion in subjects with resistantย hypertension
  970. Association of theโˆ’ 344C/Tย Aldosteroneย synthase (CYP11B2) gene variant withย hypertensionย and stroke
  971. Renoprotective effect of renin-angiotensin-Aldosteroneย system blockade in patients with predialysis advanced chronic kidney disease,ย hypertension, and anemia
  972. Role ofย Aldosteroneย blockade in resistantย hypertension
  973. Lessons from Africa: the importance of measuring plasma renin andย Aldosteroneย in resistantย hypertension
  974. The Effects ofย Aldosteroneย Synthase Inhibition onย Aldosteroneย and Cortisol in Patients Withย hypertension: A Phase II, Randomized, Doubleโ€Blind, Placeboโ€Controlled โ€ฆ
  975. A randomized controlled study of CPAP effect on plasmaย Aldosteroneย concentration in patients with resistantย hypertensionย and obstructive sleep apnea
  976. Aldosteroneย contributes to sympathoexcitation in renovascularย hypertension
  977. Salt,ย Aldosteroneย andย hypertension
  978. hypertensionย andย Aldosteroneย levels in women with earlyโ€onset androgenetic alopecia
  979. Aldosteroneย excess or escape: Treating resistantย hypertension
  980. Prospective validation of an automated chemiluminescence-based assay of renin andย Aldosteroneย for the work-up of arterialย hypertension
  981. Masked Uncontrolledย hypertensionย Is Accompanied by Increased Out-of-Clinicย Aldosteroneย Secretion
  982. Management of resistant arterialย hypertension: role of spironolactone versus double blockade of the reninโ€“angiotensinโ€“Aldosteroneย system
  983. High plasmaย Aldosteroneย concentration is a novel risk factor of cognitive impairment in patients withย hypertension
  984. Effect ofย Aldosteroneย antagonists on blood pressure in patients with resistantย hypertension: a meta-analysis
  985. hypertensionย in women: the role of progesterone andย Aldosterone
  986. Aldosterone,ย hypertension, and antihypertensive therapy: insights from a general population
  987. Renin angiotensinย Aldosteroneย system inhibitors inย hypertension: is there evidence for benefit independent of blood pressure reduction?
  988. The central mechanism underlyingย hypertension: a review of the roles of sodium ions, epithelial sodium channels, the reninโ€“angiotensinโ€“Aldosteroneย system โ€ฆ
  989. The reninโ€“angiotensinโ€“Aldosteroneย system in 2011: role inย hypertensionย and chronic kidney disease
  990. Association ofย Aldosteroneย excess and apnea-hypopnea index in patients with resistantย hypertension
  991. โ€ฆ the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterialย hypertension
  992. Effect of melatonin on the renin-angiotensin-Aldosteroneย system in L-NAME-inducedย hypertension
  993. Suppression ofย Aldosteroneย mediates regression of left ventricular hypertrophy in patients withย hypertension
  994. Sex differences and central protective effect of 17ฮฒ-estradiol in the development ofย Aldosterone/NaCl-inducedย hypertension
  995. Effects of ARB or ACE-inhibitor administration on plasma levels ofย Aldosteroneย and adiponectin inย hypertension
  996. Reninโ€angiotensinโ€Aldosteroneย system activity in hyperthyroid cats with and without concurrentย hypertension
  997. Lack of suppression ofย Aldosteroneย production leads to salt-sensitiveย hypertensionย in female but not male balb/C mice
  998. Association between polymorphisms in the renin-angiotensin-Aldosteroneย system genes and essentialย hypertensionย in the Han Chinese population
  999. High plasmaย Aldosteroneย and low renin predict blood pressure increase andย hypertensionย in middle-aged Caucasian populations
  1000. Renin-angiotensin-Aldosteroneย profiles in pregnant women with chronicย hypertension
  1001. Aldosterone-inducedย hypertensionย is sex-dependent, mediated by T cells and sensitive to GPER activation
  1002. Haplotype-based association of the renin-angiotensin-Aldosteroneย system genes polymorphisms with essentialย hypertensionย among Han Chinese: the Fangshan โ€ฆ
  1003. Are genetic polymorphisms in the reninโ€“angiotensinโ€“Aldosteroneย system associated with essentialย hypertension? Evidence from genome-wide association studies
  1004. Statins, the reninโ€“angiotensinโ€“Aldosteroneย system andย hypertensionโ€“a tale of another beneficial effect of statins
  1005. Role of central nervous systemย Aldosteroneย synthase and mineralocorticoid receptors in salt-inducedย hypertensionย in Dahl salt-sensitive rats
  1006. Association between pituitary-adrenal axis dominance over the renin-angiotensin-Aldosteroneย system andย hypertension
  1007. Salt, the reninโ€“angiotensinโ€“Aldosteroneย system and resistantย hypertension
  1008. Aldosteroneย sensitivity: an opportunity for investigation into the pathogenesis ofย hypertension
  1009. Aldosteroneย synthase inhibition inย hypertension
  1010. โ€ฆ dissection of sodium and potassium transport along theย Aldosterone-sensitive distal nephron: importance in the control of blood pressure andย hypertension
  1011. Atrial fibrillation and arterialย hypertension: a common duet with dangerous consequences where the renin angiotensin-Aldosteroneย system plays an important role
  1012. The role ofย Aldosteroneย in mediating the dependence of angiotensinย hypertensionย on IL-6
  1013. Reninโ€“angiotensinโ€“Aldosteroneย system inhibitors and the risk of mortality in patients withย hypertensionย hospitalised for COVID-19: systematic review and โ€ฆ
  1014. Primary aldosteronism andย Aldosterone-associatedย hypertension
  1015. Activation of reninโ€“angiotensinโ€“Aldosteroneย system (RAAS) in the lung of smoking-induced pulmonary arterialย hypertensionย (PAH) rats
  1016. Aldosterone-related myocardial extracellular matrix expansion inย hypertensionย in humans: a proof-of-concept study by cardiac magnetic resonance
  1017. Aldosteroneย in gynecology and its involvement on the risk ofย hypertensionย in pregnancy
  1018. Aldosteroneย synthase inhibition for the treatment ofย hypertensionย and the derived mechanistic requirements for a new therapeutic strategy
  1019. โ€ฆ in the renin-angiotensin-Aldosteroneย system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in humanย hypertensionย and heart failure
  1020. Association betweenย Aldosteroneย synthase CYP11B2 polymorphism and essentialย hypertensionย in Chinese: a meta-analysis
  1021. Polymorphisms in genes of the reninโ€angiotensinโ€Aldosteroneย system and renal cell cancer risk: Interplay withย hypertensionย and intakes of sodium, potassium and โ€ฆ
  1022. Programming ofย hypertension: associations of plasmaย Aldosteroneย in adult men and women with birthweight, cortisol, and blood pressure
  1023. Adrenal tissue-specific deletion of TASK channels causesย Aldosterone-driven angiotensin IIโ€“independentย hypertension
  1024. Renin andย Aldosteroneย measurements in the management of arterialย hypertension
  1025. Interpreting stimulated plasma renin andย Aldosteroneย to select physiologically individualized therapy for resistantย hypertension: importance of the class of stimulating โ€ฆ
  1026. Effect of ivabradine on a hypertensive heart and the renin-angiotensin-Aldosteroneย system in L-NAME-inducedย hypertension
  1027. Role of brain corticosterone andย Aldosteroneย in central angiotensin IIโ€“inducedย hypertension
  1028. hypertension, insulin resistance, andย Aldosterone: sexโ€specific relationships
  1029. โ€ฆ continuous positive airway pressure treatment onย Aldosteroneย excretion in patients with obstructive sleep apnoea and resistantย hypertension: a randomized controlled โ€ฆ
  1030. Association ofย Aldosteroneย synthase CYP11B2 (-344C/T) gene polymorphism with essentialย hypertensionย and left ventricular hypertrophy in the Egyptian population
  1031. The efficacy and safety of the novelย Aldosteroneย antagonist eplerenone in children withย hypertension: a randomized, double-blind, dose-response study
  1032. Plasmaย Aldosteroneย and left ventricular diastolic function in treatment-naรฏve patients withย hypertension: tissue-Doppler imaging study
  1033. The kidneys andย Aldosterone/mineralocorticoid receptor system in salt-sensitiveย hypertension
  1034. Association ofย Aldosteroneย synthase (CYP11B2 C-344T) gene polymorphism & susceptibility to essentialย hypertensionย in a south Indian Tamil population
  1035. Renal denervation attenuatesย Aldosteroneย expression and associated cardiovascular pathophysiology in angiotensin II-inducedย hypertension
  1036. Bimodalย Aldosteroneย distribution in low-reninย hypertension
  1037. KCNJ5 mutation as a predictor for resolution ofย hypertensionย after surgical treatment ofย Aldosterone-producing adenoma
  1038. โ€ฆ receptor-ฮฒ in the paraventricular nucleus and rostroventrolateral medulla plays an essential protective role inย Aldosterone/salt-inducedย hypertensionย in female rats
  1039. Association of the-344T/Cย Aldosteroneย synthase gene variant with essentialย hypertension.
  1040. Circulatingย Aldosteroneย levels and disease severity in pulmonary arterialย hypertension
  1041. Factors affecting completeย hypertensionย cure after adrenalectomy forย Aldosterone-producing adenoma: outcomes in a large series
  1042. Aldosterone, sodium, andย hypertension: lessons from torcetrapib?
  1043. Association of HSD3B1 and HSD3B2 gene polymorphisms with essentialย hypertension,ย Aldosteroneย level, and left ventricular structure
  1044. โ€ฆ of plasma renin concentration instead of plasma renin activity decreases the positiveย Aldosterone-to-renin ratio tests in treated patients with essentialย hypertension
  1045. Fluid retention,ย Aldosteroneย excess, and treatment of resistantย hypertension
  1046. Central infusion ofย Aldosteroneย synthase inhibitor prevents sympathetic hyperactivity andย hypertensionย by central Na+ in Wistar rats
  1047. Impact ofย Aldosteroneย receptor blockade compared with thiazide therapy on sympathetic nervous system function in geriatricย hypertension
  1048. Contribution of four polymorphisms in renin-angiotensin-Aldosterone-related genes toย hypertensionย in a Thai population
  1049. Influence of blood pressure control and application of reninโ€angiotensinโ€Aldosteroneย system inhibitors on the outcomes in COVIDโ€19 patients withย hypertension
  1050. Association ofย Aldosteroneย with left ventricular mass inย hypertension: interaction with plasma fibrinogen levels
  1051. Endogenous ouabain andย Aldosteroneย are coelevated in the circulation of patients with essentialย hypertension
  1052. Atrial natriuretic peptide andย Aldosteroneย synthase gene in essentialย hypertension: A caseโ€“control study
  1053. โ€ฆ extract of Hibiscus sabdariffa on the renin-angiotensin-Aldosteroneย system of Nigerians with mild to moderate essentialย hypertension: A comparative study โ€ฆ
  1054. Synergistic effects of gene polymorphisms of the reninโ€“angiotensinโ€“Aldosteroneย system on essentialย hypertensionย in Kazakhs in Xinjiang
  1055. Modulation ofย Aldosteroneย levels byโˆ’ 344 C/T CYP11B2 polymorphism and spironolactone use in resistantย hypertension
  1056. Renin-angiotensin-Aldosteroneย system inhibitors and mortality in patients withย hypertensionย hospitalized for COVID-19: a systematic review and meta-analysis
  1057. Aldosteroneย and alterations ofย hypertension-related vascular function in African Americans
  1058. ฮฒโ€Blocker withdrawal is preferable for accurate interpretation of theย Aldosteroneโ€“renin ratio in chronically treatedย hypertension
  1059. โ€ฆ artery denervation improves pulmonary arterialย hypertensionย induced right ventricular dysfunction by modulating the local renin-angiotensin-Aldosteroneย โ€ฆ
  1060. Upregulation of the renin-angiotensin-Aldosterone-ouabain system in the brain is the core mechanism in the genesis of all types ofย hypertension
  1061. Does the ratio of serumย Aldosteroneย to plasma renin activity predict the efficacy of diuretics inย hypertension? Results of RENALDO
  1062. Crosstalk between the heme oxygenase system,ย Aldosterone, and phospholipase C inย hypertension
  1063. K+ and the reninโ€“angiotensinโ€“Aldosteroneย system: new insights into their role in blood pressure control andย hypertensionย treatment
  1064. Effect of renin-angiotensin-Aldosteroneย system blockade on long-term outcomes in postacute kidney injury patients withย hypertension
  1065. Aldosteroneย contributes to blood pressure variance and to likelihood ofย hypertensionย in normal-weight and overweight African Americans
  1066. Aldosterone, inactive matrix gla-protein, and large artery stiffness inย hypertension
  1067. โ€ฆ โ€“Aldosteroneย system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure inย obesity-relatedย hypertension: a double-blind โ€ฆ
  1068. Discovery of spirocyclicย Aldosteroneย synthase inhibitors as potential treatments for resistantย hypertension
  1069. What โ€œDrivesโ€ the Link Between the Reninโ€“Angiotensinโ€“Aldosteroneย System and the Prothrombotic State inย hypertension?
  1070. Renin-angiotensin-Aldosteroneย system in the pathogenesis of pregnancy-inducedย hypertension
  1071. CNS neuroplasticity and salt-sensitiveย hypertensionย induced by prior treatment with subpressor doses of ANG II orย Aldosterone
  1072. Pathophysiology and treatment of resistantย hypertension: the role ofย Aldosteroneย and amiloride-sensitive sodium channels
  1073. Endogenous ouabain and the reninโ€“angiotensinโ€“Aldosteroneย system: distinct effects on Na handling and blood pressure in humanย hypertension
  1074. PVN adenovirus-siRNA injections silencing either NOX2 or NOX4 attenuateย Aldosterone/NaCl-inducedย hypertensionย in mice
  1075. Reninโ€“angiotensinโ€“Aldosteroneย system gene polymorphisms in gestationalย hypertensionย and preeclampsia: A caseโ€“control gene-association study
  1076. Management of resistantย hypertension:ย Aldosteroneย antagonists or intensification of diuretic therapy?
  1077. Urinaryย Aldosterone-to-active-renin ratio: a useful tool for predicting resolution ofย hypertensionย after adrenalectomy in patients withย Aldosterone-producing adenomas
  1078. Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistantย hypertensionย independent ofย Aldosteroneย status
  1079. Sodium pumps, ouabain andย Aldosteroneย in the brain: A neuromodulatory pathway underlying salt-sensitiveย hypertensionย and heart failure
  1080. Persistentย hypertensionย after adrenalectomy for anย Aldosterone-producing adenoma: weight as a critical prognostic factor forย Aldosteroneโ€˜s lasting effect on the cardiac โ€ฆ
  1081. Combination therapy with reninโ€angiotensinโ€Aldosteroneย receptor blockers forย hypertension: how far have we come?
  1082. Aldosterone, cognitive function, and cerebral hemodynamics inย hypertensionย and antihypertensive therapy
  1083. The effect of catheter based renal synthetic denervation on renin-angiotensin-Aldosteroneย system in patients with resistantย hypertension
  1084. โ€ฆ -andย Aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterialย hypertension
  1085. CYP11B2 gene haplotypes independently and in concurrence withย Aldosteroneย andย Aldosteroneย to renin ratio increase the risk ofย hypertension
  1086. T allele ofโˆ’ 344C/T polymorphism inย Aldosteroneย synthase gene is not associated with resistantย hypertension
  1087. New drug therapies interfering with the reninโ€“angiotensinโ€“Aldosteroneย system for resistantย hypertension
  1088. Effects of T-type calcium channel blockers on renal function andย Aldosteroneย in patients withย hypertension: a systematic review and meta-analysis
  1089. Clinical value of measuring the renin/Aldosteroneย levels: optimising the management of uncontrolled/resistantย hypertension
  1090. ฮฒ2-Adrenergic receptor genotype affects the renin-angiotensin-Aldosteroneย system response to the Dietary Approaches to Stopย hypertensionย (DASH) dietary pattern
  1091. Clinical effects of eplerenone, a selectiveย Aldosteroneย blocker, in Japanese patients with essentialย hypertension
  1092. Discovery of indazoleย Aldosteroneย synthase (CYP11B2) inhibitors as potential treatments forย hypertension
  1093. โ€ฆย Aldosteroneย synthase CYP11B2 (-344T/C) gene polymorphism and antihypertensive response to valsartan in Chinese patients with essentialย hypertension
  1094. Common genetic variations of the reninโ€“angiotensinโ€“Aldosteroneย system and response to acute angiotensin I-converting enzyme inhibition in essentialย hypertension
  1095. Five Reasons for the Failure to Diagnoseย Aldosteroneย Excess inย hypertension
  1096. Graz Endocrine Causes ofย hypertensionย (GECOH) study: a diagnostic accuracy study ofย Aldosteroneย to active renin ratio in screening for primary โ€ฆ
  1097. Relationship betweenโˆ’ 344T/C polymorphism in theย Aldosteroneย synthase gene and atrial fibrillation in patients with essentialย hypertension
  1098. Microalbuminuria and plasmaย Aldosteroneย levels in nondiabetic treatment-naรฏve patients withย hypertension
  1099. Serumย Aldosteroneย is related to left ventricular geometry and function in young adults with never-treated primaryย hypertension
  1100. Aldosterone-producing adrenocortical carcinoma withoutย hypertension
  1101. Association ofโˆ’ 344C/T polymorphism in theย Aldosteroneย synthase (CYP11B2) gene with cardiac and cerebrovascular events in Chinese patients withย hypertension
  1102. Targeting the Reninโ€“Angiotensinโ€“Aldosteroneย System to Preventย hypertensionย and Kidney Disease of Developmental Origins
  1103. Predictors of resolution ofย hypertensionย after adrenalectomy in patients withย Aldosterone-producing adenoma
  1104. โ€ฆ of plasma renin, angiotensin, andย Aldosteroneย levels to blood pressure variability and target organ damage in children with essentialย hypertension
  1105. Oestrogen receptors and T cells determine how sex affectsย Aldosterone-inducedย hypertension
  1106. Relationship ofย Aldosteroneย synthase gene (C-344T) and mineralocorticoid receptor (S810L) polymorphisms with gestationalย hypertension
  1107. Decreased mortality of COVID-19 with renin-angiotensin-Aldosteroneย system inhibitors therapy in patients withย hypertension: a meta-analysis
  1108. Aldosteroneย and stress-dependent arterialย hypertension
  1109. Role ofย Aldosterone, mitogenic growth factors, apoptosis inducers and pulmonary arterialย hypertensionย in the formation and progression of chronic pulmonary โ€ฆ
  1110. hypertensionย and depressed symptomatology: a cluster related to the activation of the reninโ€“angiotensinโ€“Aldosteroneย system (RAAS). Findings from population โ€ฆ
  1111. Body mass index predicts 24-hour urinaryย Aldosteroneย levels in patients with resistantย hypertension
  1112. Pattern of adrenal hormonal secretion in patients with adrenal adenomas: the relevance ofย Aldosteroneย in arterialย hypertension
  1113. Association of elevated plasmaย Aldosterone-to-renin ratio with future cardiovascular events in patients with essentialย hypertension
  1114. Association of post-saline load plasmaย Aldosteroneย levels with left ventricular hypertrophy in primaryย hypertension
  1115. โ€ฆ association and synergistic effect of humanย Aldosteroneย synthase (CYP11B2) gene polymorphisms causing susceptibility to essentialย hypertensionย in Indian patients
  1116. Aldosteroneย and mineralocorticoid receptor antagonists on pulmonaryย hypertensionย and right ventricular failure: A review
  1117. Secondaryย hypertensionย due to concomitantย Aldosterone-producing adenoma and parathyroid adenoma
  1118. Aldosteroneย excess and resistantย hypertension: investigation and treatment
  1119. hypertensionย and longevity: role of genetic polymorphisms in renin-angiotensin-Aldosteroneย system and endothelial nitric oxide synthase
  1120. Mizoribine ameliorates renal injury andย hypertensionย along with the attenuation of renal caspase-1 expression inย Aldosterone-salt-treated rats
  1121. Association between urineย Aldosteroneย and diastolic function in patients with primary aldosteronism and essentialย hypertension
  1122. Effect of postural changes onย Aldosteroneย to plasma renin ratio in patients with suspected secondaryย hypertension
  1123. Arterialย hypertension,ย Aldosterone, and Atrial Fibrillation
  1124. Associations of reninโ€“angiotensinโ€“Aldosteroneย system genes with blood pressure changes andย hypertensionย incidence
  1125. โ€ฆ complex 1 subunit raptor byย Aldosteroneย induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterialย hypertension
  1126. โ€ฆ ofย Aldosteroneย blockade and diuretic reinforcement vs. dual reninโ€“angiotensin blockade for left ventricular mass regression in patients with resistantย hypertension
  1127. Aldosteroneย to active renin ratio is associated with nocturnal blood pressure in obese and treated hypertensive patients: the Styrianย hypertensionย Study
  1128. โ€ฆ trial of azilsartan and olmesartan comparing effects on the renin-angiotensin-Aldosteroneย system in patients with essentialย hypertensionย after cardiac surgery (CHAOS โ€ฆ
  1129. โ€ฆ outcomes of laparoscopicโ€based renal denervation plus adrenalectomy vs adrenalectomy alone for treating resistantย hypertensionย caused by unilateralย Aldosteroneย โ€ฆ
  1130. The role of the renin-angiotensin-Aldosteroneย system in renal artery stenosis, renovascularย hypertension, and ischemic nephropathy: diagnostic implications
  1131. โ€ฆ renin activity andย Aldosteroneย concentration with ambulatory blood pressure responses to nebivolol and valsartan, alone and in combination, inย hypertension
  1132. Clinical features of COVID-19 in patients with essentialย hypertensionย and the impacts of renin-angiotensin-Aldosteroneย system inhibitors on the prognosis of COVID-19 โ€ฆ
  1133. Aldosterone-producing adrenal adenoma and idiopathic intracranialย hypertensionโ€”a pathogenetic link forย Aldosterone?
  1134. Unravelling drug-inducedย hypertension: molecular mechanisms ofย Aldosterone-independent mineralocorticoid receptor activation by posaconazole
  1135. Aldosteroneย a relevant factor in the beginning and evolution of arterialย hypertension
  1136. Long-term effect of efonidipine therapy on plasmaย Aldosteroneย and left ventricular mass index in patients with essentialย hypertension
  1137. Serum potassium levels predict blood pressure response toย Aldosteroneย antagonists in resistantย hypertension
  1138. Association of the K173R variant and haplotypes in theย Aldosteroneย synthase gene with essentialย hypertension
  1139. The Effects of Salt and Glucose Intake on Angiotensin II andย Aldosteroneย in Obese and Nonobese Patients with Essentialย hypertension
  1140. Resistantย hypertensionย characterized by increasedย Aldosteroneย levels and persistent intravascular volume expansion
  1141. โ€ฆ C-344T, angiotensin II type 1 receptor A1166C and 11-ฮฒ hydroxysteroid dehydrogenase G534A gene polymorphisms and essentialย hypertensionย in the population of โ€ฆ
  1142. Predictors of hyperkalemia risk afterย hypertensionย control withย Aldosteroneย blockade according to the presence or absence of chronic kidney disease
  1143. Clock genes and salt-sensitiveย hypertension: a new type ofย Aldosterone-synthesizing enzyme controlled by the circadian clock and angiotensin II
  1144. Dysregulation of renal transient receptor potential melastatin 6/7 but not paracellin-1 inย Aldosterone-inducedย hypertensionย and kidney damage in a model of hereditary โ€ฆ
  1145. Immune system alterations byย Aldosteroneย duringย hypertension: from clinical observations to genomic and non-genomic mechanisms leading to vascular damage
  1146. A novel haplotype of low-frequency variants in theย Aldosteroneย synthase gene among northern Han Chinese with essentialย hypertension
  1147. Association of DNA polymorphisms within the CYP11B2/CYP11B1 locus and postoperativeย hypertensionย risk in the patients withย Aldosterone-producing adenomas
  1148. Role of renin-angiotensin-Aldosteroneย system gene polymorphisms andย hypertension-induced end-stage renal disease in autosomal dominant polycystic kidney โ€ฆ
  1149. Abnormal regulation of renin angiotensinย Aldosteroneย system is associated with right ventricular dysfunction inย hypertension
  1150. Microalbuminuria andย hypertensionย in pregnancy: role ofย Aldosteroneย and inflammation
  1151. Galectin-3 andย Aldosteroneย as potential tandem biomarkers in pulmonary arterialย hypertension
  1152. The association of plasma resistin with dietary sodium manipulation, the reninโ€angiotensinโ€Aldosteroneย system, and 25โ€Hydroxyvitamin D3 in humanย hypertension
  1153. The role ofย Aldosteroneย in myocardial dysfunction of Egyptian patients with essentialย hypertension
  1154. Aldosteroneย contributed to pulmonary arterialย hypertensionย development via stimulating aquaporin expression and pulmonary arterial smooth muscle cells โ€ฆ
  1155. Renal ischemia-reperfusion leads toย hypertensionย and changes in proximal tubule Na+ transport and renin-angiotensin-Aldosteroneย system: Role of NADPH oxidase
  1156. Inefficient arterialย hypertensionย control in patients with metabolic syndrome and its link to reninโ€“angiotensinโ€“Aldosteroneย system polymorphisms
  1157. An overview of the classical and tissue-derived renin-angiotensin-Aldosteroneย system and its genetic polymorphisms in essentialย hypertension
  1158. A not-so-modest proposal that a โ€œmodestโ€ increase inย Aldosteroneย causesย hypertensionย and more
  1159. Role of angiotensinogen and relativeย Aldosteroneย excess in salt-sensitiveย hypertension
  1160. Paradoxical increase of 24-hour urinaryย Aldosteroneย levels in obese patients with resistantย hypertensionย on a high salt diet
  1161. โ€ฆ angiotensin II andย Aldosteroneย secretion in patients with pressure overloaded systemic right ventricles are similar to those observed in systemic arterialย hypertension
  1162. Effect of Renin-Angiotensin-Aldosteroneย System inhibitors on outcomes of COVID-19 patients withย hypertension: Systematic review and Meta-analysis
  1163. Association ofย Aldosterone-to-renin ratio withย hypertensionย differs by sodium intake: the Ohasama study
  1164. Improving vascular function inย hypertension: potential benefits of combination therapy with amlodipine and reninโ€“angiotensinโ€“Aldosteroneย system blockers
  1165. Aldosteroneย andย hypertensionย in African Americans
  1166. Central endogenous angiotensin-(1โ€“7) protects againstย Aldosterone/NaCl-inducedย hypertensionย in female rats
  1167. Difficult-to-controlย hypertensionย due to bilateralย Aldosterone-producing adrenocortical microadenomas associated with a cortisol-producing adrenal โ€ฆ
  1168. Role of pendrin in the pathophysiology ofย Aldosterone-inducedย hypertension
  1169. โ€ฆย Aldosteroneย synthase (CYP11B2) inhibitors: Old drugs disclose new applications for the therapy of congestive heart failure, myocardial fibrosis andย hypertension
  1170. Aldosteroneย antagonists or renin-guided therapy for treatment-resistantย hypertension: a comparative effectiveness pilot study in primary care
  1171. Genetic and functional analyses ofย Aldosteroneย synthase gene C-344T polymorphism with essentialย hypertension
  1172. A systemic review of the relationship betweenย Aldosteroneย synthaseโ€“344 C/T polymorphism andย hypertensionย in Han
  1173. โ€ฆ approach to the management of high blood pressure: efficacy and tolerability of theย Aldosteroneย synthase inhibitor LCI699 in patients with stage 1-2ย hypertension
  1174. Resistantย hypertensionย On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-Aldosteroneย system โ€ฆ
  1175. Plasmaย Aldosteroneย concentration is positively associated with pulse pressure in patients with primaryย hypertension
  1176. New therapeutic options in patients prone toย hypertension: a focus on direct renin inhibition andย Aldosteroneย blockade
  1177. Association between elevated plasmaย Aldosteroneย concentration and left atrial conduit function inย hypertension
  1178. Low plasma renin activity and highย Aldosterone/renin ratio are associated with untreated isolated systolicย hypertension
  1179. Association of theย Aldosteroneย synthase geneโˆ’ 344T> C polymorphism with essentialย hypertensionย and glucose homeostasis: A caseโ€“control study in a Han Chinese โ€ฆ
  1180. Effects of Olmesartan on the Renin-angiotensin-Aldosteroneย System for Patients with Essentialย hypertensionย after Cardiac Surgeryโ€”Investigation Using a โ€ฆ
  1181. Polymorphism of genes of renin-angiotensin-Aldosteroneย system in the development ofย hypertensionย in workers exposed to physical factors
  1182. Renin-angiotensin-Aldosteroneย system and pathobiology ofย hypertension
  1183. Ins and outs ofย Aldosterone-producing adenomas of the adrenal: from channelopathy to common curable cause ofย hypertension
  1184. โ€ฆ administration on the relationship between renin-angiotensin-Aldosteroneย system activity and plasma glucose in patients withย hypertension
  1185. Effect ofย Aldosteroneย antagonists on obstructive sleep apnea in patients with resistantย hypertension: a systematic review and meta-analysis
  1186. The role ofย Aldosteroneย inย hypertension
  1187. The role ofย Aldosteroneย in kidney diseases andย hypertension. Is it worth using mineralocorticoid receptor antagonists in clinical practice?
  1188. Sodium chloride andย Aldosterone: harbingers ofย hypertension-related cardiovascular disease
  1189. Gene mutations that promote adrenalย Aldosteroneย production, sodium retention, andย hypertension
  1190. Elevated Renin andย Aldosteroneย Levels in a Young Woman Withย hypertension
  1191. Endocrine causes ofย hypertension:ย Aldosterone
  1192. Acetaminophen increasesย Aldosteroneย secretion while suppressing cortisol and androgens: a possible link to increased risk ofย hypertension
  1193. Areโ€ functionally related polymorphismsโ€ of renin-angiotensin-Aldosteroneย system gene polymorphisms associated withย hypertension?
  1194. Effect of felodipine on myocardial and renal injury induced byย Aldosterone-high saltย hypertensionย in uninephrectomized rats
  1195. Effect of electroacupuncture of different acupoints on blood pressure, plasma angiotensin II,ย Aldosteroneย and atrial natriuretic peptide in spontaneousย hypertensionย โ€ฆ
  1196. The impact of anย Aldosteroneย synthase (CYP11B2) polymorphism on vascular function and inflammatory biomarkers in essentialย hypertension
  1197. The Role ofย hypertensionย and Renin-angiotensin-Aldosteroneย System Inhibitors in Bleomycin-induced Lung Injury
  1198. Rates of hospitalization associated with the use ofย Aldosteroneย receptor antagonists in patients with pulmonary arterialย hypertension
  1199. Differences of blood plasma renin activity, angiotensin II andย Aldosteroneย levels in essential or secondaryย hypertension
  1200. The role of renin-angiotensinย Aldosteroneย system related micro-ribonucleic acids inย hypertension
  1201. Renin-angiotensin-Aldosteroneย system in the elderly: rational use of aliskiren in managingย hypertension
  1202. A systematic review on randomized control trials on rennin angiotensinย Aldosteroneย system inhibitors role in managingย hypertensionย among hemodialysis patients
  1203. Gene expression profile of persistent postoperativeย hypertensionย patients withย Aldosterone-producing adenomas
  1204. Increased plasmaย Aldosterone-to-renin ratio is associated with impaired left ventricular longitudinal functional reserve in patients with uncomplicatedย hypertension
  1205. Polymorphism of theย Aldosteroneย synthase gene is not associated with progression of diabetic nephropathy, but associated withย hypertensionย in type 2 diabetic โ€ฆ
  1206. Chronic kidney disease progression in patients with resistantย hypertensionย subject to 2 therapeutic strategies: Intensification with loop diuretics vsย Aldosteroneย โ€ฆ
  1207. What is the role ofย Aldosteroneย excess in resistantย hypertensionย and how should it be investigated and treated?
  1208. Obstructive sleep apnea syndromeโ€“relatedย hypertensionย and sarcopenia: a brief glance on the renin-angiotensin-Aldosteroneย system
  1209. Of hammers and screws: reninโ€“angiotensinโ€“Aldosteroneย system inhibition to prevent atrial fibrillation in patients withย hypertension
  1210. Preeclampsia: the role ofย Aldosteroneย inย hypertensionย and inflammation
  1211. CaseReport:ย Aldosterone-secreting adrenal carcinoma complicating longstandingย hypertension
  1212. Role of Nox2 and p22phox in persistent postoperativeย hypertensionย inย Aldosterone-producing adenoma patients after adrenalectomy
  1213. Is renal denervation an alternative or a complement toย Aldosteroneย antagonists in treatment of resistantย hypertension?
  1214. โ€ฆ โ€based renal denervation plus unilateral laparoscopic adrenalectomy for the treatment of patients with resistantย hypertensionย caused by unilateralย Aldosteroneย โ€ฆ
  1215. Renin-Angiotensin-Aldosteroneย System Inhibitor Use and Mortality in Pulmonaryย hypertension: Insights from the Veterans Affairs Clinical Assessment Reporting and โ€ฆ
  1216. โ€ฆ ofย Aldosteroneย on Senescence and Proliferation Inhibition of Endothelial Progenitor Cells Induced by Sirtuin 1 (SIRT1) in Pulmonary Arterialย hypertension
  1217. The role of reninโ€“angiotensinโ€“Aldosteroneย system in etiology and pathogenesis of arterialย hypertensionย and its systemic complicationsโ€”what remains from Laragh โ€ฆ
  1218. Resistantย hypertensionย in the elderly-second line treatments:ย Aldosteroneย antagonists, central alpha-agonist agents, alpha-adrenergic receptor blockers, direct โ€ฆ
  1219. โ€ฆ ineffectiveย hypertensionย control in subjects treated with angiotensin-converting enzyme inhibitors is related to polymorphisms in the renin-angiotensin-Aldosteroneย โ€ฆ
  1220. Female sex hormones are associated with the reduction of serum sodium andย hypertensionย complications in patients withย Aldosterone-producing adenoma
  1221. Aldosterone, gut microbiome andย hypertension: selected papers from APCH 2019
  1222. โ€ฆ of British Clinical Diabetologists (ABCD) and Renal Association clinical guidelines:ย hypertensionย management and renin-angiotensin-Aldosteroneย system blockade in โ€ฆ
  1223. A cross-sectional study on factors associated withย hypertensionย and genetic polymorphisms of renin-angiotensin-Aldosteroneย system in Chinese hui pilgrims โ€ฆ
  1224. Novel marker of myocardial remodeling ST2 and the influence ofย Aldosteroneย antagonist in patients with heart failure caused byย hypertensionย and ischemic heart โ€ฆ
  1225. Untangling essentialย hypertension: the potential roles ofย Aldosteroneย and atrial natriuretic peptide
  1226. The role ofย Aldosteroneย receptor blocker therapy inย hypertensionย and heart failure
  1227. Long-term use ofย Aldosterone-receptor antagonists in uncontrolledย hypertension: a retrospective analysis
  1228. Role of vasopressin andย Aldosteroneย in pulmonary arterialย hypertension: A pilot study
  1229. Proinflammatory/profibrotic effects ofย Aldosteroneย in Gitelmanโ€™s syndrome, a human model opposite toย hypertension
  1230. Progression of renal insufficiency in patients with essentialย hypertensionย treated with renin angiotensinย Aldosteroneย system blockers: an electrocardiographic โ€ฆ
  1231. Polymorphic variation of CYP11B2 predicts postoperative resolution ofย hypertensionย in patients undergoing adrenalectomy forย Aldosteroneโ€producing adenomas
  1232. Association ofย Aldosteroneย synthase (CYP11B2) gene-344T/C polymorphism with essentialย hypertensionย in Mongolian nationality
  1233. Estrogen receptor-beta (ERฮฒ) in the PVN and RVLM plays an essential protective role inย Aldosterone/salt-inducedย hypertensionย in female rats
  1234. Regulators of Epithelial Sodium Channels inย Aldosterone-Sensitive Distal Nephrons (ASDN): Critical Roles of Nedd4L/Nedd4-2 and Salt-Sensitiveย hypertension
  1235. Aldosteroneย does not contribute to renal p21 expression during the development of angiotensin II-inducedย hypertensionย in mice
  1236. Cardiovascular responses to chronic baroreflex activation inย Aldosteroneย hypertension
  1237. Blind spots in the new International Society ofย hypertensionย guidelines: physiologically individualized therapy for resistantย hypertensionย based on renin/Aldosteroneย โ€ฆ
  1238. hypertensionย and the renin-angiotensin-Aldosteroneย system
  1239. Synergic effects of renin andย Aldosteroneย on right ventricular function inย hypertension: a tissue Doppler study
  1240. Aldosterone-saltย hypertensionย depends on the SFO, centralย Aldosteroneย synthase and MR specifically in the PVN
  1241. โ€ฆ effects of renin-angiotensin-Aldosteroneย inhibitor and ฮฒ-blocker combination therapy vs. ฮฒ-blocker monotherapy for portalย hypertensionย in cirrhosis: A meta โ€ฆ
  1242. โ€ฆ regulation of blood pressure: focus on โ€œRole of central nervous systemย Aldosteroneย synthase and mineralocorticoid receptors in salt-inducedย hypertensionย in Dahl salt โ€ฆ
  1243. Use of Renin-Angiotensin-Aldosteroneย System Inhibitors and Severe COVID-19 Outcomes in Patients withย hypertension: A Nationwide Cohort Study
  1244. RENIN,ย Aldosterone, THEย Aldosterone-TO-RENIN RATIO AND INCIDENT ARTERIALย hypertensionย AMONG NORMOTENSIVE SUBJECTS FROM THE โ€ฆ
  1245. Blockers of renin-angiotensin-Aldosteroneย system in the treatment of arterialย hypertension: classics versus the modern
  1246. Highย Aldosterone,ย hypertensionย and adrenal adenoma in a 36-year-old pregnant patient: Is this primary aldosteronism?
  1247. P3486 Cytokine profile, renin-angiotensinย Aldosteroneย system and left ventricular remodelling in essential arterialย hypertensionย comorbid with chronic obstructive โ€ฆ
  1248. โ€ฆ the reninโ€“angiotensinโ€“Aldosteroneย system and reduces blood pressure and albuminuria in elderly chronic kidney disease patients withย hypertension
  1249. SAT-224 Recurrent Co-Driver Mutation in CTNNB1-Mutantย Aldosterone-producing Adenomas (APA), Causing Reversibleย hypertensionย in Puberty, Pregnancy or โ€ฆ
  1250. Stimulation ofย Aldosteroneย synthesis by angiotensin II in the brain: support for positive feedback inย hypertension?
  1251. Na+-Clโˆ’ cotransporter-mediated chloride uptake contributes toย hypertensionย and renal damage inย Aldosterone-infused rats
  1252. Role of relativeย Aldosteroneย excess in salt-sensitiveย hypertensionย among African ancestry
  1253. Hormones other thanย Aldosteroneย may contribute toย hypertensionย in 3 different subtypes of primary aldosteronism
  1254. P3568 The relationship between plasma renin andย Aldosteroneย levels and the reduction of blood pressure with spironolactone in patients with resistantย hypertension
  1255. Role ofย Aldosteroneย Antagonists in Treatment of Refractoryย hypertensionย [J]
  1256. INTERACTION OFย Aldosteroneย AND SODIUM AFFECTS PREVALENCE OF ATRIAL FIBRILLATION IN PATIENTS WITH RESISTANTย hypertension
  1257. Oxidative Stress inย hypertensionย and Cardiovascular-Renal Remodeling: Focus on the Renin-Angiotensin-Aldosteroneย System
  1258. Evaluating the relationship of blood pressure, plasma angiotensin peptides andย Aldosteroneย with cognitive functions in patients withย hypertension
  1259. JS ISH-ECCR-4 The plasmaย Aldosterone/angiotensin II ratio for the screening of secondaryย hypertension
  1260. โ€ฆ characteristics of subclinical target organ damage in urban adult residents withย hypertensionย in Tianjin and its relationships with renin-angiotensin-Aldosteroneย โ€ฆ
  1261. PRINCIPAL COMPONENTS OF POLYSOMNOGRAPHY POTENTIALLY EFFECT ONย Aldosterone-RENIN-RATIO IN SNORERS WITHย hypertension
  1262. Impairedย Aldosteroneย response to the saline infusion test in patients with resistantย hypertensionย and obstructive sleep apnea
  1263. Deficiency of T-type Ca2+ channels Cav3.1 and Cav3.2 has no effect on angiotensin II-inducedย hypertensionย but differential effect on plasmaย Aldosteroneย in mice
  1264. Aldosterone,ย hypertension, and Cardiovascular Disease
  1265. GW29-e0446 The Biomarker of Atrial Fibrillation in Patients with Essentialย hypertensionโ€“Aldosterone
  1266. Effects of Interactions among Gene Polymorphisms of the Reninโ€“Angiotensin-Aldosteroneย System onย hypertensionย in Turkish People from Southeast Anatolia
  1267. Effect of sodiumโ€“glucose cotransporter-2 inhibitors onย Aldosterone-to-renin ratio in diabetic patients withย hypertension: a retrospective observational study
  1268. Aldosteroneย renin ratio in patients with resistantย hypertension
  1269. Aldosteroneย escape in treatment of essentialย hypertensionย with RAS blockers [J]
  1270. Association of Urine Na: K with Renin andย Aldosteroneย at Baseline in Pediatricย hypertension
  1271. Diagnosis of Primary Aldosteronism and Usefulness ofย Aldosterone/Renin Ratio in Secondaryย hypertension
  1272. Increasedย Aldosteroneย release during head-up tilt in early primaryย hypertension
  1273. Polymorphic variants of the renin-angiotensin-Aldosteroneย system genes associated with the risk ofย hypertensionย development
  1274. Aldosterone-Renin Ratio Is Determinant of Arterial Stiffness in Large Cohort of Patients With Severe Essentialย hypertension: Pp. 10.410
  1275. Renin-angiotensin-Aldosteroneย inhibitors for treatment ofย hypertensionย with abnormal circadian rhythm of blood pressure
  1276. Direct versus enzymatic renin measurement for the calculation ofย Aldosterone/renin ratio in patients with essentialย hypertensionย and with primary hyperaldosteronism
  1277. Estimation of Serumย Aldosteroneย and Electrolytes in Pregnancy Inducedย hypertension
  1278. Choice of an Optimal Blocker of the Renin-Angiotensin-Aldosteroneย System in Patients With Concomitant Arterialย hypertensionย and Chronic Obstructive Pulmonary โ€ฆ
  1279. โ€ฆ Global Versus Renal-Specific Sympathoinhibition inย Aldosterone-Inducedย hypertension: Implications for Medical Device-Based Treatment of Resistantย hypertension
  1280. ALISKIREN, BOTH AS MONOTHERAPY AND IN COMBINATION WITH VALSARTAN, REDUCES PLASMAย Aldosteroneย IN PATIENTS WITHย hypertension: PP โ€ฆ
  1281. Estimation of the renin-angiotensin-Aldosteroneย system, water and electrolyte imbalance and endothelial function in newborns of women with chronicย hypertension
  1282. โ€ฆ Chronic kidney disease progression in patients with resistantย hypertensionย subject to two therapeutic strategies: intensification with loop diuretics vsย Aldosteroneย โ€ฆ
  1283. Renin-angiotensin-Aldosteroneย System Blockers,ย hypertensionย and Clinical Outcomes
  1284. COVIDโ€19,ย hypertension, and reninโ€angiotensinโ€Aldosteroneย system inhibitors: Much ado about nothing or real problem to be solved?
  1285. Roles ofย Aldosteroneย Receptor Antagonists in Heart Failure,ย hypertension, and Chronic Kidney Disease
  1286. Is there truly a sympathetic component toย Aldosteroneย hypertension?
  1287. Aldosteroneย Biosynthesis: Genetic Control and Contribution to the Development of Arterialย hypertension
  1288. Letter by Zhou and Zhou Regarding Article,โ€œhypertension: Reninโ€“Angiotensinโ€“Aldosteroneย System Alterationsโ€
  1289. A5917 Principal Component Analysis and Correlated Effect onย Aldosterone-renin-ratio in Snorers withย hypertension
  1290. The blockade of renin-angiotensin-Aldosteroneย system in hemodialysis patients to controlย hypertensionย and prevent cardiovascular disease: optimal pharmacotherapy
  1291. Aldosterone-Producing Cell Clusters in Essentialย hypertension
  1292. Abstract MP13: TRPM7 Downregulation Contributes To Cardiovascular Injury Andย hypertensionย Induced Byย Aldosteroneย And Salt
  1293. P1872 Fixed combinations of renin-angiotensin-Aldosteroneย system inhibitors and calcium channel blockers in relation of patients adherence inย hypertension
  1294. โ€ฆ between Chronic Use of Reninโ€“Angiotensin-Aldosteroneย System Blockers and in-Hospital Adverse Events among COVID-19 Patients withย hypertension
  1295. Vascular and endothelial function in humanย hypertension, and the importance of the renin-angiotensin-Aldosteroneย system
  1296. Association between polymorphism of the angiotensin-converting enzyme gene and theย Aldosteroneย synthase gene in pedigreed primaryย hypertension.
  1297. Aldosteroneย synthase, polymorphism of its CYP11B2 gene in arterialย hypertensionย and cardiovascular diseases associated with it (literature review)
  1298. Regulation of Biogenesis and Fusion/Fission Processes of Vascular Mitochondria Inย Aldosterone-Inducedย hypertension
  1299. Fibroblast Growth Factor-23, Heart Failure Risk, and Reninโ€“Angiotensinโ€“Aldosterone-System Blockade inย hypertension: The MESA Study
  1300. Serumย Aldosteroneย Levels inย hypertension
  1301. Plasma renin activity, serumย Aldosteroneย concentration and selected organ damage indices in essential arterialย hypertension
  1302. Steroidogenic acute regulatory protein/Aldosteroneย synthase participates in signaling of angiotensin II/Aldosterone-induced aortic remodeling andย hypertension
  1303. A6748 The Effect of Physiological Phenotyping with Plasma Renin andย Aldosteroneย on Uncontrolledย hypertension
  1304. Gender Differences in theย Aldosteroneย Level of Young Obese Patients Withย hypertension
  1305. hypertensionย with Metabolic Alkalosis and Hypokalaemia-Could it beย Aldosterone?
  1306. Abstract P249: Central Nervous System Control of Plasmaย Aldosteroneย and Endogenous Ouabain in Angiotensin II-Saltย hypertension
  1307. Central injections of adenoโ€associated virusโ€siRNA gene to silence estrogen receptor beta (ERฮฒ) augmentย Aldosteroneโ€inducedย hypertensionย in female rats
  1308. A14580 Predictors of the results of the diagnostic tests for the primary hyperaldosteronism in patients withย hypertensionย and anย Aldosterone-to-renin ratio greater than โ€ฆ
  1309. Roles ofย Aldosterone, mineralocorticoid inhibition and G6PD activity in microvascular endothelial dysfunction in African Americans withย hypertension
  1310. Contribution of rennin-angiotensin-Aldosteroneย system genes and NO synthase gene to the development of arterialย hypertension
  1311. Aldosteroneโ€“Renin Ratio and Side-Selective Renal Perfusion in Essentialย hypertension
  1312. A2074 FAILURE OF SUPPRESSION OF THE RENIN ANGIOTENSINย Aldosteroneย SYSTEM A POSSIBLE MECHANISM OF ESSENTIALย hypertension
  1313. Optimising Renin-Angiotensin-Aldosteroneย System Inhibitor Therapy In Heart Failure And Resistantย hypertension: Challenges And Solutions
  1314. Response to Letter to Regarding Article,โ€œEffects of Novelย Aldosteroneย Synthase Inhibitor for Treatment of Primaryย hypertension: Results of a Randomized, Double โ€ฆ
  1315. The role ofย Aldosteroneย andย Aldosteroneย blockade inย hypertension
  1316. PREGNANCY INDUCEDย hypertensionย AND ITS RELATION TO VITAMIN D ANDย Aldosteroneย IN IRAQI PREGNANT WOMEN
  1317. G PROTEIN-COUPLED ESTROGEN RECEPTORS: NOVEL THERAPEUTIC TARGETS INย Aldosterone/SALT-INDUCEDย hypertension?
  1318. Aldosteroneย METABOLITES AND POSSIBLEย Aldosteroneย PRECURSORS INย hypertension
  1319. Brain natriuretic peptide counteracting the Renin-angiotensin-Aldosteroneย system in accelerated malignantย hypertension
  1320. Reninโ€“angiotensinโ€“Aldosteroneย system inhibitors may benefit patients with comorbidย hypertensionย and COVID-19
  1321. A8790 nocturnalย hypertensionย renin-angiotensin-Aldosteroneย activation target organ damage
  1322. Mutation of an antiโ€aging gene klotho causesย hypertensionย via upregulation of plasmaย Aldosteroneย levels
  1323. Relationship betweenย Aldosteroneย escape phenomena and left ventricular hypertrophy in essentialย hypertensionย treated by RAS blocker
  1324. Role ofย Aldosteroneย in postmenopausalย hypertension
  1325. Aldosteroneย antagonists in the treatment ofย hypertension
  1326. Relationship between the CYP11B_2-344T/C polymorphism ofย Aldosteroneย synthase gene and essentialย hypertensionย in Uygur, Han and Kazak population in โ€ฆ
  1327. Letter by Keidar and Gamliel-Lazarovich Regarding Article,โ€œEffects of A Novelย Aldosteroneย Synthase Inhibitor for Treatment of Primaryย hypertension: Results of a โ€ฆ
  1328. A5791 Analysis of biochemistry and angiotensin I, angiotensin II andย Aldosteroneย in Kazakh and Uygur primaryย hypertensionย in Xinjiang
  1329. Mutation of Anti-aging Gene Klotho Causesย hypertensionย via Upregulation of CYP11B2 Expression andย Aldosteroneย Syhthesis
  1330. A11744 Parameters of carotid structure and renin-Aldosteroneย system in patients with resistanceย hypertension
  1331. Rates of Hospitalization Associated with the Use ofย Aldosteroneย Receptor Antagonists in Patients with Pulmonary Arterialย hypertension
  1332. โ€ฆ the parameters of the renin-angiotensin-Aldosteroneย system, water-electrolyte metabolism, and endothelial function in newborns of women with chronicย hypertension
  1333. The Role ofย Aldosteroneย in Pulmonary Venousย hypertension
  1334. โ€ฆ ) polymorphism as a component of the renin-angiotensin-Aldosteroneย system in the pathogenesis of myocardial hypertrophy inย hypertension: literature review and own โ€ฆ
  1335. OS 29-05 renal denervation attenuatesย Aldosteroneย expression and associated cardiovascular pathophysiology in angiotensin II-inducedย hypertension
  1336. The Role ofย Aldosteroneย in Pulmonary Venousย hypertension: Response
  1337. The relationship between blood levels ofย Aldosteroneย and procollagen type โ…ข amino-terminal peptide with Left ventricular geometry in essentialย hypertensionย patients
  1338. Association of the-344T/C polymorphism ofย Aldosteroneย synthase gene CYP11 B2 with essentialย hypertensionย in Xinjiang uygur isolated group
  1339. โ€ฆ AGES, OFFICE BLOOD PRESSURE, EGFR, RENIN,ย Aldosterone, METANEPHRYLS LEVELS IN PATIENTS WITH RESISTANTย hypertension
  1340. Na+-Clโˆ’ cotransporter-mediated chloride uptake contributes toย hypertensionย and renal damage inย Aldosterone-infused rats 2
  1341. Areย Aldosteroneย antagonists effective for treatingย hypertension?
  1342. Pulmonaryย hypertensionย and Right Ventricular Dysfunction Identify Subgroups of Patients With HFpEF That Benefit Fromย Aldosteroneย Antagonist Therapy
  1343. โ€ฆ control with additive administration of eplerenone, anย Aldosteroneย receptor blocker, in a patient with bilateral renovascularย hypertensionย treated with angioplasty
  1344. Elevated Plasma Renin Activity Caused by Accelerated-malignantย hypertensionย in a Patient withย Aldosterone-producing Adenoma Complicated with Renal โ€ฆ
  1345. A10337 Intervention ofย Aldosteroneย antagonist on immune inflammatory injury in patients with essentialย hypertension
  1346. Abstract P313: Age and Response of Plasmaย Aldosteroneย to Saline Infusion in Primaryย hypertension
  1347. โ€ฆ AND THE RENIN ANGIOTENSINย Aldosteroneย SYSTEM: DISTINCT EFFECTS ON NA HANDLING AND BLOOD PRESSURE IN HUMANย hypertension: 2C. 04
  1348. Correlation betweenย Aldosteroneย andย hypertensionย among resistant hypertensive patients
  1349. โ€ฆ promotes apoptosis resistance in pulmonary artery smooth muscle cells to modulate adverse pulmonary vascular remodeling in pulmonary arterialย hypertension
  1350. TRPM7 is Cardiovascular Protective inย Aldosterone-Inducedย hypertension
  1351. Aldosteroneย levels and the-344t/cย Aldosteroneย synthase in individuals with a family history ofย hypertension
  1352. โ€ฆ of renin-aniotensin-Aldosteroneย system is associated with improved left ventricular function in STEMI survivors without previousย hypertension: a two dimensional โ€ฆ
  1353. Comparison ofย Aldosterone/plasma rennin activity ratio amongย hypertensionย patients in different posture
  1354. The relation ofย hypertensionย andย Aldosterone-renin ratio with the severity of coronary artery disease in non-diabetic patients
  1355. Challengingย hypertension: M-Atrial Natriuretic Peptide Enhances Antihypertensive Actions of Furosemide and Attenuates the Activation ofย Aldosterone
  1356. PP. 26.08: MANAGEMENT OF RESISTANTย hypertensionย (RHT):ย Aldosteroneย ANTAGONISTS OR INTENSIFICATION OF DIURETIC THERAPY?
  1357. P4561 Patients adherence with fixed dose combinations of renin-angiotensin-Aldosteroneย system inhibitors inย hypertension
  1358. Sacubitril/Valsartan Mitigates โ€œAldosteroneย Breakthroughโ€ in Rats With Arterialย hypertensionย While Valsartan and Enalapril Do Not
  1359. Effect of 3-month CPAP treatment on blood pressure and serumย Aldosteroneย concentration in patients with resistantย hypertension
  1360. Effects of irbesartan on theย Aldosteroneย escape in essentialย hypertension
  1361. โ€ฆ six-month combination therapy using indapamide with amlodipine and renin-angiotensin-Aldosteroneย system blockers in patients with high-risk essentialย hypertension
  1362. Cholecalciferol supplementation is able to modulateย hypertensionย and plasmaย Aldosteroneย in SHRSP rats.
  1363. Arterialย hypertensionย progression and changing activity of reninangiotensin-Aldosteroneย and sympatho-adrenal systems
  1364. P616BNP and BMP4, two novel targets ofย Aldosteroneย inย hypertension
  1365. Abstract P113: Early Life Stress-Induced Increases in Urinaryย Aldosteroneย Precedes Renal Dysfunction andย hypertensionย in Male Mice Fed a High Fat Diet
  1366. Abstract P163: Masked Uncontrolledย hypertensionย in Treated Hypertensive Patients Have Heightened Out-Of-Clinicย Aldosteroneย Levels
  1367. Central blockade ofย Aldosteroneย synthase (AS) and lesion of the subfornical organ (SFO) attenuate subcutaneous (sc)ย Aldosteroneโ€inducedย hypertension
  1368. CHAPTER IV-Activation of the renalย Aldosterone/MR system in aging andย hypertension
  1369. Plasmaย Aldosterone, ANP,ย hypertensionย and Stage A and B Heart Failure in the General Community
  1370. Structural and Functional Insights intoย Aldosteroneย Synthase Interaction with Ligands and Redox Partner Proteins for Enhanced Treatment ofย hypertension
  1371. Study of the relationship between the depressurization ofย Aldosteroneย antagonists and plasmaย Aldosteroneย renin activity ratio (ARR) in refractorinessย hypertensionย โ€ฆ
  1372. The Use of Renin andย Aldosteroneย Profiling in the Treatment of Complexย hypertension
  1373. Role of cardiacย Aldosteroneย on the development of cardiac fibrosis in response toย hypertension
  1374. Suppression ofย Aldosteroneย Mediates Left Ventricular Hypertrophy Regression in Patients Withย hypertension
  1375. Central AT1R stimulation increases hypothalamicย Aldosterone: further evidence for a pivotal role of hypothalamicย Aldosteroneย in Ang II inducedย hypertension
  1376. Leptinโ€inducedย hypertensionย isย Aldosteroneย Dependent in Obese Females
  1377. The Expression of Renin-angiotensin-Aldosteroneย System in Primaryย hypertension
  1378. G protein-coupled estrogen receptors: novel therapeutic targets inย Aldosterone-inducedย hypertension?
  1379. Abstract P328: Evaluation of Hyperkalemia and the Use ofย Aldosteroneย Antagonists in Resistant and Secondaryย hypertensionย in aย hypertensionย Referral Center
  1380. Decreased klotho expression in earlyย Aldosteroneโ€inducedย hypertension
  1381. The Correlation between Essentialย hypertensionย and Renin-angiotensin-Aldosteroneย System
  1382. ALTERATION OFย Aldosteroneย RESPONSE TO SALT OVERLOAD THROUGH CHRONIC KIDNEY DISEASE IN PATIENTS WITHย hypertension
  1383. Severity of obstructive sleep apnea dependent uponย Aldosteroneย status in subjects with resistantย hypertension
  1384. Leptin-mediatedย Aldosteroneย Secretion Causesย hypertensionย in Obese Females
  1385. Cilnidipine Decreases Insulin Resistance andย Aldosteroneย Levels in Essentialย hypertension
  1386. An increasedย Aldosterone-to-renin ratio in patients with non-dipperย hypertension
  1387. SEVERITY OF OBSTRUCTIVE SLEEP APNEA RELATED TOย Aldosteroneย LEVELS IN SUBJECTS WITH RESISTANTย hypertension: PP. 32.274
  1388. Response by Danser and van den Meiracker to Letter by Zhou and Zhou Regarding Article,โ€œhypertension: Reninโ€“Angiotensinโ€“Aldosteroneย System Alterationsโ€
  1389. Correction ofย Aldosteroneย level as marker of RAAS dysfunction in patients with arterialย hypertensionย degree II-III and chronic kidney diseases
  1390. Oxidative Stress is Related to Increased Sodium-Aldosteroneย Product and Left Ventricular Dysfunction in Resistantย hypertension
  1391. The measurement of the renin-angiotensin-Aldosteroneย system in patients with adrenal tumors with arterialย hypertension
  1392. Autonomousย Aldosteroneย secretion as a significant cause of arterialย hypertension: the effectiveness of targeted therapy
  1393. Aldosteroneโ€Inducedย hypertensionย is T Lymphocyteโ€Dependent and Attenuated by Activation of the G Proteinโ€Coupled Estrogen Receptor 1
  1394. Vascular Aging Inย Aldosteroneย Associatedย hypertension: Role Of NADPH Oxidase 1
  1395. Vascular Aging inย Aldosteroneย Associatedย hypertension: Role of NADPH Oxidase 1
  1396. Metabolic disorders and the state of the reninโ€“angiotensinโ€“Aldosteroneย system in obese patients with resistantย hypertension
  1397. OS 02-01 ROLE OFย Aldosteroneย AND NADPH OXIDASE 1 INย hypertension-ASSOCIATED VASCULAR AGING
  1398. Absoluterย Aldosteronexzess, Bluthochdruck und koronare Herzerkrankung/Arterialย hypertensionย and cardiovascular diseaseโ€“absoluteย Aldosteroneย excess is the tip of โ€ฆ
  1399. Variation of plasmaย Aldosteroneย level and histological ultrastructure change of adrenal gland in stress-inducedย hypertensionย rats
  1400. Relation between cardiac hemodynamics andย Aldosteroneย content two years after myocardial infarction depending on arterialย hypertension
  1401. Study of relationship between fibrinogen,ย Aldosteroneย and left ventricular mass index in patients with essentialย hypertension
  1402. โ€ฆ by Calhoun et al1 in which the authors tested the effect of a novelย Aldosteroneย synthase inhibitor, LCI699, for treatment of primaryย hypertension. An 8-week โ€ฆ
  1403. Determination ofย Aldosteroneย Hormone and Alpa Feto-Protein Concentrations in Normal Pregnant Women and in Pregnancy Inducedย hypertension
  1404. Effects of Impairedย Aldosteroneย Secretion onย hypertensionย Development in the Spontaneously Hypertensive Rat (SHR).
  1405. Response to โ€œrole of relativeย Aldosteroneย excess in salt-sensitiveย hypertensionย in people of african ancestryโ€
  1406. The role of [ldquo] stress [rdquo] inย Aldosterone-mediatedย hypertension: circumstantial evidence from the [ldquo] stress subtraction [rdquo] experiment of adrenal vein โ€ฆ
  1407. The role of central ROS and NO inย Aldosteroneย (ALDO)/saltโ€inducedย hypertension
  1408. AN INCREASEDย Aldosteroneย TO RENIN RATIO IN PATIENTS WITH NON-DIPPERย hypertension: PP. 24.477
  1409. Somatic mutations in ATP1A1 and ATP2B3 lead toย Aldosterone-producing adenomas and secondaryย hypertension
  1410. Association of the-344T/Cย Aldosteroneย synthase gene variant with essentialย hypertension
  1411. โ€ฆ OF QUINAPRIL ADD-ON TREATMENT ONย Aldosteroneย BREAKTHROUGH IN PATIENTS WITH ESSENTIALย hypertensionย RECEIVING VALSARTAN: PP โ€ฆ
  1412. Aldosterone/Renin Ratio is a Predictor of Cardiovascular Events in Patients with Essentialย hypertension
  1413. Diagnostic accuracy of theย Aldosteroneย to active renin ratio in detecting primary aldosteronism: the graz endocrine causes ofย hypertensionย (GECOH) study
  1414. Renin-Angiotensin-Aldosteroneย and Other Neurohumoral Factors in the Pathogenesis of Pulmonaryย hypertension
  1415. Response to Role of Angiotensinogen and Relativeย Aldosteroneย Excess in Salt-Sensitiveย hypertension
  1416. Aldosterone/renin Ratio is a Long-term Predicter of Cardiovascular Events in Patients With Essentialย hypertension
  1417. Aldosteroneย synthase gene polymorphism in patients withย hypertensionย combined ischemic heart disease with in various left ventricular mass
  1418. RELATIONSHIPS OF SERUM URIC ACID WITH PLASMA RENIN ACTIVITY AND PLASMAย Aldosteroneย IN PRIMARYย hypertension.
  1419. Synthesis ofย Aldosteroneย in the brain contributes to theย hypertensionย in the Dahl salt sensitive rat
  1420. Analysis of Renin-Angiotensin-Aldosteroneย System Gene Polymorphisms in Essentialย hypertensionย in Javanese Indonesian
  1421. Effect of Qingre Jiangya Granules on Plasma Angiotensin โ…ก andย Aldosteroneย in Spontaneousย hypertensionย Rats [J]
  1422. GW25-e0782 Association between plasmaย Aldosteroneย with KCNJ5 gene polymorphisms in primaryย hypertensionย patients
  1423. Regulation of theย Aldosteroneย synthase gene-role in humanย hypertensionย and adrenal corticosteroid production
  1424. 26 PREDICTORS OF COMPLETE RESOLUTION OFย hypertensionย AFTER ADRENALECTOMY AMONG JAPANESE PATIENTS WITHย Aldosteroneย โ€ฆ
  1425. The Influence of Juteng Capsule on Blood Pressure and Plasmaย Aldosteroneย and Catecholamine of Stress-inducedย hypertensionย in Rats
  1426. Blood Pressure Control and Dipping Patterns in Patients With Resistantย hypertension: Combined Effects ofย Aldosteroneย and Sodium
  1427. Effects of Reducedย Aldosteroneย Secretion onย hypertensionย Development in the Spontaneously Hypertensive Rat (SHR) as Measured by Remote Monitoring
  1428. Aldosterone: With an Unhealthy Diet (High Sodium, Low Potassium) a Little Extra May Go a Long Way Toward Development ofย hypertension
  1429. Effects ofย Aldosteroneย Hormone on Endothelial Function With Carotid Intima-media Thickness Among Resistant and Early Onsetย hypertensionย Patients
  1430. Effect of Qingxuan Jiangya decoction on renin-angiotensin-Aldosteroneย system of primaryย hypertensionย patients
  1431. Study on the association of plasma rennin angiotensin, angiotensin II andย Aldosteroneย in sleep apnea hypopnea syndrome patients withย hypertension
  1432. Albumin may preventย hypertensionย by inhibiting renin angiotensinย Aldosteroneย system
  1433. Impact of Polymorphisms in the Renin-Angiotensin-Aldosteroneย System on Vascular Alterations in Essentialย hypertension
  1434. Gender differences renin-angiotensin-Aldosteroneย system and its relation to humoral factors in patients with arterialย hypertension
  1435. โ€ฆ response to mineralocorticoid-receptor blockade in aldosteronisms: primary hyperaldosteronism vsย Aldosterone-associatedย hypertension/low-reninย hypertension
  1436. โ€ฆ Impact ofย hypertensionย and Chronic Kidney Disease on the Acute Myocardial Infarction: Pathogenic Interactions of Cardiac Remodeling Usingย Aldosteroneย โ€ฆ
  1437. Target levels of renin-angiotensin-Aldosteroneย system components and their role in cardiovascular event development among patients with arterialย hypertension
  1438. Magnesium supplementation attenuatesย Aldosteroneโ€inducedย hypertension, kidney damage and oxidative stress in genetically hypomagnesemic mice
  1439. Elevated Plasmaย Aldosterone/Renin Ratio Is Associated with Future Stroke in Japanese Patients with Essentialย hypertension
  1440. Abstract P027: Associations of Renin-Angiotensin-Aldosteroneย System Genes with Blood Pressure changes andย hypertensionย Incidence: The GenSalt Study
  1441. Circulating Inactive Matrix Gla-Protein is Associated With Highย Aldosteroneย Levels and Arterial Stiffness inย hypertension
  1442. Comparison of the role of the renin-angiotensinย Aldosteroneย system in the genesis ofย hypertensionย between two groups of nonhunting dogs and hunting dogs
  1443. PLASMAย Aldosteroneย LEVELS ON NORMAL, LOW AND HIGH SODIUM INTAKE IN PATIENTS WITH ESSENTIALย hypertensionย WITH NORMAL AND LOW โ€ฆ
  1444. Studies ofย Aldosteroneย renin ratio and genetic variation at the CYP11B1/CYP11B2 locus in human essentialย hypertension
  1445. Endocrineย hypertension, Adrenal Steroids and Development of a Saliva Basedย Aldosteroneย Assay as a Potential Screening Method
  1446. Relationship between angiotensin converting enzyme andย Aldosteroneย synthase gene polymorphisms and essentialย hypertensionย in Qiqihar Han population
  1447. Leptin Inducesย hypertensionย and Endothelial Dysfunction viaย Aldosterone-Dependent Mechanisms in Obese Female Mice
  1448. Twenty-four hour urineย Aldosteroneย level predicts left ventricular hypertrophy in patients with primary aldosteronism and essentialย hypertension
  1449. Aldosteroneย and Salt Inducesย hypertensionย Associated with Increased Oxidative Stress in the Brain of Apolipoprotein E Knockout Mice
  1450. โ€ฆ Antagonists Regulate Mitochondrial Dynamics and Localย Aldosteroneย Production Attenuating Right Ventricular Remodeling in Pulmonary Arterialย hypertension
  1451. Baselineย Aldosterone/Renin Ratios Predict Responses to Thiazide in Essentialย hypertension, Particularly for Already-Treated Patients
  1452. Aldosteroneย ANDย hypertensionย IN OVARIECTOMIZED FEMALE DAHL SALT SENSITIVE RATS ON LOW SALT DIET
  1453. Malignantย hypertensionย Leading to a Diagnosis of anย Aldosteroneย and Cortisol Co-Secreting Adrenal Tumor
  1454. Aldosterone-RECEPTOR ANTAGONISTS LEAD TO PROLONGED BLOOD PRESSURE REDUCTION IN UNCONTROLLEDย hypertension: A โ€ฆ
  1455. IRB Protocol: Rates of Practitioner Use ofย Aldosteroneย Antagonists for Resistantย hypertensionย in an Academic Quaternary Referral Ambulatory Clinic Setting A โ€ฆ
  1456. Abstract P280: Butyric Acid Protects Againstย Aldosterone-salt-inducedย hypertensionย and Renal Injury via Suppression of (Pro) Renin Receptor
  1457. ZD100: BP Lowering, Renal Enhancing andย Aldosteroneย Suppressing Properties via pGC-A in Human Resistant โ€œLikeโ€ย hypertension-A First in Human Study
  1458. Renin-angiotensin-Aldosteroneย system gene variants and their association with left ventricular function and vascular properties in essentialย hypertension
  1459. Aldosteroneย Targets Raptor to Promote Pulmonary Smooth Muscle Cell Proliferation and Modulate Pulmonary Arterialย hypertension
  1460. Serum potassium levels predict blood pressure response toย Aldosteroneย antagonists in resistantย hypertension
  1461. Angiotensinogen Gene M235T Polymorphism and Serum Renin,ย Aldosteroneย Hormones Levels among Sudanese patients with Essentialย hypertension
  1462. Upregulation of Renin Angiotensinย Aldosteroneย System (RAAS) by Methylglyoxal: Role inย hypertension
  1463. Dietary Iron Restriction Attenuatesย hypertensionย and Renal Injury inย Aldosterone/Salt-Induced Hypertensive Mice
  1464. The activity of the renin-Aldosteroneย system and arterialย hypertensionย creation in patients with congenital vesicoureteral reflux and reflux nephropathy
  1465. โ€ฆ ACTIVATION OF MINERALCORTICOID RECEPTOR-SGK1 SYSTEMS IN URINARY EPITHELIUM FOR THE MODEL OF SODIUM SENSITIVEย hypertension: PP โ€ฆ
  1466. Abstract P276:(Pro) Renin Receptor-dependent Renal Generation ofย Aldosteroneย Contributes to ENaC Activation During Angiotensin II-inducedย hypertension
  1467. THE CHANGES OF PLASMA RENIN ANDย Aldosteroneย LEVELS IN RESISTANTย hypertensionย PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA โ€ฆ
  1468. Anti-aging Gene Klotho Deficiency Causesย hypertensionย Via Upregulation of CYP11B2 Expression andย Aldosteroneย Synthesis
  1469. Endothelial function, the renin-angiotensin-Aldosteroneย axis (RAAS) andย hypertension: the therapeutic role of potassium supplementation
  1470. CNS blockade ofย Aldosteroneย synthase prevents sympathetic hyperactivity andย hypertensionย by central Na+ loading in Wistar rats
  1471. The induction of saltโ€sensitiiveย hypertensionย (HTN) in rats by sensitizing preโ€treatments with either angiotensin II (ANG II) orย Aldosteroneย (ALDO)
  1472. Influence of antihypertensive medication on the screening parameterย Aldosteroneย to renin ratio in patients with essentialย hypertensionย and primary aldosteronism
  1473. Disruption of the WNK/SPAK pathway attenuates angiotensin II, but enhancesย Aldosteroneโ€inducedย hypertensionย (1136.3)
  1474. Resistantย hypertension, Elevatedย Aldosterone/Renin Ratio and Reduced RGS2: A Pathogenetic Link Deserving Further Investigations?
  1475. A Study of a Proposed Molecular Mechanism for Idiopathic Cases ofย hypertension: Detection ofย Aldosterone-receptor Complex at Period Homolog 1 (Per1) Promoter โ€ฆ
  1476. TRPM7-kinase Modulates Renal and Splenic Macrophage and T-lymphocyte Infiltration inย Aldosterone-salt-inducedย hypertension
  1477. Function of dynamically stimulated endothelium and reninโ€“angiotensinโ€“Aldosteroneย system in normotensive subjects with a family history ofย hypertension
  1478. Effect of Circadian Variability of Dipper Blood Pressure Induced by Irbesartan in Patients with Non-Dipper Essentialย hypertensionย on Levels ofย Aldosterone
  1479. Aldosteroneย Activates Raptor to Promote Pulmonary Artery Smooth Muscle Cell Proliferation and Pulmonary Arterialย hypertension
  1480. The changes of plasma renin andย Aldosteroneย levels in resistantย hypertensionย patients with obstructive sleep apnea syndrome before and after continuous positive โ€ฆ
  1481. Renin-angiotensin-Aldosteroneย System Polymorphisms-based Risk Score In Resistant Arterialย hypertensionย And Adverse Cardiovascular Events: The Genhart-rio โ€ฆ
  1482. Dyssynchrony and Fibrosis in a Canine Model ofย hypertensionย Correlates withย Aldosterone-Mediated Depletion in Circulating Progenitor Cell Counts
  1483. Primary Prevention of Atrial Fibrillation Using Renin-Angiotensin-Aldosteroneย System Inhibitors among Medicare Beneficiaries withย hypertension
  1484. Endothelial function, the renin-angiotensin-Aldosteroneย axis (RAAS) andย hypertension: diagnostic strategies and therapeutic role of potassium supplementation
  1485. Effect of renin-angiotensin-Aldosteroneย system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterialย hypertension
  1486. Aldosteroneย Inactivates the Endothelin-B Receptor via a Thiol Redox Switch to Modulate Pulmonary Arterialย hypertension
  1487. โ€ฆ of Pulmonary Artery Endothelial Catechol-o-methyltransferase Activity byย Aldosteroneย Increases Norepinephrine Levels in Pulmonary Arterialย hypertension
  1488. Effects of chronic receptor blockade on intracardiac angiotensin II andย Aldosteroneย content in an angiotensin II-infused model ofย hypertension
  1489. 5972 The renin andย Aldosteroneย levels at resistantย hypertensionย and its connection with other clinical features
  1490. Association and Interrelation of Angiotensinogen, ACE, ACE-2, andย Aldosteroneย Synthase Gene Polymorphism in Essentialย hypertension
  1491. Selectiveย Aldosteroneย Blocker Enhances Protective Effects of Calcium Channel Blocker (CCB) Against Salt-sensitiveย hypertension-induced Cardiovascular Injury โ€ฆ
  1492. Aldosteroneย (Aldo) Interacts with PKA, MAPKs and PLC Pathway to Sensitize Angiotensin (ANG) IIโ€Inducedย hypertension
  1493. โ€ฆ Prevents the Arterial Stiffness Elevation Resulting in the Amelioration of Inappropriate Cardiovascular Response During Exercise in Patients Withย hypertension
  1494. โ€ฆ Peripheral Blood 18-oxo-cortisol Can Differentiate the Patients Withย Aldosteroneย Producing Adenoma From Those With Essentialย hypertension.-omitting many steps โ€ฆ
  1495. โ€ฆ CATHETER BASED RENAL SYMTHETIC DENERVATION ON RENIN-ANGIOTENSION-Aldosteroneย SYSTEM IN PATIENTS WITH RESISTANTย hypertension
  1496. โ€ฆ et al,โ€œThe Spironolactone, Amiloride, Losartan, and Thiazide (SALT) Double-Blind Crossover Trial in Patients With Low-Reninย hypertensionย and Elevatedย Aldosteroneย โ€ฆ
  1497. Novel description ofย Aldosteroneย synthase CYP11B2 -344 T>C gene polymorphism related toย hypertensionย in Mexican Amerindians: Teenek, Mixtec and Mayans
  1498. โ€ฆ Application of a New Chemiluminescent Method for Direct Renin Measurement to the Calculation ofย Aldosterone/Renin Ratio in Patients with Essentialย hypertension
  1499. PVN injections of adenoโ€associated virusโ€siRNA to silence either NOX2 or NOX4 attenuatesย Aldosterone/NaClโ€inducedย hypertensionย in mice
  1500. Relationship betweenย Aldosteroneย and complement c1q tumor necrosis factor-related protein 1 in sleep apnea-relatedย hypertension
  1501. โ€ฆ -ATPASE INHIBITION WITH SALT-SENSITIVITY OF BLOOD PRESSURE IN RESISTANTย hypertensionย AND EFFECTS OFย Aldosteroneย ANTAGONIST: 8A. 06
  1502. โ€ฆ injections of adenoโ€associated virusโ€siRNA to silence estrogen receptor ฮฒ (ERฮฒ) produces augmentation ofย Aldosterone/NaClโ€inducedย hypertensionย in female rats
  1503. โ€ฆ Acute Regulatory Protein (StAR) is Associated With Connective Tissue Growth Factor-Mediated Pulmonary Vascular Fibrosis in Pulmonary Arterialย hypertensionย In โ€ฆ
  1504. โ€ฆ the Endothelin-B Receptor to Decrease Pulmonary Endothelial Nitric Oxide Levels and Promote Pulmonary Vascular Remodeling in Pulmonary Arterialย hypertension
  1505. โ€ฆ Modification of Endothelin-B Receptor Cysteinyl Thiol (s) byย Aldosteroneย Decreases Pulmonary Endothelial Nitric Oxide Levels in Pulmonary Arterialย hypertension
  1506. โ€ฆ AND EXPRESSION OF ATRIAL NATRIURETIC PEPTIDE ANDย Aldosteroneย SYNTHASE GENE IN PATIENTS WITH ESSENTIALย hypertension
  1507. โ€ฆ SYSTEM WITH COMBINATIONS OF ALISKIREN AND AMLODIPINE, RAMIPRIL AND AMLODIPINE IN PATIENTS WITH ESSENTIALย hypertension
  1508. โ€ฆ ,โ€œThe Spironolactone, Amiloride, Losartan, and Thiazide (SALT) Double-Blind Crossover Trial in Patients With Low-Reninย hypertensionย and Elevatedย Aldosteroneย โ€ฆ
  1509. โ€ฆ -OXO-CORTISOL PRACTICALLY DIFFERENTIATEย Aldosteroneย PRODUCING ADENOMA FROM BILATERAL HYPERPLASIA AND PRIMARYย hypertensionย โ€ฆ
  1510. 1020 EFFECTS OFย Aldosteroneย BLOCKADE ON LIPIDS, GLUCOSE AND VISCERAL FAT IN PATIENTS WITH ESSENTIALย hypertension
  1511. 9.11 Association between Plasmaย Aldosterone, Metabolic Syndrome and Left Ventricular Mass in Essentialย hypertension
  1512. โ€ฆ IN ANGIOTENSIN II RECEPTOR GENES WITH POSTOPERATIVEย hypertensionย RISK FORย Aldosteroneย PRODUCING ADENOMA PATIENTS
  1513. โ€ฆ HIGHย Aldosterone-RENIN RATIO (ARR) IS ASSOCIATED WITH THE DEVELOPMENT OF ESSENTIALย hypertensionย FROM WHITE COATย hypertension
  1514. 1c. 12: Dietary salt intake andย Aldosterone-related organ damage inย hypertension
  1515. โ€ฆ patients with uncomplicatedย hypertension/EY Choi, JW Ha, SJ Yoon [et al.]//Am. Soc. Echocardiogr.โ€“2008.โ€“Vol. 21, N 3.โ€“P. 251โ€“256. 19. Jonar S.ย Aldosteroneย โ€ฆ
  1516. โ€ฆ OF DNA POLYMORPHISMS WITHIN CYP11B2/CYP11B1 LOCUS AND POSTOPERATIVEย hypertensionย RISK IN THE PATIENTS WITHย Aldosteroneย โ€ฆ
  1517. โ€ฆ D AND PARATHYROID HORMONE WITH AMBULATORYย hypertensionย AND THEIR INTERACTIONS WITH SERUMย Aldosteroneย AND SALT INTAKE
  1518. Lipocalinโ€2 Deficiency Protects againstย Aldosteroneโ€Inducedย hypertensionย and Organ Damages by Inhibiting Mineralocorticoid Receptor Signaling
  1519. 2 Renin-angiotensin-Aldosteroneย profiles predictive of superimposed preeclampsia: Chronicย hypertension
  1520. โ€ฆ LAND: CLINICAL STUDIES IN PULMONARYย hypertension: Galectin-3 Andย Aldosteroneย As Potential Tandem Biomarkers In Pulmonary Arterialย hypertension
  1521. PP. LB01. 20: PROSPECTIVE ASSESSMENT OF THE DIRECT RENIN ANDย Aldosteroneย ASSAY IN THE WORK-UP OF ARTERIALย hypertension
  1522. โ€ฆ -47 EFFECTS OF RENIN-ANGIOTENSIN-Aldosteroneย SYSTEM BLOCKADE MEDICATIONS ON COGNITION FUNCTION INย hypertension: HEAD-TO-HEAD โ€ฆ
  1523. MicroRNAโ€21 Overexpression Attenuatesย Aldosteroneโ€Mediated Cardiac Injury andย hypertension
  1524. LBOS 02-01ย hypertension,ย Aldosteroneย AND EPC-MEDIATED ENDOTHALIAL INJURY REPAIR
  1525. โ€ฆ CARDIOVASCULAR REMODELING EFFECTS OFย Aldosterone: INSIGHTS FROM GITELMAN SYNDROME, A HUMAN MODEL OPPOSITE TOย hypertension
  1526. โ€ฆ 17-38 CORRELATION OFย Aldosterone-RENIN RATIO AND NIGHTTIME BLOOD PRESSURE AND TARGET ORGAN DAMAGE IN ESSENTIALย hypertension
  1527. A3401 A case report of a 33-year-old man with resistantย hypertensionย and slightly elevated cortisol andย Aldosterone
  1528. Effects of Lysine-specific Demethylase 1 Deficiency onย Aldosteroneย Production and Salt-sensitiveย hypertensionย in Female Mice
  1529. โ€ฆ OF GALECTIN-3 ANDย Aldosteroneย ON DIFFERENT CLINICAL CHARACTERISTICS IN MALE AND FEMALE PATIENTS WITH ARTERIALย hypertension.
  1530. 301 ADIPONECTIN ANDย Aldosteroneย LEVELS IS ASSOCIATED WITH ARTERIAL STIFFNESS IN RESISTANTย hypertension
  1531. [PP. 17.24] THE RESPONSE OF PLASMAย Aldosteroneย TO SALINE INFUSION IS UNDER THE INFLUENCE OF AGE IN PRIMARYย hypertension
  1532. โ€ฆ PLASMA RENIN ACTIVITY, PLASMAย Aldosteroneย AND SELECTED ASYMPTOMATIC ORGAN DAMAGE INDICES IN ESSENTIAL ARTERIALย hypertension
  1533. โ€ฆ activation induces the expression of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in dendritic cells in vitro and during theย Aldosterone-dependentย hypertension
  1534. โ€ฆ The reninโ€“angiotensinโ€“Aldosteroneย system and superimposed pre-eclampsia in women with chronic kidney disease and chronicย hypertension: Chronicย hypertension
  1535. Intracerebroventricular injections of adenoโ€associated virusโ€siRNA gene to silence angiotensin type 1 receptors (AT1) preventย Aldosteroneโ€inducedย hypertension
  1536. PS-82 GENDER FEATURES OF THE RENIN-ANGIOTENSIN-Aldosteroneย SYSTEM (RAAS) IN PATIENTS WITH ARTERIALย hypertensionย IN UZBEKISTAN.
  1537. 32 Premature vascular ageing inย hypertension: role ofย Aldosteroneย and nadph oxidases
  1538. โ€ฆ aldosteronism in the COAR and SIE cohorts. To compare the numbers of patients who showed positive hormonal results or hadย hypertensionย between the COAR and โ€ฆ
  1539. PP. 32.15: POST-SALINE LOAD PLASMAย Aldosteroneย LEVEL IS A DETERMINANT OF LEFT VENTRICULAR MASS IN ESSENTIALย hypertension
  1540. Deficiency of the Tโ€type Calcium Channel Cav 3.1 attenuates Plasmaย Aldosteroneย and Cardiac Hypertrophy despite similar Ang IIโ€inducedย hypertension
  1541. 1091 CLOCK GENE,ย Aldosteroneย ANDย hypertension
  1542. PS 17-65 THE C344T GENE POLYMORPHISM OFย Aldosteroneย SYNTHASE IS RISK FACTOR OF EARLY RENAL DAMAGE INย hypertensionย IN A CHINESE โ€ฆ
  1543. Kir5. 1โ€Mediated Changes in Reninโ€Angiotensinโ€Aldosteroneย System Balance in Salt Sensitiveย hypertension
  1544. Galectin-3 Andย Aldosteroneย As Potential Tandem Biomarkers In Pulmonary Arterialย hypertension
  1545. 6.9 Plasmaย Aldosteroneย and Albumin Urinary Excretion inย hypertension
  1546. โ€ฆ :[PP. 04.11] RELATIONSHIP BETWEEN PLASMAย Aldosteroneย LEVELS AND LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN ESSENTIALย hypertension
  1547. MPS 14-03 Effects of Azilsartan medoxomil compared to other angiotensin II receptor blocker on plasmaย Aldosteroneย levels in patients with essentialย hypertension
  1548. 9B. 07: EFFECT OF POSTURAL CHANGES ONย Aldosteroneย TO PLASMA RENIN RATIO IN PATIENTS WITH SUSPECTED SECONDARYย hypertension
  1549. โ€ฆ OF THE RENIN ANGIOTENSINย Aldosteroneย SYSTEM AND ITS IMPACT ON KIDNEY OXIDATIVE STRESS, RENAL FUNCTION ANDย hypertensionย IN โ€ฆ
  1550. โ€ฆ IMPROVE ENDOTHELIAL GLYCOCALYX AND PWV AFTER 1 YEAR SUCCESSFUL TREATMENT IN UNTREATED PATIENTS WITH ESSENTIALย hypertension
  1551. GPER is involved in the stimulatory effects ofย Aldosteroneย in breast cancer cells and breast tumor-derived endothelial cells
  1552. Aldosteroneย mediates metastatic spread of renal cancer via the G proteinโ€coupled estrogen receptor (GPER)
  1553. Tetrahydropyrroloquinolinone type dual inhibitors of aromatase/Aldosteroneย synthase as a novel strategy for breast cancer patients with elevated cardiovascular risks
  1554. Renin-angiotensin-Aldosteroneย system-based antihypertensive agents and the risk of colorectal cancer among medicare beneficiaries
  1555. Primary hyperparathyroidism associatiated withย Aldosterone-producing adrenocortical adenoma and breast cancer: relation to MEN1 gene
  1556. Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
  1557. Aldosterone-and cortisol-cosecreting adrenal adenoma, ovarian hyperthecosis and breast cancer
  1558. Urinary excretion of components of the renin-angiotensin-Aldosteroneย system in patients having localized renal cancer.
  1559. RETRACTED: Relationship Betweenย Aldosteroneย Synthase CYP1A1 MspI Gene Polymorphism and Prostate Cancer Risk
  1560. Drugs affecting renin-angiotensin-Aldosteroneย system and the cancer risk: A meta-analysis of nested case-control studies.
  1561. Cancer progression in COVID-19: integrating the roles of renin angiotensinย Aldosteroneย system, angiopoietin-2, heat shock protein-27 and epithelial โ€ฆ
  1562. โ€ฆ use of renin-angiotensin-Aldosteroneย system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional โ€ฆ
  1563. Aldosterone-Producing Adrenal Cortical Cancer
  1564. Effect ofย Aldosteroneย on the amplification of oncolytic vaccinia virus in human cancer lines
  1565. Aldosteroneย mediates a mineralocorticoid receptorโ€mediated increase in prostate cancer cell migration
  1566. Resistance to Antihypertensive Drugs Targeting Renin Angiotensinย Aldosteroneย System in Cancer patients: A Case Series
  1567. Treatment-relatedย Aldosteroneย changes in cancer of the middle part of the larynx
  1568. Blood-ACTH, cortisole andย Aldosteroneย levels following complex radiation treatment for cancer of the uterine cervix
  1569. Regulation of mineralocorticoid receptor and its downstream targets by estrogen andย Aldosteroneย in breast cancer
  1570. The effect of combined radiotherapy on blood levels of ACTH, cortisol andย Aldosteroneย in cervical cancer
  1571. โ€ฆ -10: Glucocorticoid andย Aldosteroneย mimic progestin-induction of a therapy-resistant cytokeratin-5 positive cell population in estrogen receptor-positive breast cancer โ€ฆ
  1572. Theย Aldosteroneย Antagonist Spironolactone Improves Cardiac Function in Experimental Cancer Cachexia
  1573. Lowerย Aldosteroneโ€“renin ratio is a risk factor for total and cancer death in Japanese individuals: the Takahata study
  1574. The changes of serum cortisol andย Aldosteroneย in patients with cancer of vestibular section of larynx after irradiation and with and without surgery
  1575. Levels of growth hormone, prolactin, cortisone,ย Aldosteroneย and insulin in the blood of patients with stomach cancer, before and after gastrectomy
  1576. Postoperative change of atrial natriuretic peptide and renin-angiotensin-Aldosteroneย system after pulmonary resection for lung cancer
  1577. โ€ฆ between SNPs in the renin-angiotensin-Aldosteroneย system andย hypertension,ย obesity, and blood pressure-related dietary exposures regarding renal cell cancer risk
  1578. Enhancedย Aldosteroneย signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors
  1579. Relationship between visceral fat and plasmaย Aldosteroneย concentration in patients with primary aldosteronism
  1580. Aldosteroneย deficiency prevents high-fat-feeding-induced hyperglycaemia and adipocyte dysfunction in mice
  1581. Periarterial fat from two human vascular beds is not a source ofย Aldosteroneย to promote vasoconstriction
  1582. Significant association ofย Aldosteroneย and liver fat among HIV-infected individuals with metabolic dysregulation
  1583. Increasedย Aldosteroneย among HIV-infected women with visceral fat accumulation
  1584. Role of potassium excretion and percent body fat on ethnic differences in plasmaย Aldosteroneย levels
  1585. Aldosteroneย levels in patients on haemodialysis: Relationship with body fat mass and adipocytokines
  1586. System renin-Aldosteroneย in fat tissue and other organ and tissues
  1587. The renin-angiotensin-Aldosteroneย system (RAAS)-new pathogenetic and therapeutic aspects Part. I. Prorenin and renin and its receptors, convertase 2 of angiotensin โ€ฆ
  1588. Aldosteroneย production by the mouse adrenal gland is compromised by a high fat diet and 11 [beta]-hydroxysteroid dehydrogenase type 1 deficiency
  1589. โ€ฆ and glucagon-like peptide-1 and 2 receptors expression in stable patients with multivessel coronary artery disease: an association with renin-angiotensin-Aldosteroneย โ€ฆ
  1590. Neuropeptide Y (NPY) receptor 2 deletion in adipocytes blunts fatโ€derivedย Aldosteroneย production in female mice exposed to chronic stress
  1591. Primary aldosteronism
  1592. Clinical characteristics of primary aldosteronism from an analysis of 145 cases
  1593. High incidence of primary aldosteronism in 199 patients referred withย hypertension.
  1594. Primary aldosteronism
  1595. Primary aldosteronism: diagnostic evaluation
  1596. Presidential address: part I. Painting background Part II. Primary aldosteronism, a new clinical syndrome
  1597. Primary aldosteronism: diagnosis, localization, and treatment
  1598. The changing clinical spectrum of primary aldosteronism
  1599. Factors influencing outcome of surgery for primary aldosteronism
  1600. Primary aldosteronism: diagnosis and treatment
  1601. Cardiovascular complications in patients with primary aldosteronism
  1602. High prevalence of primary aldosteronism in the Taysideย hypertensionย clinic population
  1603. Primary aldosteronism, a new clinical entity
  1604. The diagnosis of primary aldosteronism and separation of two major subtypes
  1605. Reliability of screening methods for the diagnosis of primary aldosteronism
  1606. Changes in left ventricular anatomy and function inย hypertensionย and primary aldosteronism
  1607. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore
  1608. Potentially high prevalence of primary aldosteronism in a primary-care population
  1609. Further evaluation of saline infusion for the diagnosis of primary aldosteronism.
  1610. Suppression of plasma renin activity in primary aldosteronism: distinguishing primary from secondary aldosteronism in hypertensive disease
  1611. Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism
  1612. Primary aldosteronism: update on diagnosis and treatment.
  1613. Remodeling of the left ventricle in primary aldosteronism due to Connโ€™s adenoma
  1614. Primary aldosteronism. Results of surgical treatment.
  1615. Clinical and pathological diversity of primary aldosteronism, including a new familial variety
  1616. Normokalemic primary aldosteronism: a detectable cause of curable essentialย hypertension
  1617. Primary aldosteronism: A common and curable form ofย hypertension.
  1618. Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers.
  1619. Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondaryย hypertension
  1620. Outpatient screening tests for primary aldosteronism
  1621. Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype
  1622. Hypokalemia in the hypertensive patient: with observations on the incidence of primary aldosteronism
  1623. Primary aldosteronism:ย hypertensionย with a genetic basis
  1624. Association of hypokalemia, aldosteronism, and renal cysts
  1625. Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital
  1626. Primary aldosteronism: adrenal venous sampling
  1627. Single dose captopril as a diagnostic test for primary aldosteronism
  1628. Successful surgical treatment of a cat with primary aldosteronism
  1629. Plasma renin activity in primary aldosteronism: importance in differential diagnosis and in research of essentialย hypertension
  1630. Pheochromocytoma and primary aldosteronism: diagnostic approaches
  1631. Primary aldosteronism: learning from the study of familial varieties
  1632. Albuminuria in untreated patients with primary aldosteronism or essentialย hypertension.
  1633. Hemodynamic characteristics of primary aldosteronism
  1634. Calcium metabolism and parathyroid function in primary aldosteronism
  1635. Glucocorticoid-remediable aldosteronism
  1636. Primary aldosteronism. Issues in diagnosis and management.
  1637. Laparoscopic adrenalectomy for primary aldosteronism: a new operative method
  1638. Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism
  1639. Muscle sympathetic nerve activity in renovascularย hypertensionย and primary aldosteronism.
  1640. Essentialย hypertension: first reason for persistentย hypertensionย after unilateral adrenalectomy for primary aldosteronism?
  1641. Screening for primary aldosteronism with a logistic multivariate discriminant analysis*
  1642. Primary aldosteronism (Connโ€™s syndrome) in a cat; a case report and review of comparative aspects
  1643. The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism
  1644. Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism
  1645. Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism
  1646. Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism
  1647. Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism:ย Aldosteroneย response to dexamethasone and long polymerase chain reaction for โ€ฆ
  1648. Renal changes in primary aldosteronism
  1649. Success of surgery for primary aldosteronism judged by residual autonomousย Aldosteroneย production
  1650. Correctable subsets of primary aldosteronism Primary adrenal hyperplasia and renin responsive adenoma
  1651. Adjustment of the osmostat in primary aldosteronism
  1652. Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism?
  1653. CT in the diagnosis of primary aldosteronism: sensitivity in 29 patients.
  1654. Primary aldosteronism
  1655. Primary aldosteronismโ€”some genetic, morphological, and biochemical aspects of subtypes
  1656. Aldosteronism andย hypertension: primary aldosteronism versus hypertensive disease with secondary aldosteronism
  1657. Normotensive primary aldosteronism: report of a case
  1658. Circadian rhythm of plasmaย Aldosteroneย concentration in patients with primary aldosteronism
  1659. Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation ofย Aldosterone-producing adenoma
  1660. Therapeutic effect of calcium channel blockade in primary aldosteronism
  1661. The syndrome of primary aldosteronism
  1662. Pathology of primary aldosteronism
  1663. Primary aldosteronism: Photoscanning of tumors after administration of 131I-19-iodocholesterol
  1664. Control of plasmaย Aldosteroneย in primary aldosteronism: distinction between adenoma and hyperplasia
  1665. Commentary on incidence of primary aldosteronism: current estimations based on objective data
  1666. Use of the saline infusion test to diagnose the cause of primary aldosteronism
  1667. Aldosteronism in Man: Some Clinical and Climatological Aspects Part I
  1668. Use of computed tomography in diagnosing the cause of primary aldosteronism
  1669. Laparoscopic adrenalectomy for primary aldosteronism: report of initial ten cases.
  1670. Glucocorticoid-remediable aldosteronism and pregnancy
  1671. Reassessment of the predictive value of the postural stimulation test in primary aldosteronism
  1672. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal ofย Aldosteroneย โ€ฆ
  1673. Normokalemic Primary Aldosteronism: Its Masquerade as Essentialย hypertension
  1674. Primary aldosteronism: clinical staff conference at the National Institutes of Health
  1675. Left ventricular systolic function in primary aldosteronism andย hypertension
  1676. Effect of ketanserin in primary aldosteronism.
  1677. Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldosteronism
  1678. Increased disorderliness and amplified basal and pulsatileย Aldosteroneย secretion in patients with primary aldosteronism
  1679. Primary aldosteronism: clinical management
  1680. Evolution of the surgical management of primary aldosteronism.
  1681. Non-tumorousโ€ primaryโ€ aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).
  1682. Isย Aldosterone/renin ratio useful to screen a hypertensive population for primary aldosteronism?
  1683. Primary aldosteronism in pregnancy
  1684. Aldosteronism in man: some clinical and climatological aspects Part II
  1685. Primary reninism:ย hypertension, hyperreninemia, and secondary aldosteronism due to renin-producing juxtaglomerular cell tumors
  1686. Aldosteronism inย hypertension: Spironolactone Response Test.
  1687. Primary aldosteronism with malignantย hypertension
  1688. Diagnosis and treatment of primary aldosteronism
  1689. Primary aldosteronism in pregnancy
  1690. Primary aldosteronism presenting as myoglobinuric acute renal failure
  1691. Adrenalectomy in primary aldosteronism: a long-term follow-up study in 52 patients
  1692. Pregnancy and primary aldosteronism
  1693. The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels
  1694. Circadian rhythm and effect of posture on plasmaย Aldosteroneย concentration in primary aldosteronism
  1695. Primary aldosteronism due to adrenal hyperplasia: Occurrence in a boy aged 10 years
  1696. How common is primary aldosteronism? Is it the most frequent cause of curableย hypertension?
  1697. Postoperative studies of adrenal function in primary aldosteronism
  1698. The regulation ofย Aldosteroneย secretion in primary aldosteronism
  1699. Diagnosis and surgical treatment of primary aldosteronism in pregnancy: a case report
  1700. Changes in the circadian rhythm of blood pressure in primary aldosteronism in response to dietary sodium restriction and adrenalectomy
  1701. Suppression ofย Aldosteroneย by cyproheptadine in idiopathic aldosteronism
  1702. Possibility of normokalaemic primary aldosteronism as reflected in the frequency of adrenal cortical adenomas
  1703. Evolution of primary aldosteronism as a highly specific clinical entity
  1704. Renal function in primary aldosteronism
  1705. An association of primary aldosteronism and adrenaline-secreting phaeochromocytoma.
  1706. Glucocorticoid-remediable aldosteronism (GRA): diagnosis, variability of phenotype and regulation of potassium homeostasis
  1707. Normotensive primary aldosteronism.
  1708. Left ventricular structural characteristics in unilateral renovascularย hypertensionย and primary aldosteronism
  1709. Leptin levels are suppressed in primary aldosteronism
  1710. Diagnosis and localization in primary aldosteronism
  1711. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essentialย hypertension
  1712. Pseudohypo-aldosteronism and cholelithiasis: coincidence or pathogenetic correlation?
  1713. Primary aldosteronism
  1714. Impaired potassium-stimulatedย Aldosteroneย production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism
  1715. Studies on the expanded extracellular fluid and the responses to various stimuli in primary aldosteronism
  1716. Plasma levels of atrial natriuretic peptide in primary aldosteronism and essentialย hypertension
  1717. Rapid diagnosis and identification of cross-over sites in patients with glucocorticoid remediable aldosteronism
  1718. Clinical implications of primary aldosteronism with resistantย hypertension.
  1719. Spironolactone as a nonspecific treatment for primary aldosteronism
  1720. Secondary aldosteronism
  1721. Activation ofย Aldosteroneย secretion in primary aldosteronism
  1722. Normotensive primary aldosteronism
  1723. Left ventricular structural and functional characteristics in patients with renovascularย hypertension, primary aldosteronism and essentialย hypertension
  1724. Evaluation of diagnostic tests in the differential diagnosis of primary aldosteronism: unilateral adenoma versus bilateral micronodular hyperplasia
  1725. Useful parameters in the diagnosis of primary aldosteronism
  1726. Plasmaย Aldosteroneย response to ACTH in subtypes of primary aldosteronism
  1727. Primary aldosteronism.
  1728. Spironolactone-induced inhibition ofย Aldosteroneย biosynthesis in primary aldosteronism: morphological and functional studies
  1729. Primary aldosteronism: changing concepts in diagnosis and management
  1730. Primary aldosteronism due to unilateral adrenal hyperplasia
  1731. New insights into the medical management of primary aldosteronism.
  1732. Abnormalities of renal function and circulatory reflexes in primary aldosteronism
  1733. Paralytic myopathyโ€“a leading clinical presentation for primary aldosteronism in Taiwan
  1734. Normotensive primary aldosteronism
  1735. The detection of adrenal tumors and hyperplasia in patients with primary aldosteronism: comparison of scintigraphy, CT, and MR imaging
  1736. High sodium sensitivity and glomerularย hypertension/hyperfiltration in primary aldosteronism.
  1737. Idiopathic aldosteronism in pregnancy.
  1738. Intralymphocyte free magnesium in patients with primary aldosteronism:ย Aldosteroneย and lymphocyte magnesium homeostasis
  1739. Glucocorticoid-remediable aldosteronism
  1740. Scintigraphic localization of adrenal lesions in primary aldosteronism
  1741. Clinical evaluation of the captopril screening test for primary aldosteronism
  1742. Prevalence of extracranial carotid artery lesions at duplex in primary aldosteronism
  1743. Bilateral adrenal hyperplasia as a cause of primary aldosteronism withย hypertension, hypokalemia and suppressed renin activity
  1744. Preoperative diagnosis of primary aldosteronism: Including a comparison of operative findings and preoperative tumor localization by adrenal phlebography
  1745. Circulating factor with ouabain-like immunoreactivity in patients with primary aldosteronism
  1746. Plasmaย Aldosterone-plasma renin activity ratio A simple test to identify patients with primary aldosteronism
  1747. Severeย hypertensionย in primary aldosteronism and good response to surgery
  1748. Primary aldosteronism: pathophysiology, diagnosis and treatment
  1749. Selection of patients and operative approach in primary aldosteronism.
  1750. Primary aldosteronism: a new understanding
  1751. Identification and differentiation of surgically correctableย hypertensionย due to primary aldosteronism
  1752. Adrenalectomy in primary aldosteronism: a long-term follow-up study
  1753. Primary aldosteronism: experience with current diagnostic criteria and surgical treatment in fourteen patients.
  1754. Similarity of idiopathic aldosteronism and essentialย hypertension. A statistical comparison.
  1755. Diagnosis of primary aldosteronism
  1756. IN VIVO AND IN VITRO STUDIES OF ADRENAL SECRETIONS IN CUSHINGโ€™S SYNDROME AND PRIMARY ALDOSTERONISM
  1757. A Kindred with Familial Glucocorticoidโ€“Suppressible Aldosteronism
  1758. The blood pressure response to unilateral adrenalectomy in primary aldosteronism
  1759. Laparoscopic adrenalectomy for Cushingโ€™s syndrome: comparison with primary aldosteronism.
  1760. Identifying the adrenal lesion in primary aldosteronism
  1761. Primary aldosteronism
  1762. Primary aldosteronism: implications of a new familial variety
  1763. Primary aldosteronism as a cause of severe postpartumย hypertensionย in two women
  1764. Hormone and blood pressure relationships in primary aldosteronism
  1765. Aldosterone: review of its physiology and diagnostic aspects of primary aldosteronism
  1766. Adrenalectomy for primary aldosteronism: long-term follow-up study in 29 patients
  1767. Familial forms broaden the horizons for primary aldosteronism
  1768. Myopathy and primary aldosteronism: electronmicroscopic study
  1769. Primary aldosteronism: how hard should we look?
  1770. Primary aldosteronism with unusual secretory pattern
  1771. Primary aldosteronism in a hypertensive acromegalic patient
  1772. Primary aldosteronism and its variants
  1773. Primary aldosteronism in a 9-year-old child
  1774. Primary aldosteronism: a review of medical literature from 1955 to June 1958
  1775. Coexistence of aldosteronoma and contralateral nonfunctioning adrenal adenoma in primary aldosteronism
  1776. Primary aldosteronism: preoperative tumor visualization by scintillation scanning
  1777. Physiologic and surgical problems in the management of primary aldosteronism
  1778. Normalization of high plasma level of ouabain-like immunoreactivity in primary aldosteronism after removal of adenoma.
  1779. Primary Aldosteronism Diagnosis and Surgical Treatment
  1780. Pregnancy complicated by primary aldosteronism.
  1781. Adrenal arteriography and venography in primary aldosteronism
  1782. Low Renin Essentialย hypertension: A Variant of Classic Primary Aldosteronism?
  1783. Acute effects of intravenous sodium chloride load on calcium metabolism and on parathyroid function in patients with primary aldosteronism compared with subjects โ€ฆ
  1784. Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity andย Aldosteroneย in primary aldosteronism
  1785. Observations on a case of primary aldosteronism
  1786. Primary aldosteronism: an endocrine perspective.
  1787. Acute and chronic effect of nifedipine in primary aldosteronism
  1788. Triamtereneโ€thiazide combination: Alternative therapy for primary aldosteronism
  1789. Laparoscopic adrenalectomy for primary aldosteronism
  1790. Evidence of exercise-induced myocardial ischemia in patients with primary aldosteronism: The Cross-Sectional Primary Aldosteronism and Heart Italian Multicenter โ€ฆ
  1791. Hypokalemic myopathy associated with primary aldosteronism and glycyrrhizine-induced pseudoaldosteronism
  1792. Isolated clinical syndrome of primary aldosteronism in a patient with adrenocortical carcinoma
  1793. Stimulation and suppression ofย Aldosteroneย in plasma of normal man and in primary aldosteronism
  1794. Primary adrenocortical carcinoma causing aldosteronism
  1795. Plasma adrenomedullin in patients with primary aldosteronism
  1796. Differential diagnosis in primary aldosteronism
  1797. Selective hypoaldosteronism despite prolonged pre-and postoperative hyperreninemia in primary aldosteronism
  1798. Primary aldosteronism: A study in contrasts
  1799. Myocardial scintigraphic characteristics in patients with primary aldosteronism.
  1800. Primary Aldosteronism due to Unilateral Adrenal Hyperplasia Report of Two Cases and Review of the Literature
  1801. Postoperative transient aldosteronism
  1802. Intra-adrenal hemorrhage as a complication of adrenal venography in primary aldosteronism
  1803. Plasma renin activity and blood volume in uncontrolled diabetes: ketoacidosis, a state of secondary aldosteronism
  1804. Long-term results of surgical and conservative treatment of patients with primary aldosteronism
  1805. Variation of phenotype in patients with glucocorticoid remediable aldosteronism.
  1806. Primary aldosteronism
  1807. Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma.
  1808. Malignantย hypertensionย in association with primary aldosteronism
  1809. Primary aldosteronism: report of a case and discussion of the pathogenesis
  1810. Primary aldosteronism: experience with thirty-eight patients
  1811. Laparoscopic adrenalectomy in patients with primary aldosteronism.
  1812. Primary aldosteronism: difference in clinical presentation and long-term follow-up between adenoma and bilateral hyperplasia of the adrenal glands
  1813. Impaired baroreflex function and arterial compliance in primary aldosteronism
  1814. Primary aldosteronism
  1815. Primary aldosteronism due to an adrenal carcinoma
  1816. A preliminary evaluation for primary aldosteronism
  1817. Is single oral administration of captopril beneficial in screening for primary aldosteronism?
  1818. Clinical implications of renal cyst in primary aldosteronism
  1819. Primary aldosteronism
  1820. Surgical management of primary aldosteronism
  1821. Isolated clinical syndrome of primary aldosteronism in four patients with adrenocortical carcinoma
  1822. Aldosteroneย to renin ratios in the evaluation of primary aldosteronism.
  1823. Glucocorticoid-suppressible aldosteronism: a disorder of the adrenal transitional zone
  1824. Preoperative lateralisation ofย Aldosterone-producing tumours in primary aldosteronism
  1825. Evaluation of plasmaย Aldosteroneย to plasma renin activity ratio in patients with primary aldosteronism
  1826. Asymptomatic normotensive primary aldosteronism. Case report.
  1827. Plasma ฮฒ-endorphin levels in primary aldosteronism
  1828. In primary aldosteronism the circadian blood pressure rhythm is similar to that in primaryย hypertension
  1829. Primary aldosteronism: diagnosis and noninvasive lateralization procedures
  1830. Someย Aldosterone-producing adrenal tumours also secrete cortisol, but present clinically as primary aldosteronism.
  1831. A case of primary aldosteronism with chronic renal failure undergoing hemodialysis treatment
  1832. Primary aldosteronism: treatment with trilostane
  1833. Plasma levels of atrial natriuretic peptide in man in primary aldosteronism, in Gordonโ€™s syndrome and in Bartterโ€™s syndrome.
  1834. Nature of renal escape from the sodium-retaining effect ofย Aldosteroneย in primary aldosteronism and in normal subjects
  1835. Genetics of primary aldosteronism
  1836. Intermittent aldosteronism in periodic paralysis: Dependence of attacks on retention of sodium, and failure to induce attacks by restriction of dietary sodium
  1837. Primary aldosteronism in pregnancyโ€”should it be treated surgically?
  1838. Primary aldosteronism with suppressed plasma renin activity due to bilateral nodular adrenocortical hyperplasia
  1839. Synthesis and separation of 18ฮฒ-glycyrrhetyl monoglucuronide from serum of a patient with glycyrrhizin-induced pseudo-aldosteronism
  1840. The Salivary Sodium-Potassium Ratio: A Useful Screening Test for Aldosteronism in Hypertensive Subjects
  1841. PRIMARY ALDOSTERONISM: OBSERVATIONS IN SIX CASES AND REVIEW OF DIAGNOSTIC PROCEDURES: 1
  1842. Primary aldosteronism.
  1843. Erythrocytosis and primary aldosteronism
  1844. Malignantย hypertensionย in a patient with primary aldosteronism with elevated active renin concentration
  1845. Episodic secretion ofย Aldosteroneย in primary aldosteronism: relationship to cortisol
  1846. The sympathetic nervous system andย hypertensionย in primary aldosteronism.
  1847. Primary aldosteronism
  1848. Plasma renin activity andย Aldosteroneย secretion in a pregnant woman with primary aldosteronism
  1849. โ€ฆ human adrenal medulla and its messenger ribonucleic acid expression along with that of atrial natriuretic peptide are enhanced in patients with primary aldosteronism
  1850. Urinary kallikrein excretion and plasma renin activity in patients with essentialย hypertensionย and primary aldosteronism
  1851. The dexamethasone-modified adrenal scintiscan in hyporeninemic aldosteronism (tumor versus hyperplasia). A comparison with adrenal venography and adrenal โ€ฆ
  1852. Primary aldosteronism: diagnosis and differentiation of subtypes
  1853. Aldosteroneย synthase cytochrome P-450 expressed in the adrenals of patients with primary aldosteronism
  1854. Circadian rhythm of blood pressure in primary aldosteronism and renovascularย hypertension: analysis by the cosinor method
  1855. A Case of Normotensive Primary Aldosteronism Comparison with 13 Previously Experienced Cases withย hypertension
  1856. Aldosteronism and precocious puberty due to an ovarian androblastoma (Sertoli cell tumor)
  1857. Submaxillary potassium concentration in true and pseudoprimary aldosteronism
  1858. Primary aldosteronism
  1859. Glucocorticoid-remediable aldosteronism.
  1860. Hyperplasia of the juxtaglomerular complex with secondary aldosteronism withoutย hypertensionย (Bartterโ€™s syndrome)
  1861. Case studies of siblings with juxtaglomerular hyperplasia and secondary aldosteronism associated with severe azotemia and renal ricketsโ€”Bartterโ€™s syndrome or โ€ฆ
  1862. Primary aldosteronism: its diagnosis and surgical management
  1863. The management of patients with primary aldosteronism
  1864. Primary aldosteronism in a patient with familial adenomatous polyposis
  1865. Left ventricular anatomy and function in primary aldosteronism and renovascularย hypertension
  1866. Primary aldosteronism with cortisol overproduction from bilateral multiple adrenal adenomas
  1867. Primary aldosteronism aggravated during peripartum period
  1868. Primary aldosteronism detected after renal transplantation
  1869. Diagnosis of anย Aldosterone-producing adenoma in primary aldosteronism: an evaluative maneuver
  1870. DOCA test for aldosteronism: its usefulness and implications.
  1871. Aldosteroneย regulation in primary aldosteronism: differences between adenoma and bilateral hyperplasia
  1872. Differential response to thiazides and spironolactone in primary aldosteronism
  1873. Laparoscopic adrenalectomy for primary aldosteronism: clinical experience in 12 patients.
  1874. Are calcium antagonists helpful in the management of primary aldosteronism?
  1875. Free and conjugated dopamine in pheochromocytoma, primary aldosteronism and essentialย hypertension.
  1876. The Gordon Wilson Lecture. Some Clinical and Climatological Aspects of Aldosteronism in Man
  1877. Pre-operative evaluation of the prognosis ofย hypertensionย in primary aldosteronism owing to adenoma
  1878. Observations on a presumptive case of primary aldosteronism
  1879. Unilateral adrenal hyperplasia as a cause of primary aldosteronism.
  1880. Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism
  1881. Hormonal characteristics of primary aldosteronism due to unilateral adrenal hyperplasia
  1882. Spectral characteristics of heart rate and blood pressure variability in primary aldosteronism
  1883. Occurrence of primary aldosteronism in a group of ambulatory hypertensive patients
  1884. Screening for primary aldosteronism
  1885. Glucocorticoid-remediable aldosteronism
  1886. Primary aldosteronism: new approaches to diagnosis and management.
  1887. Medical treatment of low-renin aldosteronism
  1888. Primary aldosteronism and primary reninism
  1889. The evolution of primary aldosteronism from 1954 to 1960
  1890. hypertensionย due to renal artery occlusion simulating primary aldosteronism
  1891. The relationship of adrenal gland iodomethylnorcholesterol uptake to zona glomerulosa function in primary aldosteronism
  1892. Studies of impairedย Aldosteroneย response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism.
  1893. Primary aldosteronism with uncommon complications.
  1894. Diagnosis and treatment of primary aldosteronism
  1895. Adrenal transitional zone steroids, 18โ€oxo and 18โ€hydroxycortisol, useful in the diagnosis of primary aldosteronism, are ACTHโ€dependent
  1896. Primary aldosteronism and malignant adrenocortical neoplasia.
  1897. Surgical treatment of primary aldosteronism.
  1898. Thyrotoxic periodic paralysis complicated with primary aldosteronism
  1899. Reducedย Aldosteroneย secretion during spironolactone treatment in primary aldosteronism: report of a case
  1900. A case of normoreninemic, normotensive primary aldosteronism associated with essentialย hypertensionย and nephrocalcinosis
  1901. Adrenomedullin levels are high in primary aldosteronism due to adenoma and decline after surgical cure
  1902. Effects of sodium intake on the captopril test for primary aldosteronism
  1903. Primary aldosteronism: A case with severeย hypertension
  1904. Endoscopic adrenalectomy by retroperitoneal approach for primary aldosteronism
  1905. Lateralization procedures in primary aldosteronism
  1906. Primary aldosteronism
  1907. Primary aldosteronism: preoperative preparation with spironolactone
  1908. The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism
  1909. Relationship between postoperative blood pressure change and renal pathophysiology in primary aldosteronism
  1910. Endothelin stimulatesย Aldosteroneย secretion in vitro from normal adrenocortical tissue, but not adenoma tissue, in primary aldosteronism
  1911. โ€ฆ -secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism.
  1912. Coronary artery aneurysms, aortic dissection, andย hypertensionย secondary to primary aldosteronism: A rare triad: A case report
  1913. Functional black adenoma of the adrenal cortex: a rare cause of primary aldosteronism
  1914. Comparison of five modalities in localization of primary aldosteronism.
  1915. Primary aldosteronism withย Aldosterone-producing adrenal adenoma in a pregnant woman
  1916. Incidence of suppressed renin activity and of normokalemic primary aldosteronism in hypertensive negro patients
  1917. Screening for surgically correctableย hypertensionย caused by primary aldosteronism
  1918. Elevation of plasma renin activity during pregnancy and rupture of a dissecting aortic aneurysm in a patient with primary aldosteronism
  1919. Primary aldosteronism associated with chronic renal failure
  1920. Urinary freeย Aldosteroneย in healthy people and in patients with primary aldosteronism
  1921. Primary aldosteronism and its importance to the anaesthetist.
  1922. Solving the adrenal lesion (s) of primary aldosteronism
  1923. Calcium channel blockade with nifedipine in primary aldosteronism
  1924. Aldosteronism in pregnancy: association with virilization of female offspring.
  1925. Pseudoprimary aldosteronism from the topical application of 9-alpha-fluorprednisolone to the skin.
  1926. Dietary sodium change in primary aldosteronism. Atrial natriuretic factor, hormonal, and vascular responses.
  1927. Primary aldosteronism and its relationship to diabetes mellitus
  1928. Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma โ€ฆ
  1929. Effect of spironolactone on fluid volumes and adrenal steroids in primary aldosteronism
  1930. Aldosteronism
  1931. Existence of a slowly exchangeable pool of body sodium in normal subjects and its diminution in patients with primary aldosteronism
  1932. Adrenal steroid responses to ACTH in glucocorticoid-suppressible aldosteronism.
  1933. Effect of saline infusions onย Aldosteroneย secretion and electrolyte excretion in normal subjects and patients with primary aldosteronism
  1934. Preoperative tumor localization by adrenal venography in patients with primary aldosteronism: a comparison with operative findings
  1935. Primary aldosteronism due to a malignant ovarian tumour
  1936. Coexisting renal artery stenosis and primary aldosteronism.
  1937. Primary aldosteronism: review of the anaesthetic experience in sixty patients
  1938. Prominent peripheral edema associated with primary aldosteronism due to an adrenocortical adenoma
  1939. Association of accelerated (malignant)ย hypertensionย in a patient with primary aldosteronism
  1940. Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism
  1941. Problems related to aldosteronism during cesarean section
  1942. High Plasma Renin Activities in Primary Aldosteronism with Malignantย hypertensionย A Case Report
  1943. โ€ฆ of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediatesย hypertensionย in dexamethasone-suppressible aldosteronism
  1944. Surgical treatment of aldosteronism: Combined experiences at the Massachusetts Memorial and the Peter Bent Brigham Hospitals
  1945. The usefulness of the captopril test as a simultaneous screening for primary aldosteronism and renovascularย hypertension
  1946. Adrenal adenomata causing primary aldosteronism
  1947. Concurrence of primary aldosteronism and renal artery stenosis.
  1948. Heterotopic adrenocortical adenoma producing primary aldosteronism
  1949. Primary aldosteronism
  1950. In vitro studies in primary aldosteronism
  1951. Primary aldosteronism in general practice
  1952. Effect of spironolactone on urinary kallikrein excretion in patients with essentialย hypertensionย and in primary aldosteronism
  1953. Primary aldosteronism: Study of twenty-six operated cases
  1954. Idiopathic aldosteronism masquerading as discreteย Aldosterone-secreting adrenal cortical neoplasms among patients with primary aldosteronism
  1955. Primary aldosteronism: computerized tomography in preoperative evaluation.
  1956. PRODUCTION OF 18โ€OXOโ€CORTISOL IN SUBTYPES OF PRIMARY ALDOSTERONISM
  1957. Primary aldosteronism: the etiologic spectrum of disorders and their clinical differentiation
  1958. A case of secondary aldosteronism induced by pheochromocytoma
  1959. Non-tumorousโ€ primaryโ€ aldosteronism: II. Type not relieved by glucocorticoid.
  1960. Autosomal dominant polycystic kidney disease complicated by primary aldosteronism
  1961. Aldosteronism and arterialย hypertension
  1962. Changes in salivary electrolytes following treatment of primary aldosteronism
  1963. Improvement of growth hormone response to stimulation in primary aldosteronism with correction of potassium deficiency
  1964. The syndrome ofย hypertension, hyperreninemia and secondary aldosteronism associated with renal juxtaglomerular cell tumor (primary reninism)
  1965. Childhood primary aldosteronism due to an adrenal adenoma: Preoperative localization by adrenal vein catheterization
  1966. Surgical treatment ofย hypertensionโ€”primary aldosteronism: a review of 13 cases
  1967. Mechanism of impaired urinary concentrating ability in normokalemic primary aldosteronism.
  1968. A study of the juxtaglomerular body in primary aldosteronism
  1969. Normal sympathetic vasomotor and cardiac parasympathetic activities in patients with primary aldosteronism: assessment by spectral analysis
  1970. Primary aldosteronism with bilateral adrenal adenomas
  1971. Management of primary aldosteronism: evaluation of potassium and sodium balance, technic of adrenalectomy and operative results in 24 cases.
  1972. Absorption and secretion of water and electrolytes by the intact colon in a patient with primary aldosteronism.
  1973. The effect of tyramine, noradrenaline, and angiotensin on the blood pressure in hypertensive patients with aldosteronism and low plasma renin
  1974. Increased gain in baroreceptor-heart rate reflex in patients with primary aldosteronism.
  1975. Efficacy of iodine-131 6ฮฒ-methyl-iodo-19-norcholesterol scintigraphy and computed tomography in patients with primary aldosteronism
  1976. Aldosteronism updated
  1977. Renal kininases in primary aldosteronism.
  1978. Aldosteroneย regulation in primary aldosteronism: influence of salt balance, posture and ACTH
  1979. Time-related changes in plasma adrenal steroids during treatment with spironolactone in primary aldosteronism
  1980. Primary aldosteronism
  1981. Effect of a spirolactone on plasma and urinaryย Aldosteroneย in primary aldosteronism
  1982. Outpatient screening procedures for primary aldosteronism
  1983. โ€ฆ prolactin stimulation ofย Aldosteroneย in normal human subjects and patients with primary aldosteronism, including a patient with primary aldosteronism and a prolactin โ€ฆ
  1984. Primary aldosteronism with normalย Aldosteroneย levels in blood and urine
  1985. Exaggerated natriuresis in primary aldosteronism.
  1986. Bilateral adrenal tumours in primary aldosteronism: localization of a unilateral aldosteronoma by dexamethasone suppression scan
  1987. Primary aldosteronism treated by trilostane (3, ฮฒ-hydroxysteroid dehydrogenase inhibitor)
  1988. Primary Aldosteronism: A Followโ€up Study of 28 Cases of Surgically Treatedย Aldosteroneโ€producing Adenomas
  1989. Study on uric acid metabolism in patients with primary aldosteronism
  1990. Primary aldosteronism: remission and development of adrenal insufficiency after adrenal venography
  1991. ACTH-dependentย Aldosteroneย excess due to adrenocortical adenoma: a variant of primary aldosteronism
  1992. Steroid hormone production in a case of Cushingโ€™s syndrome with electrolyte changes simulating primary aldosteronism
  1993. Clinical implications of postoperative transient aldosteronism
  1994. Adrenal scintigraphy in primary aldosteronism. Spironolactone as a cause of incorrect classification between adenoma and hyperplasia
  1995. Simple screening procedure for the diagnosis of primary aldosteronism
  1996. Adrenal scintigraphy in primary aldosteronism
  1997. Abolished nocturnal blood pressure fall in a boy with glucocorticoid-remediable aldosteronism
  1998. Primary aldosteronism due to bilateral nodular hyperplasia: CT demonstration.
  1999. Normotensive primary aldosteronism due to adrenocortical carcinoma
  2000. A syndrome resembling primary aldosteronism (Conn syndrome) in untreated HIV disease
  2001. Primary aldosteronism due to adrenal cortical carcinoma
  2002. Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications
  2003. Usefulness of atrial natriuretic peptide assay in primary aldosteronism
  2004. Decreased blood pressure variability at rest in patients with primary aldosteronism
  2005. Action of antidiuretic hormone in potassium-depleted rats; relation to aldosteronism
  2006. Pheochromocytoma and primary aldosteronism
  2007. Sodium transport parameters in erythrocytes of patients with primary aldosteronism.
  2008. Does prolonged pretreatment with large doses of spironolactone hasten a recovery from juxtaglomerular-adrenal suppression in primary aldosteronism?
  2009. Plasma renin in primary aldosteronism
  2010. Hyperโ€responsiveness ofย Aldosteroneย to metoclopramide in aldosteronism
  2011. Estimation of the intrarenal hemodynamics in patients with primary aldosteronism
  2012. Primary aldosteronism with diabetes mellitus
  2013. The electrocardiogram and potassium metabolism: electrocardiographic abnormalities in primary aldosteronism and familial periodic paralysis
  2014. Dopaminergic regulation ofย Aldosteroneย secretion: its pathophysiologic significance in subsets of primary aldosteronism
  2015. Childhood primary aldosteronism with bilateral adrenocortical hyperplasia: Plasma renin activity as an aid to diagnosis
  2016. Primary aldosteronism due to adrenal carcinomas
  2017. Unilateral hypersecretion ofย Aldosteroneย associated with adrenal hyperplasia as a cause of primary aldosteronism
  2018. Idiopathic aldosteronism: a possible disease of the intermediate lobe of the pituitary
  2019. Screening for aldosteronism
  2020. Primary aldosteronism CT, MRI, scintigraphic correlation
  2021. Regulation ofย Aldosteroneย secretion in primary aldosteronism
  2022. Role of atrial natriuretic peptide in mineralocorticoid escape phenomenon in patients with primary aldosteronism
  2023. Therapeutic results of primary aldosteronism with special reference to renal or renovascular lesions
  2024. Increased Na+-H+ Exchange in Red Blood Cells of Patients With Primary Aldosteronism
  2025. The absence of long-term therapeutic effect of calcium channel blockade in the primary aldosteronism of adrenal adenomas
  2026. Primary Aldosteronism with Ipsilateral Adrenal Cyst Report of a Case
  2027. Adrenal vein epinephrine levels: a useful aid in venous sampling for primary aldosteronism
  2028. Glucocorticoid-remediable aldosteronism
  2029. Are plasmaย Aldosteroneย surges in primary aldosteronism due to a loss of an inhibitory dopaminergic control?
  2030. Fludrocortisone suppression test in normal subjects, in patients with essentialย hypertensionย and in patients with various forms of aldosteronism
  2031. Primary aldosteronism associated with a primary double cancer of the thyroid and rectum: report of a case
  2032. Effect of verapamil onย Aldosteroneย secretion in primary aldosteronism
  2033. Experience with primary aldosteronism
  2034. Adrenal venous sampling analysis of primary aldosteronism: value of ACTH stimulation in the differentiation of adenoma and hyperplasia
  2035. Interference by spironolactone on adrenocortical scintigraphy and other pitfalls in the location of adrenal abnormalities in primary aldosteronism.
  2036. Primary aldosteronism caused byย Aldosterone-producing adenoma in pregnancyโ€“complicated by EPH gestosis.
  2037. Primary tumorous aldosteronism due to a black adrenal adenoma: a light and electron microscopic study.
  2038. Localization ofย Aldosteroneโ€producing tumours in primary aldosteronism by adrenal and renal vein catheterization
  2039. Hypokalemia, aldosteronism, and renal cysts
  2040. Pathophysiology and diagnosis of primary aldosteronism
  2041. Is aldosteronism important in the maintenance of arterial blood pressure and electrolyte balance during sodium depletion?
  2042. Effect of metoclopramide on plasmaย Aldosteroneย in normal subjects, primary aldosteronism and hypopituitarism
  2043. The effect of heparin onย Aldosteroneย secretion and metabolism in primary aldosteronism (1)
  2044. Ultrastructural studies of adrenal adenoma causing primary aldosteronism
  2045. Parallel biochemical and histochemical studies of an adrenocortical adenoma from a patient with primary aldosteronism
  2046. A reappraisal of the diagnostic criteria for primary aldosteronism
  2047. Pseudoprimary Aldosteronism.
  2048. Increased adrenal medullary atrial natriuretic polypeptide synthesis in patients with primary aldosteronism.
  2049. Left ventricular myocardial structure and function in patients with primary aldosteronism
  2050. High resolution MRI of adrenal glands in patients with primary aldosteronism.
  2051. Captopril before and after spironolactone therapy in primary aldosteronism
  2052. Significance of renal kininases in patients with primary aldosteronism
  2053. Cardiovascular, renal and endocrine effects of alpha-human atrial natriuretic peptide in patients with Cushingโ€™s syndrome and primary aldosteronism.
  2054. An easy diagnostic approach to primary aldosteronism
  2055. Potassium-losing nephritis and primary aldosteronism
  2056. Renin gene expression in the adrenal and kidney of patients with primary aldosteronism
  2057. Plasma atrial natriuretic peptide concentration in patients with primary aldosteronism
  2058. Lobular pattern of choriocapillaris in pre-eclampsia with aldosteronism.
  2059. Primary aldosteronism due to unilateral adrenal hyperplasia: a case report.
  2060. Adrenocortical adenoma with primary aldosteronism in culture
  2061. Erythrocyte Na+โ€H+ exchanger and Na+โ€Li+ countertransport activity in primary aldosteronism
  2062. Low dose atrial natriuretic factor in primary aldosteronism: renal, hemodynamic, and vascular effects.
  2063. Effects ofย Aldosteroneย on intralymphocytic sodium and potassium in patients with primary aldosteronism
  2064. Some observations on the mechanism of postoperative transient aldosteronism with special reference to early changes in serum electrolyte levels
  2065. Study of the predictive factors of postoperative blood pressure in cases with primary aldosteronism
  2066. Primary aldosteronism: a review of 8 cases
  2067. Postoperative improvement ofย hypertensionย in primary aldosteronism and Cushingโ€™s syndrome
  2068. Aldosteroneย response to adrenocorticotrophin and furosemide in primary aldosteronism after prolonged spironolactone treatment
  2069. Dopaminergic regulation ofย Aldosteroneย secretion in primary aldosteronism: a clinical study
  2070. A case of normotensive primary aldosteronism with hypopituitarism, epilepsy, and medullary sponge kidney
  2071. Effect of ฮฑ-human atrial natriuretic peptide in low renin essentialย hypertensionย and primary aldosteronism
  2072. Unusual renal function associated with saluresis accompanying water loading in a case of primary aldosteronism
  2073. Evaluation of the localizing procedures of primary aldosteronism
  2074. A novel low-activity form of carbonic anhydrase I in erythrocytes of patients with primary aldosteronism. Evidence for the presence of a mixed disulfide with glutathione.
  2075. A case of primary aldosteronism with renovascularย hypertension
  2076. hypertension: when to suspect underlying pheochromocytoma or aldosteronism
  2077. Surgical management of primary aldosteronism (Connโ€™s syndrome), a correctable cause ofย hypertension
  2078. โ€ฆ article Oct 19, 1964: Suppression of plasma renin activity in primary aldosteronism. Distinguishing primary from secondary aldosteronism in hypertensive disease. By โ€ฆ
  2079. Failure to visualize bilateral adrenal glands in a patient with primary aldosteronism
  2080. Metabolic and hormonal studies in a patient with primary aldosteronism, presenting with acute hypokalaemic paresis induced by chlorothiazide
  2081. Prognostic factors of primary aldosteronism.
  2082. Primary aldosteronism with bilateral multipleย Aldosterone-producing adrenal adenomas
  2083. The adrenal cortex (excluding aldosteronism)
  2084. Aldosteronism
  2085. Single oral administration of captopril may not bring an improvement in screening of primary aldosteronism
  2086. Isolated primary aldosteronism in a patient with adrenal carcinoma and XY/XXY mosaic Klinefelterโ€™s syndrome
  2087. Aldosteroneย regulation in primary aldosteronism
  2088. Primary aldosteronism caused by adrenal cortical carcinoma
  2089. Atrial Natriuretic Peptide Infusion in Primary Aldosteronism: Renal, Hemodynamic and Hormonal Effects
  2090. Primary aldosteronism by carcinoma of the adrenal cortex
  2091. Captopril Test in the Evaluation of Primary Aldosteronism.
  2092. Aldosteronism after severe trauma.
  2093. Effects of change in body posture on plasma and serum electrolytes in normal subjects and in primary aldosteronism
  2094. Renal and adrenal sparing surgery for patients with primary aldosteronism and primary reninoma
  2095. Variant forms of primary aldosteronism: reconsideration of the differential diagnosis and treatment
  2096. Primary aldosteronism: Observations on water and electrolyte changes during partial immersion
  2097. The kidney in endocrineย hypertension: Cushingโ€™s syndrome, pheochromocytoma, and aldosteronism
  2098. Evidence for a defect in urinary concentrating ability in primary aldosteronism and its reversal by adrenal surgery
  2099. Two uncommon causes of mineralocorticoid excess: syndrome of apparent mineralocorticoid excess and glucocorticoid-remediable aldosteronism
  2100. Use of amiloride in preoperative management of a patient with primary aldosteronism
  2101. Effect of spironolactone on urinary excretion of immunoreactive prostaglandin E in essentialย hypertensionย and primary aldosteronism
  2102. Manipulation by corticotropin and cortisol ofย Aldosteroneย secretion in primary aldosteronism
  2103. Localization ofย Aldosterone-producing adenoma: venous sampling in primary aldosteronism
  2104. Plasma renin activity in primary aldosteronism
  2105. Cytosolic free calcium concentration in platelets in patients with renovascularย hypertensionย and primary aldosteronism.
  2106. Infusion of Chlorothiazide in a Patient With Primary Aldosteronism: Observations on Potassium Clearance
  2107. Primary Aldosteronism Associated with Acute Intermittent Porphyria: Report of a Case
  2108. Adrenal venography and sampling in the diagnosis and treatment of primary aldosteronism.
  2109. Abnormality ofย Aldosteroneย and cortisol late pathways in glucocorticoid-remediable aldosteronism
  2110. The syndrome of juxtaglomerular hyperplasia with aldosteronism, hypokalemic alkalosis and normal blood pressure.
  2111. โ€ฆ in aldosteronomas and in the attached adrenals. Enzyme histochemical study of 19 cases of primary aldosteronism and a case of aldosteronism due to bilateral โ€ฆ
  2112. The Diagnostic Implication of Restriction of Salt Intake and Adminitstration of Various Drugs in Primary Aldosteronism
  2113. Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism.
  2114. Plasma ouabain-like activity in essential hypertensive patients and in subjects with primary aldosteronism.
  2115. Glucocorticoid-remediable aldosteronism.
  2116. Primary aldosteronism: diagnosis, surgical management, and report of two cases operated upon
  2117. Lack ofย Aldosteroneย inhibition by atrial natriuretic factor in primary aldosteronism: in vitro studies
  2118. Non-surgical therapy of primary aldosteronism: transcatheter arterial infusion of ethanol into an aldosteronoma
  2119. Renal dopaminergic activity in patients with primary aldosteronism
  2120. Ultrastructural types of cell in adrenal cortical adenoma with primary aldosteronism.
  2121. Hypokalemic alkalosis, hyperreninemia, aldosteronism, normal blood pressure and normal juxtaglomerular apparatusโ€“a new syndrome of renal alkalosis.
  2122. Coexistence of Primary Aldosteronism and Pheochromocytoma in a Vietnamese Patient.
  2123. โ€ฆ of electrolyte excretion in normal and hypertensive subjects before and after saline infusions: a simple electrolyte formula for the diagnosis of primary aldosteronism
  2124. The effect of adrenal surgery on plasma atrial natriuretic factor and sodium escape phenomenon in patients with primary aldosteronism
  2125. Treatment of primary aldosteronism
  2126. Adrenal scintiscanning and aldosteronism
  2127. Spironolactone Prevents Na+/H+ Exchange Enhancement in Primary Aldosteronism
  2128. Nocturnal, daytime, and postural changes of plasmaย Aldosteroneย before and during dexamethasone in adenomatous and idiopathic aldosteronism
  2129. Secondary aldosteronism documented by plasma renin andย Aldosteroneย circadian rhythm in subjects with kidney or heart transplantation
  2130. Renal electrolyte cycles and mechanism of nocturia in primary aldosteronism
  2131. Effect of naloxone on the adrenal cortex in primary aldosteronism
  2132. Effects of stilbestrol on the renal pressor system as modified by adrenalectomy and secondary aldosteronism
  2133. A simulation study on renin andย Aldosteroneย secretions in primary aldosteronism.
  2134. Adrenocortical carcinoma manifesting pure primary aldosteronism: a case report and analysis of steroidogenic enzymes
  2135. Immunohistochemical localization of atrial natriuretic peptide in primary aldosteronism.
  2136. Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasmaย Aldosteroneย concentration
  2137. Isolated primary aldosteronism in adrenocortical carcinoma: a case report and review of literature
  2138. Influence of unilateral adrenalectomy on renin-angiotensin-Aldosteroneย system in primary aldosteronism
  2139. A case of bilateral adrenal cortical adenomas causing Cushingโ€™s syndrome and primary aldosteronism
  2140. The molecular basis of a hereditary form ofย hypertension, glucocorticoid-remediable aldosteronism
  2141. A rare case of primary aldosteronism due to bilateral functioning adrenocortical adenomas
  2142. Anorexia nervosa, secondary aldosteronism and angiopathy
  2143. ฮฑ-h-ANP injection in normals, low reninย hypertensionย and primary aldosteronism
  2144. A new diagnostic test for primary aldosteronism
  2145. A case of primary aldosteronism presenting hypokalemic myopathy induced by benidipine hydrochloride; a dihydropyridine calcium channel blocker
  2146. Aldosteronism associated with adrenal cortical adenoma
  2147. Recurrence ofย hypertensionย in primary aldosteronism after discontinuation of spironolactone. Time course of changes in cardiac output and body fluid volumes
  2148. Primary aldosteronism
  2149. Adrenocortical carcinoma presenting as primary aldosteronism in a young man
  2150. Impaired vasopressin suppression and enhanced atrial natriuretic hormone release following an acute water load in primary aldosteronism
  2151. Increased plasma renin activity, secondary aldosteronism, andย hypertension
  2152. A case of primary aldosteronism due to unilateral multiple adrenal adenomas
  2153. A probable relationship between an endogenous digitalis-like substance and concentric cardiac hypertrophy in primary aldosteronism
  2154. Primary aldosteronism: case observed in a patient subjected previously to thoracolumbar sympathectomy
  2155. Primary aldosteronism in a patient with anย Aldosterone-producing adenoma
  2156. Urinary kallikrein excretion in patients with primary aldosteronism: differentiation of adrenal adenoma from idiopathic adrenal hyperplasia
  2157. Reduced renal extraction of atrial natriuretic peptide in primary aldosteronism
  2158. Primary Aldosteronism
  2159. I027: Saline infusion test in the diagnosis of primary aldosteronism
  2160. Diagnosis of primary aldosteronism
  2161. Comparative study of diagnosis for location of adrenal adenoma in patients with primary aldosteronism (authorโ€™s transl)
  2162. Primary aldosteronism. A report of 2 cases.
  2163. Withdrawal of endogenous sympathetic drive lowers blood pressure in primary aldosteronism
  2164. Multiple forms of immunoreactive renin in human adrenocortical tumour tissue from patients with primary aldosteronism
  2165. A SIMPLIFIED SCREENING TEST FOR DIFFERENTIATING PRIMARY ALDOSTERONISM FROM ESSENTIAL HYPERTENTION WITH LOW PLASMA RENIN โ€ฆ
  2166. Evaluation of select criteria for the diagnosis of primary aldosteronism in normokalemicย hypertension
  2167. Primary aldosteronism: Importance of the level of plasma renin as an adjunct in diagnosis
  2168. Syncope as a manifestation of primary aldosteronism
  2169. Activity of [des-Aspartyl1]-Angiotensin II in Primary Aldosteronism
  2170. Glucocorticoid-remediable aldosteronism
  2171. Endogenous dopaminergic inhibition ofย Aldosteroneย and prolactin secretion is apparently not increased in primary aldosteronism
  2172. Surgical management of primary aldosteronismโ€“progress in localization studies and operative treatment
  2173. Detection of primary aldosteronism by the 6-hour integratedย Aldosterone/renin ratio.
  2174. Approach to a patient with suspected primary aldosteronism.
  2175. Diagnosis and Treatment of Primary Aldosteronism (120 Cases Report)
  2176. Primary aldosteronism due to hyperplasia of zona glomerulosa: failure of suppression by DOCA or stimulation by angiotensin
  2177. Importance of atrial natriuretic hormone in an exaggerated natriuresis during acute sodium load in primary aldosteronism
  2178. Clinical and pathological aspects of primary aldosteronism
  2179. Adrenal Imaging with 131I-19-Iodocholesterol in the Diagnostic Evaluation of Patients with Aldosteronism
  2180. Macronodule associated with bilateral adrenal hyperplasia. A rare misleading cause of primary aldosteronism (two cases)
  2181. Effects of naloxone on adrenal cortex regulation in patients with primary aldosteronism
  2182. โ€ฆ ROLE OF HYPOKALEMIA IN THE MANIFESTATION OF HIGH QRS VOLTAGE AND SINUS RADYCARDIA IN PATIENTS WITH PRIMARY ALDOSTERONISM
  2183. Cyproheptadine in Idiopathic Aldosteronism
  2184. A case of primary aldosteronism, nephrotic syndrome and chronic renal failure: a diagnostic dilemma
  2185. Regulation of Atrial Natriuretic Peptide in Primary Aldosteronism and in Cushingโ€™s Disease
  2186. A case report of obstructive sleep apnea syndrome associated with primary aldosteronism
  2187. Three cases of primary aldosteronism including one case with postoperative ventricular tachycardia
  2188. Aldosteronism
  2189. Restoration of renin-Aldosteroneย dynamics to normal following surgery in primary aldosteronism
  2190. Anesthetic Experience of Adrenalectomy with Primary Aldosteronism-Report of two cases.
  2191. Diagnosing primary aldosteronism with frusemide stimulation test in hypertensive patients with raisedย Aldosteroneย to renin ratio
  2192. Captopril vย Aldosteroneย to plasma renin activity ratio in screening for primary aldosteronism
  2193. Lateralisation ofย Aldosterone-producing adenoma in primary aldosteronism
  2194. โ€ฆ of glutathione-peroxidase (GSH-PO) in human adrenal glandโ€“studies on adrenocortical adenomas associated with primary aldosteronism and Cushingโ€™s syndrome.
  2195. Primary aldosteronism in pregnancy
  2196. Plasma cortisol and primary aldosteronism
  2197. Comparison of steroidogenesis in adrenal tissue and adrenal adenoma from a case of primary aldosteronism
  2198. Evaluation of a test using saralasin to differentiate primary aldosteronism due to anย Aldosterone-producing adenoma from idiopathic hyperaldosteronism
  2199. Anesthetic Management of a patient with Primary Aldosteronism caused by Adrenal Adenoma.
  2200. Salt loading in renal aldosteronism before and after nephrectomy
  2201. Urinary excretion of catecholamines in patients with primary aldosteronism before and after unilateral adrenalectomy.
  2202. Adrenal adenoma with primary aldosteronism in a child: a case report.
  2203. Anesthetic management of adrenalectomy in a patient with aldosteronism complicated with hypertrophic cardiomyopathy
  2204. Concomitant laparoscopic treatment for primary aldosteronism and cholelithiasis
  2205. Glucocorticoid remediable aldosteronism: a case report.
  2206. Pituitary peptides other than ACTH may not beย Aldosteroneย secretagogue in primary aldosteronism
  2207. Urinary citrate excretion in primary aldosteronism
  2208. Morphofunctional characteristics of endocrine nephropathy in primary aldosteronism
  2209. A Cardiac Arrest during Surgery for Adrenal Tumor Causing Primary Aldosteronism.
  2210. Simplified screening procedures for primary aldosteronism. Studies on the mechanism of the hyper-responsiveness to furosemide and standing
  2211. A case of normotensive primary aldosteronism in association with non-functioning adenoma andย Aldosteroneย producing adenoma in ipsilateral adrenal gland
  2212. In primary aldosteronism hypertensive patients endothelial dysfunction is caused by an impairment in no availability
  2213. Diagnosis, localization, and treatment of primary aldosteronism.
  2214. Secretory regulation and episodic secretion ofย Aldosteroneย in patients with primary aldosteronism (authorโ€™s transl)
  2215. Plasma concentration and urinary excretion of arginine-vasopressin in primary aldosteronism during the fluid deprivation tests
  2216. Effect of spironolactone on cytosolic free sodium concentration in platelets from hypertensive patients with primary aldosteronism
  2217. Biosynthesis of various steroids in vitro by isolated adrenal cells in primary aldosteronism, Cushingโ€™s syndrome, and adrenogenital syndrome due to adrenocortical โ€ฆ
  2218. Faecal sodium/potassium ratio and aldosteronism in experimentalย hypertensionย in the rat
  2219. British Medical Association (Mashonaland branch): Primary syndromes of aldosteronism
  2220. STUDY ON CLINICAL CHARACTERISTICS OFย hypertensionย IN PATIENTS WITH PRIMARY ALDOSTERONISM
  2221. Diagnostic value of imaging in localizing primary aldosteronism
  2222. 19-Nor-deoxycorticosterone excretion in primary aldosteronism and low reninย hypertension
  2223. Does a digoxin-like substance participate in vascular and pressure control during dietary sodium changes in patients with primary aldosteronism?
  2224. Image diagnosis of adrenal disordersโ€“I. CT images of control subjects and image diagnosis of primary aldosteronism
  2225. Elevated โ€˜freeโ€™18-hydroxy-corticosterone excretion as a possible indicator for early diagnosis of primary aldosteronism
  2226. Enzyme histocytochemical studies in human adrenocortical adenomas.[I]. Primary aldosteronism.
  2227. Effect of captopril onย Aldosteroneย response to potassium infusion in primary aldosteronism.
  2228. A case of neurinoma of the pancreas in a patient with primary aldosteronism
  2229. Studies on the in vitro production ofย Aldosteroneย and other corticoids in the adrenal adenoma of a primary aldosteronism
  2230. Expression of cytochrome P-450 mRNAs in steroidogenesis of adrenocortical adenomas from patients with primary aldosteronism
  2231. Primary Aldosteronism
  2232. Anesthesiological management of a patient with primary aldosteronism complicated with hypertrophic cardiomyopathy
  2233. Pattern classification of renal electrolyte cycles in primary aldosteronism
  2234. Effects of metoclopramide, a dopamine antagonist, on secretion ofย Aldosteroneย and renin release in patients with primary aldosteronism
  2235. โ€ฆ natriuretic peptide responses to upright posture and furosemide administration in patients with normal-, low renin essentialย hypertensionย and primary aldosteronism
  2236. Fecal and salivary electrolytes in the diagnosis of primary aldosteronism
  2237. Primary aldosteronism
  2238. Primary aldosteronism-A Report of 26 cases
  2239. Primary aldosteronism at Henry Ford Hospital in the 1980s
  2240. A case of secondary aldosteronism similar to Bartterโ€™s syndrome with no abnormality in renal chloride reabsorption
  2241. Adrenal scintigraphy in primary aldosteronism
  2242. In vivo and in vitro studies on steroid metabolism in a case of primary aldosteronism with multiple lesions of adenoma and nodular hyperplasia
  2243. Hypertensive crisis during the resection of an adrenal tumor in primary aldosteronism
  2244. Renin content of the kidney in primary aldosteronism
  2245. Hyperpigmentation on Cortisone After Adrenalectomy for Primary Aldosteronism
  2246. Night-Day Variations of Renin-Activity in Primary Aldosteronism
  2247. โ€ฆ on clinical and endocrine characteristics of dexamethasone-suppressible hyperaldosteronism compared with those in primary aldosteronism owing toย Aldosteroneย โ€ฆ
  2248. Primary aldosteronism in childhood due to primary adrenal hyperplasia
  2249. When To Hospitalize for Primary Aldosteronism
  2250. Primary Aldosteronism Caused by Unilateral Adrenal Hyperplasia
  2251. Urinary Arginine Esterase Activity in the Patients withย hypertension, Chronic Nephritis and Primary Aldosteronism
  2252. Effects of salt restriction, spironolactone, and ammonium chloride on acid-base relations in a case of primary aldosteronism
  2253. Change in plasma renin activity by cold storage of plasma in normal subjects and patients with essentialย hypertensionย and primary aldosteronism
  2254. Primary aldosteronism caused by an adrenal tumor: a correctable cause ofย hypertension.
  2255. Plasma renin in primary aldosteronism
  2256. Connโ€™s syndrome: case report and a review of the syndrome of primary aldosteronism (SOPA)
  2257. Heterogeneous blood pressure response to furosemide and captopril in primary aldosteronism.
  2258. Primary Aldosteronism, Recumbent Posture, and Salt Loading Are Associated with Higher Levels of Atrial Natriuretic Peptide
  2259. Primary Aldosteronism
  2260. Primary Aldosteronism
  2261. Primary Aldosteronism
  2262. Primary Aldosteronism and the Effects of Two Mineralocorticoid Inhibitorsโ€”Triamterene and Spironolactone (Aldactone)
  2263. Primary aldosteronism
  2264. Report: Primary Aldosteronism.
  2265. Primary aldosteronism due to adrenocortical adenoma (Connโ€™s syndrome)
  2266. Ultrastructural and biochemical studies in human adrenocortical adenomas associated with primary aldosteronism.
  2267. Therapy of primary aldosteronism with trilostane
  2268. Secondary Aldosteronism
  2269. Primary Aldosteronism: 13 Cases Analysis
  2270. A case of nephrotic syndrome with diabetes mellitus and primary aldosteronism
  2271. Surgery of primary aldosteronism
  2272. TWO CASES OF PRIMARY ALDOSTERONISM
  2273. The syndrome of primary aldosteronism: a case study.
  2274. Screening for Aldosteronism
  2275. Renin in aldosteronism: relating kidney and adrenal
  2276. Primary Aldosteronism: A Challenging Case
  2277. Bilateral renal artery stenosis with aldosteronism
  2278. Primary Aldosteronism and Other Mineralocorticoid Excess Syndromes inย hypertension: Incidence, Screening, and Diagnosis
  2279. Mineralocorticoid and prolactin response to the dopamine antagonist metoclopramide in patients with primary aldosteronism
  2280. General anesthesia for a patient with primary aldosteronism complicated with hypertrophic nonobstructive cardiomyopathy
  2281. Diurnal variation and responses of corticoids to dexamethasone and ACTH before and after adrenal surgery in primary aldosteronism
  2282. Synchronous changes in active and inactive renin secretion after furosemide in patients with primary aldosteronism
  2283. Adrenal Scintigraphy in Primary Aldosteronism Caused by anย Aldosteroneย Producing Adenoma
  2284. Diagnosis and treatment of primary aldosteronism
  2285. Primary aldosteronism. Diagnostic aspects and treatment
  2286. The spitting image of primary aldosteronism
  2287. Primary Aldosteronism: Report of 38 Cases
  2288. The syndrome of mineralocorticoid excess: Primary aldosteronism
  2289. Pathological and clinical studies on primary aldosteronism
  2290. Plasmaย Aldosteroneย concentration in patients with primary aldosteronism in the last decade
  2291. Computer tomographic localisation in primary aldosteronism. Comparison with adrenal scintigraphy (authorโ€™s transl)
  2292. Primary Reninism:ย hypertension, Hyperreninaemia and Secondary Aldosteronism Due to Juxtaglomerular Renal Cell Tumours
  2293. Diagnosis of Primary Aldosteronism: Clinical Analysis of 26 Cases
  2294. Diagnosis and Treatment of Primary Aldosteronism
  2295. Formation of steroid hormones in the adrenal adenoma and adjacent adrenal tissue of a patient with primary aldosteronism
  2296. Effects on muscle electrolytes of potassium and magnesium infusions, spironolactone medication and operation in a case of primary aldosteronism
  2297. Intravenously Administered Chlorothiazide For Aldosteronism
  2298. Surgical management of primary aldosteronism: Experience of 9 cases
  2299. Primary Aldosteronismโ”€ Clinical Experiences and Literature Review
  2300. Surgical Therapy of Primary Aldosteronism
  2301. Urinary 18, 19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone excretion in patients with primary and secondary aldosteronism
  2302. Primary aldosteronism in general practice
  2303. Kinins in relation to renin activity in renal and inferior caval veins in normal individuals and patients with primary aldosteronism
  2304. A direct enzyme immunoassay for 18-hydroxycortisol in urine: a new tool for screening primary aldosteronism
  2305. โ€ฆ system: studies on histological changes in adrenal and renal tissue; a follow-up study of postoperative blood pressure in primary and idiopathic aldosteronism
  2306. The plasmaย Aldosterone/plasma renin activity ratio at different salt intakes has a limited value for the diagnosis of primary aldosteronism.
  2307. Eccrine sweat gland sensitivity to catecholamines in patients with pheochromocytoma and primary aldosteronism
  2308. Differences between adrenal adenoma causing primary aldosteronism and other adrenal tissues in the incorporation of labeled steroid precursors into their products
  2309. PREGNANCY AND PRIMARY ALDOSTERONISM
  2310. An Autopsy Case of Primary Aldosteronism
  2311. Endocrine characterization of the adrenal adenomas in a case of primary aldosteronism.
  2312. Suppressed Plasma Renin Activity in Hypertensive Patients-Its Evaluation for the Diagnosis of Primary Aldosteronism
  2313. ATYPICAL ALDOSTERONISM
  2314. Primary Aldosteronism: Changing Concepts in Diagnosis and Management
  2315. M010: Primary aldosteronism: A clinical profile based in 294 cases
  2316. Current concepts of primary aldosteronism
  2317. Intracellular sodium and potassium concentrations in erythrocytes of patients with primary aldosteronism
  2318. โ€ฆ adrenal steroid biosynthesis, on blood pressure, plasmaย Aldosteroneย and other steroid hormones, serum potassium and plasma renin activity in primary aldosteronism โ€ฆ
  2319. Is theย Aldosterone-renin ratio useful in screening for primary aldosteronism?
  2320. Primary Aldosteronism by Adenoma 1 Case
  2321. Anesthetic Experience with Primary Aldosteronism: Report of a case.
  2322. Primary Aldosteronism with Uncommon Complications
  2323. An Anesthetic Experience with Primary Aldosteronism.
  2324. Primary aldosteronism and adrenal incidentaloma.
  2325. Primary aldosteronism: complete remission after adrenal venography
  2326. Inactive form of carbonic anhydrase I in erythrocytes from primary aldosteronism.
  2327. Effect of dibutyryl cyclic AMP on plasma renin activity in normal men and patients with primary aldosteronism
  2328. Primary aldosteronismโ€“screening, diagnosis and therapy.
  2329. Fallacy of theย Aldosterone: renin ratio (ARR) used to screen for primary aldosteronism
  2330. The Recognition, Confirmation, and Course of Primary Aldosteronism.
  2331. CLINICOPATHOLOGIC STUDIES OF PRIMARY ALDOSTERONISM
  2332. Multiple calcified adrenal myelolipoma suggestive of association of primary aldosteronism: report of a case
  2333. Utility of Iodocholesterol Scanning in Primary Aldosteronism
  2334. Therapeutic experience of primary aldosteronism associated with chronic renal failure
  2335. Screening for primary aldosteronism in hypertensive patients
  2336. Determination of urinary 18-hydroxycortisol in the diagnosis of primary aldosteronism
  2337. Primary Aldosteronism: A Clinical Profile Based in 294 Cases: P1. 75
  2338. Aldosteronism after hypokalemia in diuretic therapy of systemic arterialย hypertension
  2339. Circulatory reflexes in primary aldosteronism (authorโ€™s transl)
  2340. โ€ฆ : Effect of the Antihypertensive Agent Diazoxide on Plasma Renin Activity and its Clinical Application, especially in Screening Primary Aldosteronism and its Similar โ€ฆ
  2341. Direct radioimmunoassays forโ€ย Aldosteroneโ€ andโ€ 18-hydroxycorticosteroneโ€ in unprocessed urine, and their use in screening to distinguish primary aldosteronism โ€ฆ
  2342. Cardiac Arrest Induced by Primary Aldosteronism
  2343. I004: Diagnostic value of the post-captopril test in primary aldosteronism
  2344. Renal kininase I, kininase II and neutral endopeptidase 24.11 activities in patients with essentialย hypertension, primary aldosteronism and Cushingโ€™s syndrome
  2345. Asymptomatic Normotensive Primary Aldosteronism
  2346. Primary aldosteronism and arterialย hypertension
  2347. Systemic hemodynamics in primary aldosteronism
  2348. โ€ฆ antibodies specific for 18-hydroxycortisol and their use in an enzyme immunoassay for human urinary 18-hydroxycortisol for diagnosis of primary aldosteronism
  2349. Detection of primary aldosteronism using the captopril test
  2350. M011: A follow-up study of patients with primary aldosteronism treated medically
  2351. Unexpected incidence of low blood pressure 2 years after unilateral adrenalectomy for primary aldosteronism
  2352. Prolactin in primary aldosteronism
  2353. Studies on Curableย hypertension: Special Reference to Renovascularย hypertensionย and Primary Aldosteronism: Panel Discussion on Some Problems in the โ€ฆ
  2354. Some Recent Contributions to Pathogenesis and Diagnosis of The Syndrome of Primary Aldosteronism
  2355. Some remaining problems of aldosteronism from personal case
  2356. Studies on abnormalities of adrenal steroidogenesis in essentialย hypertension, primary aldosteronism and renovascularย hypertension: responses of plasma steroids to โ€ฆ
  2357. A CASE OF GRAVESโ€™DISEASE ASSOCIATED WITH PRIMARY ALDOSTERONISM TREATED BY SIMULTANEOUS SUBTOTAL THYROIDECTOMY AND โ€ฆ
  2358. Aldosteroneย and Aldosteronism
  2359. PLASMA RENIN IN ALDOSTERONISM.
  2360. USE OF COMPUTED TOMOGRAPHY IN DIAGNOSING THE CAUSE OF PRIMARY ALDOSTERONISM
  2361. Crisis of arterialย hypertensionย in patients with primary aldosteronism
  2362. Primary aldosteronism is an independent determinant of albumin excretion.
  2363. Insulin resistance and abnormal glucose metabolism in patients with primary aldosteronism
  2364. Effect of SK&F-12185 [dl-2(p-Aminophenyl)-2-phenylethylamine] on Adrenocortical Function in Primary Aldosteronism
  2365. Aldosteronism and Spironolactone
  2366. Changes of urinary kallikrein excretion and plasma natriuretic factor in a patient with primary aldosteronism with special reference to adrenal histology
  2367. โ€ฆ ADRENOCORTICAL GLOMERULAR ZONE BY INCOMPLETE LIGATION OF BILATERAL URETERS OF RATS: An Experimental Model for Secondary Aldosteronism
  2368. 21-DeoxyAldosteroneย excretion in patients with primary aldosteronism and 21-hydroxylase deficiency
  2369. DEXAMETHASONE SUPPRESSION SCINTISCAN IN PRIMARY ALDOSTERONISM WITH SCINTADREN
  2370. Investigation of the prevalence and genetic characterisation of patients with glucocorticoid remediable aldosteronism
  2371. Primary aldosteronism due to adrenal carcinomas. Klin Wochenschr.
  2372. Plasma Renin Activity in Primary Aldosteronism-Reply
  2373. I-131 NP-59 adrenal cortical scintigraphy in suspected primary aldosteronism.
  2374. Radioimmunoassay of urinary 21-deoxytetrahydroAldosteroneย in primary aldosteronism and 21-hydroxylase deficiency
  2375. Crisis of arterialย hypertensionย in patients with primary aldosteronism. Krizovoe techenie arterialโ€™noj gipertonii u bolโ€™nykh pervichnym alโ€™dosteronizmom
  2376. Aldosteroneย and Aldosteronism
  2377. Presidential address: Part I. Painting background part II primary aldosteronism, a new clinical syndrome
  2378. Use of the Saline Infusion Test to Diagnose the Cause of Primary Aldosteronism
  2379. Computer tomographic localisation in primary aldosteronism. Comparison with renal scintigraphy
  2380. A SUCCESSFUL CASE OF ADRENALECTOMY FOR PRIMARY ALDOSTERONISM
  2381. The clinical use of captopril in the diagnosis and treatment of primary aldosteronism
  2382. Coexisting primary aldosteronism and pheochromocytoma (report of 4 cases)
  2383. hypertensionย Controlled by Adrenalectomy: A Case of Primary Aldosteronism
  2384. Localization of te Adrenal Lesions in Primary Aldosteronism
  2385. โ€ฆ of single-administration captopril on plasma and urinary vasopressin in normotensive subjects and patients with essentialย hypertensionย and primary aldosteronism
  2386. Aldosterone-producing microadenoma in a patient with primary aldosteronism.
  2387. Suppressed plasma renin activity and primary aldosteronism.
  2388. The diagnosis and surgical management of primary aldosteronism: Joseph C. Cerny, Detroit, Michigan
  2389. The significance of sodium intake in postoperative aldosteronism
  2390. Clinical study on primary aldosteronismโ€“localization of adrenal tumors
  2391. โ€ฆ the hypochloremic state and postural change (from supine posture to standing and walking)โ€“new diagnostic criteria for primary aldosteronism (with normal potassium โ€ฆ
  2392. The prediction of blood pressure after adrenalectomy in primary aldosteronism
  2393. Twenty-Four Hour Blood Pressure Profile in Subjects with Different Subtypes of Primary Aldosteronism
  2394. Five cases of primary aldosteronism: a comparative study on diagnosis for localization of adrenal tumor
  2395. Effect of spironolactone on circadian rhythm of plasma renin activity, plasmaย Aldosteroneย and cortisol in primary aldosteronism
  2396. Primary aldosteronism: diagnosis, laterality and regulation of hormone secretion
  2397. Anesthetic Experience of Adrenalectomy with Primary Aldosteronism.
  2398. Significance of single-dose captopril test in the differential diagnosis of primary aldosteronism
  2399. PRIMARY ALDOSTERONISM RELATIONS BETWEEN PATHOLOGICAL FINDINGS AND LOCALIZATION OF THE TUMOR AND FOLLOW-UP RESULTS
  2400. Anesthetic Experience of a Patient with Primary Aldosteronism Complicated with Aortic Dissection: A case report.
  2401. Primary Aldosteronism: An Anesthetic Experience with Adrenalectomy.
  2402. ANALYSIS OF THE DIURNAL BLOOD PRESSURE VARIATION IN PRIMARY ALDOSTERONISM: P1. 133
  2403. I002: Primary aldosteronism; a community based survey in 3 ethnic communities in cape town, south africa
  2404. The circadian rhythm of serumย Aldosteroneย in the diagnostics of primary aldosteronism
  2405. Clinical study of one Chinese pedigree with glucocorticoid-remediable aldosteronism
  2406. Primary Aldosteronism and Effects of Two Mineralocorticoid Inhibitors
  2407. โ€ฆ suppression test and long-PCR of chimeric gene for the diagnosis of glucocorticoid-remediable aldosteronism (GRA) in patients with primary aldosteronism (PA)
  2408. M012: Positive screening for primary aldosteronism in blacks and whites with essentialย hypertension
  2409. Corticoids secretion in primary aldosteronism. I. Diurnal variation and the effect of dexamethasone (authorโ€™s transl)
  2410. Scintigraphic Localization of Adrenal Lesions in Primary Aldosteronism
  2411. Fimilial primary aldosteronism with delayed glucocorticoid responsiveness: A new sndrome
  2412. D016:ย Aldosteroneย synthase gene polymorphisms in primary aldosteronism
  2413. Localization of adrenal adenomas in primary aldosteronism
  2414. A Case Report of Primary Aldosteronism with Sustainedย hypertensionย After Adrenalectomy
  2415. Primary Aldosteronism Versus Other Forms ofย hypertensionย Associated with Hypokalemia.
  2416. A case of primary aldosteronism with severe hypokalemic myopathy
  2417. Diurnal Blood Pressure Changes in Primary Aldosteronism-A Study of Ambulatory Blood Pressure Monitoring and Neurohormonal Changes
  2418. Radioimmunological determination ofย Aldosteroneย in the serum. New method for the localization of aldosteronism
  2419. Isolated Clinical Syndrome of Primary Aldosteronism in Four Patients With Adrenocortical Carcinoma
  2420. Nuclear medicine diagnostic localization in primary aldosteronism and Cushing syndrome
  2421. Nonnokalemic Primary Aldosteronism. A Detectable Cause of Curable Essentialย hypertension
  2422. Plasma Levels of Atrial Natriuretic Peptide in Primary Aldosteronism and Essentialย hypertension
  2423. The role of endogenous dopamine on mineralocorticoids secretion in normal subjects, patients with primary aldosteronism, and idiopathic hyperaldosteronism
  2424. CLINICAL SIGNIFICANCE OF CHANGES OF ATRIAL NATRIURETIC POLYPEPTIDE (ANP) IN PRIMARY ALDOSTERONISM AND THEIR RELATION WITH THE
  2425. Plasmaย Aldosteroneย and electrolytes in primary and secondard aldosteronism (authorโ€™s transl)
  2426. A possible role for intermediate lobe peptides in the pathogenesis of idiopathic aldosteronism.
  2427. Variations in severity ofย hypertensionย in a large pedigree with glucocorticoid-remediable aldosteronism
  2428. โ€ฆ -Adosterol (NCL-6-131I) by Diverging and Pinhole Methods III. Comparative Studies of Baseline and Dexamethasone Suppression Imaging in Aldosteronism
  2429. Whole body computed tomographic findings of each one case with primary aldosteronism and Cushing syndrome
  2430. The x-ray endovascular treatment of renin-dependent arterialย hypertensionย with secondary aldosteronism in patients without vasorenal involvement
  2431. Studies on the mechanism of secretion of adrenal steroid hormones from adenomas of primary aldosteronism and Cushingโ€™s syndrome (authorโ€™s transl)
  2432. M014: Identification of the aetiology of primary aldosteronism (PA) with adrenal vein sampling (AVS) in a CT and MRI era: Results in 104 consecutive cases
  2433. PLASMAย Aldosteroneย RESPONSE TO LONG TERM SPIRONOLACTONE TREATMENT IN PRIMARY ALDOSTERONISM
  2434. Response of several adrenal steroids to rapid ACTH stimulation test in essentialย hypertensionย and primary aldosteronism (authorโ€™s transl)
  2435. Abnormality of circulatory reflex andย Aldosteroneย response during head-up tilting in patients with primary aldosteronism
  2436. ROLE OF NATRIURETIC FACTORS IN MINERALOCORTICOID ESCAPE PHENOMENON IN PATIENTS WITH PRIMARY ALDOSTERONISM
  2437. Hyperkalaemia secondary to hypo-aldosteronism-a report of 2 cases differentiating hyperreninaemic from hyporeninaemic hypo-aldosteronism
  2438. Dietary sodium change in primary aldosteronism. Atrial natriuretic factor, hormonal, and vascular responses.ย hypertension.
  2439. Prevalence and determinants of non-rheumatic Atrial Fibrillation (AF) in patients with primary aldosteronism
  2440. Effect of captopril onย Aldosteroneย response to potassium infusion in primary aldosteronism
  2441. Clinical analysis on 40 cases of primary aldosteronismโ€“long-term follow-up of blood pressure
  2442. Corticoid secretion in primary aldosteronism. II. The renin releasing test and the angiotensin II analog infusion test (authorโ€™s transl)
  2443. Effects of surgical treatment on circadian variations of arterial pressure in patients with primary aldosteronism and renovascularย hypertension
  2444. A CASE OF PRIMARY ALDOSTERONISM TREATED BY ADRENAL ARTERY EMBOLIZATION USING ABSOLUTE ETHANOL
  2445. A Case of Primary Aldosteronism due to Bilateral Adrenal Hyperplasia with Hidden Undiagnosed Adrenal Adenoma for Eight Years
  2446. Prostaglandin E2 and the renin-angiotensin system in primary aldosteronism and Cushingโ€™s syndrome
  2447. Multiple Endocrine Neoplasia Type I: A Case of Parathyroid Adenoma, Colloid Nodules and Aldosteronism
  2448. Glucocorticoid remediable aldosteronism: a rare hereditary form of adrenocorticotropic hormone regulated mineralocorticoidย hypertension
  2449. Adrenal venous sampling analysis of primary aldosteronism: value of ACTH stimulation in the differentiation of adenoma and hyperplasia
  2450. Diagnosis and roentgeno-endovascular treatment of patients with renin-dependent arterialย hypertensionย and secondary aldosteronism without damage to the main โ€ฆ
  2451. Morphology of the juxtaglomerular appartus in Bartterโ€™s syndrome (hyperplasia of the juxtaglomerular complex with secondary aldosteronism withoutย hypertension)
  2452. An unexpected rise in plasmaย Aldosteroneย to furosemide-upright test in primary aldosteronism due toย Aldosteroneย producing adenoma.
  2453. Current problems in primary aldosteronismโ€“4 cases of normokalemic primary aldosteronism (1st degree) caused by adenoma and 3 cases of aldosteronism, 1st โ€ฆ
  2454. โ€ฆ and dopamine onย Aldosteroneย secretion in cultured adrenocortical adenoma cells and adjacent non-adenoma cells from patients with primary aldosteronism
  2455. โ€ฆ and Urinaryย Aldosteroneย Excretion in Hypertensive Patients: with Special Reference to Incidence of Normokalemic Primary Aldosteronism in Essentialย hypertension
  2456. A clinicopathological and ultrastructural study on 147 cases of primary aldosteronism
  2457. Endocrinopathies of hyperfunction: Cushingโ€™s syndrome and aldosteronism
  2458. DIAGNOSTIC APPROACH TO 144 PATIENTS WITH PRIMARY ALDOSTERONISM: P2. 130
  2459. Results of Treatment in 68 Patients with Idiopathic Aldosteronism in Japan
  2460. DIAGNOSTIC AND THERAPEUTIC UNDERSTANDING OF 37 CASES OF PRIMARY ALDOSTERONISM [J]
  2461. 1 Case of Primary Aldosteronism Caused by Adrenal Hyperplasia
  2462. โ€ฆ 131/I-adosterol (NCL-6-/sup 131/I) by diverging and pinhole methods, 3. Comparative studies of baseline and dexamethasone suppression imaging in aldosteronism
  2463. Clinical observation of 12 cases of primary aldosteronism, special reference to the diagnostic problem (authorโ€™s transl)
  2464. 24 hours ambulatory blood pressure in primary aldosteronism
  2465. Follow up of 123 patients submitted to adrenalectomy in primary aldosteronism
  2466. A clinical analysis of 146 cases of primary aldosteronism
  2467. Analysis of the Pre and Post operative Blood Pressure and Blood Biochemical Changes in 40 Cases of Primary Aldosteronism
  2468. The diagnosis of unilateral adrenal adenoma in 123 patients with primary aldosteronism
  2469. The Diagnostic Value of Urinary Free 18-Hydroxycorticosterone in Primary Aldosteronism
  2470. 60 Primary Aldosteronism-Treatment with Trilostane, an Inhibitor of Steroid Biosynthesis
  2471. Adrenal scintigraphy with 131I-19-iodocholesterol in primary aldosteronism
  2472. 1.4 Characteristics of patients with glucocorticoid remediable aldosteronism in the North East of Scotland
  2473. 109 Improvement of arterial baroreflex function by adrenalectomy and its effect on the variability of arterial pressure in primary aldosteronism
  2474. Primary aldosteronism: renaissance of a syndrome
  2475. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
  2476. Primary aldosteronism: diagnostic and treatment strategies
  2477. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
  2478. Primary aldosteronism and hypertensive disease
  2479. Renal damage in primary aldosteronism: results of the PAPY Study
  2480. Minireview: primary aldosteronismโ€”changing concepts in diagnosis and treatment
  2481. Cardiovascular outcomes in patients with primary aldosteronism after treatment
  2482. A review of the medical treatment of primary aldosteronism
  2483. Diagnosis and management of primary aldosteronism
  2484. Update in primary aldosteronism
  2485. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism
  2486. Primary aldosteronismโ€”careful investigation is essential and rewarding
  2487. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents
  2488. A comprehensive review of the clinical aspects of primary aldosteronism
  2489. Long-term renal outcomes in patients with primary aldosteronism
  2490. Comparison of confirmatory tests for the diagnosis of primary aldosteronism
  2491. Primary aldosteronism: an update on screening, diagnosis and treatment
  2492. Insulin sensitivity in patients with primary aldosteronism: a follow-up study
  2493. Primary aldosteronism: management issues
  2494. Role for adrenal venous sampling in primary aldosteronism
  2495. Primary aldosteronism: cardiovascular, renal and metabolic implications
  2496. The current epidemic of primary aldosteronism: causes and consequences
  2497. Primary aldosteronism
  2498. Psychological aspects of primary aldosteronism
  2499. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline
  2500. Prevalence of primary aldosteronism in patientโ€™s cohorts and in population-based studiesโ€“a review of the current literature
  2501. Guidelines for the diagnosis and treatment of primary aldosteronism-The Japan Endocrine Society 2009
  2502. Primary aldosteronism: factors associated with normalization of blood pressure after surgery
  2503. Diagnosis and treatment of primary aldosteronism
  2504. Laboratory investigation of primary aldosteronism
  2505. Diagnosis of primary aldosteronism: from screening to subtype differentiation
  2506. Observational study mortality in treated primary aldosteronism: the German Connโ€™s registry
  2507. Aldosteronism andย hypertension
  2508. Prevalence and diagnosis of primary aldosteronism
  2509. Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism
  2510. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol
  2511. Bone involvement in aldosteronism
  2512. Confirmatory testing in primary aldosteronism
  2513. Excess ldosterone Is Associated With Alterations of Myocardial Texture in Primary Aldosteronism
  2514. Risk factors associated with a low glomerular filtration rate in primary aldosteronism
  2515. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism
  2516. Primary aldosteronism: current knowledge and controversies in Connโ€™s syndrome
  2517. Kidney impairment in primary aldosteronism
  2518. Glucocorticoid-remediable aldosteronism
  2519. Relative glomerular hyperfiltration in primary aldosteronism
  2520. A novel form of human mendelianย hypertensionย featuring nonglucocorticoid-remediable aldosteronism
  2521. Primary aldosteronism and metabolic syndrome
  2522. A clinical prediction score to diagnose unilateral primary aldosteronism
  2523. High rate of detection of primary aldosteronism, including surgically treatable forms, after โ€˜non-selectiveโ€™screening of hypertensive patients
  2524. Is primary aldosteronism associated with diabetes mellitus? Results of the German Connโ€™s Registry
  2525. Drug effects onย Aldosterone/plasma renin activity ratio in primary aldosteronism
  2526. Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies
  2527. Primary aldosteronism: are we diagnosing and operating on too few patients?
  2528. Psychological assessment of primary aldosteronism: a controlled study
  2529. Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment
  2530. Comorbidities in primary aldosteronism
  2531. Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms)
  2532. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Connโ€™s Registry
  2533. Long-term follow-up after adrenalectomy for primary aldosteronism
  2534. Prevalence, Clinical, and Molecular Correlates of KCNJ5 Mutations in Primary Aldosteronism
  2535. Response to Is There an Unrecognized Epidemic of Primary Aldosteronism?(Pro)
  2536. What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism?
  2537. Primary aldosteronism in diabetic subjects with resistantย hypertension
  2538. Screening for primary aldosteronism without discontinuing hypertensive medications: plasmaย Aldosterone-renin ratio
  2539. Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study
  2540. Confirmatory tests in the diagnosis of primary aldosteronism
  2541. The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism
  2542. Inappropriate left ventricular mass in patients with primary aldosteronism
  2543. Aldosteroneย synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronism
  2544. Intrarenal hemodynamics in primary aldosteronism before and after treatment
  2545. Hyperparathyroidism and the calcium paradox of aldosteronism
  2546. Use of plasmaย Aldosteroneย concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature.
  2547. Cautions over the current epidemic of primary aldosteronism.
  2548. Role of radiology in the management of primary aldosteronism
  2549. Captopril suppression versus salt loading in confirming primary aldosteronism
  2550. Loss of bone minerals and strength in rats with aldosteronism
  2551. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism
  2552. Aldosteroneย as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study
  2553. Adiponectin and insulin sensitivity in primary aldosteronism
  2554. A possible association between primary aldosteronism and a lower ฮฒ-cell function
  2555. Relationships of plasma renin levels with renal function in patients with primary aldosteronism
  2556. Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study
  2557. Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience
  2558. Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication?
  2559. hypertensionย of Kcnmb1โˆ’/โˆ’ is linked to deficient K secretion and aldosteronism
  2560. Screening for primary aldosteronism in essentialย hypertension: diagnostic accuracy of the ratio of plasmaย Aldosteroneย concentration to plasma renin activity
  2561. Primary hyperparathyroidism with concurrent primary aldosteronism
  2562. Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group)
  2563. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication
  2564. Increased arterial wall stiffness in primary aldosteronism in comparison with essentialย hypertension
  2565. Treatment of primary aldosteronism
  2566. Vascular remodeling and duration ofย hypertensionย predict outcome of adrenalectomy in primary aldosteronism patients
  2567. Progress in primary aldosteronism: present challenges and perspectives
  2568. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings โ€ฆ
  2569. Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism
  2570. Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects
  2571. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism
  2572. Surgically correctableย hypertensionย caused by primary aldosteronism
  2573. Increased intimaโ€“media thickness of the common carotid artery in primary aldosteronism in comparison with essentialย hypertension
  2574. Adrenal causes ofย hypertension: pheochromocytoma and primary aldosteronism
  2575. Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism
  2576. Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes
  2577. The metabolic syndrome in primary aldosteronism
  2578. The challenge of more robust and reproducible methodology in screening for primary aldosteronism
  2579. Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men?
  2580. Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism
  2581. โ€ฆ -blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients withย hypertensionย and evidence of primary aldosteronism
  2582. Primary aldosteronism in normokalemic patients with adrenal incidentalomas
  2583. The role of aldosteronism in causingย obesity-related cardiovascular risk
  2584. Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism
  2585. Primary aldosteronism: diagnosis and treatment
  2586. Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism
  2587. Adrenalectomy improves arterial stiffness in primary aldosteronism
  2588. Screening for membrane hormone receptor expression in primary aldosteronism
  2589. High prevalence of primary aldosteronism using postcaptopril plasmaย Aldosteroneย to renin ratio as a screening test among Italian hypertensives
  2590. Oxidative stress in aldosteronism
  2591. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism
  2592. Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism
  2593. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due toย Aldosterone-producing adenoma
  2594. Diagnostic value of the post-captopril test in primary aldosteronism
  2595. Differential diagnosis of primary aldosteronism subtypes
  2596. Resistantย hypertensionย and aldosteronism
  2597. Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism
  2598. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of anย Aldosterone/renin ratio above 25 as a โ€ฆ
  2599. Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study
  2600. Variability in the renin/Aldosteroneย profile under random and standardized sampling conditions in primary aldosteronism
  2601. Captopril test can give misleading results in patients with suspect primary aldosteronism
  2602. Aldosteronism and resistantย hypertension
  2603. Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling
  2604. Diagnosis and treatment of primary aldosteronism
  2605. Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface
  2606. Clinicopathological features of primary aldosteronism associated with subclinical Cushingโ€™s syndrome
  2607. Validity of theย Aldosterone-renin ratio used to screen for primary aldosteronism
  2608. Primary aldosteronism: revival of a syndrome
  2609. Primary aldosteronism: who should be screened?
  2610. Rapid cortisol assays improve the success rate of adrenal vein sampling for primary aldosteronism
  2611. Renin-angiotensin-Aldosteroneย system in patients with sleep apnoea: prevalence of primary aldosteronism
  2612. Primary aldosteronism: diagnostic accuracy of the losartan and captopril tests
  2613. Predictors of successful outcome after adrenalectomy for primary aldosteronism
  2614. Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases
  2615. Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype
  2616. The genetic basis of primary aldosteronism
  2617. Diagnosis and management of primary aldosteronism
  2618. Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism
  2619. Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients
  2620. Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism
  2621. Within-patient reproducibility of theย Aldosterone: renin ratio in primary aldosteronism
  2622. The genetics of primary aldosteronism
  2623. Primary aldosteronismโ€“treatment options
  2624. Primary aldosteronism
  2625. Commentary on the Endocrine Society Practice Guidelines: Consequences of adjustment of antihypertensive medication in screening of primary aldosteronism
  2626. Calcium paradox of aldosteronism and the role of the parathyroid glands
  2627. What we still do not know about adrenal vein sampling for primary aldosteronism
  2628. Genetics of primary aldosteronism
  2629. Evaluation of primary aldosteronism
  2630. A diagnostic algorithmโ€”the holy grail of primary aldosteronism
  2631. Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization ofย Aldosteroneย oversecretion in primary aldosteronism patients
  2632. Screening for primary aldosteronism
  2633. Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy
  2634. Diagnosis and management of primary aldosteronism in pregnancy: case report and review of the literature
  2635. Detecting and treating primary aldosteronism
  2636. Aldosteroneย to renin ratioโ€“a reliable screening tool for primary aldosteronism?
  2637. Primary aldosteronism: from genesis to genetics
  2638. Urinary tetrahydroAldosteroneย as a screening method for primary aldosteronism: a comparative study
  2639. Primary aldosteronism: part II: subtype differentiation and treatment
  2640. Diuretics and bone loss in rats with aldosteronism
  2641. Theย Aldosterone-to-renin ratio as a screening test for primary aldosteronism.
  2642. Active renin versus plasma renin activity to defineย Aldosterone-to-renin ratio for primary aldosteronism
  2643. Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different โ€ฆ
  2644. Aldosterone-and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism
  2645. Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism
  2646. Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates
  2647. Trends in the prevalence of primary aldosteronism,ย Aldosterone-producing adenomas, and surgically correctableย Aldosterone-dependentย hypertension
  2648. Hyperparathyroidism can be useful in the identification of primary aldosteronism due toย Aldosterone-producing adenoma
  2649. Glucocorticoid-remediable aldosteronism is associated with severeย hypertensionย in early childhood
  2650. Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment
  2651. 18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes
  2652. The prevalence of familial hyperaldosteronism in apparently sporadic primary aldosteronism in Germany: a single center experience
  2653. Primary aldosteronism-part I: prevalence, screening, and selection of cases for adrenal vein sampling
  2654. Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization ofย Aldosteroneย excess baseline and after adrenocorticotropic โ€ฆ
  2655. Peripheral arterial stiffness in primary aldosteronism.
  2656. Subclinical primary aldosteronism
  2657. Relative kidney hyperfiltration in primary aldosteronism: a meta-analysis
  2658. Cardiovascular changes in patients with primary aldosteronism after surgical or medical treatment
  2659. Response to Is There an Unrecognized Epidemic of Primary Aldosteronism?(Con)
  2660. Primary aldosteronism
  2661. Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism
  2662. Demonstration of blood pressure-independent noninfarct myocardial fibrosis in primary aldosteronism: a cardiac magnetic resonance imaging study
  2663. The phosphorylated sodium chloride cotransporter in urinary exosomes is superior to prostasin as a marker for aldosteronism
  2664. Primary aldosteronism: the case for screening
  2665. Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinaryย Aldosteroneย metabolites
  2666. Aldosteronism and a Proinflammatory Vascular Phenotype: Role of Mg2+, Ca2+, and H2O2 in Peripheral Blood Mononuclear Cells
  2667. Aldosterone-to-renin ratio as a screening test for primary aldosteronismโ€“the Dutch ARRAT Study
  2668. Reversible sympathetic overactivity in hypertensive patients with primary aldosteronism
  2669. The ovarian cycle as a factor of variability in the laboratory screening for primary aldosteronism in women
  2670. Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and/or amiloride, including a comparison with our โ€ฆ
  2671. Diagnosis and management of primary aldosteronism
  2672. Adrenal vein sampling may not be a gold-standard diagnostic test in primary aldosteronism: final diagnosis depends upon which interpretation rule is used
  2673. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree
  2674. Concurrent primary aldosteronism and subclinical cortisol hypersecretion: a prospective study
  2675. A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III
  2676. Diagnosis and management of primary aldosteronism
  2677. Endothelial progenitor cells in primary aldosteronism: a biomarker of severity forย Aldosteroneย vasculopathy and prognosis
  2678. Predictive factors of left ventricular mass changes after treatment of primary aldosteronism
  2679. Impact of accessory hepatic veins on adrenal vein sampling for identification of surgically curable primary aldosteronism
  2680. Primary aldosteronism among newly diagnosed and untreated hypertensive patients in a Swedish primary care area
  2681. From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation
  2682. Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study
  2683. A screening procedure for primary aldosteronism based on the Diasorin Liaisonยฎ automated chemiluminescent immunoassay for direct renin
  2684. Primary aldosteronism in pregnancy
  2685. Screening for primary aldosteronism: implications of an increased plasmaย Aldosterone/renin ratio
  2686. Screening for primary aldosteronism-normal ranges forย Aldosteroneย and renin in three South African population groups
  2687. Eplerenone use in primary aldosteronism during pregnancy
  2688. Primary aldosteronism: evidence against a second epidemic
  2689. Atrial fibrillation in primary aldosteronism
  2690. Quality of life in patients with primary aldosteronism: gender differences in untreated and long-term treated patients and associations with treatment andย Aldosterone
  2691. Vascular disturbances in primary aldosteronism: clinical evidence
  2692. Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism
  2693. Blood pressure and medication changes following adrenalectomy for unilateral primary aldosteronism: a follow-up study
  2694. Primary aldosteronism: results of adrenalectomy for nonsingle adenoma
  2695. Aldosteronism revisited: perspectives on less well-recognized actions ofย Aldosterone
  2696. Primary aldosteronism: a needle in a haystack or a yellow cab on Fifth Avenue?
  2697. Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion
  2698. Bone loss in rats with aldosteronism
  2699. Cardiac remodeling in patients with primary aldosteronism
  2700. Primary aldosteronism: are we missing the wood for the trees?
  2701. Primary aldosteronism, diagnosis and treatment in Japan
  2702. Integrating genetics and genomics in primary aldosteronism
  2703. Captopril suppression: limitations for confirmation of primary aldosteronism
  2704. Management of primary aldosteronism: its complications and their outcomes after treatment
  2705. Aldosteronism in heart failure: a proinflammatory/fibrogenic cardiac phenotype. Search for biomarkers and potential drug targets
  2706. Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment
  2707. Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism
  2708. Confirmatory testing in primary aldosteronism: extensive medication switching is not needed in all patients
  2709. Primary aldosteronism.
  2710. Metabolic syndrome in primary aldosteronism and essentialย hypertension: relationship to adiponectin gene variants
  2711. A case of primary aldosteronism in pregnancy: do LH and GNRH receptors have a potential role in regulatingย Aldosteroneย secretion?
  2712. Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning
  2713. Myocardial and aortic stiffening in the early course of primary aldosteronism
  2714. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism
  2715. Screening tests and diagnostic examinations of hypertensives for primary aldosteronism
  2716. Theย Aldosteroneโ€“renin ratio in screening for primary aldosteronism
  2717. Diurnal blood pressure variationin pheochromocytoma, primary aldosteronism and Cushingโ€™s syndrome
  2718. Progress in primary aldosteronism
  2719. The association of serum potassium level with left ventricular mass in patients with primary aldosteronism
  2720. Case Report: Laparoscopic Adrenalectomy on a Patient with Primary Aldosteronism during Pregnancy
  2721. Diagnostic accuracy of adrenal venous sampling in comparison with other parameters in primary aldosteronism
  2722. Plasma osteopontin levels are higher in patients with primary aldosteronism than in patients with essentialย hypertension
  2723. Primary aldosteronism, a common entity? The myth persists
  2724. Intraprocedural cortisol measurement increases adrenal vein sampling success rate in primary aldosteronism
  2725. Would wider screening for primary aldosteronism give any health benefits?
  2726. Cause of residualย hypertensionย after adrenalectomy in patients with primary aldosteronism
  2727. Aberrant hormone receptors in primary aldosteronism
  2728. Familial varieties of primary aldosteronism
  2729. Postoperative differentiation between unilateral adrenal adenoma and bilateral adrenal hyperplasia in primary aldosteronism by mRNA expression of the gene โ€ฆ
  2730. Is random screening of value in detecting glucocorticoid-remediable aldosteronism within a hypertensive population?
  2731. The role of adrenal venous sampling in the surgical management of primary aldosteronism
  2732. A prospective evaluation of postural stimulation testing, computed tomography and adrenal vein sampling in the differential diagnosis of primary aldosteronism
  2733. The neurohormonal natural history of essentialย hypertension: towards primary or tertiary aldosteronism?
  2734. Primary aldosteronism: the role of confirmatory tests
  2735. Primary aldosteronism associated with severe rhabdomyolysis due to profound hypokalemia
  2736. Primary aldosteronism, a major form of low reninย hypertension: from screening to diagnosis
  2737. Single-center outcome of laparoscopic unilateral adrenalectomy for patients with primary aldosteronism: lateralizing disease using results of adrenal venous sampling
  2738. Primary aldosteronism: a common and important problem A practical guide to the diagnosis and treatment
  2739. Evidence for a Role of Vasopressin in the Control ofย Aldosteroneย Secretion in Primary Aldosteronism: in Vitro and in Vivo Studies
  2740. Plasma and urineย Aldosteroneย to plasma renin activity ratio in the diagnosis of primary aldosteronism
  2741. Serum 18-hydroxycortisol in primary aldosteronism,ย hypertension, and normotensives
  2742. A German family with glucocorticoid-remediable aldosteronism
  2743. Pseudoโ€aldosteronismโ€™induced by intravenous glycyrrhizin treatment of chronic hepatitis C patients
  2744. New concepts in adrenal vein sampling forย Aldosteroneย in the diagnosis of primary aldosteronism
  2745. Adrenal venous sampling in primary aldosteronism: a low dilution of adrenal venous blood is crucial for a correct interpretation of the results
  2746. Non-invasive adrenal imaging in primary aldosteronism. Sensitivity and positive predictive value of radiocholesterol scintigraphy, CT scan and MRI
  2747. Factors influencing left ventricular mass regression in patients with primary aldosteronism post adrenalectomy
  2748. Primary aldosteronism: rare bird or common cause of secondaryย hypertension?
  2749. Treatment of primary aldosteronism: Where are we now?
  2750. The role of adrenal scintigraphy in the preoperative management of primary aldosteronism
  2751. QT interval in patients with primary aldosteronism and low-renin essentialย hypertension
  2752. Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity
  2753. New aspects on primary aldosteronism
  2754. Primary aldosteronism: from bench to bedside
  2755. Left ventricular changes in primary aldosteronism
  2756. Primary aldosteronism can alter peripheral levels of transforming growth factor ฮฒ and tumor necrosis factor ฮฑ
  2757. Primary aldosteronism in 2011: towards a better understanding of causation and consequences
  2758. Is it possible to extirpate cardiovascular events in primary aldosteronism after surgical treatment
  2759. Familial or genetic primary aldosteronism and Gordon syndrome
  2760. Discriminating factors for recurrentย hypertensionย in patients with primary aldosteronism after adrenalectomy
  2761. Does primary aldosteronism exist in normotensive and mildly hypertensive patients, and should we look for it?
  2762. Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism
  2763. Primary aldosteronism: what consensus for the diagnosis
  2764. Prediction of successful outcome in patients with primary aldosteronism
  2765. Idiopathic intracranialย hypertensionย with primary aldosteronism: report of 2 cases
  2766. Recent advances in diagnosis and treatment of primary aldosteronism.
  2767. A case of primary aldosteronism due to unilateral adrenal hyperplasia
  2768. Genetic alterations in patients with primary aldosteronism
  2769. Active renin mass concentration to determineย Aldosterone-to-renin ratio in screening for primary aldosteronism
  2770. Primary aldosteronism: actual epidemics or false alarm?
  2771. Dietary sodium restriction restores nocturnal reduction of blood pressure in patients with primary aldosteronism
  2772. Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism
  2773. Uncoupling the coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria seen in aldosteronism
  2774. Mitochondria-targeted cardioprotection in aldosteronism
  2775. Is primary aldosteronism underdiagnosed in clinical practice?
  2776. Primary aldosteronism withย Aldosterone-producing adenoma consisting of pure zona glomerulosa-type cells in a pregnant woman
  2777. Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene
  2778. Spontaneous resolution of idiopathic aldosteronism after long-term treatment with potassium canrenoate
  2779. Zinc dyshomeostasis in rats with aldosteronism. Response to spironolactone
  2780. Primary Aldosteronismโ€”One Picture Is Not Worth a Thousand Words
  2781. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy
  2782. Prolongation of the QT interval in primary aldosteronism
  2783. Glucocorticoid remediable aldosteronism (GRA) screening in hypertensive patients from a primary care setting
  2784. โ€ฆ /renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serumย Aldosteroneย concentration for primary aldosteronism screening in different age โ€ฆ
  2785. Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients
  2786. Primary aldosteronism
  2787. Echocardiographic comparison of left ventricular structure and function in hypertensive patients with primary aldosteronism and essentialย hypertension
  2788. Somatic Mutations in the KCNJ5 Gene Raise the Lateralization Index: Implications for the Diagnosis of Primary Aldosteronism by Adrenal Vein Sampling
  2789. The pharmacological treatment of primary aldosteronism
  2790. Left heart morphology and function in primary aldosteronism
  2791. Diurnal blood pressure pattern in patients with primary aldosteronism
  2792. Spontaneous remission of idiopathic aldosteronism after longโ€term treatment with spironolactone: results from the German Connโ€™s Registry
  2793. Laboratory diagnosis of primary aldosteronism, and drospirenone-ethinylestradiol therapy
  2794. โ€ฆ Endocrine Causes ofย hypertensionย (GECOH) study: a diagnostic accuracy study ofย Aldosteroneย to active renin ratio in screening for primary aldosteronism
  2795. Blood pressure, thyroid-stimulating hormone, and thyroid disease prevalence in primary aldosteronism and essentialย hypertension
  2796. Combined primary aldosteronism and preclinical Cushingโ€™s syndrome: an unusual case presentation of adrenal adenoma
  2797. Recurrent calcium nephrolithiasis associated with primary aldosteronism
  2798. Authorsโ€™ Response: Prevalence of Primary Aldosteronism in Unselected Hypertensive Populationsโ€”Screening and Definitive Diagnosis
  2799. Is primary aldosteronism rare or common among hypertensive patients?
  2800. Preventing oxidative stress in rats with aldosteronism by calcitriol and dietary calcium and magnesium supplements
  2801. Primary aldosteronism: A contrarian view
  2802. Functional tests for primary aldosteronism: value of captopril suppression
  2803. Cinacalcet and the prevention of secondary hyperparathyroidism in rats with aldosteronism
  2804. Coexistence of normotensive primary aldosteronism in two patients with Gitelmanโ€™s syndrome and novel thiazide-sensitive Na-Cl cotransporter mutations.
  2805. Establishment of reference values for endocrine tests. III: primary aldosteronism
  2806. Problems in diagnostics of primary aldosteronism-analysis of the own data
  2807. Primary aldosteronism: clinical lateralization and costs
  2808. Value of adrenal venous sampling for lesion localization in primary aldosteronism
  2809. Life-threatening arrhythmia caused by primary aldosteronism
  2810. Chromogranin a measurement for assessing the selectivity of adrenal venous sampling in primary aldosteronism
  2811. Treatment of primary aldosteronism
  2812. Is there an epidemic of primary aldosteronism?
  2813. 131I-6ฮฒ-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results
  2814. Clinical characteristics ofย Aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism
  2815. Diagnostics of primary aldosteronism: is obligatory use of confirmatory tests justified?
  2816. Blood Pressure in Patients with Primary Aldosteronism Is Influenced by Bradykinin B2 Receptor and ฮฑ-Adducin Gene Polymorphisms
  2817. A case with primary aldosteronism due to unilateral multiple adrenocortical micronodules
  2818. The cutoff value ofย Aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine
  2819. Atrial and brain natriuretic peptides as markers of cardiac load and volume retention in primary aldosteronism
  2820. A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern
  2821. Prevalence and role of a raisedย Aldosteroneย to renin ratio in the diagnosis of primary aldosteronism: a debate on the scientific logic of the use of the ratio in practice
  2822. Expression and functional role of urotensin-II and its receptor in the adrenal cortex and medulla: novel insights for the pathophysiology of primary aldosteronism
  2823. Reverse remodeling and recovery from cachexia in rats with aldosteronism
  2824. Primary aldosteronism: a practical approach to diagnosis and treatment
  2825. Sporadic solitaryย Aldosterone-and cortisol-co-secreting adenomas: endocrine, histological and genetic findings in a subtype of primary aldosteronism
  2826. Primary aldosteronism: a pictorial essay
  2827. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism
  2828. Primary aldosteronism
  2829. A case of primary aldosteronism revealed after renal transplantation
  2830. The genetics of primary aldosteronism: chapter two
  2831. Screening and diagnosis of primary aldosteronism
  2832. High prevalence of thyroid ultrasonographic abnormalities in primary aldosteronism
  2833. Mitochondriocentric pathway to cardiomyocyte necrosis in aldosteronism: cardioprotective responses to carvedilol and nebivolol
  2834. Contrastโ€enhanced MRI index of diffuse myocardial fibrosis is increased in primary aldosteronism
  2835. Coexistence of primary aldosteronism and Hashimotoโ€™s thyroiditis
  2836. Adrenal Venous Sampling for Primary Aldosteronism and Clinical Outcomes After Unilateral Adrenalectomy: A Singleโ€Center Experience
  2837. Primary aldosteronism
  2838. 18-oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism
  2839. Selection of patients for surgery for primary aldosteronism.
  2840. โ€ฆ with heme arginate alleviates adipose tissue inflammation and improves insulin sensitivity and glucose metabolism in a rat model of Human primary aldosteronism
  2841. Evolution of diagnostic criteria for primary aldosteronism: why is it more common inโ€ drug-resistantโ€ย hypertensionย today?
  2842. Current diagnosis and treatment of primary aldosteronism
  2843. Long-term results of laparoscopic adrenalectomy for primary aldosteronism
  2844. Diagnosis of primary aldosteronism: for medical management, not just surgery
  2845. Pathophysiological roles of the adrenal renin-angiotensin system in patients with primary aldosteronism
  2846. The prevalence of primary aldosteronism in diabetic patients
  2847. Tissue 65Zinc translocation in a rat model of chronic aldosteronism
  2848. Diagnosis of primary aldosteronism in a patient with an incidentally found adrenal mass
  2849. Twenty-four hour blood pressure profile in subjects with different subtypes of primary aldosteronism
  2850. Primary aldosteronism combined with preclinical Cushingโ€™s syndrome in an elderly patient
  2851. Paralysis as first manifestation of primary aldosteronism
  2852. Coexistence of three distinct adrenal tumors in the same adrenal gland in a patient with primary aldosteronism and preclinical Cushingโ€™s syndrome
  2853. Progress in primary aldosteronism 2
  2854. Primary aldosteronism associated with severe hypokalemic rhabdomyolysis
  2855. Discrepant results of adrenal venous sampling in seven patients with primary aldosteronism
  2856. Responses in extracellular and intracellular calcium and magnesium in aldosteronism
  2857. Retroperitoneal laparoscopic management of primary aldosteronism with report of 130 cases
  2858. โ€ฆ for detecting precisely functional state of various lesions in unilateral and bilateral adrenal disorders, inducing primary aldosteronism with subclinical Cushingโ€™s โ€ฆ
  2859. A rare case of primary hyperparathyroidism associated with primary aldosteronism, Hรผrthle cell thyroid cancer and meningioma
  2860. Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism
  2861. Primary aldosteronism: diagnostic and therapeutic considerations
  2862. Caution about the overdiagnosis of primary aldosteronism
  2863. Primary aldosteronism and its impact on the generation of arterialย hypertension, endothelial injury and oxidative stress
  2864. Primary aldosteronism: the most frequent form of secondaryย hypertension?
  2865. Combined primary aldosteronism and Gushingโ€™s syndrome due to a single adrenocortical adenoma complicated by Hashimotoโ€™s thyroiditis
  2866. Prevalence of primary aldosteronism in hypertensive patients and its effect on the heart
  2867. Usefulness of adrenal vein sampling in the evaluation of aldosteronism
  2868. Impact of essentialย hypertensionย and primary aldosteronism on plasma brain natriuretic peptide concentration
  2869. Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism
  2870. Role of K+ Channels in the Pathophysiology of Primary Aldosteronism
  2871. Analysis of unilateral adrenal hyperplasia with primary aldosteronism from the aspect of messenger ribonucleic acid expression for steroidogenic enzymes: a โ€ฆ
  2872. Primary aldosteronism: comparison between guidelines of the Japanese and the US Endocrine Society
  2873. Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children
  2874. Japanese family with glucocorticoid-remediable aldosteronism diagnosed by long-polymerase chain reaction
  2875. 11 C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism
  2876. Assessment of serum sodium to urinary sodium divided by (serum potassium) ยฒ to urinary potassium as a screening tool for primary aldosteronism
  2877. QT interval is prolonged but QT dispersion is maintained in patients with primary aldosteronism
  2878. Primary aldosteronism and a Texas two-step
  2879. Aldosteroneย antisecretagogue and antihypertensive actions of adrenomedullin in patients with primary aldosteronism
  2880. Primary aldosteronism caused by a unilateral adrenal adenoma accompanied by autonomous cortisol secretion
  2881. Primary aldosteronism and hypercortisolism due to bilateral functioning adrenocortical adenomas
  2882. A clinical observation on twelve cases of primary aldosteronism
  2883. Aldosterone/renin ratio in the diagnosis of primary aldosteronism
  2884. Efficacy of screening for primary aldosteronism by adrenocortical scintigraphy without discontinuing antihypertensive medication
  2885. Primary aldosteronism (PA) and endothelial progenitor cell (EPC) bioavailability
  2886. Prorenin cryoactivation as a possible cause of normal renin levels in patients with primary aldosteronism
  2887. Some considerations about evolution of idiopathic primary aldosteronism
  2888. Non-glucocorticoid-remediable aldosteronism in an infant with low-reninย hypertension
  2889. Animal models of primary aldosteronism
  2890. Cautions over idiopathic aldosteronism
  2891. Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases
  2892. Aldosteroneย improves contractile function of adult rat ventricular cardiomyocytes in a non-acute way: potential relationship to the calcium paradox of aldosteronism
  2893. Clinical and gene mutation studies on a Chinese pedigree with glucocorticoid-remediable aldosteronism.
  2894. Genetic forms of primary aldosteronism
  2895. A case of primary aldosteronism with rhabdomyolysis
  2896. Primary aldosteronism: evolving concepts in diagnosis and treatment
  2897. More fuel to the debate on the โ€œepidemics of primary aldosteronismโ€
  2898. Single-incision laparoscopic adrenalectomy for primary aldosteronism: report of a case
  2899. Ventricular repolarization before and after treatment in patients with secondaryย hypertensionย due to renal-artery stenosis and primary aldosteronism
  2900. Primary aldosteronism
  2901. Possibly simultaneous primary aldosteronism and preclinical Cushingโ€™s syndrome in a patient with double adenomas of right adrenal gland
  2902. One-hour upright posture is an ideal position for serumย Aldosteroneย concentration and plasma renin activity measuring on primary aldosteronism screening
  2903. Prevalence of primary aldosteronism among Bulgarian hypertensive patients
  2904. Renal function in primary aldosteronism
  2905. Does infusion of ANG II increase muscle sympathetic nerve activity in patients with primary aldosteronism?
  2906. Have main types of primary aldosteronism different phenotype?
  2907. Primary aldosteronism and pregnancy: report of 2 cases
  2908. A case of primary aldosteronism associated with renal artery stenosis and preclinical Cushingโ€™s syndrome
  2909. Multiple intracerebral microhemorrhages associated with primary aldosteronism: a case report
  2910. Transumbilical laparo-endoscopic single site surgery for adrenal cortical adenoma inducing primary aldosteronism: initial experience
  2911. Type 2 diabetic patients with resistantย hypertensionย should be screened for primary aldosteronism
  2912. Analytical variation in plasma renin activity: implications for the screening of primary aldosteronism
  2913. Misdiagnosis of two cases of primary aldosteronism owing to failure of computed tomography to detect adrenal microadenoma
  2914. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism
  2915. Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients
  2916. Spironolactone prevents the inducibility of ventricular tachyarrhythmia in rats with aldosteronism
  2917. Diagnosis of surgically-treatable forms of primary aldosteronism
  2918. Theย Aldosterone-renin ratio and primary aldosteronism/In reply
  2919. Diagnostic procedures for primary aldosteronism/diagnostische methoden fรผr den primรคren hyperaldosteronismus
  2920. Salivaryย Aldosteroneย as a diagnostic aid in primary aldosteronism
  2921. Primary aldosteronism. A risk factor for aortic dissection?
  2922. Recurrence of primary aldosteronism after percutaneous ethanol injection
  2923. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers inย hypertensionย due to primary aldosteronism: a case for exclusion
  2924. Aldosteroneย and aldosteronism
  2925. A case of primary aldosteronism with end stage renal disease
  2926. Malignantย hypertensionย and hypertensive encephalopathy in primary aldosteronism caused by adrenal adenoma
  2927. Effects of hypokalemia and left ventricular hypertrophy on QT interval in patients with primary aldosteronism
  2928. About an epidemic of primary aldosteronism
  2929. Primary aldosteronism caused by unilateral adrenal hyperplasia: rethinking the accuracy of imaging studies
  2930. Measurement of 18-hydroxycorticosterone during adrenal vein sampling for primary aldosteronism
  2931. Primary aldosteronism due to unilateral adrenal microadenoma in an elderly patient: efficacy of selective adrenal venous sampling
  2932. Primary aldosteronism with ventricular fibrillation: a case report
  2933. Diagnosis of primary aldosteronism in chronic kidney disease by I-131 NP-59 SPECT/CT imaging.
  2934. Primary aldosteronism takes (KCNJ) five!
  2935. Primary aldosteronism simulating polymyositis
  2936. A case of primary aldosteronism caused by multiple adrenocortical macronodules
  2937. Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland
  2938. The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism
  2939. Surgical management of primary aldosteronism. not everything that shines is gold
  2940. Metabolic dysfunction in primary aldosteronism
  2941. Change in the pattern of adrenal venous sampling over time in patients with primary aldosteronism
  2942. Overt diabetes mellitus in a patient with combined primary aldosteronism and Cushingโ€™s syndrome
  2943. Bilateral renal artery stenosis and primary aldosteronism in a diabetic patient
  2944. Primary aldosteronism: the case against screening
  2945. Effect of short-term losartan treatment in patients with primary aldosteronism and essentialย hypertension.
  2946. Myocardial remodeling in low-reninย hypertension: molecular pathways to cellular injury in relative aldosteronism
  2947. Case of ruptured multiple cerebral aneurysms associated with primary aldosteronism
  2948. Screening for primary aldosteronism in a cohort of Brazilian patients with resistantย hypertension
  2949. Experience of retroperitoneoscopic adrenalectomy in 195 patients with primary aldosteronism
  2950. Primary aldosteronism
  2951. Simultaneous surgery for chronic aortic dissection and adrenal adenoma with primary aldosteronism
  2952. Hypertensive Complications in Patients with Primary Aldosteronism.
  2953. Successful treatment of primary aldosteronism due to computed tomographyโ€negative microadenoma
  2954. Response to renal function in primary aldosteronism: is glomerular hyperfiltration a hallmark of primary aldosteronism? Further results from the Primary Aldosteronism โ€ฆ
  2955. Morning plasmaย Aldosteroneย predicts the subtype of primary aldosteronism independant of sodium intake
  2956. Glucocorticoid-remediable aldosteronism
  2957. Primary aldosteronism with right-dominant heart failure
  2958. Clinical characteristics and surgery outcomes of unilateral nodular adrenal hyperplasia in primary aldosteronism: study of 145 cases
  2959. hypertensionย due to primary aldosteronism
  2960. Episodic rage associated with primary aldosteronism resolved with adrenalectomy
  2961. Aortic dissection-a rare complication of primary aldosteronism-a case report
  2962. A case of primary aldosteronism accompanied by rhabdomyolysis
  2963. Primary aldosteronism and resistant arterialย hypertension
  2964. Comparison of target organ damages between primary aldosteronism and essentialย hypertension
  2965. The neuroendocrine-immune interface gone awry in aldosteronism
  2966. Plasmaย Aldosteroneย to renin ratio predicts treatment response in primary aldosteronism: Is volume loading needed?
  2967. Characteristics of left ventricular structural damage in patients with primary aldosteronism
  2968. A rare case of primary aldosteronism caused by bilateral functioning adrenocortical adenomas with renal cell carcinoma
  2969. A case of primary aldosteronism in childhood
  2970. Acute cerebral hemorrhage normalized plasma renin activity in a patient with primary aldosteronism
  2971. Metabolic syndrome and primary aldosteronism: time for reappraisal?
  2972. Clinical relevance of dietary salt intake onย Aldosteroneย and theย Aldosterone-to-renin ratio as screening parameters for primary aldosteronism
  2973. Aortic cell apoptosis in rat primary aldosteronism model
  2974. Cushingโ€™s syndrome by left adrenocortical adenoma synchronously associated with primary aldosteronism by right adrenocortical adenoma: report of a case
  2975. Primary Aldosteronism
  2976. Left ventricular hypertrophy in patients with primary aldosteronism
  2977. Primary aldosteronism
  2978. Should primary aldosteronism be diagnosed among normotensive subjects during general health check-up and/or at general outpatient clinics?
  2979. New diagnostic procedure for primary aldosteronism: adrenal venous sampling under adrenocorticotropic hormone and angiotensin II receptor blockerโ€”application to โ€ฆ
  2980. Value of saline load test in diagnosis of primary aldosteronism [J]
  2981. Screening for primary aldosteronism: progress and frustration
  2982. Diagnosis and management of primary aldosteronism
  2983. TREATMENT OF PRIMARY ALDOSTERONISM: SHORT AND MIDDLE-TERM EFFECTS OF MEDICAL AND SURGICAL THERAPY IN PRIMARY โ€ฆ
  2984. Combining body mass index and serum potassium to urine potassium clearance ratio is an alternative method to predict primary aldosteronism
  2985. Primary aldosteronism due to adrenocortical adenoma with concurrent ileum carcinoid tumor: case report
  2986. Primary aldosteronism presented with intracranial hemorrhage
  2987. Is primary aldosteronism a benign disorder? Old evidence reconfirmed
  2988. โ€ฆ producing adrenal adenoma associated with a latent aldosteronoma: usefulness of the ACTH loading test for the detection of covert aldosteronism in overt Cushing โ€ฆ
  2989. A case of primary aldosteronism with aortic dissection
  2990. Risk factors of decreased glomerular filtration rate in patients with primary aldosteronism
  2991. A possible association between primary aldosteronism and a lower ฮฒ-cell function
  2992. 100 cases of primary aldosteronism: careful choice of patients for surgery using adrenal venous sampling and CT imaging results in excellent blood pressure and โ€ฆ
  2993. Evolution features of hypertensive patients with primary aldosteronism-Prospective Study
  2994. The Clinical Implication and Problems of Adrenal Vein Sampling in Patients with Primary Aldosteronism.
  2995. Cautions over idiopathic aldosteronism
  2996. The current epidemic of primary aldosteronism: causes and consequences
  2997. Primary aldosteronism in diabetic subjects with resistantย hypertension: response to Umpierrez et al.
  2998. Diagnosis of primary aldosteronism-debate continues. Part I
  2999. Primary aldosteronism presenting as bibrachial paralysis
  3000. Adrenal cortex scintigraphy with and without dexamethasone suppression in the study of primary aldosteronism
  3001. Primary Aldosteronism: The Surgical Perspective
  3002. Potassium supplementation improves the natriuretic response to central volume expansion in primary aldosteronism
  3003. Primary Aldosteronism and public health: new definitions, new challenges
  3004. Anesthesia and laparoscopic adrenalectomy for primary aldosteronism.
  3005. Factors influencing outcome of surgical treatment for primary aldosteronism
  3006. Recovery from renal failure in malignantย hypertensionย associated with primary aldosteronism: effect of an ACE inhibitor
  3007. Use of gadolinium contrast adrenal venography for the assessment of primary aldosteronism in a patient with iodine allergy
  3008. PREVALENCE OF PRIMARY ALDOSTERONISM (PA) IN NEWLY DIAGNOSED HYPERTENSIVE PATIENTS: RESULTS OF A NATIONWIDE SURVEY IN ITALY: 5B. 3
  3009. A patient with concurrent primary aldosteronism and Page kidney
  3010. Primary aldosteronism importance to the
  3011. Diagnosis and treatment of primary aldosteronism (report of 46 cases)
  3012. Primary aldosteronism complicated with chronic renal failure
  3013. A case of nephrocalcinosis associated with primary aldosteronism
  3014. Anterior ischemic optic neuropathy associated with idiopathic aldosteronism andย hypertension
  3015. Animal models of primary aldosteronism
  3016. Medical Management of Primary Aldosteronism
  3017. Laparoscopic management of primary aldosteronism: a report of 227 cases
  3018. Diagnosis of adenomatous primary aldosteronism in a patient with severeย hypertension
  3019. Insulin signaling in adipose tissue of patients with primary aldosteronism
  3020. Adrenalectomy for Primary Aldosteronism
  3021. Biomarkers of endothelial dysfunction and risk of early organ damage: a comparison between patients with primary aldosteronism and essentialย hypertension
  3022. Bilateral aldosteronoma associated with secondary aldosteronism in a chronic hemodialysis subject
  3023. Adrenal venous sampling crucial in primary aldosteronism?
  3024. A case of adrenocortical carcinoma with concurrent Cushingโ€™s syndrome and primary aldosteronism
  3025. Development of pseudo-aldosteronism depends on amount of glycyrrhizae radix in each individual
  3026. Primary aldosteronism with HIV infection: important considerations when using theย Aldosterone: renin ratio to screen this unique population
  3027. Longโ€term followโ€up of a girl with primary aldosteronism: Effect of potassium supplement
  3028. Primary Aldosteronism Due toย Aldosteroneย Producing Adenama in the Presence of Contralateral Nonfunctioning Adenama.
  3029. Adrenal venous sampling but not computed tomography is essential before undertaking adrenalectomy for primary aldosteronism
  3030. Surgical Operation of Primary Aldosteronism [J]
  3031. Improving adrenal venous sampling in primary aldosteronism
  3032. A case of primary aldosteronism accompanied by hypokalemic rhabdomyolysis
  3033. Diagnosis and management of primary aldosteronism in cats
  3034. โ€ฆ Role for P450 scc in the Overproduction ofย Aldosteroneย inย Aldosterone-Producing Adenoma and Idiopathic Hyperaldosteronism in Patients with Primary Aldosteronism
  3035. A new method of super-selective acth-stimulated adrenal venous sampling is revolutionarily useful for treatment of primary aldosteronism: PP. 18.179
  3036. Laboratory Test of Primary Aldosteronism
  3037. Primary aldosteronism and diabetes mellitus
  3038. Response to More Fuel to the Debate on the โ€œEpidemic of Primary Aldosteronismโ€
  3039. Interpretation of clinical practice guidelines of primary aldosteronism.
  3040. The study of screening rates of primary aldosteronism in obstructive sleep apnea syndrome withย hypertensionย as the blood pressure classification
  3041. Gender difference in QT interval in patients with primary aldosteronism
  3042. Diagnostic value of I-131 NP-59 SPECT/CT scintigraphy in patients with subclinical or atypical features of primary aldosteronism
  3043. Prevalence of metabolic syndrome in patients with primary aldosteronism
  3044. Primary aldosteronism in type 1 diabetes mellitus
  3045. Primary aldosteronism in a patient after surgical treatment of primary hyperparathyroidism
  3046. Observation on the prevalence of primary aldosteronism in the in-patients in Xinjiang [J]
  3047. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism
  3048. Response to the Article:โ€œPrimary Aldosteronism: Are We Missing the Wood for the Trees?โ€
  3049. HIGH EXPRESSION OF THE PRO-RENIN RECEPTOR INย Aldosteroneย PRODUCING ADENOMA CAUSING HUMAN PRIMARY ALDOSTERONISM: 4D. 02
  3050. Time to normalization of blood pressure after an adrenalectomy for patients with primary aldosteronism
  3051. Prevalence of glucose metabolism disturbance in primary aldosteronism
  3052. โ€ฆ PRESSURE AND POTASSIUM EFFECTS OF THE NEW DIRECTย Aldosteroneย SYNTHASE INHIBITOR, LCI699, IN PATIENTS WITH PRIMARY ALDOSTERONISM โ€ฆ
  3053. Adrenal venous sampling revisited-Crucial role in the management of primary aldosteronism patients
  3054. โ€ฆ adrenal incidentalomas from normotensive and hypertensive patients: Distinguishing subclinical or atypical primary aldosteronism from adrenal incidentaloma
  3055. Diagnosis and treatment of primary aldosteronism
  3056. Kidney in primary aldosteronism: A key determinant of treatment outcome
  3057. Primary Aldosteronism
  3058. Association of renovascularย hypertensionย and primary aldosteronism
  3059. Myasthenia gravis complicated with primary aldosteronism and hypokalemic myopathy
  3060. A possible association between primary aldosteronism and a lower ฮฒ-cell function
  3061. Anesthetic management for electroconvulsive therapy (ECT) in a patient with primary aldosteronism
  3062. OR-39: Prevalence of unrecognized primary aldosteronism in essentialย hypertension
  3063. Treatment of primary aldosteronism-debate continues. Part II
  3064. Clinical significance ofย Aldosteroneย to renin ratio in screening primary aldosteronism
  3065. Primary Aldosteronism
  3066. A Case Study of Primary Aldosteronism
  3067. Adrenalectomy for primary aldosteronism
  3068. Role of adrenal venous sampling in the treatment strategy for primary aldosteronism
  3069. Clinical Analysis of Primary Aldosteronism
  3070. Primary aldosteronism
  3071. K001 Is primary aldosteronism a channelopathy?
  3072. Primary Aldosteronism
  3073. Misleading diagnosis of renal artery stenosis by magnetic resonance angiography in a patient with primary aldosteronism
  3074. Primary Aldosteronism Complicated by Severe Hypokalemic Myopathy
  3075. HORMONAL EFFECTS OF THE NEW DIRECTย Aldosteroneย SYNTHASE INHIBITOR, LCI699, IN PATIENTS WITH PRIMARY ALDOSTERONISM: 5C. 06
  3076. Will the lessons from primary aldosteronism change the treatment ofย hypertensionย and left ventricular hypertrophy?
  3077. Factors Influencing Outcome of Surgical Treatment for Primary Aldosteronism
  3078. Primary aldosteronism
  3079. Nonprimary Aldosteronism
  3080. Surgical treatment of primary aldosteronism [J]
  3081. Diagnosis and surgical Treatment of primary Aldosteronism
  3082. aldosteronism. Some, possibly many, normokalemic
  3083. Analysis of diagnosis and treatment of primary aldosteronism:(Report of 63 cases)
  3084. Primary aldosteronism: analysis of a series of 54 patients
  3085. The evolution of primary aldosteronism
  3086. Long-term consequences of primary aldosteronism
  3087. Primary aldosteronism: an update
  3088. Hypokalemic paralysis in a young woman with thyrotoxicosis and primary aldosteronism
  3089. Diagnosis and treatment of primary aldosteronism
  3090. Evaluation of High-Dose Spironolactone in the Preoperative Preparation of Primary Aldosteronism
  3091. Glucolipid metabolism characteristics analysis of primary aldosteronism
  3092. A brief history of diagnosis and treatment of primary aldosteronism.
  3093. Diagnosis and Treatment of Primary Aldosteronism
  3094. Surgical treatment of primary aldosteronism.
  3095. Is confirmation of an adrenal adenoma in patients with primary aldosteronism sufficient for indication of adrenalectomy?
  3096. Estimation of the efficacy of the measurement of plasma renin activity and direct renin in diagnostics of primary aldosteronism
  3097. The diagnosis and treatment of primary aldosteronism (report of 507 cases)
  3098. Primary aldosteronism presenting withย hypertensionย and quadriparesis
  3099. Controversies on the Diagnosis of Primary Aldosteronism
  3100. Clinical Features of Patients with Primary Aldosteronism
  3101. Studies of diagnosis and differential diagnosis in primary aldosteronism
  3102. Seeing is Believingโ€”Just not in Primary Aldosteronism
  3103. Primary Aldosteronism and Pregnancy: A Case Report
  3104. Current opinion on primary aldosteronism
  3105. Characteristics of glucolipid metabolism and analysis of related factors in patients with primary aldosteronism [J]
  3106. Supracentrimetric nodule on computed tomography does not exclude adrenal venous sampling before surgery for primary aldosteronism
  3107. Theย Aldosterone-Renin Ratio and Primary Aldosteronism: In Response
  3108. Diagnosis and treatment of primary aldosteronism. An analysis of 18 cases
  3109. Diagnosis and Treatment of Primary Aldosteronism (Report of 14 Cases)[J]
  3110. Normokalaemic primary aldosteronism due to anย Aldosterone-producing adrenal adenomaโ€“Case 06/2009
  3111. Genomic profile in primary aldosteronism
  3112. Differential diagnosis of subtypes in primary aldosteronism
  3113. How to screen for pheochromocytoma, primary aldosteronism and Cushingโ€™s syndrome
  3114. Primary aldosteronism-why is the diagnosis difficult?
  3115. Response to About an Epidemic of Primary Aldosteronism
  3116. Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism
  3117. CLINICAL AND BIOLOGICAL ASPECTS OF PRIMARY ALDOSTERONISM: 18 CASES: P3. 115
  3118. New index of using serum sodium and potassium and urine sodium and potassium jointly in screening primary aldosteronism in hypertensive patients
  3119. Primary aldosteronism: from genesis to genetics q
  3120. Progress in medications of primary aldosteronism.
  3121. Response to Metabolic Dysfunction in Primary Aldosteronism
  3122. Evaluation ofย Aldosteroneย to renin concentration ratio as a reliable screening parameter for primary aldosteronism applying currently available assays
  3123. Altered heart rate variability but preserved temporal relationship with sleep stages in a patient with primary aldosteronism
  3124. Primary Aldosteronism: An Update on Screening, Diagnosis and Treatment
  3125. Patient Guide to Detection, Diagnosis and Treatment of Primary Aldosteronism
  3126. Recent progress of diagnosis and treatment of primary aldosteronism
  3127. Cardiovascular complications in patients with primary aldosteronism
  3128. Endocrineโ€”Primary Aldosteronism
  3129. Endocrineโ€”Primary Aldosteronism
  3130. Clinical significance of determination of SAC/PRA value in patients with primary aldosteronism
  3131. โ€ฆ ON LEFT VENTRICULAR MASS INDEX AND BLOOD PRESSURE IN PATIENTS WITH PRIMARY ALDOSTERONISMโ€“RETROSPECTIVE ANALYSIS: 5B. 4
  3132. Delayed Arterial Switch Operation for D-Transposition of the Great Arteries and Glucocorticoid Remediable Aldosteronism
  3133. Non-surgical therapy of primary aldosteronism
  3134. Ratio of plasmaย Aldosteroneย concentration to renin activity in screening for primary aldosteronism: the current situation and influencing factors.
  3135. 6.15 Roles of Clinical Criteria, CT Scan and Adrenal Vein Sampling in Differential Diagnosis of Primary Aldosteronism Subtypes
  3136. Application of captopril test in the diagnosis of primary aldosteronism
  3137. The value of CT in the etiological classification of primary aldosteronism
  3138. METABOLIC DIFFERENCES BETWEEN MAIN TYPES OF PRIMARY ALDOSTERONISM: PP. 18.188
  3139. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism
  3140. Primary aldosteronism during 2007-2011 in Iceland
  3141. Aberrant receptor expression in primary aldosteronism
  3142. To stimulate or not to stimulate: the differential diagnosis of aldosteronism revisited
  3143. Primary aldosteronism in newly diagnosed hypertensive patients
  3144. Comparison of strategies for biochemical diagnosis of primary aldosteronism in German academic centres
  3145. Screening and diagnosis of primary aldosteronism
  3146. The laparoscopic surgical treatment of primary aldosteronism
  3147. Screening for primary aldosteronism in a secondary care diabetes population
  3148. Atypical clinical manifestations of primary aldosteronism.
  3149. Adrenal venous sampling (AVS) is essential for detecting unilateral or bilateral adrenal lesions in primary aldosteronism
  3150. โ€ฆ OF BLOOD PRESSURE AND LEFT VENTRICULAR (LV) GEOMETRY AFTER ADRENALECTOMY OR MEDICAL TREATMENT FOR PRIMARY ALDOSTERONISM โ€ฆ
  3151. Demonstration of Blood Pressure-Independent Non Infarct Myocardial Fibrosis in Primary Aldosteronism: A Cardiac MRI Study
  3152. PREVALENCE OF PRIMARY ALDOSTERONISM AMONG HYPERTENSIVE PATIENTS: P 774
  3153. Imaging diagnosis of primary aldosteronism.
  3154. The confirmatory Tests of primary aldosteronism should be selected in each countries-the analysis of 83 patients in our hospital
  3155. OR-46: High prevalence of primary aldosteronism among black and white subjects with resistantย hypertension
  3156. Role of imaging diagnosis in surgical treatment of primary aldosteronism
  3157. Recent progress in the treatment of idiopathic aldosteronism
  3158. Partial Adrenalectomy in Patients with Primary Aldosteronism
  3159. AN EXPERIENCE OF SURGICAL TREATMENT FOR PRIMARY ALDOSTERONISM ASSOCIATED WITH CHRONIC RENAL FAILURE
  3160. Treatment of primary aldosteronism with retroperitoneal laparoscopic surgery [J]
  3161. Primary Aldosteronism And Inappropriateness Of Left Ventricular Mass
  3162. Retroperitoneal laparoscopic surgery for primary aldosteronism (report of 90 cases)
  3163. Female patients with primary aldosteronism are diagnosed earlier and have a better outcome
  3164. Endocrineย hypertensionย due to primary aldosteronism
  3165. Vitamin D deficiency in primary aldosteronism
  3166. Pseudo-hypo aldosteronism: Type II
  3167. ANALYSING THE RELATIVE FACTORS THAT INFLUENCE GLOMERULAR FILTRATION RATE IN PRIMARY ALDOSTERONISM.
  3168. A Case of Primary Aldosteronism after Renal Transplantation
  3169. A case of nephrocalcinosis with primary aldosteronism
  3170. PSYCHOLOGICAL ASSESSMENT OF PRIMARY ALDOSTERONISM. A CONTROLLED STUDY: PP. 39.279
  3171. Prevalence of primary aldosteronism among hypertensive patients (preliminary results)
  3172. Michaล‚ Lityล„ski, MD-the author of the first description in the world literature of primary aldosteronism-after 50 years
  3173. Investigating children of glucocorticoid remediable aldosteronism patients
  3174. Glucocorticoid-remediable aldosteronism: Report of a family and literature review
  3175. Clinical Significance of Strengthening Screening and Diagnosis of Primary Aldosteronism
  3176. Periodic paralysis: an uncommon complication of primary aldosteronism
  3177. Prevalence of primary aldosteronism in hypertensive subjects with hyperglycaemia
  3178. Renal function in patients with primary aldosteronism: comparison with essentialย hypertension
  3179. Guidelines for diagnosis and treatment of primary aldosteronism
  3180. PREVALENCE OF PRIMARY ALDOSTERONISM AMONG UNSELECTED HYPERTENSIVE PATIENTS: P2. 104
  3181. Potassium channels in primary aldosteronism
  3182. Investigation and Management of Primary Aldosteronism-A Review of Cases and Audit of Outcomes in a Tertiary Referral Centre
  3183. Left ventricular mass in patients with primary aldosteronism after etiologic treatment
  3184. Severe hypokalemia-associated rhabdomyolise and unusual poliuria in patient with primary aldosteronism: A case presentation
  3185. Combined primary aldosteronism and preclinical Cushing
  3186. Primary Aldosteronism: Current Concepts of Epidemic, Diagnosis, and Treatment.
  3187. The influence of the ovarian cycle on the first-step laboratory screening for primary aldosteronism
  3188. PERIPHERAL ARTERIAL STIFFNESS IN PRIMARY ALDOSTERONISM: 8D. 03
  3189. Osteopontin in patients with primary aldosteronism
  3190. Treating Primary Aldosteronism with Newย Aldosteroneย Receptor Antagonists
  3191. Moleculan Genetics of Glucocorticoid Remediable Aldosteronism.
  3192. Primary aldosteronism and sleep apnea syndrome.
  3193. Primary Aldosteronism Screening and Diagnosis in Primary Health Care
  3194. DIFFERENCES IN PULSE WAVE VELOCITY BETWEEN MAIN TYPES OF PRIMARY ALDOSTERONISM: 8D. 04
  3195. TRANSCRIPTIONAL AND PATHOLOGICAL ANALYSIS OF PRIMARY ALDOSTERONISM: 4D. 01
  3196. Evaluation of renal function of primary aldosteronism between pre-and post-treatment
  3197. THE COMPARISON OF CLINICAL FEATURES BETWEEN HYPOKALEMIC AND NORMOKALEMIC PRIMARY ALDOSTERONISM PATIENTS: 8D. 05
  3198. Retrospective analysis of diagnostic and treatment outcomes of primary aldosteronism
  3199. Clinical analysis of 330 patients with primry aldosteronism
  3200. Factors Associated with Amelioration of Blood Pressure after Surgery for Primary Aldosteronism
  3201. Metabolic syndrome among patients with primary aldosteronism: a common feature?
  3202. Evaluation of cardiac structure and function changes with tissue Doppler echocardiography in primary aldosteronism patients
  3203. Predicting factors of the post-surgical decline in renal function in patients with primary aldosteronism
  3204. Aortic Intramural Hematoma Associated with Primary Aldosteronism.
  3205. Screening for peptide hormone receptor expression in primary aldosteronism
  3206. Factors Associated with Normal Blood Pressure after Surgery To Treat Primary Aldosteronism
  3207. Glucocorticoid remediable aldosteronism. A Northern Ireland experience
  3208. Anxiety and depressive symptoms in patients with primary aldosteronism in a longitudinal study
  3209. Primary Aldosteronism: Rare or Common Condition in Hypertensive Patients and Normotensive Individuals?
  3210. RELATIVE HYPERFILTRATION IN PRIMARY ALDOSTERONISM: OP 146
  3211. Comparing the Prevalence of Primary Aldosteronism in Hypertensive Diabetic and Non-diabetic Patients.
  3212. P-628: Primary Aldosteronism (PA) Prevalence in Italy (PAPY) study: Results of a nationwide survey
  3213. Primary aldosteronism due to right adrenal adenoma case report.
  3214. Primary aldosteronism: renal effects compared with primaryย hypertension
  3215. Study on significance of serum level of high-sensitivity C-reactive protein in patients with primary aldosteronism
  3216. Prevalence of primary aldosteronism in Chinese patients with resistantย hypertension
  3217. Screening for aberrant peptide hormone responsiveness in primary aldosteronism
  3218. Gene polymorphisms related to metabolic and cardiac complications in patients with primary aldosteronism
  3219. Plasma and urineย Aldosteroneย to PRA ratio in the diagnosis of Primary Aldosteronism
  3220. Adrenal venous sampling in the differential diagnosis of primary aldosteronism
  3221. THE KIDNEY AS TARGET ORGAN IN PRIMARY ALDOSTERONISM: 4B. 7
  3222. Analysis of left ventricular hypertrophy in patients with unilateral and bilateral primary aldosteronism
  3223. Primary aldosteronism screening: What is theย Aldosterone: renin test?
  3224. Simultaneous presentation of Brugada syndrome and primary aldosteronism
  3225. INCREASED DIAGNOSIS OF PRIMARY ALDOSTERONISM, INCLUDING SURGICALLY CORRECTABLE FORMS, IN CENTERS FROM FIVE CONTINENTS: P2. 102
  3226. Predictors for cure and normotension after adrenalectomy for primary aldosteronism
  3227. Metabolic disturbance and cardiovascular events in primary aldosteronism: recent advance.
  3228. IS RELYING ON CT-SCAN FOR SUBTYPING OF PRIMARY ALDOSTERONISM REALLY THAT BAD? A FOLLOW-UP BASED APPROACH: PP. 18.180
  3229. Primary aldosteronism associated with subclinical Cushing syndrome
  3230. Daily profiles ofย Aldosteroneย secretion in primary aldosteronism
  3231. Incidence of metabolic disorders in patients with essentialย hypertensionย and patients with primary aldosteronism
  3232. Primary aldosteronism due to unilateral adrenal hyperplasia: report of a case and review of the literature
  3233. Audit of adrenal vein sampling for primary aldosteronism
  3234. Adrenal venous sampling in the differential diagnosis of primary aldosteronism
  3235. Cornell product left ventricular hypertrophy in electrocardiogram in patients with primary aldosteronism
  3236. The difficulties in differential diagnosis of primary aldosteronism subtypes in women with strokes at a young age
  3237. Retroperitoneal laparoscopic surgery vs open adrenalectomy for primary aldosteronism [J]
  3238. Usefulness of FDG-PET for detecting primary aldosteronism in patient who have bilateral adrenal incidentaloma
  3239. Aldosterone/plasma renin activity ratio is a sensitive parameter for screening patients with primary aldosteronism
  3240. Retroperitoneal laparoscopic surgery for primary aldosteronism as compared with open adrenalectomy
  3241. A case of The Primary Aldosteronism with Hypokalemic Periodic Paralysis
  3242. Primary Aldosteronism in Diabetic Subjects With Resistantย hypertension: Response to Ng et al.
  3243. Human primary aldosteronism; investigation of the mechanism leading to autonomousย Aldosteroneย excess
  3244. Postoperative Outcomes in Patients Undergoing Adrenalectomy for Primary Aldosteronism
  3245. The Diagnosis Value of Plasmaย Aldosterone/renin Activity Ratio in Primary Aldosteronism [J]
  3246. HUMORAL AND CELL-MEDIATED AUTOIMMUNITY MECHANISMS IN THE PATHOGENESIS OF PRIMARY ALDOSTERONISM: PP. 39.286
  3247. Incidental primary aldosteronism and incidental Cushingโ€™s syndrome
  3248. Comparison of Three Different Doses of ACTH Stimulation During AVS For Primary Aldosteronism
  3249. PREVALENCE OF PRIMARY ALDOSTERONISM IN RESISTANTย hypertensionย AND ITS ASSOCIATION WITH EARLY VASCULAR DAMAGE: PP. 18.197
  3250. Use of the 250mcg short synacthen test to differentiate between patients with primary aldosteronism and essentialย hypertension
  3251. Pathophysiological significance of CYP11B2 immunohistochemical staining in primary aldosteronism
  3252. PRIMARY ALDOSTERONISM AND ESSENTIALย hypertension: ASSESSMENT OF THE GLOBAL CARDIOVASCULAR RISK AT DIAGNOSIS AND FOLLOW-UP โ€ฆ
  3253. Primary aldosteronism and secondary hyperparathyroidism of the vitamin D deficiency
  3254. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal imaging findings
  3255. Metabolic parameters in patients with primary aldosteronism: relation to snps of the adiponectin gene
  3256. CONCURRENT PRIMARY ALDOSTERONISM AND SUBCLINICAL CORTISOL HYPERSECRETION. A PERSPECTIVE STUDY: PP. 39.278
  3257. Intrathoracic blood volume during laparoscopic adrenectomy for primary aldosteronism under general anesthesia
  3258. Arterial stiffness, intima-media thickness and fibrosis of carotid arteries in patients with primari aldosteronism
  3259. Regulation ofย Aldosteroneย synthase expression in normal adrenal and primary aldosteronism
  3260. Adrenal Vein Sampling for Identification of the Subtypes of Primary Aldosteronism: Results on 2635 Cases of the Avis Study
  3261. Significance ofย Aldosterone/plasma renin activity ratio in diagnosis of primary aldosteronism with ROC curve
  3262. Expressions and significance of two kinds of vascular endothelial growth factors of different origin in adrenocortical lesions of primary aldosteronism
  3263. Sympathetic Overactivity in Hypertensive Patients With Primary Aldosteronism
  3264. Usefulness of theย Aldosterone-to-Renin Ratio for Screening Primary Aldosteronism
  3265. Diagnostic evaluation of plasmaย Aldosteroneย concentration to plasma renin activity ratio in primary aldosteronism
  3266. Secondaryย hypertensionย Caused by Endocrine Disorders Except Primary Aldosteronism and Pheochromocytoma
  3267. A-006 PRIMARY ALDOSTERONISM: CYSTATIN C AND ENDOTHELIAL DYSFUNCTION
  3268. Long-Term Regression of Left Ventricular Hypertrophy Through Inward Remodeling with Specific Treatment of Primary Aldosteronism
  3269. ABNORMALITIES OF THE HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS IN PRIMARY ALDOSTERONISM: P2. 129
  3270. ADRENALECTOMY IMPROVES COMMON CAROTID INTIMA-MEDIA THICKNESS IN PRIMARY ALDOSTERONISM: PP. 39.290
  3271. BLOOD PRESSURE REDUCTION FOLLOWING ADRENALECTOMY IN PRIMARY ALDOSTERONISM: A RETROSPECTIVE FOLLOW-UP STUDY: PP. 18.174
  3272. Two Case of Primary Aldosteronism Induced byย Aldosteroneย Producing Adrenal Adenoma in a Family.
  3273. Adiponectin gene polymorphisms in primary aldosteronism and their relation to the metabolic syndrome
  3274. Control study of clinical effect in retroperitoneal laparoscopic adrenalectomy and open surgery for primary aldosteronism
  3275. Low detection Rate of Primary Aldosteronism when Screening Among Hypertensive Patients with Ongoing Medication
  3276. Adrenal venous sampling should be performed before adrenalectomy in primary aldosteronism?
  3277. Using plasma renin concentration to screen primary aldosteronism in hypertensive patients and to observe the effect of posture
  3278. Lipoprotein (a) is Elevated in Patients with Renovascularย hypertension, but not in Patients with Primary Aldosteronism
  3279. A unique case of recurrent malignantย hypertensionย after removal of an adrenal tumor for primary aldosteronism
  3280. Demonstration of blood pressure-independent diffuse cardiac fibrosis in Primary Aldosteronism-a cardiac MRI study
  3281. โ€ฆ APNEA SYNDROME IN HYPERTENSIVE PATIENTS REFERRED TO A SPECIALIZED OUTPATIENT CLINIC AND ASSOCIATION WITH PRIMARY ALDOSTERONISM โ€ฆ
  3282. New quick cortisol assay during adrenal vein sampling in patients with primary aldosteronism
  3283. Percutaneous Transluminal Adrenal Ablation for Aldosteronism: Report of Initial Three Cases
  3284. ACUTE AORTIC DISSECTION COMPLICATING CLINICAL COURSE OF PRIMARY ALDOSTERONISM DUE TOย Aldosteroneย PRODUCING ADENOMA: P1. 300
  3285. Plasmaย Aldosterone/renin ratioโ€”โ€”a sensitive screening test and parameter for primary aldosteronism
  3286. Primary aldosteronism is very frequent in resistantย hypertensionย and is associated to early renal vascular damage
  3287. The effectiveness on screening for primary aldosteronism in patients withย hypertensionย by using the urinary potassium to (serum potassium)~ 2 ratio
  3288. Salivaryย Aldosteroneย to cortisol ratio: Potential screening tool for primary aldosteronism
  3289. A Case of Primary Aldosteronism due to Remnant Adenoma after Adrenalectomy in Pregnant Woman
  3290. Successful treatment of a mycotic aortic pseudoaneurysm in a patient with type 2 diabetes mellitus while treating primary aldosteronism with spironolactone
  3291. Influential factors on the ratio of plasmaย Aldosteroneย concentration to plasma renin activity in screening primary aldosteronism
  3292. Renal complications of aldosteronism and diabetes: role of oxidative stress and protective effects of polyphenol extract
  3293. โ€ฆ -TERM CHANGES OF LEFT VENTRICULAR DIASTOLIC FUNCTION AFTER ADRENALECTOMY OR MEDICAL TREATMENT FOR PRIMARY ALDOSTERONISM: PP โ€ฆ
  3294. Pseudo-aldosteronism induced by intravenous glycyrrhizin treatment of chronic hepatitis C patients
  3295. Inhibitory effect of carbamazepine on hypotensive action of spironolactone in primary aldosteronism
  3296. primary aldosteronism and (2) the probable hyper-secretion of renin secondary to hypertrophy of the
  3297. Research advance of plasmaย Aldosteroneย concentration to plasma renin activity ratio-the screening index of primary aldosteronism
  3298. P-559: Prevalence of primary aldosteronism among unselected hypertensive patients
  3299. Adrenal Adenoma Removal Improves Glucose Control in A Diabetic Patient with Primary Aldosteronism: A Case Report and Literature Review
  3300. Differential diagnosis of primary aldosteronism by peripheral plasma levels of 18-oxo-cortisol: a noninvasive method with a high specificity
  3301. The sodium to urinary sodium to potassium to urinary potassium (SUSPUP) ratio in primary aldosteronism
  3302. Long-term changes of left ventricular (LV) structure and function after adrenalectomy or medical treatment for primary aldosteronism
  3303. EFFECTS OF FEMALE SEX HORMONES AND CONTRACEPTIVE PILL ON THE DIAGNOSTIC WORK-UP FOR PRIMARY ALDOSTERONISM: PP. 18.181
  3304. SUBTLE HYPERPARATHYROIDISM: A NOVEL FEATURE OF PRIMARY ALDOSTERONISM THAT IS CORRECTED BY ADRENALECTOMY: PP. 39.272
  3305. Hyper Transcardiac Extraction ofย Aldosteroneย Promote Ventricular Remodeling and Cardiac Mass in Patients with Primary Aldosteronism
  3306. SENSITIVITY, SPECIFICITY AND REPRODUCIBILITY OF THEย Aldosterone-TO-RENIN-RATIO AS A SCREENING TEST FOR PRIMARY ALDOSTERONISM: PP โ€ฆ
  3307. Assessing the quality of studies on screening primary aldosteronism by using plasmaย Aldosteroneย to renin activity ratio
  3308. DIFFERENTIAL DIAGNOSIS OF PRIMARY ALDOSTERONISM SUBTYPES USING ADRENAL VEIN SAMPLING: EVALUATION OF THE GERMANS CONNโ€™S โ€ฆ
  3309. The accuracy of combiningย Aldosteroneย to renin ratio and low renin level in diagnosing primary aldosteronism
  3310. INTRA-OPERATIVE CORTISOL ASSAY IMPROVES THE SUCCESS RATE OF ADRENAL VENOUS SAMPLING FOR PRIMARY ALDOSTERONISM: PP. 18.198
  3311. The effectiveness on screening for primary aldosteronism in patients withย hypertensionย by using the urinary potassium to (serum potassium) ratio.
  3312. Long-term modifications in left ventricular structure and function after adrenalectomy or medical treatment in patients with primary aldosteronism
  3313. Aldosteroneย elevation during the luteal phase of the menstrual cycle may suggest primary aldosteronism in hypertensive women
  3314. P-534: Predictive value of theย Aldosterone-renin ratio in screening for primary aldosteronism
  3315. Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism following adrenalectomy
  3316. Sporadic solitaryย Aldosterone-and cortisol-cosecreting adenomas: a subtype of primary aldosteronism
  3317. 49 HYPOZINCEMIA AND OXIDATIVE STRESS IN RATS WITH CHRONIC ALDOSTERONISM.
  3318. Cardiovascular effects of unilateral adrenalectomy are superior to those ofย Aldosteroneย antagonist treatment in primary aldosteronism
  3319. GENETIC PROFILING OF OMENTAL ADIPOSE TISSUE IN PATIENTS WITH PRIMARY ALDOSTERONISM AND CANDIDATE GENES FOR CARDIOMETABOLIC โ€ฆ
  3320. Simultaneous occurrence of hypokalemic periodic paralysis and rhabdomyolysis as complications of hypokalemia with primary aldosteronism
  3321. Aldosteroneย REDUCTION BY UNILATERAL ADRENALECTOMY REDUCES SALT APPETITE IN PATIENTS CURED OF PRIMARY ALDOSTERONISM: LB2. 4
  3322. Aldosterone-PRODUCING ADENOMA CAUSING HUMAN PRIMARY ALDOSTERONISM ARE CHARACTERISED BY UNDER-EXPRESSION OF THE TWIK โ€ฆ
  3323. 18-Hydroxycorticosterone, 18-hydroxycortisol and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes
  3324. โ€ฆ Adrenal Vein Sampling International Study (Avis) on Use and Interpretation of Adrenal Vein Sampling for Differentiating the Major Subtypes of Primary Aldosteronism โ€ฆ
  3325. In primary aldosteronism, plasmaย Aldosteroneย concentration is an independent risk factor for albuminuria, and the higher baseline urinary albumin excretion predicts โ€ฆ
  3326. Mutations in the KCNJ5 Gene Imply a Higher Lateralization Index at Adrenal Vein Sampling for Primary Aldosteronism
  3327. Oxidative Stress, Mitochondrial Permeability Pore Opening and Cardiac Hypertrophy With Fibrosis in Aldosteronism: Response to Supplemental Zinc
  3328. SHOULD MANAGEMENT OF PRIMARY ALDOSTERONISM BE BASED ON ADRENAL VEIN SAMPLING OR ADRENAL CT-SCAN? A RETROSPECTIVE STUDY OF โ€ฆ
  3329. Anger and anxiety in patients with primary aldosteronism treated with amiloride hydrochloride or spironolactone or adrenalectomy
  3330. โ€ฆ DOES NOT AFFECT ADRENAL CORTISOL AND CHROMOGRANIN A RELEASE: IMPLICATIONS FOR THE DIAGNOSIS OF PRIMARY ALDOSTERONISM: PP โ€ฆ
  3331. โ€ฆย Aldosteroneย EFFECTS OFย Aldosteroneย SYNTHASE INHIBITION VS. MINERALOCORTICOID BLOCKADE IN PATIENTS WITH PRIMARY ALDOSTERONISM โ€ฆ
  3332. 201 CYTOSOLIC CALCIUM AND ZINC IN CARDIOMYOCYTES OF RATS WITH ALDOSTERONISM: RESPONSE TO SPIRONOLACTONE AND AMLODIPINE โ€ฆ
  3333. P-567: Prevalence of primary aldosteronism (PA) nationwide in Italy in newly diagnosed hypertensive patients
  3334. 636 PREVALENCE OF METABOLIC SYNDROME IN PATIENTS WITH PRIMARY ALDOSTERONISM
  3335. P-592: Active renin concentration and theย Aldosterone/renin ratio in screening primary aldosteronism
  3336. 7.20 Adiponectin Gene Variants in the Metabolic Syndrome of Patients with Primary Aldosteronism and Essentialย hypertension
  3337. Aldosteroneย regulation for 18 years in a case of primary aldosteronism
  3338. OR-12: No association between primary aldosteronism and two CYP11B2 polymorphisms in a well-characterized Australian sample
  3339. P-640: Prevalence of primary aldosteronism among hypertensive patients
  3340. P-598: Prevalence of primary aldosteronism among hypertensive patients
  3341. 73 BONE LOSS IN ALDOSTERONISM. RESCUE WITH HYDROCHLOROTHIAZIDE AND SPIRONOLACTONE.
  3342. 53 CYTOSOLIC AND MITOCHONDRIAL CALCIUM IN RAT CARDIOMYOCYTES: RESPONSE TO ALDOSTERONISM AND COTREATMENT WITH โ€ฆ
  3343. 642 INFLUENCE OF AGING ON THE SCREENING TEST OF PRIMARY ALDOSTERONISM DIAGNOSIS
  3344. 657 RE-EVALUATION OF THE SALINE INFUSION TEST FOR PRIMARY ALDOSTERONISM: DURATION, THE SUBTYPE CLASSIFICATION AND CUT-OFF LIMITS โ€ฆ
  3345. AS-248: Primary Aldosteronism: Treated by Superselecive Adrenal Arterial Embolization
  3346. 84 Angiotensin AT2 receptors: control of renal sodium excretion and blood pressure 88 Primary aldosteronism: cardiovascular, renal and metabolic implications
  3347. 46 URINARY ZINC LOSSES IN RATS WITH ALDOSTERONISM: PREVENTION BY ACETAZOLAMIDE.
  3348. 21 PRIMARY ALDOSTERONISM IN A PATIENT WITH IDIOPATHIC INTRACRANIALย hypertension
  3349. P-568: Apparent prevalence of primary aldosteronism in a referral practice: a retrospective study
  3350. 7. Young W, Stanson A, Thompson G, et al. Role for adrenal ve-nous sampling in primary aldosteronism. Surgery 2004; 136: 1227โ€“1235. 8. Kahn S, Angle J. Adrenal โ€ฆ
  3351. U-004 PRIMARY ALDOSTERONISM: CHANGES IN CYSTATIN C-BASED KIDNEY FILTRATION, PROTEINURIA, AND RENAL DUPLEX INDICES WITH TREATMENT
  3352. 9.13 Metabolic Alterations in Patients with Primary Aldosteronism (PA): Role of Adipokines
  3353. 641 EFFECT OF AGING ON VARIOUS CONFIRMATORY TESTS AND ADRENAL VEIN SAMPLING FOR PRIMARY ALDOSTERONISM DIAGNOSIS
  3354. 5.1 Adiponectin and Insulin Sensitivity in Primary Aldosteronism
  3355. 57 OBSTRUCTIVE SLEEP APNEA IS PREVALENT IN PRIMARY ALDOSTERONISM: 3D MAGNETIC RESONANCE IMAGING TO STUDY IMPROVEMENT WITH โ€ฆ
  3356. 166 ZINC DYSHOMEOSTASIS IN RATS WITH ALDOSTERONISM: RESPONSE TO SPIRONOLACTONE.
  3357. P-667: Circadian rythm of blood pressure in patients with primary aldosteronism compared with essentialย hypertensionย patients
  3358. 178 ZINC DYSHOMEOSTASIS IN RATS WITH ALDOSTERONISM: RESPONSE TO SPIRONOLACTONE.
  3359. CLINICAL CHARACTERISES OF 224 CASES WITH NORMOKALEMIC AND HYPERTENSIVE PRIMARY ALDOSTERONISM
  3360. P-611: The application of theย Aldosterone/PRA ratio (ARR) in the diagnosis of primary aldosteronism
  3361. 71 CALCIUM AND MAGNESIUM HOMEOSTASIS IN ALDOSTERONISM: RESPONSE TO DIURETICS
  3362. 44 ONGOING KIDNEY IMPAIRMENT IN JAPANESE PATIENTS WITH PRIMARY ALDOSTERONISM: PREDICTORS OF NEW-ONSET CHRONIC KIDNEY DISEASE โ€ฆ
  3363. 51 STRUCTURAL REMODELING OF THE HEART IN RATS WITH ALDOSTERONISM: RESPONSE TO SPIRONOLACTONE OR DIETARY ZINC SUPPLEMENT.
  3364. โ€ฆ (NP-59) uptake per unit volume of adrenal adenoma for differentiation between patients with Cushingโ€™s syndrome, primary aldosteronism, and non-hypersecreting โ€ฆ
  3365. 6.4 Cardiac Modifications in Patients with Primary Aldosteronism Before and After Specific Treatment
  3366. P-593: Drug effects onย Aldosterone/plasma renin activity ratio in primary aldosteronism
  3367. 2.30 Diagnostic workup of primary aldosteronism
  3368. P-627: Does the availability of Adrenal Vein Sampling (AVS) affect the diagnosis of the adrenocortical pathology underlying Primary Aldosteronism (PA)? Results of โ€ฆ
  3369. A-004 ENDOTHELIAL PROGENITOR CELLS IN PRIMARY ALDOSTERONISM: A BIOMARKER OF SEVERITY FORย Aldosteroneย VASCULOPATHY AND โ€ฆ
  3370. P-601: Long-term management of hypertensive patients with primary aldosteronism
  3371. Insulin sensitivity in 32 patients with primary aldosteronism
  3372. โ€ฆ ACID-SENSITIVE K+ CHANNEL 2 (TASK-2) GENE IS A HALLMARK OFย Aldosteroneย PRODUCING ADENOMA CAUSING HUMAN PRIMARY ALDOSTERONISM โ€ฆ
  3373. โ€ฆ EVALUATION OF STRUCTURAL AND FUNCTIONAL CHANGES IN THE HEART AND LARGE ARTERIES IN PATIENTS WITH PRIMARY ALDOSTERONISM
  3374. Serum 18 hydroxycortisol identifies aldosteronoma in the differential diagnosis of primary aldosteronism
  3375. 6.12 Long-Term Effects of Pharmacological and Surgical Treatment on Cardiovascular Parameters in Patients with Primary Aldosteronism
  3376. P-560: Low prevelence of primary aldosteronism in hypertensive diabetics
  3377. 4.26 Left Ventricular Mass Appropriateness in Patients with Primary Aldosteronism
  3378. U-002 DISSECTED AORTIC ANEURYSM: UNCOMMON INITIAL PRESENTATION OF PRIMARY ALDOSTERONISM
  3379. 5.4 Vascular Remodelling in Carotid Arteries of Patients with Primary Aldosteronism by Backscatter Signal and Peripheral Vascular Stiffness Analysis
  3380. P-674: Adrenal catecholamines venous sampling in primary aldosteronism
  3381. OR-13: Serum inflammatory cytokines in patients with primary aldosteronism
  3382. P-532: Identification of hypertensive patients with normokaliemic primary aldosteronism
  3383. 44 SKELETAL MUSCLE ATROPHY, BONE LOSS, AND OXIDATIVE STRESS IN RATS WITH ALDOSTERONISM.
  3384. A-005 MYOCARDIAL ULTRASOUND TISSUE CHARACTERIZATION IN PATIENTSWITH PRIMARY ALDOSTERONISM
  3385. P. 097 ADRENALECTOMY IS MORE EFFECTIVE THAN SPIRONOLACTONE IN REDUCING ARTERIAL STIFFNESS IN PRIMARY ALDOSTERONISMโ˜†
  3386. 637 PREVALENCE OF PRIMARY ALDOSTERONISM IN HYPERTENSIVE SUBJECTS WITH HYPERGLYCEMIA
  3387. 47 SPIRONOLACTONE IN THE TREATMENT OF HYPOZINCEMIA FOUND IN RATS WITH ALDOSTERONISM.
  3388. Characteristics of 330 cases with primary aldosteronism
  3389. 45 SPIRONOLACTONE IN THE PREVENTION OF SKELETAL MUSCLE ATROPHY AND BONE LOSS IN RATS WITH ALDOSTERONISM.
  3390. 18-Oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism
  3391. 5.6 Assessment of the Selectivity and Lateralisation Index for Adrenal Vein Sampling in Primary Aldosteronism
  3392. 12.16 Primary Aldosteronism and Endothelial Progenitor Cell Bioavailability
  3393. 6.16 Rapid Cortisol Assay during Adrenal Vein Sampling in Patients with Primary Aldosteronism
  3394. Use of the 250 mcg short synacthen test in the diagnosis of primary aldosteronism
  3395. 6.2 Comparison of Three Different Doses of ACTH Stimulation During Adrenal Vein Sampling (AVS) in the Work-Up of Primary Aldosteronism
  3396. P-600: Primary aldosteronism with and without hypertensive urgency: Clinical and biochemical features
  3397. 367 ALDOSTERONISM: A PROINFLAMMATORY PHENOTYPE SECONDARY TO CALCIUM OVERLOAD
  3398. โ€ฆ HYPERPARATHYROIDISM AND THE RECOVERY OF FALLEN EXTRACELLULAR CALCIUM AND MAGNESIUM IN RATS WITH CHRONIC ALDOSTERONISM.
  3399. THE COMPLEMENT C1Q TUMOUR NECROSIS FACTOR-RELATED PROTEIN 1 LEVEL IN PATIENTS WITH SLEEP APNOEA AND PRIMARY ALDOSTERONISM
  3400. P-358: Cardiovascular and non-cardiovascular events in patients with primary aldosteronism
  3401. 4 PARATHYROIDECTOMY PREVENTS CALCIUM LOADING AND OXIDATIVE STRESS IN RATS WITH ALDOSTERONISM.
  3402. 624 A NEED TO RE-FOCUS ON PRECISION OF SCREENING AND DIAGNOSTIC TESTS IN PRIMARY ALDOSTERONISM
  3403. 4.6 QT Interval in Patients with Primary Aldosteronism and Low-Renin Essentialย hypertension
  3404. Clinical nursing experience of 8 patients with primary aldosteronism
  3405. Report of 27 cases of primary aldosteronism
  3406. 1.7 Carotid Intima-Media Thickness and Prevalence of Plaques in Patients with Primary Aldosteronism and With Essentialย hypertension
  3407. 131 PARATHYROIDECTOMY PREVENTS CALCIUM LOADING AND OXIDATIVE STRESS IN RATS WITH ALDOSTERONISM.
  3408. 70 HYPERPARATHYROIDISM AND THE CALCIUM PARADOX OF ALDOSTERONISM
  3409. Adrenal vein sampling in 22 patients with primary aldosteronism
  3410. 279 SECONDARY HYPERPARATHYROIDISM, INTRACELLULAR CALCIUM OVERLOADING, AND OXIDATIVE STRESS IN RATS WITH ALDOSTERONISM.
  3411. P-562: Atrial and brain natriuretic peptides as markers for afterload and volume retention in primary aldosteronism
  3412. 54 CARDIOMYOCYTE EXPRESSION OF METALLOTHIONEIN AND ZINC TRANSPORTER 1 IN RATS WITH ALDOSTERONISM: RESPONSE TO SPIRONOLACTONE โ€ฆ
  3413. โ€ฆ including saliva-type amylase-secreting secondary parathyroid hyperplasia (SPTH) and insulinoma with adrenal adenoma (AA) showing primary aldosteronism
  3414. O-19: Primary aldosteronism in a referralย hypertensionย center
  3415. P-164: Primary aldosteronism may be associated with albuminuria and hyperfiltration
  3416. Q-008 THE METABOLIC SYNDROME DOES DIFFERENCES IN PATIENTS WITH PRIMARY ALDOSTERONISM
  3417. 643 COSYNTROPIN STIMULATION TEST IS USEFUL IN DISTINGUISHING UNILATERAL FROM BILATERAL PRIMARY ALDOSTERONISM
  3418. A-008 THE ASSOCIATION OF HYPERFILTRATION AND LEFT VENTRICULAR MASS IN PATIENTS WITH PRIMARY ALDOSTERONISM
  3419. 652 LONG-TERM TREATEMENT WITHย Aldosteroneย BLOCKER CAN CAUSE SPONTANEOUSLY REMISSION IN PATIENTS WITH PRIMARY ALDOSTERONISM
  3420. 1090 INTEGRATING GENETICS AND GENOMICS IN PRIMARY ALDOSTERONISM
  3421. โ€ฆย Aldosteroneย EXCESS BETWEEN BASELINE AND ACTH STIMULATION IN THE ADRENAL VEIN SAMPLING OF PATIENTS WITH PRIMARY ALDOSTERONISM
  3422. 632 SENSITIVITY, SPECIFICITY AND REPRODUCIBILITY OF THEย Aldosterone-TO-RENIN-RATIO AS A SCREENING TEST FOR PRIMARY ALDOSTERONISM
  3423. P-664: The captopril test for the screening of primary aldosteronism
  3424. P-497: Biochemical profile of severe obstructive sleep apnea can mimic primary aldosteronism
  3425. โ€ฆ SODIUM DIVIDED BY (SERUM POTASSIUM) 2 TO URINARY POTASSIUM (SUSPPUP RATIO) AS A SCREENING TOOL FOR PRIMARY ALDOSTERONISM: PP โ€ฆ
  3426. U-007 THE INFLUENCE OF HYPOKALEMIA ON VASCULAR STIFFNESS IN PATIENTS WITH PRIMARY ALDOSTERONISM
  3427. 648 ANALYSIS OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH PRIMARY ALDOSTERONISM
  3428. 656 COMPARISON OF VARIOUS CONFIRMATORY TESTS FOR FINAL DIAGNOSIS OF PRIMARY ALDOSTERONISM
  3429. 646 GUIDELINES MAY IMPROVE CLINICAL PRACTICE FOR DIAGNOSIS OF PRIMARY ALDOSTERONISM IN JAPAN
  3430. 42 COST-EFFECTIVE AND FEASIBLE SCREENING OF PRIMARY ALDOSTERONISM WITH POTASSIUM EXCRETION CAPACITY/BODY MASS INDEX RATIO
  3431. โ€ฆ EFFECT AFTER TRANSUMBILICAL LAPAROSCOPIC SINGLE-SITE ADRENALECTOMY IN PATIENTS WITH PRIMARY ALDOSTERONISM: A MATCHED CASE โ€ฆ
  3432. P-344: Unusual phenotype in a family affected by glucocorticoid remediable aldosteronism
  3433. โ€ฆ ASSOCIATED WITH PHYSIOLOGICAL INTERMEDIATE PHENOTYPES IN PATIENTS WITH ESSENTIALย hypertension, BUT NOT PRIMARY ALDOSTERONISM
  3434. P-333: Primary aldosteronism and cushingโ€™s syndrome treated by CT-guided radiofrequency thermal ablation in SR-Adenomas
  3435. โ€ฆ OFย Aldosteroneย AND CORTISOL BY HPLC-TANDEM MASS SPECTROMETRY: COULD THIS IMPROVE DECISION MAKING IN PRIMARY ALDOSTERONISM?
  3436. 992 Proceedings ofthe Royal Society ofMedicine mation on everything from aldosteronism to Cushingโ€™s disease, and from the minutia of the history of chemistry of the โ€ฆ
  3437. 659 USEFULNESS OF NEW QUICK CORTISOL ASSAY DURING ADRENAL VEIN SAMPLING IN PATIENTS WITH PRIMARY ALDOSTERONISM
  3438. 647 DIURNAL VARIATION OF ADRENAL VENOUSย Aldosteroneย CONCENTRATION IN PATIENTS WITH PRIMARY ALDOSTERONISM
  3439. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study
  3440. Primary aldosteronism: practical approach to diagnosis and management
  3441. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice
  3442. Diagnosis and management of primary aldosteronism: an updated review
  3443. Primary Aldosteronism and ARMC5 Variants
  3444. Diagnosis and management of primary aldosteronism
  3445. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline
  3446. The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment
  3447. An update on novel mechanisms of primary aldosteronism
  3448. Long-term cardio-and cerebrovascular events in patients with primary aldosteronism
  3449. Long term outcome of aldosteronism after target treatments
  3450. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study
  3451. Guidelines for primary aldosteronism: uptake by primary care physicians in Europe
  3452. Update in primary aldosteronism
  3453. Cardiovascular events and target organ damage in primary aldosteronism compared with essentialย hypertension: a systematic review and meta-analysis
  3454. CACNA1H mutations are associated with different forms of primary aldosteronism
  3455. Age-related autonomous aldosteronism
  3456. Progress in aldosteronism: a review of the prevalence of primary aldosteronism in pre-hypertensionย andย hypertension
  3457. Systematic review of surgery and outcomes in patients with primary aldosteronism
  3458. Primary aldosteronism: the next five years
  3459. Continuum of renin-independent aldosteronism in normotension
  3460. Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis
  3461. Long-term control of arterialย hypertensionย and regression of left ventricular hypertrophy with treatment of primary aldosteronism
  3462. Old and new concepts in the molecular pathogenesis of primary aldosteronism
  3463. Management ofย hypertensionย in primary aldosteronism
  3464. Laboratory challenges in primary aldosteronism screening and diagnosis
  3465. Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan
  3466. Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study
  3467. The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes
  3468. Nuclear imaging in the diagnosis of primary aldosteronism
  3469. Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy
  3470. Primary aldosteronism: emerging trends
  3471. Risk of fracture in primary aldosteronism: a populationโ€based cohort study
  3472. Pregnancy, Primary Aldosteronism, and Adrenal CTNNB1 Mutations
  3473. Case detection and diagnosis of primary aldosteronismโ€“the consensus of Taiwan Society of Aldosteronism
  3474. Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study
  3475. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism
  3476. Progress in the management of primary aldosteronism
  3477. Outcome of surgical treatment of primary aldosteronism
  3478. SFE/SFHTA/AFCE primary aldosteronism consensus: introduction and handbook
  3479. Is primary aldosteronism still largely unrecognized?
  3480. Primary aldosteronism: changing definitions and new concepts of physiology and pathophysiology both inside and outside the kidney
  3481. Primary aldosteronism: challenges in diagnosis and management
  3482. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 2: first diagnostic steps
  3483. Update in diagnosis and management of primary aldosteronism
  3484. Bone and mineral metabolism in patients with primary aldosteronism
  3485. Genetics in endocrinology: the expanding genetic horizon of primary aldosteronism
  3486. Subtyping of patients with primary aldosteronism: an update
  3487. Adrenal vein sampling in primary aldosteronism: towards a standardised protocol
  3488. Renal outcomes in medically and surgically treated primary aldosteronism
  3489. Treatment of primary aldosteronism and organ protection
  3490. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an โ€ฆ
  3491. Clinical characteristics and postoperative outcomes of primary aldosteronism in the elderly
  3492. Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism
  3493. Primary aldosteronism and salt
  3494. The spectrum of subclinical primary aldosteronism and incidentย hypertension: a cohort study
  3495. Primary aldosteronism: key characteristics at diagnosis: a trend toward milder forms
  3496. Oxidative stress in patients affected by primary aldosteronism
  3497. Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years
  3498. A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism
  3499. Role of KCNJ5 in familial and sporadic primary aldosteronism
  3500. Primary aldosteronism: diagnosis and management
  3501. Management of endocrine disease: diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited
  3502. Primary aldosteronism and pregnancy
  3503. Refining the definitions of biochemical and clinical cure for primary aldosteronism using the primary aldosteronism surgical outcome (PASO) classification system
  3504. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 3: Confirmatory testing
  3505. Primary aldosteronism as a cause of secondary osteoporosis
  3506. Understanding primary aldosteronism: impact of next generation sequencing and expression profiling
  3507. Somatic and germline CACNA1D calcium channel mutations inย Aldosterone-producing adenomas and primary aldosteronism
  3508. Recent developments in primary aldosteronism
  3509. Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism
  3510. Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism
  3511. Potential effects of age on screening for primary aldosteronism
  3512. Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism patients at long term
  3513. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial
  3514. Prevalence of primary aldosteronism in primary care: a cross-sectional study
  3515. Recurrent gain of function mutation in calcium channel CACNA1H causes early-onsetย hypertensionย with primary aldosteronism
  3516. Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study
  3517. Adrenal histopathology in primary aldosteronism: is it time for a change?
  3518. Quality of life in primary aldosteronism: a comparative effectiveness study of adrenalectomy and medical treatment
  3519. The time has come for systematic screening for primary aldosteronism in all hypertensives
  3520. Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism
  3521. Primary aldosteronism: a common cause of resistantย hypertension
  3522. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry
  3523. Can screening and confirmatory testing in the management of patients with primary aldosteronism be improved?
  3524. Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism
  3525. Treatment of primary aldosteronism is associated with a reduction in the severity of obstructive sleep apnoea
  3526. Somatic and inherited mutations in primary aldosteronism
  3527. Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Connโ€™s Registry
  3528. Glucocorticoid-remediable aldosteronism
  3529. Primary aldosteronism and obstructive sleep apnea: is this a bidirectional relationship?
  3530. Genetic and histopathologic intertumor heterogeneity in primary aldosteronism
  3531. Glucose metabolism in primary aldosteronism
  3532. Development and validation of subtype prediction scores for the workup of primary aldosteronism
  3533. Mouse models of primary aldosteronism: from physiology to pathophysiology
  3534. The influence of aging on the diagnosis of primary aldosteronism
  3535. Prevalence of and risk factors for primary aldosteronism among patients with resistantย hypertensionย in China
  3536. Significance of computed tomography and serum potassium in predicting subtype diagnosis of primary aldosteronism
  3537. Role of ACTH and other hormones in the regulation ofย Aldosteroneย production in primary aldosteronism
  3538. Primary aldosteronism as a risk factor for vertebral fracture
  3539. Update in adrenal venous sampling for primary aldosteronism
  3540. โ€ฆ Efficacy of Adrenal Vein Sampling and Imaging Findings in Predicting Clinical Outcomes Following Unilateral Adrenalectomy for Primary Aldosteronism
  3541. Immunohistopathology and steroid profiles associated with biochemical outcomes after adrenalectomy for unilateral primary aldosteronism
  3542. Health-related quality of life and mental health in primary aldosteronism: a systematic review
  3543. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases
  3544. Mass spectrometryโ€“based adrenal and peripheral venous steroid profiling for subtyping primary aldosteronism
  3545. Approach to the surgical management of primary aldosteronism
  3546. Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism
  3547. Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes
  3548. Diagnostic rate of primary aldosteronism in Emilia-Romagna, Northern Italy, during 16 years (2000โ€“2015)
  3549. Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?
  3550. Aldosteroneย excess impairs first phase insulin secretion in primary aldosteronism
  3551. Disordered CYP11B2 expression in primary aldosteronism
  3552. Cortisol excess in patients with primary aldosteronism impacts left ventricular hypertrophy
  3553. An LCโ€“MS/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism
  3554. Accuracy of adrenal imaging and adrenal venous sampling in diagnosing unilateral primary aldosteronism
  3555. Subtype diagnosis of primary aldosteronism: is adrenal vein sampling always necessary?
  3556. Unanswered questions in the genetic basis of primary aldosteronism
  3557. Immunohistochemistry ofย Aldosteroneย synthase leads the way to the pathogenesis of primary aldosteronism
  3558. The PI3K/AKT/mTOR signaling pathway is overactivated in primary aldosteronism
  3559. ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions
  3560. New advances in the diagnostic workup of primary aldosteronism
  3561. An individualized approach to the evaluation and management of primary aldosteronism
  3562. Test characteristics of theย Aldosterone-to-renin ratio as a screening test for primary aldosteronism
  3563. Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism
  3564. Dietary sodium restriction increases the risk of misinterpreting mild cases of primary aldosteronism
  3565. Anxiety, depression, and impaired quality of life in primary aldosteronism: why we shouldnโ€™t ignore it!
  3566. Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterialย hypertension
  3567. Diagnostic value of ACTH stimulation test in determining the subtypes of primary aldosteronism
  3568. Cost-effectiveness of screening for primary aldosteronism and subtype diagnosis in the resistant hypertensive patients
  3569. Evaluation of the saline infusion test and the captopril challenge test in Chinese patients with primary aldosteronism
  3570. Primary aldosteronism and pregnancy
  3571. Voltage-gated calcium channels in the human adrenal and primary aldosteronism
  3572. Cardiac remodeling in patients with primary and secondary aldosteronism: a tissue Doppler study
  3573. Primary aldosteronism and impaired natriuresis in mice underexpressing TGFฮฒ1
  3574. Primary aldosteronism and essentialย hypertension: assessment of cardiovascular risk at diagnosis and after treatment
  3575. Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis
  3576. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 4: subtype diagnosis
  3577. Effects of treating primary aldosteronism on renal function
  3578. Diagnostic accuracy ofย Aldosteroneย and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism
  3579. Local control ofย Aldosteroneย production and primary aldosteronism
  3580. Long-term effect of specific treatment of primary aldosteronism on carotid intimaโ€“media thickness
  3581. hypertensionย outcomes of adrenalectomy in patients with primary aldosteronism: a systematic review and meta-analysis
  3582. A subtype prediction score for primary aldosteronism
  3583. Risk of sepsis in patients with primary aldosteronism
  3584. Primary aldosteronism in the primary care setting
  3585. Comparative genomics and transcriptome profiling in primary aldosteronism
  3586. Basal and post-ACTHย Aldosteroneย and its ratios are useful during adrenal vein sampling in primary aldosteronism
  3587. Autoimmune mechanisms activating the angiotensin AT1 receptor inโ€™primaryโ€™aldosteronism
  3588. Optimum position of left adrenal vein sampling for subtype diagnosis in primary aldosteronism
  3589. Changes in the clinical manifestations of primary aldosteronism
  3590. Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies
  3591. Clinical management of primary aldosteronism
  3592. Clinical management and outcomes of adrenal hemorrhage following adrenal vein sampling in primary aldosteronism
  3593. Aldosteroneย LC-MS/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism
  3594. โ€ฆ of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation ofย Aldosteroneย in primary aldosteronism
  3595. Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study
  3596. Overview of the genetic determinants of primary aldosteronism
  3597. Dissecting the molecular pathways of primary aldosteronism
  3598. Primary aldosteronism: functional histopathology and longโ€term followโ€up after unilateral adrenalectomy
  3599. Is there a role for segmental adrenal venous sampling and adrenal sparing surgery in patients with primary aldosteronism?
  3600. Outcomes of drug-based and surgical treatments for primary aldosteronism
  3601. The molecular basis of primary aldosteronism: from chimeric gene to channelopathy
  3602. โ€ฆ mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism
  3603. Primary aldosteronism as a public health issue
  3604. Development of a novel nomogram to predictย hypertensionย cure after laparoscopic adrenalectomy in patients with primary aldosteronism
  3605. Does ACTH improve the diagnostic performance of adrenal vein sampling for subtyping primary aldosteronism?
  3606. In primary aldosteronism, mineralocorticoids influence exosomal sodium-chloride cotransporter abundance
  3607. Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-reninย hypertensionย on low-dose spironolactone
  3608. Adrenal vein sampling is the preferred method to select patients with primary aldosteronism for adrenalectomy: pro side of the argument
  3609. Administrative data on diagnosis and mineralocorticoid receptor antagonist prescription identified patients with primary aldosteronism in Taiwan
  3610. Epicardial fat thickness and primary aldosteronism
  3611. A novel CYP11B2-specific imaging agent for detection of unilateral subtypes of primary aldosteronism
  3612. Idiopathic intracranialย hypertensionย associated with either primary or secondary aldosteronism
  3613. A novel phenotype of familial hyperaldosteronism type III: concurrence of aldosteronism and Cushingโ€™s syndrome
  3614. Genetic characterization of GnRH/LH-responsive primary aldosteronism
  3615. Proportion of patients withย hypertensionย resolution following adrenalectomy for primary aldosteronism: a systematic review and metaโ€analysis
  3616. Defining contralateral adrenal suppression in primary aldosteronism: implications for diagnosis and outcome
  3617. KCNJ5 Mutations Are the Most Frequent Genetic Alteration in Primary Aldosteronism
  3618. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism
  3619. Pregnancy, Primary Aldosteronism, and Somatic CTNNB1 Mutations.
  3620. Diagnosing unilateral primary aldosteronismโ€“comparison of a clinical prediction score, computed tomography and adrenal venous sampling
  3621. Adrenal vein sampling is the preferred method to select patients with primary aldosteronism for adrenalectomy: con side of the argument
  3622. Quantitative value ofย Aldosteroneโ€renin ratio for detection ofย Aldosteroneโ€producing adenoma: theย Aldosteroneโ€Renin Ratio for Primary Aldosteronism (AQUARR) โ€ฆ
  3623. Immunohistochemistry improves histopathologic diagnosis in primary aldosteronism
  3624. Clinical characteristics ofย Aldosterone-and cortisol-coproducing adrenal adenoma in primary aldosteronism
  3625. Adrenal venous sampling versus computed tomographic scan to determine treatment in primary aldosteronism (The SPARTACUS Trial) a critique
  3626. Impact of new quick gold nanoparticle-based cortisol assay during adrenal vein sampling for primary aldosteronism
  3627. Correlation between lateralization index of adrenal venous sampling and standardized outcome in primary aldosteronism
  3628. Primary aldosteronism associated with subclinical Cushing syndrome
  3629. Saline suppression test parameters may predict bilateral subtypes of primary aldosteronism
  3630. Rapid screening of primary aldosteronism by a novel chemiluminescent immunoassay
  3631. Primary aldosteronism: Seismic shifts
  3632. Adrenal venous sampling for primary aldosteronism: laboratory medicine best practice
  3633. Primary aldosteronism in hypertensive patients: clinical implications and target therapy
  3634. Potassium channels related to primary aldosteronism: Expression similarities and differences between human and rat adrenals
  3635. Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronism
  3636. Importance of contralateralย Aldosteroneย suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism
  3637. Is it time to screen all patients withย hypertensionย for primary aldosteronism?
  3638. Inflammatory markers in primary aldosteronism
  3639. Cardiac dysfunction in association with increased inflammatory markers in primary aldosteronism
  3640. โ€ฆ -specific monoclonal antibodies against 3ฮฒ-hydroxysteroid dehydrogenase/isomerase family provide markers for subclassification of human primary aldosteronism
  3641. Age-related cutoffs of plasmaย Aldosterone/renin concentration for primary aldosteronism screening
  3642. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 6: Adrenal surgery
  3643. Primary aldosteronism and thyroid disorders in atrial fibrillation: A Swedish nationwide caseโ€“control study
  3644. The impact of Connshingโ€™s syndrome-mild cortisol excess in primary aldosteronism drives diabetes risk
  3645. Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone?
  3646. Medical versus surgical treatment of primary aldosteronism
  3647. Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale โ€ฆ
  3648. Genetics of primary aldosteronism
  3649. The latest developments of functional molecular imaging in the diagnosis of primary aldosteronism
  3650. Highโ€probability features of primary aldosteronism may obviate the need for confirmatory testing without increasing falseโ€positive diagnoses
  3651. Prevelence of primary aldosteronism in an urban hypertensive population
  3652. Renin phenotypes characterize vascular disease, autonomous aldosteronism, and mineralocorticoid receptor activity
  3653. Cardiovascular risk markers in patients with primary aldosteronism: a systematic review and meta-analysis of literature studies
  3654. A clinical prediction score for diagnosing unilateral primary aldosteronism may not be generalizable
  3655. Plasmaย Aldosteroneย level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism
  3656. Contralateral suppression ofย Aldosteroneย at adrenal venous sampling predicts hyperkalemia following adrenalectomy for primary aldosteronism
  3657. Clinicopathologic correlates of primary aldosteronism
  3658. Primary aldosteronism and cardiovascular risk, before and after treatment
  3659. Sequential comparison ofย Aldosteroneย synthase inhibition and mineralocorticoid blockade in patients with primary aldosteronism
  3660. Role of adrenal vein sampling in primary aldosteronism: impact of imaging, localization, and age
  3661. Sodium infusion test for diagnosis of primary aldosteronism in chinese population
  3662. โ€ฆ somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism
  3663. Comparisons of microvascular and macrovascular changes in aldosteronism-relatedย hypertensionย and essentialย hypertension
  3664. Lower trabecular bone score in patients with primary aldosteronism: human skeletal deterioration byย Aldosteroneย excess
  3665. Primary aldosteronism: New answers, new questions
  3666. Genetic disorders in primary aldosteronismโ€”familial and somatic
  3667. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 1: Epidemiology of PA, who should be screened for sporadic PA?
  3668. Prevalence and clinical characteristics of primary aldosteronism in Japanese patients with type 2 diabetes mellitus andย hypertension
  3669. Adrenal CYP11B1/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies
  3670. The occurrence of apparent bilateralย Aldosteroneย suppression in adrenal vein sampling for primary aldosteronism
  3671. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 7: Medical treatment of primary aldosteronism
  3672. A new highly sensitive and specific overnight combined screening and diagnostic test for primary aldosteronism
  3673. Subtyping of primary aldosteronism with adrenal vein sampling: hormone-and side-specific effects of cosyntropin and metoclopramide
  3674. Diagnosis of primary aldosteronism in theย hypertensionย specialist centers in Italy: a national survey
  3675. The renaissance of primary aldosteronism: what has it taught us?
  3676. Aldosterone-producing adenoma in primary aldosteronism: CT-guided radiofrequency ablationโ€”long-term results and recurrence rate
  3677. Comparison between adrenal venous sampling and computed tomography in the diagnosis of primary aldosteronism and in the guidance of adrenalectomy
  3678. Criteria for diagnosing primary aldosteronism on the basis of liquid chromatographyโ€“tandem mass spectrometry determinations of plasmaย Aldosteroneย concentration
  3679. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism
  3680. A Renin-ssance in Primary Aldosteronism Testing: Obstacles and Opportunities for Screening, Diagnosis, and Management
  3681. Current pattern of primary aldosteronism diagnosis: Delayed and complicated
  3682. Assay characteristics influence theย Aldosteroneย to renin ratio as a screening tool for primary aldosteronism: results of the German Connโ€™s registry
  3683. New insights intoย Aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5
  3684. Long-term effects of adrenalectomy or spironolactone on blood pressure control and regression of left ventricle hypertrophy in patients with primary aldosteronism
  3685. Human red blood cells alterations in primary aldosteronism
  3686. Adrenal vein sampling in primary aldosteronism: concordance of simultaneous vs sequential sampling
  3687. Adrenal venous sampling in patients with positive screening but negative confirmatory testing for primary aldosteronism
  3688. Primary aldosteronism and low-reninย hypertension: a continuum?
  3689. Suppression ofย Aldosteroneย secretion after recumbent saline infusion does not exclude lateralized primary aldosteronism
  3690. Primary aldosteronism: making sense of partial data sets from failed adrenal venous sampling-suppression of adrenalย Aldosteroneย production can be used in clinical โ€ฆ
  3691. Comparison of left ventricular structure and function in primary aldosteronism and essentialย hypertensionย by echocardiography
  3692. Aldosteroneย to active renin ratio as screening test for primary aldosteronism: reproducibility and influence of orthostasis and salt loading
  3693. Dietary salt intake is a determinant of cardiac changes after treatment of primary aldosteronism: a prospective study
  3694. Macrolides for KCNJ5โ€“mutatedย Aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism
  3695. obesityย and the diagnostic accuracy for primary aldosteronism
  3696. Unadjusted plasma renin activity as a โ€œfirstโ€lookโ€ test to decide upon further investigations for primary aldosteronism
  3697. Preoperative masked renal damage in J apanese patients with primary aldosteronism: Identification of predictors for chronic kidney disease manifested after โ€ฆ
  3698. Somatic KCNJ5 mutation occurring early in adrenal development may cause a novel form of juvenile primary aldosteronism
  3699. Primary aldosteronism in patients with acute stroke: prevalence and diagnosis during initial hospitalization
  3700. Prevalence of primary aldosteronism in hypertensive subjects with hyperglycemia
  3701. Diagnosis and treatment of unilateral forms of primary aldosteronism
  3702. Mineralocorticoid receptor antagonists in primary aldosteronism
  3703. Post-saline infusion testย Aldosteroneย levels indicate severity and outcome in primary aldosteronism
  3704. Effect ofย Aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism
  3705. Mineralocorticoid receptor antagonists and clinical outcomes in primary aldosteronism: as good as surgery?
  3706. A new clinical prediction criterion accurately determines a subset of patients with bilateral primary aldosteronism before adrenal venous sampling
  3707. Diagnostic utility of data from adrenal venous sampling for primary aldosteronism despite failed cannulation of the right adrenal vein
  3708. Minireview: potassium channels andย Aldosteroneย dysregulation: is primary aldosteronism a potassium channelopathy?
  3709. Endothelial dysfunction in patients with primary aldosteronism: a biomarker of target organ damage
  3710. Combination of LCโ€“MS/MSย Aldosteroneย and automated direct renin in screening for primary aldosteronism
  3711. Reversible heart rhythm complexity impairment in patients with primary aldosteronism
  3712. Primary aldosteronism and cerebrovascular diseases
  3713. The cardiovascular markers copeptin and high-sensitive C-reactive protein decrease following specific therapy for primary aldosteronism
  3714. Subclinical primary aldosteronism
  3715. Scoring system for the diagnosis of bilateral primary aldosteronism in the outpatient setting before adrenal venous sampling
  3716. Impact ofย Aldosterone-producing cell clusters on diagnostic discrepancies in primary aldosteronism
  3717. โ€ฆ of strict criteria in adrenal venous sampling increases the proportion of missed patients with unilateral disease who benefit from surgery for primary aldosteronism
  3718. Hyperkalemia in both surgically and medically treated patients with primary aldosteronism
  3719. Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism
  3720. Risk of ischemic stroke in primary aldosteronism patients
  3721. Does concomitant autonomous adrenal cortisol overproduction have the potential to confound the interpretation of adrenal venous sampling in primary aldosteronism โ€ฆ
  3722. Relationship between primary aldosteronism and obstructive sleep apnoea, metabolic abnormalities and cardiac structure in patients with resistant โ€ฆ
  3723. Regulation ofย Aldosteroneย production by ion channels: from basal secretion to primary aldosteronism
  3724. Catheterization during adrenal vein sampling for primary aldosteronism: failure to use (1โ€“24) ACTH may increase apparent failure rate
  3725. Cost-effectiveness analysis of the diagnosis and treatment of primary aldosteronism in Japan
  3726. Aldosteroneย excess may inhibit insulin secretion: a comparative study on glucose metabolism pre-and post-adrenalectomy in patients with primary aldosteronism
  3727. An adverse pregnancy-associated outcome due to overlooked primary aldosteronism
  3728. Myocardial ultrasound tissue characterization of patients with primary aldosteronism
  3729. Change in kidney function after unilateral adrenalectomy in patients with primary aldosteronism: identification of risk factors for decreased kidney function
  3730. Parathyroid gland function in primary aldosteronism
  3731. Renal resistive index predicts postoperative blood pressure outcome in primary aldosteronism
  3732. Genetics of primary aldosteronism
  3733. Primary aldosteronism patients show skin alterations and abnormal activation of glucocorticoid receptor in keratinocytes
  3734. Chronic kidney disease score for predicting postoperative masked renal insufficiency in patients with primary aldosteronism
  3735. Factors affecting parathyroid hormone levels in different types of primary aldosteronism
  3736. A short review of primary aldosteronism in a question and answer fashion
  3737. Is there a role for Nuclear Medicine in diagnosis and management of patients with primary aldosteronism?
  3738. Immunohistochemistry of the adrenal in primary aldosteronism
  3739. The subtyping of primary aldosteronism by adrenal vein sampling: sequential blood sampling causes factitious lateralization
  3740. Prevalence of primary aldosteronism withoutย hypertensionย in the general population: results in Shika study
  3741. How to escape from primary aldosteronism? News and views on an adrenal disorder of salt retention
  3742. Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism
  3743. Genetic variations in the KCNJ5 gene in primary aldosteronism patients from Xinjiang, China
  3744. Novel approach to establishing anย Aldosterone: renin ratio cutoff for primary aldosteronism
  3745. Prevalence of malignancies in patients with primary aldosteronism
  3746. Mineralocorticoid receptor antagonists and renal involvement in primary aldosteronism: opening of a new era
  3747. Screening for primary aldosteronism using the newly developed IDS-iSYSยฎ automated assay system
  3748. Genetic and potential autoimmune triggers of primary aldosteronism
  3749. โ€ฆ of peripheral blood mononuclear cells reveal transcriptional signatures as novel biomarkers of cardiac remodeling in rats with aldosteronism and hypertensive heart โ€ฆ
  3750. Clinical Practice Guideline for Management of Primary Aldosteronism: What is New in the 2016 Update?
  3751. Dual adrenal venous phase contrast-enhanced MDCT for visualization of right adrenal veins in patients with primary aldosteronism
  3752. The potential of ACTH in the genesis of primary aldosteronism
  3753. Characteristics predicting clinical improvement and cure following laparoscopic adrenalectomy for primary aldosteronism in a large cohort
  3754. Primary aldosteronism and potassium channel mutations
  3755. Role of endogenous ACTH on circadianย Aldosteroneย rhythm in patients with primary aldosteronism
  3756. Liddle syndrome misdiagnosed as primary aldosteronism resulting from a novel frameshift mutation of SCNN1B
  3757. Subtype diagnosis of primary aldosteronism: Approach to different clinical scenarios
  3758. Circadian hemodynamic characteristics in hypertensive patients with primary aldosteronism
  3759. Sleep quality in patients with primary aldosteronism
  3760. Primary aldosteronism and its various clinical scenarios
  3761. Prevalence of primary aldosteronism among patients with type 2 diabetes
  3762. Optimization of left adrenal vein sampling in primary aldosteronism: coping with asymmetrical cortisol secretion
  3763. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 5: genetic diagnosis of primary aldosteronism
  3764. Identifying unilateral disease in Chinese patients with primary aldosteronism by using a modified prediction score
  3765. Adrenal vein sampling in primary aldosteronism: sensitivity and specificity of basal adrenal vein to peripheral vein cortisol andย Aldosteroneย ratios to confirm โ€ฆ
  3766. Medication adherence during laboratory workup for primary aldosteronism: pilot study
  3767. Saline Infusion Test highly associated with the incidence of cardio-and cerebrovascular events in primary aldosteronism
  3768. Role of adrenal vein sampling in primary aldosteronism: the M onash H ealth experience
  3769. Psychological symptoms and well-being after treatment for primary aldosteronism
  3770. Shortened saline infusion test for subtype prediction in primary aldosteronism
  3771. Right adrenal venography findings correlated with C-arm CT for selection during C-arm CT-assisted adrenal vein sampling in primary aldosteronism
  3772. Diagnosis of primary aldosteronism
  3773. Eplerenone use in primary aldosteronism during pregnancy
  3774. Marinobufagenin in essentialย hypertensionย and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications
  3775. Association of primary aldosteronism with chronic thyroiditis
  3776. Association of the variations in the HSD3ฮฒ gene with primary aldosteronism
  3777. Screening for primary aldosteronism in a primary care unit
  3778. Novel genes in primary aldosteronism
  3779. Costโ€Effectiveness of Therapeutic Drug Monitoring in Diagnosing Primary Aldosteronism in Patients With Resistantย hypertension
  3780. Primary aldosteronism with concurrent primary hyperparathyroidism: clinical case load in a single centre
  3781. Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism
  3782. Primary aldosteronism with concurrent primary hyperparathyroidism in a patient with arrhythmic disorders
  3783. Worsening of lipid metabolism after successful treatment of primary aldosteronism
  3784. Case detection in primary aldosteronism: high-diagnostic value of theย Aldosterone-to-renin ratio when performed under standardized conditions
  3785. A case of primary aldosteronism combined with acquired nephrogenic diabetes insipidus
  3786. Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism
  3787. Hypokalemic rhabdomyolysis: a rare manifestation of primary aldosteronism
  3788. Evaluation of insulin sensitivity and secretion in primary aldosteronism
  3789. Risk factors for renal impairment revealed after unilateral adrenalectomy in patients with primary aldosteronism
  3790. Progress in primary aldosteronism: translation on the move
  3791. Deciphering the role of vasopressin in primary aldosteronism
  3792. Clinical utility of the adrenocorticotropin stimulation test with/without dexamethasone suppression for definitive and subtype diagnosis of primary aldosteronism
  3793. Despite limited specificity, computed tomography predicts lateralization and clinical outcome in primary aldosteronism
  3794. Volumetric and densitometric evaluation of the adrenal glands in patients with primary aldosteronism
  3795. Non-stimulated adrenal venous sampling using Dyna computed tomography in patients with primary aldosteronism
  3796. Evaluation of right adrenal vein anatomy by Dyna computed tomography in patients with primary aldosteronism
  3797. Bilateralย Aldosteroneย suppression and its resolution in adrenal vein sampling of patients with primary aldosteronism: analysis of data from the WAVESโ€J study
  3798. Alterations in vascular function in primary aldosteronism: a cardiovascular magnetic resonance imaging study
  3799. The many faces of primary aldosteronism and cushing syndrome: a reflection of adrenocortical tumor heterogeneity
  3800. Adrenal vein sampling versus CT scanning in primary aldosteronism
  3801. Development of novel nomograms to predict renal functional outcomes after laparoscopic adrenalectomy in patients with primary aldosteronism
  3802. A useful tool to improve the case detection rate of primary aldosteronism: theย Aldosteroneโ€“renin ratio (ARR)-App
  3803. Aldosterone/direct renin concentration ratio as a screening test for primary aldosteronism: a meta-analysis
  3804. Primary aldosteronism: a channelopathy?
  3805. Hypokalemia may mask primary aldosteronism: a case series
  3806. NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism
  3807. Risk of new-onset dyslipidemia after laparoscopic adrenalectomy in patients with primary aldosteronism
  3808. Subtype prediction in primary aldosteronism: measurement of circadian variation of adrenocortical hormones and 24โ€h urinaryย Aldosterone
  3809. The relationship among cardiac structure, dietary salt andย Aldosteroneย in patients with primary aldosteronism
  3810. Factors associated with resolution ofย hypertensionย after adrenalectomy in patients with primary aldosteronism
  3811. Transcriptome analysis of primary aldosteronism in adrenal glands and controls
  3812. Analysis of postoperative biochemical values and clinical outcomes after adrenalectomy for primary aldosteronism
  3813. Aldosteroneย to renin ratio as a screening instrument for primary aldosteronism in a middle-aged population with atrial fibrillation
  3814. Twenty-four-hour urinaryย Aldosteroneย predicts inappropriate left ventricular mass index in patients with primary aldosteronism
  3815. Significance of adrenal computed tomography in predicting laterality and indicating adrenal vein sampling in primary aldosteronism
  3816. A late diagnosis of primary aldosteronism
  3817. Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result ofย Aldosterone-producing adenoma
  3818. Relationship of ocular microcirculation, measured by laser speckle flowgraphy, and silent brain infarction in primary aldosteronism
  3819. The role of urinaryย Aldosteroneย for the diagnosis of primary aldosteronism
  3820. โ€ฆ of the TWIK-Related Acid-Sensitive K+ Channel 2 (TASK-2) Gene Is a Hallmark ofย Aldosterone-Producing Adenoma Causing Human Primary Aldosteronism
  3821. Body mass index and contralateral ratio predict outcome following unilateral adrenalectomy in primary aldosteronism
  3822. The third case report a patient with primary aldosteronism, seizures, and neurologic abnormalities (PASNA) syndrome de novo variant mutations in the CACNA1D โ€ฆ
  3823. A case of primary aldosteronism caused by unilateral multiple adrenocortical micronodules presenting as muscle cramps at rest: the importance of functional โ€ฆ
  3824. Visualizing adrenal steroids in primary aldosteronism: the expected and the unexplained
  3825. โ€ฆ rise in IVCย Aldosteroneย following cosyntropin administration during AVS is a signal to the presence of adrenal hyperplasia in primary aldosteronism
  3826. A case of monozygotic twins with primary aldosteronism: a case report
  3827. Primary aldosteronism: a field on the move
  3828. Improvement of bone turnover markers and bone mineral density following treatment of primary aldosteronism.
  3829. Fully automated chemiluminescence vs RIAย Aldosteroneย assay in primary aldosteronism work-up
  3830. Decreased plasma prorenin levels in primary aldosteronism: potential diagnostic implications
  3831. Expression and functional role of the prorenin receptor in the human adrenocortical zona glomerulosa and in primary aldosteronism
  3832. Primary aldosteronism: a new insight into pathogenesis, diagnosis, and treatment in hypertensive patients
  3833. Electrical and myocardial remodeling in primary aldosteronism
  3834. Hypokalemic myopathy in primary aldosteronism: A case report
  3835. Rational Approach to a Patient with Suspected Primary Aldosteronism.
  3836. Screening for primary aldosteronism in an argentinian population: a multicenter prospective study
  3837. Ambulatory blood pressure monitoringโ€“derived shortโ€term blood pressure variability in primary aldosteronism
  3838. Pathophysiological functions of adrenomedullin and natriuretic peptides in patients with primary aldosteronism
  3839. Aldosteronism with mild hypokalemia presenting as life-threatening ventricular arrhythmias: A case report
  3840. Primary aldosteronism with type 2 diabetes mellitus requires more antihypertensive drugs for blood pressure control: a retrospective observational study
  3841. The clinical value of salivaryย Aldosteroneย in diagnosis and follow-up of primary aldosteronism
  3842. Adrenal reserve function after unilateral adrenalectomy in patients with primary aldosteronism
  3843. PROGRESS IN PRIMARY ALDOSTERONISM: Mineralocorticoid antagonist treatment forย Aldosterone-producing adenoma
  3844. ACTH stimulation test and computed tomography are useful for differentiating the subtype of primary aldosteronism
  3845. Adrenal vein sampling in the diagnosis of aldosteronism
  3846. Genetic characterization of a mouse line with primary aldosteronism
  3847. Enhanced soluble serum CD40L and serum P-selectin levels in primary aldosteronism
  3848. Implication of aortic calcification on persistentย hypertensionย after laparoscopic adrenalectomy in patients with primary aldosteronism
  3849. Prevalence of angiotensin II type 1 receptor (AT1R)โ€“activating autoantibodies in primary aldosteronism
  3850. Long-term re-evaluation of primary aldosteronism after medical treatment reveals high proportion of normal mineralocorticoid secretion.
  3851. Heterogeneous machine learning system for improving the diagnosis of primary aldosteronism
  3852. Primary aldosteronism: from case detection to histopathology with up to 6 years of followโ€up
  3853. Reversing the established order: Should adrenal venous sampling precede crossโ€sectional imaging in the evaluation of primary aldosteronism?
  3854. Reassessment of the cosyntropin stimulation test in the confirmatory diagnosis and subtype classification of primary aldosteronism
  3855. Effect of eplerenone on the glomerular filtration rate (GFR) in primary aldosteronism: sequential changes in the GFR during preoperative eplerenone treatment to โ€ฆ
  3856. Primary Aldosteronism or Not Primary Aldosteronism: Is This Now the Question in Normotension?
  3857. Simultaneous occurrence of primary aldosteronism due to aldosteronoma and ectopic meningioma in the adrenal gland: a case report
  3858. Comparison of 24-h urinaryย Aldosteroneย level and random urinaryย Aldosterone-to-creatinine ratio in the diagnosis of primary aldosteronism
  3859. Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy
  3860. Response to effectiveness of adrenalectomy andย Aldosteroneย antagonists for long-term treatment of primary aldosteronism
  3861. A normotensive patient with primary aldosteronism
  3862. Association of serum parathyrine and calcium levels with primary aldosteronism: a meta-analysis
  3863. Persistent primary aldosteronism despite iatrogenic adrenal hemorrhage after adrenal vein sampling
  3864. A case of Adrenocoricotrophic hormone-independent bilateral adrenocortical macronodular hyperplasia concomitant with primary aldosteronism
  3865. Association of CYP11B2 polymorphisms with susceptibility to primary aldosteronism: a meta-analysis
  3866. Delayed diagnosis of primary aldosteronism in patients with autosomal dominant polycystic kidney diseases
  3867. Biological diagnosis of primary aldosteronism: summary of new French and international guidelines
  3868. Clinical characteristics and long-term outcome of primary aldosteronism in a Norwegian population
  3869. The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old
  3870. Hypokalemia correlated with arterial stiffness but not microvascular endothelial function in patients with primary aldosteronism
  3871. Assessment of postoperative changes in antihypertensive drug consumption in patients with primary aldosteronism using the defined daily dose
  3872. Splitting atoms: the Endocrine Society guideline for the management of primary aldosteronism
  3873. Are catecholamine-derived indexes in adrenal venous sampling useful for judging selectivity and laterality in patients with primary aldosteronism?
  3874. Aldosterone-renin ratio in the assessment of primary aldosteronism
  3875. Diagnosing and managing primary aldosteronism in hypertensive patients: a case-based approach
  3876. Lateralization index but not contralateral suppression at adrenal vein sampling predicts improvement in blood pressure after adrenalectomy for primary aldosteronism
  3877. Aldosterone-induced oxidative stress: a potential mechanism ofย Aldosteroneย autonomy in primary aldosteronism
  3878. Adrenal androgen measurement for assessing the selectivity of adrenal venous sampling in primary aldosteronism
  3879. Investigation of primary aldosteronism in patients with resistantย hypertensionโ€“Authorsโ€™ reply
  3880. Confirmatory testing for primary aldosteronism
  3881. Primary aldosteronism as a public health issueโ€“Authorsโ€™ reply
  3882. Subtype prediction of primary aldosteronism by combiningย Aldosteroneย concentrations in the left adrenal vein and inferior vena cava: a multicenter collaborative study โ€ฆ
  3883. Rapid diagnosis of primary Aldosteronism: oxymoron or one small step?
  3884. Downregulated serum 14, 15-epoxyeicosatrienoic acid is associated with abdominal aortic calcification in patients with primary aldosteronism
  3885. The spectrum of subclinical primary aldosteronism and incidentย hypertension
  3886. The application of captopril challenge test in the diagnosis of primary aldosteronism
  3887. Cardiac magnetic resonance imaging of myocardial mass and fibrosis in primary aldosteronism
  3888. Issues in the diagnosis and treatment of primary aldosteronism
  3889. A multi-institutional comparison of adrenal venous sampling in patients with primary Aldosteronism: caution advised if successful bilateral adrenal vein sampling is not โ€ฆ
  3890. An app for the diagnosis of primary aldosteronism
  3891. A prediction model for primary aldosteronism when the salt loading test is inconclusive
  3892. Primary Aldosteronism and Cardiovascular Events: It is time to take guideline recommendations seriously
  3893. Association of polymorphisms in AGTR1 and AGTR2 genes with primary aldosteronism in the Chinese Han population
  3894. A case of glucocorticoid remediable aldosteronism and thoracoabdominal aneurysms
  3895. The relation between the degree of left ventricular mass regression and serum potassium level change in patients with primary aldosteronism after adrenalectomy
  3896. Diagnosis and management of primary aldosteronism
  3897. Hypokalemia-induced rhabdomyolysis by primary aldosteronism coexistent with sporadic inclusion body myositis
  3898. Unmasked chronic renal function deterioration after unilateral adrenalectomy in patients with primary aldosteronism
  3899. Comment on โ€œBody mass index and contralateral ratio predict outcome following unilateral adrenalectomy in primary aldosteronismโ€
  3900. Effect of body mass index on the location of the right adrenal vein in patients with primary aldosteronism
  3901. Primary Aldosteronism
  3902. Primary aldosteronismโ€”not just about potassium and blood pressure
  3903. Call for screening for primary aldosteronism: an underdiagnosed and treatable disease
  3904. Bone health among patients with primary aldosteronism: a systematic review and meta-analysis.
  3905. hypertensionย in the course of primary aldosteronism during pregnancy
  3906. Clinical outcomes following unilateral adrenalectomy in patients with primary aldosteronism
  3907. Pathophysiology and clinical features of primary aldosteronism
  3908. GATA6, SF1, NGFIB and DAX1 in the remodeled subcapsular zones in primary aldosteronism
  3909. The potential role of primary care in case detection/screening of primary aldosteronism
  3910. Evaluation of angiotensin II typeโ€1 receptor antibodies in primary aldosteronism and further considerations about their possible pathogenetic role
  3911. Primary Aldosteronism Presenting with an Atypicalย Aldosterone-renin Ratio in the Acute Phase of Cerebral Hemorrhage
  3912. Screening of primary aldosteronism by clinical features and daily laboratory tests: combination of urine pH, sex, and serum K+
  3913. Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTHโ€dependent โ€ฆ
  3914. Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary โ€ฆ
  3915. The association between glomerular hyperfiltration and left ventricular structure and function in patients with primary aldosteronism
  3916. 2016 Endocrine Society guidelines update for the diagnosis of primary aldosteronism: are the proposedย Aldosterone-to-renin ratio cut-off values relevant in the era of โ€ฆ
  3917. Stroke disclosing primary aldosteronism: Report on three cases and review of the literature
  3918. The value of plasma renin concentration in diagnosis of primary aldosteronism
  3919. OS 35-04 The AA2-Ratio: Towards improved screening for primary aldosteronism inย hypertension
  3920. The importance of not overlooking curableย hypertension: primary aldosteronism rarely screened for reflecting poor uptake of Endocrine Society Guidelines
  3921. Predictors of malignancy in primary aldosteronism
  3922. Adrenal venous sampling for differentiating unilateral from bilateral primary aldosteronism: still the best, but could be better
  3923. The prevalence of primary aldosteronism (PA) in a group of 350 hypertensive patients
  3924. Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism
  3925. Primary aldosteronism
  3926. C-arm computed tomography-assisted adrenal venous sampling improved right adrenal vein cannulation and sampling quality in primary aldosteronism
  3927. Update in diagnosis and management of primary aldosteronism: reply to a Letter to the Editor
  3928. Evolution of computed tomography-detectable adrenal nodules in patients with bilateral primary aldosteronism
  3929. Clinical value of captopril test for primary aldosteronism diagnosis
  3930. Systolic heart failure in a patient with primary aldosteronism
  3931. Canย Aldosteroneย break your heart? Takotsubo cardiomyopathy in a patient with newly diagnosed primary aldosteronism
  3932. Isolation of human parathyroid cell type as a tool for investigating the mechanisms of human primary aldosteronism
  3933. Adrenal venous sampling in primary aldosteronism: multinomial regression modeling to detectย Aldosteroneย secretion lateralization when right adrenal sampling is โ€ฆ
  3934. โ€ฆ of the ratio of plasmaย Aldosteroneย to rennin concentration measured by an automated chemiluminescent immunoassay in screening for primary aldosteronism
  3935. Diagnosis and management of primary aldosteronism
  3936. โ€ฆ benefits of administering super-selective segmental adrenal venous sampling and performing adrenal sparing surgery in the patients with primary aldosteronism
  3937. Comparison betweenย Aldosteroneย and renin measurement by chemiluminescent immunoassay and radioimmunoassay for the diagnosis of primary aldosteronism
  3938. Rhabdomyolysis in Primary Aldosteronism: A Case Report and Review of the Literature
  3939. Urine steroid metabolomics as a diagnostic tool in primary aldosteronism
  3940. Suppression of primary aldosteronism and resistantย hypertensionย by the peroxisome proliferator-activated receptor gamma agonist pioglitazone
  3941. Impact of electrocardiographic findings for diagnosis of left ventricular hypertrophy in patients with primary aldosteronism
  3942. Studies on the optimal diagnostic criteria of primary aldosteronism in captopril challenge test
  3943. The importance of knowing the timing within the menstrual cycle in nonmenopausal hypertensive women in the diagnostic workup for primary aldosteronism.
  3944. Management of primary aldosteronism in patients with adrenal hemorrhage following adrenal vein sampling: a brief review with illustrative cases
  3945. Familial aggregation and heritability of primary Aldosteronism with Cardiovascular events: a population-based family cohort study
  3946. Primary aldosteronism in AF patients: To screen or not to screen?
  3947. Case Report: A case report of acromegaly associated with primary aldosteronism
  3948. Mutations of the Twik-Related Acid-Sensitive K+ Channel 2 Promoter in Human Primary Aldosteronism
  3949. The Effect of Adrenalectomy on Exercise Response of the Renin-Angiotensin-Aldosteroneย System and Exercise Tolerance in Primary Aldosteronism
  3950. Genetic alterations in primary aldosteronism
  3951. Alteration of left ventricular longitudinal systolic function in 2D-strain in primary aldosteronism: A new target organ damage marker
  3952. Is aldosteronism really a relatively common cause ofย hypertension?
  3953. Case of primary aldosteronism with discordant hormonal and computed tomographic findings
  3954. Clinical Evaluation of Primary Aldosteronism with Subclinical Cushingโ€™s Syndrome
  3955. Predictors ofย hypertensionย urgency in primary aldosteronism patients during the first 24 hours after surgery
  3956. Update on theย Aldosteroneย resolution score and lateralization in patients with primary aldosteronism
  3957. Primary Aldosteronism and Its Various Scenarios
  3958. High-sensitive C-reactive protein in primary aldosteronism
  3959. Clinical significance of contralateral adrenal suppression during adrenal vein sampling in primary aldosteronism
  3960. A case of adrenal vein sampling in primary aldosteronism with homolateral suppression
  3961. Primary Aldosteronism of Late Onset: A Case Report
  3962. โ€ฆ evaluated by pulse wave velocity is not predictive of the improvement inย hypertensionย after adrenal surgery for primary aldosteronism: a multicentre study โ€ฆ
  3963. A challenging case of primary aldosteronism presenting in pregnancy
  3964. Primary hyperparathyroidism in a patient with primary aldosteronism
  3965. Primary Aldosteronism: Molecular Mechanisms and Diagnosis
  3966. Investigation of primary aldosteronism in patients with resistantย hypertension
  3967. The association of serum parathyriod hormone and calcium levels with primary aldosteronism: a meta-analysis.
  3968. Laparoscopic adrenalectomy due to primary aldosteronism during pregnancy
  3969. Intracranial aneurysm in a patient with glucocorticoid-remediable aldosteronism
  3970. PRIMARY ALDOSTERONISM AND PREGNANCY
  3971. Primary aldosteronism diagnosed in a patient with severe renal disease.
  3972. Serum dehydroepiandrosterone sulfate concentration is lower in women with primary aldosteronism
  3973. A case of primary aldosteronism who experienced cardiopulmonary arrest, was resuscitated and cured
  3974. Adrenal vein sampling for primary aldosteronism: A 2-week protocol for withdrawal of renin-stimulating antihypertensives
  3975. Annals On Call-Primary Aldosteronism: How Often Are We Missing It?
  3976. SY 14-3 primary aldosteronism IN resistantย hypertension
  3977. Diagnosis and treatment of primary aldosteronism in 2017: Did we achieve our goals?
  3978. Subclinical target organ damage in primary aldosteronism: resistant to spironolactone therapy?
  3979. Adrenal venous sampling in dye-allergic primary aldosteronism patients: prevalence, pitfalls and a possible solution
  3980. Asymmetric dimethylarginin (adma) as a marker of endothelial dysfunction in primary aldosteronism
  3981. Assessment of the quantitative value usefulness of theย Aldosterone-Renin Ratio (ARR) for Primary Aldosteronism (AQUARR) Study
  3982. New germline mutation in CACNA1H calcium channel causing primary aldosteronism
  3983. Effects of gender on screening value ofย Aldosterone-renin ratio for primary aldosteronism
  3984. CLCN2 chloride channel mutations in primary aldosteronism
  3985. Tolvaptan for Primary Aldosteronism and Autosomal Dominant Polycystic Kidney Disease: A Case Report
  3986. Primary aldosteronism: progress in diagnosis, therapy, and genetics
  3987. A case of resistantย hypertensionย secondary to primary aldosteronism
  3988. Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease
  3989. Association of KCNJ5 gene rs3740835 (C/A) and rs2604204 (A/C) polymorphism with unilateral and bilateral primary aldosteronism
  3990. A13186 Primary Aldosteronism in Klinefelterโ€™s Syndrome: Two Cases Report
  3991. Endocrine Surgery Review Cardiovascular events and target organ damage in primary aldosteronism compared with essentialย hypertension: a systematic โ€ฆ
  3992. OS 22-08 Prevalence of primary aldosteronism and its cardio-metabolic factors Chinese hypertensive patients in Xinjiang of China
  3993. The prevalence ofย hypertensionย after adrenalectomy in patients with primary aldosteronism
  3994. Neuroglobin correlates with cryptochrome-1 in obstructive sleep apnea with primary aldosteronism
  3995. Oxidative stress in patients affected by primary aldosteronism
  3996. Screening for Primary Aldosteronism in Resistantย hypertension
  3997. Ankylosing spondylitis associated with primary aldosteronism in a middle-aged woman
  3998. A11218 A normotensive patient with primary aldosteronism: a case report
  3999. Diagnostic accuracy of three confirmatory tests for primary aldosteronism: a prospective study and systematic review
  4000. NP-59 SPECT/CT imaging in stage 1 hypertensive and atypical primary aldosteronism: a 5-year retrospective analysis of clinicolaboratory and imaging โ€ฆ
  4001. A15382 Primary Hyperparathyroidism in a Patient with Primary Aldosteronism
  4002. Effects of Altered Calcium Metabolism on Cardiac Parameters in Primary Aldosteronism
  4003. Plasma galectin-3 concentrations in patients with primary aldosteronism
  4004. Renin assay interference may conceal the diagnosis of primary aldosteronism
  4005. A case of primary aldosteronism presenting as non-ST elevation myocardial infarction
  4006. Primary aldosteronism during long-term ulcerative colitis: a diagnostic challenge
  4007. CONFIRMATORY AND SUBTYPE TESTING IN PATIENTS WITH SUSPECTED PRIMARY ALDOSTERONISM
  4008. Adrenal cortical scintigraphy for lateralization of bilateral adrenal nodules in primary aldosteronism
  4009. Primary Aldosteronism at Prapokklao Hospital
  4010. Lower physical fitness in patients with primary aldosteronism is linked to the severity ofย hypertensionย and kalemia
  4011. Primary aldosteronism
  4012. P5402 Evidence for an increased prevalence of aldosteronism among patients with coronary artery disease during the time of military conflict in Donbass region
  4013. 7d. 11: Retinal Arteriolar Structure in Patients with Primary Aldosteronism
  4014. Molecular mechanisms in primary aldosteronism
  4015. Comparison on metabolic disorders and uric acid levels between patients with primary aldosteronism and essentialย hypertension
  4016. hypertension, Atrial Fibrillation and Aldosteronism-A study of interplay, predictors and outcome
  4017. CARDIOVASCULAR EVENTS AND TARGET ORGAN DAMAGE IN PRIMARY ALDOSTERONISM: A SYSTEMATIC REVIEW AND META-ANALYSIS
  4018. Primary Aldosteronism
  4019. Prevalence and Clinical Phenotype of Primary Aldosteronism in Primary Care Hypertensives
  4020. Primary Aldosteronism
  4021. A CASE OF PRIMARY ALDOSTERONISM
  4022. Monozygotic twins discordant for primary aldosteronism: a case report
  4023. Primary Aldosteronism
  4024. Genetic aspects in primary aldosteronism
  4025. DO WE HAVE TO SCREEN PATIENTS WITH ADRENAL INCIDENTALOMA FOR PRIMARY ALDOSTERONISM?
  4026. Primary aldosteronism: making the diagnosis and why it matters
  4027. Kidney dysfunction following adrenalectomy in autosomal dominant polycystic kidney disease complicated with primary aldosteronism: A case report
  4028. ASSESSEMENT OF MYOCARDIAL MECHANOENERGETIC EFFICIENCY IN PATIENTS WITH PRIMARY ALDOSTERONISM
  4029. Primary Aldosteronism
  4030. The infradiagnosis of primary aldosteronism as a public health problem
  4031. Isolated unilateral leg weakness as the presenting symptom of primary aldosteronism: a case report
  4032. Genetics of primary aldosteronism
  4033. The importance of adrenal vein sampling in primary aldosteronism. Necessary examination for many patients as computed tomography can lead to errors
  4034. The Identification of Primary Aldosteronism
  4035. Editorial Comment from Dr Nishikawa et al. to Preoperative masked renal damage in Japanese patients with primary aldosteronism: Identification of predictors for โ€ฆ
  4036. Evaluation of the (1โ€“24) adrenocorticotropin stimulation test for the diagnosis of primary aldosteronism
  4037. A8196 Both Medical and Surgical Treatment leads to Marked Improvement ofย hypertensionย in Patients with Primary Aldosteronism (PA)
  4038. Adrenal vein sampling versus CT scanning in primary aldosteronism
  4039. A12871 Saline suppression test may predict bilateral subtypes of primary aldosteronism
  4040. The therapeutic effect of bromocriptine in combination with spironolactone in patients with primary aldosteronism: a hypothesis generating pilot study
  4041. Medical Treatment of Primary Aldosteronism
  4042. Value of combination strategy based on plasmaย Aldosterone/renin concentration ratio in screening of primary aldosteronism
  4043. Surgical outcomes of patients with primary aldosteronism lateralized with I-131-6 ฮฒ-iodomethyl-norcholesterol single photon emission/computed tomography โ€ฆ
  4044. Primary Aldosteronism (Conn Syndrome)
  4045. MDT treatment for primary aldosteronism
  4046. Subclinical Cushingโ€™s syndrome with primary aldosteronism with the developing symptom of complications: a case report
  4047. Analysis of the influencing factors for screening primary aldosteronism
  4048. Diagnosis, treatment and progress of primary aldosteronism in China
  4049. Primary Aldosteronism: From Genetic Causes to Clinical Guidelines
  4050. Origins of primary aldosteronism
  4051. Application of SUSPPUP ratio in patients with primary aldosteronism
  4052. Setting up a primary aldosteronism program: an Australian experience
  4053. Seated saline suppression testing for the diagnosis of primary aldosteronism. A validation study
  4054. Primary Aldosteronism in Hypertensive Patients
  4055. Progress on genetic basis of primary aldosteronism
  4056. obesityย and the Diagnostic Accuracy for Primary Aldosteronism
  4057. CIRCADIAN HAEMODYNAMIC CHARACTERISTICS IN PATIENTS WITH PRIMARY ALDOSTERONISM
  4058. โ€ฆ : assessment of the raas-status using triple-a-testing: combining molecular profiling ofย hypertensionย with advanced screening for primary aldosteronism in a single โ€ฆ
  4059. Quality-of-Life Aspects of Primary Aldosteronism
  4060. Do patients with primary aldosteronism have cardiovascular damage at time of diagnosingย hypertensionย in primary care?
  4061. 22-Year-old patient with malignantย hypertensionย associated with primary aldosteronism
  4062. Outcomes of Drug-Based and Surgical Treatments for Primary Aldosteronism
  4063. A12864 Ambulatory Blood Pressure Monitoring May Unveil Primary Aldosteronism
  4064. ADRENAL VENOUS SAMPLING: THE GOLD-STANDARD FOR SURGICAL INDICATION IN PRIMARY ALDOSTERONISM
  4065. Adrenal vein catecholamine levels and ratios: reference intervals derived from patients with primary aldosteronism
  4066. The long-term effect of adrenal arterial embolization for unilateral primary aldosteronism on cardiorenovascular protection, blood pressure, and the endocrinological โ€ฆ
  4067. Primary aldosteronism-management can be challenging and complex
  4068. A1960 Ablation of the adrenal artery can treat primary aldosteronism
  4069. Glucocorticoidโ€remediable aldosteronism in a young adult with a family history of Connโ€™s syndrome
  4070. VALUE OF PLASMA RENIN ACTIVITY CHANGES WITH DIFFERENT POSTURE ON IDENTIFICATION OF PRIMARY ALDOSTERONISM
  4071. 2Study heterogeneity and estimation of prevalence of primary aldosteronism
  4072. Revised guidelines for finding and treating primary aldosteronism
  4073. MEDICATION ADHERENCE AND UNREPORTED DRUG USE DURING WORKUP FOR PRIMARY ALDOSTERONISM
  4074. Primary aldosteronism in Western Norway. Studies of diagnostic approach and treatment outcome
  4075. Routine Versus Selective Adrenal Vein Sampling for Primary Aldosteronism
  4076. EP31: Primary Aldosteronismโ€“results from the first Portuguese multicentre study
  4077. Time to change the focus with a new treatment for primary aldosteronism
  4078. GW26-e2487 Clinical Analysis of Primary Aldosteronism withย hypertension
  4079. Abstract P612: The AA2-Ratio: Towards Improved Screening for Primary Aldosteronism
  4080. How should we treat patients with primary aldosteronism to prevent new-onset diabetes mellitus?
  4081. Os 35-05 measurement of angiotensin II at equilibrium in the diagnostic workup of primary aldosteronism-impact of patient positioning and ACE inhibitor treatment
  4082. A UNIQUE CASE OF TAKOTSUBO CARDIOMYOPATHY ASSOCIATED WITH PRIMARY ALDOSTERONISM
  4083. A7140 Layer-specific Strain Analysis of Myocardial Dysfunction by Speckle Tracking Echocardiography in Patients with Primary Aldosteronism
  4084. Decrease in serum potassium levels post saline suppression test in primary aldosteronism: an under-recognised phenomenon?
  4085. Primary aldosteronism in general practice: organ damage, epidemiology, and treatment
  4086. Hyperglycemia in patients with primary aldosteronism
  4087. Papilledema in Patient with Primary Aldosteronism: an Unusual Case Report
  4088. Application of a novel equilibrium angiotensin II assay in screening and confirmatory testing for primary aldosteronism: a pilot study
  4089. Primary aldosteronism: new insights into familial forms
  4090. A3370 The outcome comparisons of patients with primary aldosteronism and resistantย hypertensionย after adrenalectomy or medical treatment
  4091. Corrigendum: Long term outcome of Aldosteronism after target treatments
  4092. Primary Aldosteronism in the Primary Care Clinic: Rife or Rare?
  4093. โ€ฆ to Potassium in Adrenocorticotropin Stimulation Test is a Possible New Index for Diagnosis ofย Aldosterone-producing Adenoma in Patients with Primary Aldosteronism
  4094. Cardiovascular Complications Associated With Primary Aldosteronism
  4095. Clinical and Laboratory Assessment of Patients with Suspected Primary Aldosteronism
  4096. Autosomal dominant polycystic kidney disease andย hypertensionย masquerading primary aldosteronism
  4097. A18459 Research of KCNJ5 gene mutation and cardiac damage in patients with primary aldosteronism
  4098. Re-evaluation of screening and confirmatory tests in primary aldosteronism
  4099. The influence of aging on the diagnosis of primary aldosteronism
  4100. Microalbuminuria in primary aldosteronism
  4101. โ€ฆ OF LEFT VENTRICULAR FUNCTION BY GLOBAL LONGITUDINAL STRAIN IN PATIENTS WITH PRIMARY ALDOSTERONISM AND ESSENTIALย hypertension
  4102. Epidemiologic study of primary aldosteronism in northern Jiangsu
  4103. Os 35-06 comparison of n-terminal pro-b-type natriuretic peptide level in primary aldosteronism and essentialย hypertension
  4104. A16434 Antiplatelet and Anticoagulant therapies in Patients with Primary Aldosteronism: Results of the PA Sendai Study registry
  4105. Primary aldosteronism: more common than once thought: Two clinical cases
  4106. Prevalance of primary aldosteronism in hypertensive patients: epidemiological data from a tertiary centre
  4107. A2830 Serum soluble (pro) renin receptor concentration is correlated with organ dysfunctions in patients with primary aldosteronism
  4108. Primary aldosteronism-results from the first Portuguese multicentre study
  4109. A9431 Characteristics of cardiac structural changes and cardiac arrhythmias in patients with primary aldosteronism
  4110. A case of primary aldosteronism and Hashimoto
  4111. โ€ฆย Aldosterone: comparison of liquid chromatography-tandem mass spectrometry with radioimmunoassay in screening and confirmatory testing for primary aldosteronism
  4112. PROSPECTIVE APPRAISAL ON THE PREVALENCE OF PRIMARY ALDOSTERONISM AND ITS SUTYPES IN HYPERTENSIVE PATIENTS PRESENTING WITH โ€ฆ
  4113. No difference between CT and AVS for determining treatment options in primary aldosteronism
  4114. Genetic mutations cause primary aldosteronism
  4115. PP. 09.27: genetic abnormalities in lateralized multinodular primary aldosteronism
  4116. Biventricular Cardiac Hypertrophy in a Patient with Primary Aldosteronism and Atrial Septal Defect
  4117. Changes of parathyroid hormone in primary aldosteronism and its effects
  4118. Abstract P333: Effect of Autonomous Cortisol Secretion on Cerebrovasuclular Events in Patients With Primary Aldosteronism
  4119. The Predictive Value of Left Versus Right Adrenal Volume Ratio (L/Rv) in Discrimination between AVS Confirmed Unilateral and Bilateral Primary Aldosteronism
  4120. Patient selection for confirmatory tests of primary aldosteronism (PA) using the PA discrimination score
  4121. A11374 RAAS Triple A-Testing: LC-MS/MS Based Molecular Profiling ofย hypertensionย and Advanced Screening for Primary Aldosteronism
  4122. Characteristics of patients with normal adrenal imaging in primary aldosteronism
  4123. Glucocorticoid production in primary aldosteronism-from mechanisms to clinical implications
  4124. A9910 Correlation between vitamin D and plasmaย Aldosteroneย concentration in Primary aldosteronism patients
  4125. Four Cases of Hypovolemic Renin-Aldosteroneย Axis Deficiency Without Hyperkalemia Following Unilateral Adrenalectomy for Primary Aldosteronism
  4126. Utility of F-18 FDG-PET in detecting primary aldosteronism in patients with bilateral adrenal incidentalomas
  4127. Primary Aldosteronism with Rhabdomyolysis: A Case Report
  4128. Target Organ Damage and Treatment of Primary Aldosteronism
  4129. Primary Aldosteronism in Iceland, nationwide results from 2012-2016
  4130. Metabolic and hormonal profile in primary aldosteronism as compared with essentialย hypertension
  4131. Sleep quality in patients with primary aldosteronism
  4132. Primary Aldosteronism in a Patient with Autosomal Dominant Polycystic Kidney Disease Associated with Polycystic Liver Disease
  4133. Progress in the identification of responsible genes and molecular mechanisms in primary aldosteronism
  4134. PRIMARY ALDOSTERONISM IN YOUNG PATIENT WITH RECURRENT RESISTANTย hypertensionย AFTER SOLITARY ADRENAL ADENOMA SURGICAL โ€ฆ
  4135. Response to โ€˜Oxidative stress in patients affected by primary aldosteronismโ€™
  4136. Primary Aldosteronism: Molecular Genetics, Endocrinology, and Translational Medicine
  4137. โ€ฆ A-TESTING: COMBINING LC-MS/MS BASED MOLECULAR PROFILING OFย hypertensionย AND ADVANCED SCREENING FOR PRIMARY ALDOSTERONISM
  4138. The value of high effective liquid chromatography in the diagnosis of primary aldosteronism
  4139. Glucocorticoid axis in patients with primary aldosteronism
  4140. Confirmatory tests for diagnosis of primary aldosteronism among Chinese hypertensives
  4141. New diagnostic methods for primary aldosteronism with specific antibodies
  4142. ACTH stimulation test for study of primary aldosteronism
  4143. Prevalence of AT1R-activating autoantibodies in primary aldosteronism: AT1R autoantibodies in primary aldosteronism
  4144. Laboratory challenges in primary aldosteronism screening and diagnosis
  4145. Prevalence of neoplasms in patients with primary aldosteronism
  4146. Primary aldosteronismโ€“prevalence and prognosis in primary care
  4147. A2006 Ablation of the adrenal artery can treat idiopathic aldosteronism
  4148. Molecular Derangements in Sporadic Primary Aldosteronism
  4149. Treatment strategy and outcome with primary aldosteronism: a nationwide longitudinal cohort based study
  4150. Significance and utility of selective tributary sampling for accurate diagnosis of unilateral primary aldosteronism.
  4151. Expression and Functional Role of The Prorenin Receptor in Human Primary Aldosteronism
  4152. Prevalence and clinical correlates of CACNA1D mutations in primary aldosteronism
  4153. Is adrenal computed tomography accurate for the diagnosis of unilateral primary aldosteronism? A retrospective international cohort study
  4154. Primary aldosteronism is an underdiagnosed cause ofย hypertension. Important to find undiagnosed patientsโ€“effective treatment available
  4155. Method verification forย Aldosteroneย and renin assay-a reliable screening test for primary aldosteronism
  4156. Patients with primary aldosteronism have lower circulating adenosine levels but similar susceptibility to ischemia-reperfusion compared to patients with essential โ€ฆ
  4157. Complete remission ofย hypertensionย in a hemodialysis patient after adrenalectomy for primary aldosteronism and renal transplantation
  4158. Abstract MP12: The AA2-Ratio: A Novel Screening Test for Primary Aldosteronism in Hypertensive Patients
  4159. Validation ofย Aldosterone-to-Renin Ratio Cut-offs in Screening for Primary Aldosteronism
  4160. Predictors of the Long-Term Outcomes in Patients With Secondaryย hypertensionย Caused by Primary Aldosteronism
  4161. Parathyroid Hormone Levels Are Positively Correlated With Left Ventricular Hypertrophy in Patients With Primary Aldosteronism
  4162. Intermittent Primary Aldosteronism-Another Hurdle in the Connโ€™s Story?
  4163. Normotensive hypokalemic primary aldosteronism: How is this Possible?
  4164. TDM-guided screening for primary aldosteronism cost saving
  4165. A0996 downregulated serum 14, 15-EET is associated with abdominal aortic calcification in patients with primary aldosteronism
  4166. Intermittent primary aldosteronism-another hurdle in the Conn
  4167. Os 35-01 the prevalence of sleep apnea syndrome in primary aldosteronism
  4168. Hair cortisol in patients with primary aldosteronism
  4169. Re-evaluation of the optimal cutoff of saline infusion test in the diagnosis of primary aldosteronism
  4170. CD3 ALDOSTERONISM, HEART AND VESSELS
  4171. Role of adrenal venous sampling in differential diagnosis of subtypes in primary aldosteronism
  4172. Aspects of diagnostic and management of bilateral adrenal glandโ€™s lesions associated with primary aldosteronism
  4173. Cardiovascular complications during medication adjustment for the diagnosis of primary aldosteronism
  4174. Glucose and lipid metabolism characteristics in the male primary aldosteronism patients
  4175. THE LOCATION SPECTRUM OF THE ORIFICE OF RIGHT ADRENAL VEIN IN PATIENTS WITH PRIMARY ALDOSTERONISM: THE EXPERIENCE BASED ON 575 โ€ฆ
  4176. A case of primary aldosteronism with the subclinical Cushing
  4177. 4114Adrenal venous sampling in primary aldosteronism: cosyntropin infusion increases the success rate of the procedure but can mask the lateralization of โ€ฆ
  4178. The Detection Rate and Characteristics of Primary Aldosteronism in Hypertensive Patients
  4179. Adrenal vein sampling vs imaging in primary aldosteronism
  4180. Primary aldosteronism due to adrenocortical adrenal tumor in child: clinical case and literature review
  4181. Primary Aldosteronism Presenting as Hypokalemia and Rhabdomyolysis
  4182. Clinical and biochemical outcomes in surgically treated patients with primary aldosteronism. A multicentric retrospective study
  4183. The Urinaryย Aldosteroneย in the Diagnosis of Primary Aldosteronism
  4184. Application of captopril challenge test in the diagnosis of primary aldosteronism
  4185. Adrenal Venous Sampling in Patients with Primary Aldosteronism: Which Is the Best Evaluation Method for Laterality Assessments?
  4186. Persistent Hyperkalemia Status Postadrenalectomy for Primary Aldosteronism
  4187. OS 33-06 In patients with primary aldosteronism, obstructive sleep apnoea improves with treatment by adrenalectomy or medical therapy
  4188. Role of adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes
  4189. Assessing the new Primary Aldosteronism guidelines recommendation to omit confirmatory testing in selected patients-severity of hypokalaemia may be included
  4190. Investigation of the prevalence of primary aldosteronism among newly diagnosed patients withย hypertension
  4191. Identification ofย Aldosteroneย production sites in primary aldosteronism
  4192. Adrenal venous sampling vs imaging for primary aldosteronism
  4193. Abstract P451: Cerebrovasuclular Events in Patients With Primary Aldosteronism: Results of the PA Sendai Study Registry
  4194. Posterior reversible encephalopathy syndrome (PRES) in a patient with primary aldosteronism
  4195. Postural orthostatic tachycardia syndrome unmasked by successful treatment of primary aldosteronism
  4196. The New Cholesterol Treatment Guidelines Represents a Paradigm Shift for Primary Aldosteronism Patients
  4197. Diagnostic Value of Saline Load Test in Patients With Primary Aldosteronism
  4198. The usage of computed tomography and serum potassium in determining the subtypes of primary aldosteronism
  4199. A9099 Diagnostic Significance of Contralateral Suppression Index of the Adrenal Venous Sampling in Primary Aldosteronism Subtyping
  4200. Role of imaging and adrenal venous sampling techniques in the diagnosis of primary aldosteronism
  4201. Captopril challenge test-is it useful for the diagnosis of primary aldosteronism?
  4202. โ€ฆ in Response to the Correspondence by Damien Denimal Entitled:โ€ Comments on French SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, Part 2: Diagnosis โ€ฆ
  4203. Prolactinoma and primary aldosteronism: is there a causal link?
  4204. Use of NP-59 SPECT/CT imaging in atypical primary aldosteronism
  4205. Reversal of Arterial Stiffness in Patients with Primary Aldosteronism after Treatment
  4206. Abstract P117: Blood Pressure Outcomes in Patients With Primary Aldosteronism after Adrenalectomy versus Medical Management in Relation to the New 2017 ACC โ€ฆ
  4207. Discordance between imaging and adrenal vein sampling in primary aldosteronism
  4208. Renin: a possible novel marker for the efficacy of pharmacological treatment of primary aldosteronism
  4209. Differential diagnosis of primary aldosteronism by measurement of hybrid steroids using mass spectrometry
  4210. Prevalence of primary aldosteronism among hypertensive population in Trabzon City, Turkey
  4211. Adrenal vein sampling versus CT scanning in primary aldosteronismโ€“Authorsโ€™ reply
  4212. Glucocorticoid-Remediable Aldosteronism: An Uncommon and Often Overlooked Cause of Adrenalย hypertension
  4213. Aortic root dilatation in primary aldosteronism: is treatment effective in reducing aortic damage?
  4214. Against-Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
  4215. Long-term outcome from unilateral adrenalectomy in patients with primary aldosteronism
  4216. Genetic Steroid Disorders: Chapter 6C. Glucocorticoid-Remediable Aldosteronism
  4217. Primary aldosteronism: The role of plasma free metanephrines as a lateralization marker in adrenal vein sampling and its concordance with CT-scan.
  4218. Amplified Screening and Workup Protocol for Primary Aldosteronism: A Strategy to Improve New Zealandโ€™s Woefully Low
  4219. Value of adrenal venous sampling in the subtype diagnosis of primary aldosteronism
  4220. [OP. 4B. 06] FREQUENCY OF PRIMARY ALDOSTERONISM IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEAโ€“OSA-PA STUDY
  4221. Intraoperative hypertensive crisis as a key symptom in a normotensive patient with primary aldosteronism-clinical case
  4222. COINCIDENCE OF PRIMARY ALDOSTERONISM AND RENAL ARTERY STENOSISโ€“A RARE CAUSE OFย hypertension
  4223. Primary aldosteronism and the occurrence of hyperparathyroidism in the German Connโ€™s registry
  4224. Female patients with primary aldosteronism are diagnosed earlier and have a better cardiovascular outcome after treatment
  4225. In Focus Primary aldosteronism and low-reninย hypertension: a continuum?
  4226. Primary Aldosteronismโ€”An Endocrine Society Clinical Practice Guideline
  4227. Selective adrenal venous sampling is not always useful in primary aldosteronism
  4228. 9B. 08: CARDIAC AND VASCULAR DAMAGE IN PATIENTS WITH PRIMARY ALDOSTERONISM AND ESSENTIALย hypertension
  4229. GW24-e2371 The association between KCNJ5 gene polymorphism and primary aldosteronism
  4230. Efficacy of Screening and Confirmatory Tests of Primary Aldosteronism in Diagnosingย Aldosteroneย Producing Adenoma
  4231. Primary aldosteronism associated with a giant coronary aneurysm after drug-eluting stent implantation
  4232. A case of subclinical primary aldosteronism and subclinical Cushing
  4233. Role of adrenal venous sampling in primary aldosteronism: Salford royal NHS foundation trust experience
  4234. Paradoxical worsening of lipid metabolism after successful treatment of primary aldosteronism
  4235. Is steroid profiling using LC-MS/MS useful in the diagnostic work-up of primary aldosteronism?
  4236. West Australian experience with adrenal venous sampling studies in the diagnosis of primary aldosteronism
  4237. Rapid reduction in left ventricular mass in primary aldosteronism after treatment; a prospective cardiac MRI study
  4238. A Fisher discriminant model to predict the outcome of postoperative blood pressure in primary aldosteronism
  4239. Dissociation of subtype diagnosis by various criteria on adrenal venous samplings in primary aldosteronism
  4240. Coexisting Prolactinoma and Primary Aldosteronism: Is There a Pathophysiological Link?
  4241. Association of polymorphisms in angiotensin โ…ก receptor gene with primary aldosteronism
  4242. Clinical and biochemical outcome after unilateral adrenalectomy in primary aldosteronism
  4243. Rating the blood pressure outcome after adrenalectomy for unilateral primary aldosteronism.
  4244. Hyperreninemic Aldosteronism in Caucasian and African-American Patients With Apparent Resistantย hypertension
  4245. Primary aldosteronism studies on screening, outcome of adrenalectomy and functional pathology
  4246. Pregnancy, Primary Aldosteronism and Somatic CTNNB1 Mutations in the Adrenal
  4247. โ€ฆ reply: The importance of knowing the timing within the menstrual cycle in nonmenopausal hypertensive women in the diagnostic workup for primary aldosteronism.
  4248. Pathogenic Origins of Fibrosis in the Hypertensive Heart Disease that Accompanies Aldosteronism
  4249. Adrenal vein sampling for subtype classification of primary aldosteronism in British Columbia: insights and challenges
  4250. Application of endothelial markers detection in early target organ damage degree determination for patients with primary aldosteronism
  4251. Laparoscopic Partial Adrenalectomy for Primary Aldosteronism Combined with Cushingโ€™s Syndrome: Report of a Case
  4252. Several Types of Somatic Mutations Induce Autonomous Production ofย Aldosteroneย in Primary Aldosteronism
  4253. Specificity of the posture test for subtyping of primary aldosteronism, a 10 year nationwide summary in Iceland
  4254. Cost-Effectiveness of PET-CT Versus Adrenal Vein Sampling for the Diagnosis ofย hypertensionย Caused by Primary Aldosteronism
  4255. Case Report: A case report of acromegaly associated with primary aldosteronism [version 1; referees: 2 approved]
  4256. Improvement of bone turnover markers and bone mineral density following treatment of primary aldosteronism
  4257. GW26-e2276 Relationship between Serum ฮฒ2-microglobulin and Arteriosclerosis in Primary Aldosteronism
  4258. Long-term survival of a feline with primary aldosteronism secondary to an adrenal carcinoma.
  4259. Posture-responsive primary aldosteronism-the utility of seated saline suppression test
  4260. Successful treatment of primary aldosteronism with partial adrenalectomy, facilitated by the use of 11C-Metomidate PET/CT
  4261. A case of primary aldosteronism with secondary hyperparathyroidism and bilateral adrenal tumors
  4262. Theย Aldosteroneย Renin Ratio (ARR) APP as Tool to Enhance the Detection Rate of Primary Aldosteronism
  4263. GW26-e0139 The relationship between the KCNJ5 gene polymorphisms and lipid metabolism in patients with primary aldosteronism
  4264. Low ACTH and cortisol production following adrenalectomy for primary aldosteronism
  4265. Plasmaย Aldosteroneย level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism
  4266. Effectiveness of Adrenalectomy andย Aldosteroneย Antagonists for Long-Term Treatment of Primary Aldosteronism
  4267. Experimental study on the rationality of amiloride off-label use in treating primary aldosteronism
  4268. Immunohistochemical staining for histopathological subclassification of primary aldosteronism: nationwide 10-year results from Iceland
  4269. Role of adrenal vein sampling in primary aldosteronism: impact of different diagnostic criteria on subtype diagnosis
  4270. Episodic primary aldosteronism associated with a novel gain-of-function mutation in a cell adhesion molecule
  4271. OS 35-09 long-term outcome of surgically-and medically-treated patients of the primary aldosteronism prevalence in hypertensives (PAPY) study
  4272. New germline mutation in calcium channel CACNA1H causes late-onset primary aldosteronism
  4273. Application and evaluation of postural stimulation test and captopril challenge test in diagnosis of primary aldosteronism
  4274. PRIMARY ALDOSTERONISM AND SUBCLINICAL CUSHINGโ€™S FROM THE SAME ADENOMA: AN UNCOMMON VARIANT
  4275. Simultaneous assays ofย Aldosteroneย and renin concentrations in just ten minutes could change the clinical assessment for the diagnosis of primary aldosteronism
  4276. GW24-e3740 Comparison of biomarkers of endothelial dysfunction and risk of early organ damage between primary aldosteronism and essentialย hypertension
  4277. A Rare Case of Subclinical Primary Aldosteronism and Subclinical Cushingโ€™s Syndrome without Cardiovascular Complications
  4278. MEDICAL MANAGEMENT OF MILD HYPERCORTISOLISM AND PRIMARY ALDOSTERONISM IN A PATIENT WITH ACTH-INDEPENDENT MACRONODULAR โ€ฆ
  4279. Post saline infusion testย Aldosteroneย levels indicate severity and outcome in primary aldosteronism
  4280. First phase insulin secretion is impaired byย Aldosteroneย excess in primary aldosteronism
  4281. Abstract P398: Screening of Primary Aldosteronism by Clinical Features and Daily Laboratory Tests: Combination of Urine pH, Sex, and Serum K+
  4282. Itโ€™s Complicated: How Often are Patients with Primary Aldosteronism Cured After Adrenalectomy?
  4283. The correlation between C171Tmutation of potassium inwardly-rectifying channel, subfamily J, member 5gene and hypokalemic in patients with primary aldosteronism
  4284. Is the adrenal vein sampling the gold standard diagnostic test for the subtyping of primary aldosteronism?
  4285. A case of subclinical primary aldosteronism and subclinical Cushingโ€™s syndrome without risk factors of cardiovascular disease
  4286. Influence of Endothelial Function and Rho-Associated Kinase Activity in Patients With Primary Aldosteronism
  4287. GW24-e3533 Correlation between C171T mutation of KCNJ5 gene and hypokalemic in patients with primary aldosteronism
  4288. Ascending aorta dilatation in primary aldosteronism: a new deleterious consequence ofย Aldosteroneย excess
  4289. PRIMARY ALDOSTERONISM: UTILITY OF LEFT ADRENAL VEINย Aldosteroneย RATIO TO PREDICT UNILATERAL DISEASE
  4290. 5970 Who to test for primary aldosteronism: development of a decision tool to select the right patients
  4291. FP088 COMBINATION OF URINE PH AND FEMALE GENDER FOR SCREENING PRIMARY ALDOSTERONISM IN NEWLY DIAGNOSED HYPERTENSIVE PATIENTS
  4292. Prevalence rate, characteristics and predictive factors of primary aldosteronism among hypertensive patients who hadย Aldosterone-renin ratio screening in Southern โ€ฆ
  4293. Mass spectrometry-based adrenal venous steroid profiling for subtyping primary aldosteronism
  4294. LATERALIZATION CRITERIA IN ADRENAL VEIN SAMPLING IN PATIENSWITH PRIMARY ALDOSTERONISM BY HIGH EFFECTIVE LIQUID CHROMATOGRAPHY
  4295. [PP. 27.23] GUIDELINES FOR PRIMARY ALDOSTERONISM: UPTAKE BY PRIMARY CARE PHYSICIANS IN EUROPE
  4296. Radiofrequency bipolar ablation therapy for primary aldosteronism patients: investigator-initiated exploratory clinical trial
  4297. โ€ฆ DAILY DOSE CAN ASSESS POSTOPERATIVE CHANGE IN ANTIHYPERTENSIVE DRUG CONSUMPTION IN PATIENTS WITH PRIMARY ALDOSTERONISM
  4298. Lb02. 07: effect of acute Da2 dopaminergic receptor blockade on performance of adrenal vein sampling for subtyping of primary aldosteronism
  4299. MP37-19 short-term impact on health-related quality of life of laparoscopic adrenalectomy for primary aldosteronism in Japanese patients
  4300. โ€ฆ of endoscopic ultrasound and other imaging techniques compared to adrenal vein sampling regarding therapeutic decisions in patients with primary aldosteronism
  4301. โ€ฆ -producing adenoma by histological, immunohistochemical and radiological features; a basis for individualised treatment strategies in primary aldosteronism?
  4302. โ€ฆ from Dr Catena, Dr Colussi and Dr Sechi to Preoperative masked renal damage in Japanese patients with primary aldosteronism: Identification of predictors for โ€ฆ
  4303. A Novel Score System for Primary Aldosteronism Screening, PUK2 score: Combination of Urine pH and Serum Uric Acid and K+ Levels
  4304. Are we missing patients with primary aldosteronism (PA) if we require both elevatedย Aldosterone: renin ratio (ARR) and elevatedย Aldosteroneย levels?
  4305. Comparison betweenย Aldosteroneย and renin measurement by chemiluminescent immunoassay and RIA for the diagnosis of primary aldosteronism
  4306. โ€ฆ -Saline Infusion Plasmaย Aldosteroneย Concentrations are Well Correlated with the Lateralized Ratio of Adrenal Venous Sampling in Patients of Primary Aldosteronism
  4307. Cardiovascular outcome in patients with primary aldosteronism following adrenalectomy and mineralocorticoid antagonist treatment: prospective results of the Munich โ€ฆ
  4308. โ€ฆ Study on Steroidgenic Activity inย Aldosterone-Producing Adenoma With ATPase or CACNA1D Gene Mutations in Japanese Patients With Primary Aldosteronism
  4309. Activated Intrarenal Renin Angiotensin System Contributes to the Development of Chronic Kidney Disease in Primary Aldosteronism
  4310. โ€ฆ Mutations and a Rare Coding Single Nucleotide Polymorphism Within KCNJ5 Potassium Channel in a Large Cohort of Sporadic Cases of Primary Aldosteronism.
  4311. PS 17-02 TARGET ORGAN DAMAGE OF PRIMARY ALDOSTERONISM DIFFERENT SUBTYPES
  4312. Evaluation of Chemiluminescence Immunoassay for Detecting Blood Levels ofย Aldosteroneย and Renin With its Diagnostic Value of Primary Aldosteronism
  4313. Activated Intrarenal Renin Angiotensin Systems Is the Primary Source of Progressing Renal Damage in Primary Aldosteronism
  4314. Impact ofย Aldosteroneย Producing Adenoma on Endothelial Function and Rho-Associated Kinase Activity in Patients With Primary Aldosteronism
  4315. [LB. 01.32] URINARY METABOLIC SIGNATURE OF PRIMARY ALDOSTERONISM: GENDER AND SUBTYPE SPECIFIC ALTERATIONS
  4316. Adequate salt intake attenuates mineralocorticoid receptor antagonist-induced hyperkalemia in patients with primary aldosteronism
  4317. โ€ฆ Comment from Dr Catena, Dr Colussi and Dr Sechi to Preoperative masked renal damage in Japanese patients with primary aldosteronism: Identification of predictors โ€ฆ
  4318. โ€ฆ Association between the levels of carboxy-terminal propeptide of type I procollagen andย Aldosteroneย in patients with primary aldosteronism and essentialย hypertension
  4319. Careful selection of patients with primary aldosteronism using combination of age, serum potassium and CT adrenal glands can avoid the need for adrenal venous โ€ฆ
  4320. [PP. 27.07] QUALITY OF LIFE IN PRIMARY ALDOSTERONISM IMPROVES MORE AFTER ADRENALECTOMY THAN AFTER MEDICAL THERAPY
  4321. Diagnostic Efficacy of CT/MR Imaging and Adrenal Vein Sampling for Localization ofย Aldosterone-producing Adrenal Adenomas in Primary Aldosteronism
  4322. MYOCARDIAL ULTRASOUND TISSUE CHARACTERIZATION OF PATIENTS WITH PRIMARY ALDOSTERONISM HSIU-HAO LEE,* y CHI-SHENG HUNG, z โ€ฆ
  4323. Immuno-phenotypic Characterization of Lateralized Primary Aldosteronism with New Monoclonal Antibodies against the Humanย Aldosteroneย Synthase (CYP11B2) โ€ฆ
  4324. PS 14-77 THE DIAGNOSIS OF PATIENTS WITH PRIMARY ALDOSTERONISM IN CARDIOLOGY DEPARTMENT OF MIE UNIVERSITY HOSPITAL IN JAPAN
  4325. PP. 09.16: 24-HOUR CENTRAL SYSTOLIC AORTIC BLOOD PRESSURE IN ALDOSTERONISM, ESSENTIALย hypertensionย AND NORMOTENSION
  4326. 8d. 02: Peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in primary aldosteronism patients
  4327. โ€ฆ 14-01 COMPARISON OF LEFT VENTRICULAR STRUCTURE AND FUNCTION IN PATIENTS WITH PRIMARY ALDOSTERONISM AND ESSENTIALย hypertensionย โ€ฆ
  4328. โ€ฆ induced galectin-3 secretion via MR/PI3K/Akt/NF-kB signaling in THP-1 cell: a possible mediator of myocardial fibrosis in patients with primary aldosteronism
  4329. Use of NP-59 (131I-iodocholesterol) scan as a potential alternative to adrenal venous sampling in the investigation of primary aldosteronism: a 5-year โ€ฆ
  4330. [PP. 25.11] GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM (GRA): A MODEL OF DISCREPANCY BETWEEN GENOTYPE AND CLINICAL PHENOTYPE
  4331. MP03-06 PATIENT SELECTION FOR CONFIRMATORY TESTS OF PRIMARY ALDOSTERONISM (PA) USING THE PA DISCRIMINATION SCORE
  4332. [BP. 05.01] THE CLINICAL CHARACTERISTICS OF PATIENTS WITH PRIMARY ALDOSTERONISM COMPLICATED WITH OBSTRUCTIVE SLEEP APNEA โ€ฆ
  4333. Os 35-08 Does Adrenocorticotropic Hormone (Acth) Administration Improve the Diagnostic Performance of Adrenal Vein Sampling for Primary Aldosteronism?
  4334. OS 35-03 LEFT VENTRICULAR CHANGES ARE AFFECTED BY DIETARY SALT INTAKE IN PRIMARY ALDOSTERONISM: A PROSPECTIVE STUDY
  4335. 0456 Relation between Primary Aldosteronism and Obstructive Sleep Apnea
  4336. PS 14-76 CLINICAL CHARACTERISTICS OF THE YOUNG (=< 40Y) WITH PRIMARY ALDOSTERONISM IN JAPAN
  4337. โ€ฆ Does Contralateral Suppression at Adrenal Venous Sampling Predict Outcome Following Unilateral Adrenalectomy for Primary Aldosteronism? A Retrospective Study
  4338. LBPS 02-37 ADRENAL HEMORRHAGE FOLLOWING ADRENAL VEIN SAMPLING IN PRIMARY ALDOSTERONISM: A SIX-CENTER EXPERIENCE.
  4339. Perioperative nursing of 44 patients with primary aldosteronism undergoing super-selective adrenal arterial embolization
  4340. P-158: Long-term evolution of blood pressure and kalemia in patients with primary aldosteronism: surgical treatment versus medical treatment
  4341. MP03-07 ADRENALECTOMY ATTENUATES THE RISK OF END STAGE RENAL DISEASE OF PRIMARY ALDOSTERONISMโ€“A COMPETING RISK ANALYSIS
  4342. 5.4. 2. Primary Aldosteronism
  4343. [OP. 6B. 02] LONG-TERM EFFECTS OF ADRENALECTOMY OR SPIRONOLACTONE ON ARTERIAL STIFFNESS IN PRIMARY ALDOSTERONISM
  4344. MP03-08 POST ADRENALECTOMY RENAL FUNCTION IN PATIENTS WITH PRIMARY ALDOSTERONISM
  4345. A14761 Random 24-hour urinary sodium andย Aldosteroneย excretion in hypertensive patients may indicate underlying primary aldosteronism
  4346. [PP. 17.22] PRIMARY ALDOSTERONISM AND TWIN PREGNANCY WITH INTRAUTERINE DEATH OF ONE FOETUS: A CASE REPORT
  4347. Imaging mass spectrometry reveals co-accumulation ofย Aldosteroneย and 18-oxocortisol with CYP11B2 in pre-adenomatous states of primary aldosteronism
  4348. 11C-metomidate PET-CT in primary aldosteronism: five possible indications for a non-invasive alternative to adrenal vein sampling
  4349. โ€ฆ -TO-RENIN RATIO IS A PREDICTOR OF DECREMENT IN GLOMERULAR FILTRATION RATE AFTER ADRENALECTOMY FOR PRIMARY ALDOSTERONISM
  4350. S-322: Unmasked renal damage after unilateral adrenalectomy for primary aldosteronism: Report of two cases
  4351. PP. 09.07: THE NECESSITY OF ADRENAL VENOUS SAMPLING IN ALDOSTERONISM PATIENTS YOUNGER THAN AGE 45
  4352. [PP. 27.05] THE THERAPEUTIC EFFECT OF BROMOCRIPTINE IN COMBINATION WITH SPIRONOLACTONE IN PATIENTS WITH PRIMARY ALDOSTERONISM
  4353. PS 14-73 SUBTYPE CLASSIFICATION OF PRIMARY ALDOSTERONISM WITH SUBCLINCAL CUSHING SYNDROME BY SUPER-SELECTIVE ADRENAL VEIN โ€ฆ
  4354. โ€ฆ ] COSYNTROPIN INFUSION SIGNIFICANTLY INFLUENCES THE RESULTS OF ADRENAL VENOUS SAMPLING IN PATIENTS WITH PRIMARY ALDOSTERONISM.
  4355. โ€ฆ -FOUR HOUR BLOOD PRESSURE PROFILE AND LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS WITH PRIMARY ALDOSTERONISM
  4356. [OP. 6B. 04] DEVELOPMENT OF A PREDICTION MODEL FOR PATIENTS WITH SUSPECTED PRIMARY ALDOSTERONISM AND AN INCONCLUSIVE SALT โ€ฆ
  4357. PP. 09.30: DIETARY SALT INTAKE AND RENAL DAMAGE IN PRIMARY ALDOSTERONISM
  4358. [BP. 08.05] SUBTYPING OF PRIMARY ALDOSTERONISM BY AVS: HORMONE-AND SIDE-SPECIFIC EFFECTS OF COSYNTROPIN AND METOCLOPRAMIDE
  4359. โ€ฆ BETWEEN T REGULATORY AND TH17 LYMPHOCYTE SUBSETS IN PATIENTS WITH RESISTANTย hypertensionย AND PRIMARY ALDOSTERONISM
  4360. โ€ฆ COMPARISON OF LEFT VENTRICULAR STRUCTURE AND FUNCTION IN PATIENTS WITH PRIMARY ALDOSTERONISM AND ESSENTIALย hypertension
  4361. CYP11B2/CYP11B1 Immunophenotyping of 111 Adrenal Glands Excised from Primary Aldosteronism Patients leads to a Novel Classification of the Disease
  4362. PP. 09.13: COMPLIANCE WITH ANTIHYPERTENSIVE TREATMENT IN PRIMARY ALDOSTERONISM
  4363. PP. 09.29: AORTIC DILATATION IN PATIENTS WITH PRIMARY ALDOSTERONISM AFTER THERAPY WITH MINERALOCORTICOID RECEPTORS ANTAGONISTS
  4364. Abstract P212: A Meta Analysis of Somatic KCNJ5 Mutations in 1636 Primary Aldosteronism Patients
  4365. โ€ฆ ] SUPPRESSION OFย Aldosteroneย SECRETION AFTER RECUMBENT SALINE INFUSION DOES NOT EXCLUDE LATERALIZED PRIMARY ALDOSTERONISM
  4366. Supplementary Fig. 3. Biochemical and clinical characteristics of patients with primary aldosteronism in the COAR and SIE cohorts. To compare the numbers of โ€ฆ
  4367. โ€ฆ : ASSOCIATION OF PLASMAย Aldosteroneย CONCENTRATION WITH PREVALENCE OF DIABETES MELLITUS IN SUSPECTED PRIMARY ALDOSTERONISM
  4368. [PP. 27.21]ย hypertensionย AND PRIMARY ALDOSTERONISM
  4369. 44 IMPACT OF ADRENAL VENOUS SAMPLING (AVS) ON DETERMINATION OF RESPONSIBLE LESION OF PRIMARY ALDOSTERONISM (PA)
  4370. S-448: Bilateral Adrenal Adenomas in the Presence of Primary Aldosteronism
  4371. Melanocortin 2 Receptor Mutations and Clinical Significance in Case of Cushing Syndrome and Subclinical Cushing Syndrome and Primary Aldosteronism
  4372. PP. 23.22: CARDIAC REMODELING IN PATIENTS WITH PRIMARY AND SECONDARY ALDOSTERONISM
  4373. โ€ฆ RENIN-Aldosteroneย AXIS DEFICIENCY WITHOUT HYPERKALEMIA FOLLOWING UNILATERAL ADRENALECTOMY FOR PRIMARY ALDOSTERONISM
  4374. โ€ฆ BY PULSE WAVE VELOCITY PREDICTIVE OF THE IMPROVEMENT OFย hypertensionย AFTER ADRENAL SURGERY FOR PRIMARY ALDOSTERONISM?
  4375. โ€ฆ PHASE OF THE MENSTRUAL CYCLE AFFECT THE RESULTS OF ADRENAL VENOUS SAMPLING AND SUBTYPING OUTCOME OF PRIMARY ALDOSTERONISM โ€ฆ
  4376. [OP. 3A. 05] THE USE OF PREDICTION SCORE TO DIAGNOSE UNILATERAL DISEASE IN CHINESE PATIENTS WITH PRIMARY ALDOSTERONISM
  4377. PP. 23.20: PRIMARY ALDOSTERONISM ANDย hypertension
  4378. S-445 Outcomes Analysis of Surgical and Medical Treatments for Patients with Primary Aldosteronism
  4379. [PP. 25.02] A NOVEL TREATMENT FOR BILATERAL HYPERPLASIA AS A CAUSE OF PRIMARY ALDOSTERONISM
  4380. [OP. LB01. 11] MEASUREMENT OF ANGIOTENSIN II AT EQUILIBRIUM IN THE DIAGNOSTIC WORKUP OF PRIMARY ALDOSTERONISM. IMPACT OF PATIENT โ€ฆ
  4381. [OP. 6D. 07] ASSESSMENT OF THE QUANTITATIVE VALUE OF THEย Aldosterone-RENIN RATIO (ARR) FOR PRIMARY ALDOSTERONISM (AQUARR) STUDY
  4382. [LB. 03.20] APPLICATIONS OF RAS-EQUILIBRIUM-ANALYSIS IN THE DIAGNOSIS OF PRIMARY ALDOSTERONISM AND BIOCHEMICAL PROFILING OF โ€ฆ
  4383. LBPS 02-61 GUIDELINES FOR PRIMARY ALDOSTERONISM: UPTAKE BY PRIMARY CARE PHYSICIANS IN EUROPE
  4384. โ€ฆ -ANGIOTENSIN SYSTEMS AND OXIDATIVE STRESS IN TUBULAR CAN BE THE ORIGINAL MECHANISM OF RENAL DAMAGE IN PRIMARY ALDOSTERONISM
  4385. [PP. 25.13] PRIMARY ALDOSTERONISM AND LEFT VENTRICLE IN 2D ECHOCARDIOGRAPHY: NEW INSIGHTS
  4386. 9B. 01: CLINICAL SIGNIFICANCE OF CONTRALATERAL ADRENAL SUPPRESSION DURING ADRENAL VEIN SAMPLING IN PRIMARY ALDOSTERONISM.
  4387. PS 14-74 EVALUATION OF INSULIN SENSITIVITY AND SECRETION IN PRIMARY ALDOSTERONISM
  4388. SP 01-2 HYPERTENSIVE TARGET ORGAN DAMAGE IN PRIMARY ALDOSTERONISM
  4389. [PP. 25.15] THYROID ABNORMALITIES IN PRIMARY ALDOSTERONISM
  4390. โ€ฆ OF STRESS REACTION ON THE ASSESSMENT OF LATERALIZATION DURING SEQUENTIAL ADRENAL VEIN SAMPLING FOR PRIMARY ALDOSTERONISM
  4391. โ€ฆ TYPE: ORAL OR POSTER ABSTRACT SUBMISSION NO.: PN-2639; THE RELATIONSHIP BETWEEN PARATHYROID HORMONE AND PRIMARY ALDOSTERONISM
  4392. PD1-01 AORTIC CALCIFICATION INDEX (ACI) OF THE PATIENTS WITH PRIMARY ALDOSTERONISM (PA) IS AN INDEPENDENT PREDICTOR OF HYPERTENSIVE โ€ฆ
  4393. OS 05-06 IN PRIMARY ALDOSTERONISM, MINERALOCORTICOIDS AND POTASSIUM INFLUENCE ABUNDANCE OF THE THIAZIDE SENSITIVE SODIUM โ€ฆ
  4394. PP. 09.24: A META ANALYSIS OF 1504 PRIMARY ALDOSTERONISM PATIENTS WITHย Aldosteroneย PRODUCING ADENOMA GENOTYPED FOR KCNJ5 โ€ฆ
  4395. PP. 09.22: POTENTIAL EFFECTS OF AGE ON SCREENING FOR PRIMARY ALDOSTERONISM
  4396. โ€ฆ POTASSIUM TO URINARY SODIUM DIVIDED BY SERUM POTASSIUM TO SERUM SODIUM (UPUSPS) AS A SCREENING TOOL FOR PRIMARY ALDOSTERONISM
  4397. [PP. 23.15] RELATIONSHIP BETWEEN PATIENT CHARACTERISTICS, RISK FACTORS, FREQUENCY OF PRIMARY ALDOSTERONISM AND THE NUMBER OF โ€ฆ
  4398. โ€ฆ ANALYSIS OF THIAZIDE SODIUM COTRANSPORTER IN URINARY EXOSOMES FROM NORMAL CONTROLS AND PATIENTS WITH PRIMARY ALDOSTERONISM
  4399. [OP. LB01. 12] CACNA1H MUTATIONS ARE ASSOCIATED WITH YOUNG ONSET AND FAMILIAL FORMS OF PRIMARY ALDOSTERONISM
  4400. โ€ฆ AMONG DIETARY SALT,ย Aldosteroneย AND LEFT VENTRICULAR STRUCTURE IN PATIENT S WITH PRIMARY ALDOSTERONISM-A CASE-CONTROL STUDY
  4401. [PP. 07.12] ARMC5 MUTATIONS IN PATIENTS WITH PRIMARY ALDOSTERONISM AND BILATERAL ADRENAL LESIONS
  4402. โ€ฆ 23.18: POSTOPERATIVE DYNAMICS IN PULSE WAVE VELOCITY AND PARAMETERS OF LOCAL CAROTID ARTERY STIFFNESS IN PRIMARY ALDOSTERONISM
  4403. โ€ฆ -79 ROLE OF ENDOGENOUS ADRENOCORTICOTROPIC HORMONE ON CIRCADIANย Aldosteroneย RHYTHM IN PATIENTS WITH PRIMARY ALDOSTERONISM
  4404. โ€ฆ ON MORNING AND EVENING BLOOD PRESSURE MEASURED BY SELF-MEASURED BLOOD PRESSURE MONITORING IN PRIMARY ALDOSTERONISM โ€ฆ
  4405. PS 14-84 PREDICTORS OF BLOOD PRESSURE OUTCOME FOLLOWING LAPAROSCOPIC UNILATERAL ADRENALECTOMY IN PRIMARY ALDOSTERONISM
  4406. PP. 09.26: AMBULATORY BLOOD PRESSURE MONITORING-DERIVED SHORT-TERM BLOOD PRESSURE VARIABILITY IN PRIMARY ALDOSTERONISM
  4407. โ€ฆ INDEX AND CONTRALATERAL RATIO PREDICT BLOOD PRESSURE OUTCOME FOLLOWING UNILATERAL ADRENALECTOMY IN PRIMARY ALDOSTERONISM
  4408. [PP. 25.16] FREQUENCY OF PRIMARY ALDOSTERONISM IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEAโ€“OSA-PA STUDY
  4409. [PP. 25.17] THE AA2-RATIO: IMPROVED SCREENING FOR PRIMARY ALDOSTERONISM INย hypertension
  4410. [PP. 25.07] EVOLUTION OF COMPUTED TOMOGRAPHY-DETECTABLE ADRENAL NODULES IN PATIENTS WITH BILATERAL PRIMARY ALDOSTERONISM
  4411. [OP. 3A. 04] ADRENAL HEMORRHAGE FOLLOWING ADRENAL VEIN SAMPLING IN PRIMARY ALDOSTERONISM: A SIX-CENTER EXPERIENCE
  4412. Circulating levels of miR24-1 cluster microRNAs are increased in primary aldosteronism
  4413. PP. 09.28: INCREASED URINARY RELEASE OF ENAC-ACTIVATING PROSTASIN IN PATIENTS AFFECTED BY PRIMARY ALDOSTERONISM
  4414. PP. 23.21: IMMUNO-PHENOTYPIC CHARACTERIZATION OF LATERALIZED PRIMARY ALDOSTERONISM WITH NOVEL MONOCLONAL ANTIBODIES AGAINST โ€ฆ
  4415. PD3-02 IN PRIMARY ALDOSTERONISM WITH BILATERAL ADRENAL ADNOMAS, LAPAROSCOPIC BILATERAL ADRENAL SURGERY COULD BE AN OPTIONAL โ€ฆ
  4416. โ€ฆ . 23.19: ACTIVATED INTRARENAL RENIN-ANGIOTENSIN-SYSTEM CONTRIBUTES TO THE DEVELOPMENT OF RENAL DAMAGE IN PRIMARY ALDOSTERONISM
  4417. PP. 23.24: THE AA2-RATIO: A NOVEL SCREENING TEST FOR PRIMARY ALDOSTERONISM IN HYPERTENSIVE PATIENTS
  4418. Measurement of Peripheral Blood 18-Oxocortisol as the Diagnostic Method of Primary Aldosteronism and Its Subtypes
  4419. GW24-e2292 The complement c1q tumor necrosis factor-related protein 1 level in patients with sleep apnea and primary aldosteronism
  4420. PP. 32.13: CAN 128-SLICE DUAL-SOURCE CT REPLACE ADRENAL VEIN SAMPLING FOR SUBTYPING PATIENTS WITH PRIMARY ALDOSTERONISM?
  4421. The Adrenal Vein Sampling International Study-2: Results in 1636 Primary Aldosteronism Patients
  4422. P1-10: Renin-Aldosteroneย axis deficiency without frank hyperkalemia following unilateral adrenalectomy for primary aldosteronism (PA): about 4 cases
  4423. MP12-06 MEDIUM-TERM OUTCOMES AFTER LAPAROSCOPIC ADRENALECTOMY FOR PRIMARY ALDOSTERONISM
  4424. Diagnosis and treatment of primary aldosteronism: practical clinical perspectives
  4425. The unrecognized prevalence of primary aldosteronism: a cross-sectional study
  4426. Primary aldosteronism: where are we now? Where to from here?
  4427. Genetic causes of primary aldosteronism
  4428. Evolution of the primary aldosteronism syndrome: updating the approach
  4429. Prevalence, diagnosis and outcomes of treatment for primary aldosteronism
  4430. Renal damage in primary aldosteronism: a systematic review and meta-analysis
  4431. Primary Aldosteronism: JACC State-of-the-Art Review
  4432. Primary aldosteronism is a public health issue: challenges and opportunities
  4433. Primary aldosteronism in patients in China with recently detectedย hypertension
  4434. Old and new genes in primary aldosteronism
  4435. Keeping primary aldosteronism in mind: deficiencies in screening at-risk hypertensives
  4436. Classification of microadenomas in patients with primary aldosteronism by steroid profiling
  4437. Genetic and genomic mechanisms of primary aldosteronism
  4438. Impaired glucose metabolism in primary aldosteronism is associated with cortisol cosecretion
  4439. The primary aldosteronism surgical outcome score for the prediction of clinical outcomes after adrenalectomy for unilateral primary aldosteronism
  4440. Screening rates for primary aldosteronism in resistantย hypertension: a cohort study
  4441. Primary aldosteronism: Treatment of the disease, and new therapeutic approaches
  4442. Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiaryย hypertensionย unit
  4443. Subtyping of primary aldosteronism in the AVIS-2 study: assessment of selectivity and lateralization
  4444. Atrial fibrillation as presenting sign of primary aldosteronism: results of the prospective appraisal on the prevalence of primary aldosteronism in hypertensive (PAPPHY โ€ฆ
  4445. Progress in primary aldosteronism 2019: new players on the block?
  4446. Clinical outcomes after unilateral adrenalectomy for primary aldosteronism
  4447. THERAPY OF ENDOCRINE DISEASE: Medical treatment of primary aldosteronism
  4448. Pathogenesis and treatment of primary aldosteronism
  4449. Primary aldosteronism: at the tipping point
  4450. MANAGEMENT OF ENDOCRINE DISEASE: The role of confirmatory tests in the diagnosis of primary aldosteronism
  4451. Primary aldosteronism: cardiovascular risk, diagnosis, and management
  4452. Confirmatory tests for the diagnosis of primary aldosteronism: A systematic review and metaโ€analysis
  4453. Endothelial dysfunction in primary aldosteronism
  4454. Measurement of equilibrium angiotensin II in the diagnosis of primary aldosteronism
  4455. Development and validation of criteria for sparing confirmatory tests in diagnosing primary aldosteronism
  4456. Primary aldosteronism
  4457. Primary aldosteronism in the elderly
  4458. Development and validation of prediction models for subtype diagnosis of patients with primary aldosteronism
  4459. Primary aldosteronism and obstructive sleep apnea: a cross-sectional multi-ethnic study
  4460. Low quality of reports on blood pressure in patients adrenalectomized for unilateral primary aldosteronism
  4461. Controversies and advances in adrenal venous sampling in the diagnostic workup of primary aldosteronism
  4462. The effect of vitamin D treatment on clinical and biochemical outcomes of primary aldosteronism
  4463. Sex difference in the association between subtype distribution and age at diagnosis in patients with primary aldosteronism
  4464. Left ventricular remodeling and dysfunction in primary aldosteronism
  4465. Primary Aldosteronism: Mutations, Mechanisms, Prevalence, and Public Health
  4466. Cardiovascular risk in primary aldosteronism: A systematic review and meta-analysis
  4467. Safety of medical adjustment and confirmatory testing in the diagnostic work-up of primary aldosteronism
  4468. Three discrete patterns of primary aldosteronism lateralization in response to cosyntropin during adrenal vein sampling
  4469. Predictors of clinical success after surgery for primary aldosteronism in the Japanese Nationwide Cohort
  4470. Primary and Secondary Hyperparathyroidism in Patients with Primary Aldosteronismโ€“Findings From the German Connโ€™s Registry
  4471. Characterization and gene expression analysis of serum-derived extracellular vesicles in primary aldosteronism
  4472. Seated saline infusion test in predicting subtype diagnosis of primary aldosteronism
  4473. Developments in primary aldosteronism subtyping using steroid profiling
  4474. Management of primary aldosteronism and mineralocorticoid receptor-associatedย hypertension
  4475. Precise mapping of intra-adrenalย Aldosteroneย activities provides a novel surgical strategy for primary aldosteronism
  4476. Long-Term mortality for patients of primary aldosteronism compared with essentialย hypertension: A systematic review and meta-analysis
  4477. Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism
  4478. Steroid profiling and immunohistochemistry for subtyping and outcome prediction in primary aldosteronismโ€”a review
  4479. Age, gender, and body mass index as determinants of surgical outcome in primary aldosteronism
  4480. Hypokalemia and the prevalence of primary aldosteronism
  4481. Primary aldosteronism diagnosis and management: A clinical approach
  4482. Discordance between imaging and adrenal vein sampling in primary aldosteronism irrespective of interpretation criteria
  4483. Primary aldosteronism and obstructive sleep apnea: casual association or pathophysiological link?
  4484. Role ofย Aldosteroneย and potassium levels in sparing confirmatory tests in primary aldosteronism
  4485. Primary aldosteronism: present and future
  4486. Primary aldosteronism: higher volume load, cardiac output and arterial stiffness than in essentialย hypertension
  4487. 11Cโ€Metomidate PET/CT is a useful adjunct for lateralization of primary aldosteronism in routine clinical practice
  4488. Variability ofย Aldosteroneย measurements during adrenal venous sampling for primary aldosteronism
  4489. Low-grade Cortisol Cosecretion Has Limited Impact on ACTH-stimulated AVS Parameters in Primary Aldosteronism
  4490. Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism
  4491. Primary aldosteronism: KCNJ5 mutations and adrenocortical cell growth
  4492. Effects of mineralocorticoid and AT1 receptor antagonism on theย Aldosterone-renin ratio in primary aldosteronismโ€”the EMIRA study
  4493. Use of Steroid Profiling Combined With Machine Learning for Identification and Subtype Classification in Primary Aldosteronism
  4494. Arterial wall inflammation and increased hematopoietic activity in patients with primary aldosteronism
  4495. China nationwide screening and registry of primary aldosteronism in hypertensive patients
  4496. Targeted treatment of primary aldosteronismโ€“The consensus of Taiwan Society of Aldosteronism
  4497. The potential pathophysiological role ofย Aldosteroneย and the mineralocorticoid receptor in anxiety and depressionโ€“Lessons from primary aldosteronism
  4498. Basal plasmaย Aldosteroneย concentration predicts therapeutic outcomes in primary aldosteronism
  4499. Primary aldosteronism subtype discordance between computed tomography and adrenal venous sampling
  4500. Circulating miRNA expression profiling in primary aldosteronism
  4501. KCNJ5 Somatic Mutation Is a Predictor ofย hypertensionย Remission After Adrenalectomy for Unilateral Primary Aldosteronism
  4502. Baseline plasmaย Aldosteroneย level and renin activity allowing omission of confirmatory testing in primary aldosteronism
  4503. Familial Aggregation and Heritability of Aldosteronism with Cardiovascular Events
  4504. Diverse pathological lesions of primary aldosteronism and their clinical significance
  4505. Vitamin D supplementation: a novel therapy for aldosteronism?
  4506. High prevalence of diabetes in patients with primary aldosteronism (PA) associated with subclinical hypercortisolism and prediabetes more prevalent in bilateral than โ€ฆ
  4507. Functional imaging by 11C-metomidate PET: a really useless technique for primary aldosteronism subtyping?
  4508. The risk factors for hepatic steatosis in patients with primary aldosteronism
  4509. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrineย hypertensionย of โ€ฆ
  4510. Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Scoreโ€“Matching Followโ€Up Study With Tissue Doppler Imaging
  4511. Adrenal insufficiency after unilateral adrenalectomy in primary aldosteronism: long-term outcome and clinical impact
  4512. Disease monitoring of Primary Aldosteronism
  4513. Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism
  4514. Primary aldosteronism with nonlocalizing imaging
  4515. International histopathology consensus for unilateral primary aldosteronism
  4516. Aldosterone-potassium ratio predicts primary aldosteronism subtype
  4517. Mineralocorticoid receptor antagonists decrease the rates of positive screening for primary aldosteronism
  4518. Cellular Pathophysiology of Mutant Voltage-Dependent Ca2+ Channel CACNA1H in Primary Aldosteronism
  4519. Outcomes after surgery for unilateral dominant primary aldosteronism in Sweden
  4520. The crosstalk betweenย Aldosteroneย and calcium metabolism in primary aldosteronism: a possible calcium metabolism-associated aberrant โ€œneoplasticโ€ โ€ฆ
  4521. Left atrial myocardial dysfunction in patients with primary aldosteronism as assessed by speckle-tracking echocardiography
  4522. Renin-angiotensin-Aldosteroneย system triple-A analysis for the screening of primary aldosteronism
  4523. Primary aldosteronism: cardiovascular outcomes pre-and post-treatment
  4524. Aldosteroneย reduction rate after saline infusion test may be a novel prediction in patients with primary aldosteronism
  4525. Primary aldosteronism: does underlying pathology impact clinical presentation and outcomes following unilateral adrenalectomy?
  4526. Immunohistochemistry of the human adrenal CYP11B2 in normal individuals and in patients with primary aldosteronism
  4527. Comprehensive analysis of steroid biomarkers for guiding primary aldosteronism subtyping
  4528. Adrenal vein sampling lateralization despite mineralocorticoid receptor antagonists exposure in primary aldosteronism
  4529. Primary Aldosteronism decreases insulin secretion and increases insulin clearance in humans
  4530. Impact of immunohistochemistry on the diagnosis and management of primary aldosteronism: an important tool for improved patient follow-up
  4531. MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism
  4532. Adherence to consensus guidelines for screening of primary aldosteronism in an urban healthcare system
  4533. Assessment of postoperative renal function after adrenalectomy in patients with primary aldosteronism
  4534. Confirmatory testing of primary aldosteronism with saline infusion test and LC-MS/MS
  4535. Clinical outcomes after surgery for primary aldosteronism: Evaluation of the PASO-investigatorsโ€™ consensus criteria within a worldwide cohort of patients
  4536. Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the โ€ฆ
  4537. Salt appetite and its effects on cardiovascular risk in primary aldosteronism
  4538. Effects of ramipril on theย Aldosterone/renin ratio and theย Aldosterone/angiotensin II ratio in patients with primary aldosteronism
  4539. Aldosteroneย to renin ratio as screening tool in primary aldosteronism
  4540. Primary aldosteronism in a general population sample. The Czech post-MONICA study
  4541. โ€ฆ number of positive confirmatory tests is associated with the clinical presentation and incidence of cardiovascular and cerebrovascular events in primary aldosteronism
  4542. Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractoryย hypertension
  4543. Significance of Discordant Results Between Confirmatory Tests in Diagnosis of Primary Aldosteronism
  4544. Approach to the Patient with Primary Aldosteronism: Utility and Limitations of Adrenal Vein Sampling
  4545. Aldosteroneย is aberrantly regulated by various stimuli in a high proportion of patients with primary aldosteronism
  4546. obesityย predicts persistence of resistantย hypertensionย after surgery in patients with primary aldosteronism
  4547. Primary Aldosteronism and Bone Metabolism: A Systematic Review and Meta-Analysis
  4548. hypertensionย with primary aldosteronism is associated with increased carotid intimaโ€media thickness and endothelial dysfunction
  4549. Surgery decreases the long-term incident stroke risk in patients with primary aldosteronism
  4550. Impact of Victoriaโ€™s first dedicated Endocrineย hypertensionย Service on the pattern of primary aldosteronism diagnoses
  4551. Cosyntropin stimulation in adrenal vein sampling improves the judgment of successful adrenal vein catheterization and outcome prediction for primary aldosteronism
  4552. Enigma of the origin of primary aldosteronism
  4553. Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism
  4554. Simultaneous bilateral adrenal vein sampling for primary aldosteronism: useful tips to make it simple and safe
  4555. Development of a prediction score to avoid confirmatory testing in patients with suspected primary aldosteronism
  4556. Influence of Different Treatment Strategies on Newโ€Onset Atrial Fibrillation Among Patients With Primary Aldosteronism: A Nationwide Longitudinal Cohortโ€Based โ€ฆ
  4557. Risk of new-onset autoimmune diseases in primary aldosteronism: A nation-wide population-based study
  4558. Utility of microcatheter in adrenal venous sampling for primary aldosteronism
  4559. Nomogram-Based Preoperative Score for Predicting Clinical Outcome in Unilateral Primary Aldosteronism
  4560. Association between acute fall in estimated glomerular filtration rate after treatment for primary aldosteronism and long-term decline in renal function
  4561. Primary aldosteronism-associated cardiomyopathy: Clinical-pathologic impact ofย Aldosteroneย normalization
  4562. Primary aldosteronism in elderly, old, and very old patients
  4563. Adrenalectomy improves the long-term risk of end-stage renal disease and mortality of primary aldosteronism
  4564. Unilateral disease is common in patients with primary aldosteronism without adrenal nodules
  4565. Effects of primary Aldosteronism and different therapeutic modalities on glucose metabolism
  4566. Evaluation of biochemical conditions allowing bypass of confirmatory testing in the workup of primary aldosteronism: a retrospective study in a French hypertensive โ€ฆ
  4567. Clinical presentation and surgical outcomes in primary aldosteronism differ by race
  4568. Application of CT texture analysis to assess the localization of primary aldosteronism
  4569. Long-term blood pressure outcomes of patients with adrenal venous sampling-proven unilateral primary aldosteronism
  4570. Atrial fibrillation in primary aldosteronism
  4571. Phosphodiesterase 2A and 3B variants are associated with primary aldosteronism
  4572. The prevalence of primary aldosteronism and evolving approaches for treatment
  4573. Primary Aldosteronism: Strike Two
  4574. A disease-specific Quality of Life questionnaire for primary aldosteronism
  4575. Serum-soluble (pro) renin receptor concentration as a biomarker for organ damage in primary aldosteronism
  4576. Primary Aldosteronism: Three Strikes and Out
  4577. Theย Aldosteroneย to renin ratio in the diagnosis of primary aldosteronism: promises and challenges
  4578. Quality of life in primary aldosteronism: A prospective observational study
  4579. Letter to the Editor from Zhu and Rossi:โ€œDevelopment and Validation of Criteria for Sparing Confirmatory Tests in Diagnosing Primary Aldosteronismโ€
  4580. New advances in the diagnosis of primary aldosteronism
  4581. Impact of cone beam-CT on adrenal vein sampling in primary aldosteronism
  4582. Intraindividual Variability ofย Aldosteroneย Concentrations in Primary Aldosteronism: Implications for Case Detection
  4583. Abdominal aortic calcification is more severe in unilateral primary aldosteronism patients and is associated with elevatedย Aldosteroneย and parathyroid hormone levels
  4584. Sex Differences in Renal Outcomes After Medical Treatment for Bilateral Primary Aldosteronism
  4585. Effect of cosyntropin during adrenal venous sampling on subtype of primary aldosteronism: analysis of surgical outcome
  4586. The Unrecognized Prevalence of Primary Aldosteronism
  4587. Higher prevalence of metabolic disorders in patients with bilateral primary aldosteronism than unilateral primary aldosteronism
  4588. Autonomous cortisol secretion influences psychopathological symptoms in patients with primary aldosteronism
  4589. Theย Aldosterone/renin ratio predicts cardiometabolic disorders in subjects without classic primary aldosteronism
  4590. The association of primary aldosteronism with glaucoma-related fundus abnormalities
  4591. Assessing the quality of guidelines for primary aldosteronism: which guidelines are worth applying in diverse settings?
  4592. Mild primary aldosteronism (PA) followed by overt PA are possibly the most common forms of low reninย hypertension: a single-center retrospective study
  4593. The impact of glucocorticoid co-secretion in primary aldosteronism on thyroid autoantibody titers during the course of disease
  4594. Surgical Outcomes Among Primary Aldosteronism Patients Without Visible Adrenal Lesions
  4595. Exploration Of The Seated Saline Suppression Test For The Diagnosis Of Primary Aldosteronism In The Chinese Population
  4596. Adrenalectomy for primary aldosteronism: significant variability in work-up strategies and low guideline adherence in worldwide daily clinical practice
  4597. Diabetes mellitus itself increases cardio-cerebrovascular risk and renal complications in primary aldosteronism
  4598. Treatment of Primary Aldosteronism Increases Plasma Epoxyeicosatrienoic Acids
  4599. Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan
  4600. Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among US Veterans: A Retrospective Cohort Study
  4601. Outcomes in unilateral primary aldosteronism after surgical or medical therapy
  4602. Primary aldosteronism and obstructive sleep apnea: a cross-sectional multi-ethnic study
  4603. Adrenal venous sampling in young patients with primary aldosteronism. Extravagance or irreplaceable?
  4604. Effect of unilateral adrenalectomy on the quality of life of patients with lateralized primary aldosteronism
  4605. A novel clinical nomogram to predict bilateral hyperaldosteronism in Chinese patients with primary aldosteronism
  4606. Extracellular vesicles as biomarkers and biovectors in primary aldosteronism
  4607. Altered Taste Perception for Sodium Chloride in Patients With Primary Aldosteronism: A Prospective Cohort Study
  4608. Heterogenous Responses to Cosyntropin in Primary Aldosteronism: Commentary to: Three Discrete Patterns of Primary Aldosteronism Lateralization in Response to โ€ฆ
  4609. Surgical approach to patients with primary aldosteronism
  4610. Response to Letter on use of functional imaging by 11C-metomidate PET for primary aldosteronism subtyping
  4611. Lateralizing asymmetry of adrenal imaging and adrenal vein sampling in patients with primary aldosteronism
  4612. Adrenal Venous Samplingโ€“Guided Adrenalectomy Rates in Primary Aldosteronism: Results of an International Cohort (AVSTAT)
  4613. Comparisons of skin microvascular changes in patients with primary aldosteronism and essentialย hypertension
  4614. Primary aldosteronism complicated by hyperparathyroidism: report of one case and literature review
  4615. Proteomic profile of urinary extracellular vesicles identifies AGP1 as a potential biomarker of primary aldosteronism
  4616. Association of Adrenal Venous Sampling With Outcomes in Primary Aldosteronism for Unilateral Adenomas
  4617. Patients with primary aldosteronism respond to unilateral adrenalectomy with long-term reduction in salt intake
  4618. The quality of clinical practice guidelines and consensuses on the management of primary aldosteronism: A critical appraisal
  4619. Urinary Metabolic Signature of Primary Aldosteronism: Gender and Subtypeโ€Specific Alterations
  4620. Aldosterone-to-renin ratio is related to arterial stiffness when the screening criteria of primary aldosteronism are not met
  4621. Somatic mutations in adrenocortical carcinoma with primary aldosteronism or hyperreninemic hyperaldosteronism
  4622. CACNA1H Calcium Channel Mutations in Primary Aldosteronism โ€“ Is Sodium the Culprit?
  4623. Molecular mechanisms in primary aldosteronism
  4624. Insulin sensitivity and pancreatic ฮฒ-cell function in patients with primary aldosteronism
  4625. A speckle tracking echocardiographic study on right ventricular function in primary aldosteronism
  4626. Arterial Stiffness Is Associated with Clinical Outcome and Cardiorenal Injury in Lateralized Primary Aldosteronism
  4627. Timeline of Advances in Genetics of Primary Aldosteronism
  4628. The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population
  4629. Using microwave thermal ablation to develop a subtotal, cortical-sparing approach to the management of primary aldosteronism
  4630. Dr. Conn Lives on: Insights Into Screening and Genetics of Primary Aldosteronism
  4631. Repeat adrenal vein sampling in aldosteronism: reproducibility and interpretation of persistently discordant results
  4632. Left-right differences in adrenal vein sampling for primary aldosteronism
  4633. Long-term outcome success after operative treatment for primary aldosteronism
  4634. Is primary aldosteronism a potential risk factor for aortic dissection? A case report and literature review
  4635. Primary aldosteronism: Novel insights
  4636. Sleep-EEG in patients with primary aldosteronism in comparison to healthy controls and patients with depression
  4637. Determining the prevalence of primary aldosteronism in patients with new-onset type 2 diabetes andย hypertension
  4638. Long-term impact of spironolactone compliance on microalbuminuria in patients with primary aldosteronism
  4639. Plasmaย Aldosteroneย after seated saline infusion test outperforms captopril test at predicting clinical outcomes after adrenalectomy for primary aldosteronism
  4640. Prediction of unilateral hyperaldosteronism on adrenal vein sampling using captopril challenge test in patients with primary aldosteronism
  4641. โ€ฆ concentration and response to ACTH during simultaneous bilateral adrenal veins sampling to predict the source ofย Aldosteroneย secretion in primary aldosteronism
  4642. The Unrecognized Prevalence of Primary Aldosteronism
  4643. Comparison of ambulatory blood pressure between patients with primary aldosteronism and other forms ofย hypertension
  4644. Comparison of the shortened and standard saline infusion tests for primary aldosteronism diagnostics
  4645. Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis
  4646. Diagnosis of Primary Aldosteronism by Seated Saline Suppression Testโ€”Variability Between Immunoassay and HPLC-MS/MS
  4647. Primary aldosteronism is associated with decreased lowโ€density and highโ€density lipoprotein particle concentrations and increased GlycA, a proโ€inflammatory โ€ฆ
  4648. A Multicenter Study of Neutrophil-to-Lymphocyte Ratio in Primary Aldosteronism
  4649. Aldosteroneย level after saline infusion test could predict clinical outcome in primary aldosteronism after adrenalectomy
  4650. Higher blood urea nitrogen and urinary calcium: new risk factors for diabetes mellitus in primary aldosteronism patients
  4651. High body fat percentage is associated with primary aldosteronism: a cross-sectional study
  4652. Primary aldosteronism is highly prevalent in patients withย hypertensionย and moderate to severe obstructive sleep apnea
  4653. High efficiency of theย Aldosterone-to-renin ratio in precisely detecting primary aldosteronism
  4654. Mosaicism for KCNJ5 Causing Early-Onset Primary Aldosteronism due to Bilateral Adrenocortical Hyperplasia
  4655. Speckle-Tracking Echocardiographic Layer-Specific Strain Analysis on Subclinical Left Ventricular Dysfunction in Patients With Primary Aldosteronism
  4656. Simplifying the Diagnosis of Primary Aldosteronism
  4657. Clinical characterization of patients with primary aldosteronism plus subclinical Cushingโ€™s syndrome
  4658. โ€ฆ levels in peripheral veins following intravenous sedation during adrenal vein sampling: implications for the concept of nonsuppressibility in primary aldosteronism
  4659. Screening for primary aldosteronism:โ€™How to adjust existing antihypertensive medications to avoid diagnostic errorsโ€™
  4660. Association between plasmaย Aldosteroneย and markers of tubular and glomerular damage in primary aldosteronism
  4661. Diurnal blood pressure pattern and cardiac damage in hypertensive patients with primary aldosteronism
  4662. Taiwan mini-frontier of primary aldosteronism: Updating detection and diagnosis
  4663. Larger ascending aorta in primary aldosteronism: a 3-year prospective evaluation of adrenalectomy vs. medical treatment
  4664. Impact of primary aldosteronism on renal function in patients with type 2 diabetes
  4665. Transtubular potassium gradient predicts kidney function impairment after adrenalectomy in primary aldosteronism
  4666. Treatment of primary aldosteronism with mTORC1 inhibitors
  4667. Associations between primary aldosteronism and diabetes, poor bone health, and sleep apneaโ€”what do we know so far?
  4668. Molecular Basis of Primary Aldosteronism and Adrenal Cushing Syndrome
  4669. Renal impairment is closely associated with plasmaย Aldosteroneย concentration in patients with primary aldosteronism
  4670. Non-neoplastic/hyperplastic primary aldosteronismโ€“Its histopathology and genotype
  4671. Associations Between Metabolic Profiles and Target-Organ Damage in Chinese Individuals With Primary Aldosteronism
  4672. Can incomplete adrenal venous sampling data be used in predicting the subtype of primary aldosteronism?
  4673. Guideline Adherence for Primary Aldosteronism: Breaking the Vicious Cycle
  4674. Primary Aldosteronism: New Insights Into its Detection and Cardiac Involvement
  4675. Clinical outcomes of 1625 patients with primary aldosteronism subtyped with adrenal vein sampling
  4676. Atrial fibrillation, arterialย hypertension, and primary aldosteronism: a dangerous and unexpected trio
  4677. Segmental Adrenal Vein Sampling in Patients With Primary Aldosteronism: Superlative or Superfluous?
  4678. The value of the post-captoprilย Aldosterone/renin ratio for the diagnosis of primary aldosteronism and the influential factors: A meta-analysis
  4679. Bilateralย Aldosteroneย suppression in patients with right unilateral primary aldosteronism and review of the literature
  4680. Mass spectrometry imaging establishes 2 distinct metabolic phenotypes ofย Aldosterone-producing cell clusters in primary aldosteronism
  4681. Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-controlย hypertension
  4682. Primary aldosteronism concurrent with subclinical Cushingโ€™s syndrome: a case report and review of the literature
  4683. Clinical characteristics of snoring patients with primary aldosteronism and obstructive sleep apneaโ€“hypopnea syndrome
  4684. Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism
  4685. Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism
  4686. Abnormal Dexamethasone Suppression Tests in a Rifapentine-Treated Patient With Primary Aldosteronism
  4687. Treatment of primary aldosteronism reduces the probability of obstructive sleep apnea
  4688. The Unrecognized Prevalence of Primary Aldosteronism
  4689. Prevalence of primary aldosteronism in hypertensive kidney transplant recipients: A crossโ€sectional study
  4690. Urinary sodium potassium ratio is associated with clinical success after adrenalectomy in patients with unilateral primary aldosteronism
  4691. Splice-variant-specific effects of primary aldosteronism point mutations on human CaV3. 2 calcium channels
  4692. Diverse responses of autoantibodies to the angiotensin II type 1 receptor in primary aldosteronism
  4693. Novel chemiluminescent immunoassay to measure plasmaย Aldosteroneย and plasma active renin concentrations for the diagnosis of primary aldosteronism
  4694. Primary aldosteronism: a consensus statement
  4695. Primary aldosteronism: considerations about the evaluation of theย Aldosteroneย to renin ratio during canrenone treatment
  4696. Molecular Mechanisms of Primary Aldosteronism
  4697. Minor Change of Plasma Renin Activity during the Saline Infusion Test Provide an Auxiliary Diagnostic Value for Primary Aldosteronism
  4698. Trends in blood pressure-related outcomes after adrenalectomy in patients with primary aldosteronism: A systematic review
  4699. Effects of chronically high levels ofย Aldosteroneย on different cognitive dimensions: an investigation in patients with primary aldosteronism
  4700. โ€ฆ diagnosis and identification of the chimeric CYP11B1/CYP11B2 gene in two pediatric cases of a Japanese family with glucocorticoid-remediable aldosteronism
  4701. Primary aldosteronism subtyping in the setting of partially successful adrenal vein sampling
  4702. Parameters of captopril challenge test can predict results of other confirmatory tests for primary aldosteronism and propose the next test to be done
  4703. Basal contralateralย Aldosteroneย suppression is rare in lateralized primary aldosteronism
  4704. Tp-e interval, Tp-e/QT and Tp-e/QTc ratio in hypertensive patients with primary aldosteronism
  4705. Letter to the editor: primary aldosteronism: does underlying pathology impact clinical presentation and outcomes following unilateral adrenalectomy?
  4706. Clinical outcomes of primary aldosteronism based on lateralization index and contralateral suppression index after adrenal venous sampling in real-world โ€ฆ
  4707. Clinical characteristics of concurrent primary aldosteronism and renal artery stenosis: A retrospective caseโ€“control study
  4708. Molecular basis of Primary Aldosteronism and adrenal Cushing
  4709. Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism:ย Aldosteroneโ€producing adenoma and idiopathic hyperaldosteronism
  4710. Predicting factors related with uncuredย hypertensionย after retroperitoneal laparoscopic adrenalectomy for unilateral primary aldosteronism
  4711. Atherosclerotic Burden and Arterial Stiffness are Not Increased in Patients with Milder Forms of Primary Aldosteronism Compared to Patients with Essential โ€ฆ
  4712. Influence of adrenal venous sampling on management in patients with primary aldosteronism independent of lateralization on cross-sectional imaging
  4713. Evaluation of Adrenal Vein Sampling Use and Outcomes in Patients With Primary Aldosteronism
  4714. Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal venous sampling
  4715. Significance ofย Aldosteroneย gradient within left adrenal vein in diagnosing unilateral subtype of primary aldosteronism
  4716. Web Exclusive. The Unrecognized Prevalence of Primary Aldosteronism.
  4717. Quality of life of primary aldosteronism patients by mineralocorticoid receptor antagonists
  4718. Hereditary causes of primary aldosteronism and other disorders of apparent excess mineralocorticoid activity
  4719. Reassessment of urinaryย Aldosteroneย measurement after saline infusion in primary aldosteronism
  4720. Primary aldosteronism diagnostics: KCNJ5 mutations and hybrid steroid synthesis inย Aldosterone-producing adenomas
  4721. Adrenal (Pro) renin Receptor Expression and Serum Soluble (Pro) renin Receptor Concentration in Primary Aldosteronism
  4722. Hypercortisolism and primary aldosteronism caused by bilateral adrenocortical adenomas: a case report
  4723. Primary aldosteronism in young adults with acute stroke: Prevalence and clinical characteristics
  4724. Feasibility and effectiveness of a single-catheter approach for adrenal vein sampling in patients with primary aldosteronism
  4725. Suspected Borderline Aldosteronism inย hypertension: The Next Target?
  4726. Reply: Suspected Borderline Aldosteronism inย hypertension: The Next Target?
  4727. Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism
  4728. Mass spectrometry reveals misdiagnosis of primary aldosteronism with scheduling for adrenalectomy due to immunoassay interference
  4729. 10 good reasons why adrenal vein sampling is the preferred method for referring primary aldosteronism patients for adrenalectomy
  4730. AT1AA (Angiotensin II Type-1 Receptor Autoantibodies) Cause or Consequence of Human Primary Aldosteronism?
  4731. Myocardial mechano-energetic efficiency in primary aldosteronism
  4732. PREVALENCE, SUBTYPE CLASSIFICATION, AND OUTCOMES OF TREATMENT OF PRIMARY ALDOSTERONISM: A PROSPECTIVE STUDY IN CHINA
  4733. Adrenal vein sampling for primary aldosteronism: a 15-year national referral center experience
  4734. The Outcomes of Primary Aldosteronism Patients in the AVIS-2 Study
  4735. Primary Aldosteronism Associated with Multiple Adrenocortical Micronodules in a Patient with Renal Cell Carcinoma
  4736. Haemodynamics of primary aldosteronism associated with adrenocortical adenoma: insights from bioimpedance cardiography measurements
  4737. Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: An efficacy and safety, proofโ€ofโ€principle trial
  4738. The Role of the CYP11B2 Promoter Polymorphism in the Diagnosis of Primary Aldosteronism
  4739. The Association between eGFR and theย Aldosterone-to-Renin Ratio and Its Effect on Screening for Primary Aldosteronism
  4740. The 2020 Italian Society of Arterialย hypertensionย (SIIA) practical guidelines for the management of primary aldosteronism
  4741. Letter to the Editor:โ€œImpaired Glucose Metabolism in Primary Aldosteronism Is Associated With Cortisol Cosecretionโ€
  4742. Primary Aldosteronism in Newly Diagnosed Hypertensive Patients: Lessons From China
  4743. Minimally Invasive Partial Versus Total Adrenalectomy for the Treatment of Primary Aldosteronism: Results of a Multicenter Series According to the PASO Criteria
  4744. Response to Letter to the Editor: Impaired Glucose Metabolism in Primary Aldosteronism Is Associated With Cortisol Cosecretion
  4745. A patient with bilateral primary aldosteronism refractory to oral eplerenone who responded to esaxerenone with increased renin activity
  4746. High Efficiency and Problems of Chemiluminescence Assay-Detectedย Aldosterone-To-Renin Ratio in Practical Primary Aldosteronism Screening
  4747. Unilateral primary aldosteronism as an independent risk factor for vertebral fracture
  4748. Masking by hypokalemiaโ€”primary aldosteronism with undetectableย Aldosterone
  4749. A combination of captopril challenge test after saline infusion test improves diagnostic accuracy for primary aldosteronism
  4750. MON-LB129 A Pilot Genome Wide Association Study (GWAS) on Primary Aldosteronism Patients in a Multi-Ethnic Malaysian Cohort
  4751. โ€ฆ SUPPRESSION TESTING IS COMPARABLE TO CAPTOPRIL CHALLENGE TEST FOR THE DIAGNOSIS OF PRIMARY ALDOSTERONISM: A PROSPECTIVE STUDY
  4752. Response to Letter to the Editor:โ€œComparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronismโ€
  4753. Preoperative non-stimulated adrenal venous sampling index for predicting outcomes of adrenalectomy for unilateral primary aldosteronism
  4754. Impaired Glucose Metabolism in Primary Aldosteronism Is Associated With Cortisol Cosecretion
  4755. Primary aldosteronism and pregnancy
  4756. Subclinical Primary Aldosteronism and Cardiometabolic Disorders
  4757. Primary aldosteronism associated with a germline variant in CACNA1H
  4758. Adrenal Venous Sampling in Primary Aldosteronism: The Usefulness of Contralateral Suppression Index
  4759. The role of adrenal venous sampling and computed tomography in the management of primary aldosteronism
  4760. PREVALENCE AND CHARACTERISTICS OF METABOLIC SYNDROME AND ITS COMPONENTS IN PRIMARY ALDOSTERONISM: INCREASED PREVALENCE OF โ€ฆ
  4761. Angiotensin II type 1 receptor autoantibodies in primary aldosteronism
  4762. Feasibility of screening primary aldosteronism byย Aldosterone-to-direct renin concentration ratio derived from chemiluminescent immunoassay measurement โ€ฆ
  4763. Adrenal vein sampling with and without cosyntropin stimulation for detection of surgically remediable aldosteronism
  4764. Primary aldosteronism long-term outcome: Medical versus surgical therapy
  4765. Assessing outcomes after adrenalectomy for unilateral primary aldosteronism
  4766. Steroid Profiling as an Additional Tool to Confirm One-Sided Hormone Overproduction in Primary Aldosteronism: A Case Report
  4767. Letter to the Editor:โ€œComparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronismโ€
  4768. Biochemical and clinical characteristics of patients with primary aldosteronismโ€“single centre experience
  4769. Automated Mindray CL-1200i chemiluminescent assays of renin andย Aldosteroneย for the diagnosis of primary aldosteronism
  4770. โ€ฆ ANDย Aldosteroneย LEVELS AND CHANGES IN KIDNEY FUNCTION AFTER TREATMENT FOR PRIMARY ALDOSTERONISM: A LARGE MULTICENTER โ€ฆ
  4771. A primary aldosteronism-like phenotype identified with theย Aldosterone-to-angiotensin II ratio in black men: the SABPA study: cardiovascular topics
  4772. A speckle-tracking echocardiographic study on right ventricular function in primary aldosteronism
  4773. Mineralocorticoid receptor-dependent impairment of baroreflex contributes toย hypertensionย in a mouse model of primary aldosteronism
  4774. Increased Prevalence of Diabetes in Elderly Patients with Primary Aldosteronism
  4775. Challenges inย obesityย and primary aldosteronism: Diagnosis and treatment
  4776. โ€ฆ Between Changes in Plasma Renin Activity andย Aldosteroneย Concentrations and Changes in Kidney Function After Treatment for Primary Aldosteronism
  4777. Germline and somatic genetic basis of primary aldosteronism
  4778. SUN-LB96 Basal Contralateralย Aldosteroneย Suppression Is Rare in Lateralized Primary Aldosteronism and Can Be Useful in Predicting Surgical Outcome
  4779. Plasma levels of the cardiovascular protective endogenous nucleoside adenosine are reduced in patients with primary aldosteronism without affecting ischaemia โ€ฆ
  4780. CUL4-DDB1-CRBN E3 Ubiquitin Ligase Regulates Proteostasis of ClC-2 Chloride Channels: Implication for Aldosteronism and Leukodystrophy
  4781. โ€ฆ and safety of esaxerenone (CS-3150), a newly available nonsteroidal mineralocorticoid receptor blocker, in hypertensive patients with primary aldosteronism
  4782. Diagnostic value of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for primary aldosteronism: a retrospective study at a medical center โ€ฆ
  4783. U-shaped relationship between left ventricular mass index and estimated glomerular filtration rate in patients with primary aldosteronism
  4784. Secondary Aldosteronism
  4785. Primary aldosteronism inย hypertension: more than a factoid
  4786. Primary Aldosteronism
  4787. Nadirย Aldosteroneย levels after confirmatory tests are correlated with left ventricular hypertrophy in primary aldosteronism
  4788. Salt intake in mineralocorticoid receptor antagonist-treated primary aldosteronism: foe or ally?
  4789. Primary aldosteronism:ย Aldosterone/renin ratio cut-off points
  4790. Application of CT texture analysis to assess the localization of primary aldosteronism
  4791. Microvascular and macrovascular endothelial function in two different types of primary aldosteronism
  4792. The Clโˆ’/HCO 3โˆ’ exchanger pendrin is downregulated during oral co-administration of exogenous mineralocorticoid and KCl in patients with primary aldosteronism
  4793. SUN-LB92 The Importance of Early Diagnosis and Treatment of Primary Aldosteronism on the Progression of Chronic Kidney Disease, Compared With Essential โ€ฆ
  4794. Can unilateral forms of primary aldosteronism be excluded with confidence preoperatively by methods other than adrenal venous sampling? The search continues
  4795. Pregnancy induced Cushingโ€™s syndrome and primary aldosteronism: a case report
  4796. Primary aldosteronism due to bilateral micronodular hyperplasia and concomitant subclinical Cushingโ€™s syndrome: A case report
  4797. Letter to the Editor: Very high cortisol concentration in adrenal venous sampling in primary aldosteronismโ€”physiological or pathological
  4798. Aldosterone-to-renin ratio is related to arterial stiffness when the screening criteria of primary aldosteronism are not met
  4799. Oral salt loading test is associated with 24-hour blood pressure and organ damage in primary aldosteronism patients
  4800. Incidence of Acute Kidney Injury after Adrenalectomy in Patients with Primary Aldosteronism
  4801. Theย Aldosteroneย index could be used to diagnose the dominant gland in primary aldosteronismโ€”a retrospective study
  4802. MON-217 New Methods for Primary Aldosteronism Screening by Exploring the Values of Different Indicators and in Combination with Predictive Model
  4803. A Case of Primary Aldosteronism Due to A Primary Adrenal Adenoma Diagnosed by Segmental Adrenal Venous Sampling (S-AVS) Using a Modified Catheter โ€ฆ
  4804. Unusual presentation of primary aldosteronism with advanced target organ damage: A case report
  4805. Improvement of Cardiac Function by Laparoscopic Adrenalectomy in a Patient with Severe Heart Failure Attributable to Primary Aldosteronism
  4806. Primary aldosteronism: The Mayo Clinic approach
  4807. Development and validation of a novel chemiluminescent immunoassay for diagnosing primary aldosteronism
  4808. Challenging aspects of Primary Aldosteronism
  4809. Age-Stratified Comparison of Clinical Outcomes Between Medical and Surgical Treatments in Patients with Unilateral Primary Aldosteronism
  4810. Effects of mineralocorticoid and AT-1 receptor antagonism on theย Aldosteroneโ€“renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and โ€ฆ
  4811. Left-versus-right-adrenal-volume ratio as a screening index before adrenal venous sampling to identify unilateral primary aldosteronism patients
  4812. SAT-561 Effects of Mineralocorticoid Receptor Antagonists on Primary Aldosteronism Screening
  4813. Developing a Research Database of Primary Aldosteronism: Rationale and Baseline Characteristics
  4814. Diagnostic Accuracy of theย Aldosteroneโ€“toโ€“Active Renin Ratio for Detecting Primary Aldosteronism
  4815. SAT-547ย Aldosterone-Potassium Ratio Predicts Primary Aldosteronism Subtype
  4816. NONALCOHOLIC FATTY LIVER DISEASE IN TWO SUBTYPES OF PRIMARY ALDOSTERONISM
  4817. Response to Letter to the Editor from Zhu and Rossi:โ€œDevelopment and Validation of Criteria for Sparing Confirmatory Tests in Diagnosing Primary Aldosteronismโ€
  4818. Update on the Diagnosis and Management of Primary Aldosteronism
  4819. Primary aldosteronism: Genetics and pathology
  4820. Electrochemical Detection of Kallikrein Using a p-Methoxyaniline-conjugated Tripeptide towards Simple Diagnosis of Primary Aldosteronism
  4821. Annals On Call-Underdiagnosis of Primary Aldosteronism
  4822. 11 C-metomidate PET in the diagnosis of adrenal masses and primary aldosteronism: a review of the literature
  4823. DRUG-RESISTANTย hypertension: A COMMON PRESENTATION OF PRIMARY ALDOSTERONISM IN THE AVIS-2:*: STUDY
  4824. High prevalence and a long delay in the diagnosis of primary aldosteronism among patients with youngโ€onsetย hypertension
  4825. โ€ฆ -131 6ฮฒ-Methyl-Iodo-19 Norcholesterol (NP-59) Scintigraphy to Complement Adrenal Venous Sampling in Management of Primary Aldosteronism: A Case Series
  4826. SEX SPECIFICITY OF METABOLIC CHANGES IN PATIENTS WITH PRIMARY ALDOSTERONISM
  4827. Primary Aldosteronism
  4828. Association of Papillary Thyroid Carcinoma with Primary Aldosteronism
  4829. Possible causes of plasmaย Aldosteroneย reduction in primary aldosteronism
  4830. Primary Aldosteronism: the Results of the Treatment According to the Data of Renal Arteries Duplex Scanning
  4831. Aldosterone-induced cardiac damage in primary aldosteronism depends on its subtypes
  4832. Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical versus Surgical Treatment: A Meta-Analysis
  4833. OR34-03 Variable and Pulsatile Circulatingย Aldosteroneย Levels in Primary Aldosteronism: Implications for Diagnosis and Sub-Type Differentiation
  4834. MON-197 Developing a Research Database About Primary Aldosteronism: Rationale and Baseline Characteristics
  4835. SUN-LB98 RAAS Triple-A Analysis for the Screening of Primary Aldosteronism
  4836. SURGICAL TREATMENT OF THE PATIENTS WITH PRIMARY ALDOSTERONISM
  4837. Update and Research Progress in the Diagnosis of Primary Aldosteronism
  4838. Primary Aldosteronism: A Glimpse into the Most Common Endocrine Cause of Arterialย hypertension
  4839. MALIGNANTย hypertension: A CLINICAL PRESENTATION OF PRIMARY ALDOSTERONISM
  4840. IS CONFIRMATORY TESTING NEEDED IN ALL PATIENTS WITH POSITIVE SCREENING TEST FOR PRIMARY ALDOSTERONISM?
  4841. CMR-Verified Myocardial Fibrosis is Associated With Subclinical Diastolic Dysfunction in Primary Aldosteronism Patients
  4842. OR34-02 Somatic Transmembrane Domain Mutations of a Cell Adhesion Molecule, CADM1, Cause Primary Aldosteronism by Preventing Gap Junction โ€ฆ
  4843. Higher risk of chronic kidney disease and progressive kidney function impairment in primary aldosteronism than in essentialย hypertension. Case-control study
  4844. Cardiovascular Events and All-Cause Mortality in Surgically or Medically Treated Primary Aldosteronism: A Meta-Analysis
  4845. Transient pseudohypo-aldosteronism
  4846. Primary aldosteronism-why is it still underdiagnosed in clinical practice?
  4847. Erythromelalgia Caused by Polycythemia Vera Combined with Primary Aldosteronism
  4848. PRIMARY ALDOSTERONISM
  4849. URINARY EXOSOMAL MRNA ANALYSIS OF NCC IN PRIMARY ALDOSTERONISM
  4850. Primary Aldosteronism: Itโ€™s Out There
  4851. A case of primary aldosteronism with resistantย hypertensionย successfully treated by unilateral adrenalectomy after unsuccessful classification of subtype in adrenal โ€ฆ
  4852. Curative resection of an aldosteronoma causing primary aldosteronism in the second trimester of pregnancy
  4853. Clinical characteristics of primary aldosteronism in newly diagnosed diabetes mellitus with hypertensive patients.
  4854. Aldosteroneย to Potassium Ratio after Adrenocorticotropin Stimulation in Unilateral Primary Aldosteronism Diagnosis
  4855. Association of Outcome Definitions With Success Following Adrenalectomy for Primary Aldosteronism
  4856. Should all Hypertensive Patients be Screened for Primary Aldosteronism?
  4857. Clinical Presentation, Diagnosis, and Management of Primary Aldosteronism and Pheochromocytoma
  4858. Aldosteronism with elevated active renin concentration: Primary versus secondary? Importance of follow-up for the diagnosis
  4859. PRIMARY ALDOSTERONISM: LC-MS/MS ASSAY FOR 24-HOUR URINEย Aldosteroneย DETERMINATION IMPROVES SCREENING
  4860. PREVALENCE OF PRIMARY ALDOSTERONISM IN A GENERAL POPULATION SAMPLE OF HYPERTENSIVE SUBJECTS. THE CZECH POST-MONICA STUDY
  4861. DIABETES MELLITUS AND THE METABOLIC SYNDROME IN PATIENTS WITH PRIMARY ALDOSTERONISM IN XIN JIANG IN NORTH-WEST CHINA: SEX SPECIAL โ€ฆ
  4862. Prevalence and Clinical Phenotype of Primary Aldosteronism in Primary Care Hypertensives
  4863. Spironolactone Chronotherapy of Hypertensive Patient with Aldosteronism: Case Report
  4864. SAT-545 Diabetes Mellitus Is the Risk Factor of Cardiovascular and Cerebrovascular Events in Primary Aldosteronism
  4865. Diagnostic Efficiency of Different Screening Indexes for Primary Aldosteronism
  4866. SUN-711 Association of Single Nucleotide Polymorphisms of CYP11B2, CYP11B1 and CYP17A1 with Primary Aldosteronism in a Multi-Ethnic Malaysian Cohort
  4867. Primary aldosteronism: follow up of 17 cases
  4868. SAT-540 Primary Aldosteronism Represents Earlier Myocardial Fibrosis Than Essentialย hypertensionย by T1 Mapping
  4869. MON-192 Comparison of the Seated and Recumbent Saline Infusion Test for the Diagnosis of Primary Aldosteronism in Chinese Population
  4870. Primary aldosteronism in Klinefelterโ€™s syndrome: two cases
  4871. SAT-564 Effectiveness of Treatment with Mineralocorticoid Receptor Antagonistsin Primary Aldosteronism
  4872. MON-221 Seated Saline Suppression Testing Is Comparable to Captopril Challenge Test for the Diagnosis of Primary Aldosteronism: A Prospective Study
  4873. SAT-541 Difference inย Aldosteroneย Dependency Between Cardiovascular Diseases and Renal Impairments in Patients with Primary Aldosteronism
  4874. SAT-556 Use of ACTH-Stimulated Lateralization Indices Underestimates Surgically Curable Primary Aldosteronism
  4875. โ€ฆ CUT-OFF PLASMAย Aldosteroneย LEVEL MEASURED BY IMMUNOASSAY FOR THE DIAGNOSIS OF PRIMARY ALDOSTERONISM USING SEATED SALINE โ€ฆ
  4876. Stress the standardized diagnosis and management of primary aldosteronism
  4877. SUN-195 Bilateralย Aldosterone-Producing Adenomas: A New Subtype of Bilateral Primary Aldosteronism?
  4878. Diagnosis and Treatment of Primary Aldosteronism in West China Hospital of Sichuan University from 2009 to 2018
  4879. Growth differentiation factor 15 levels are similar in primary aldosteronism and essentialย hypertensionย and do not predict arterial inflammation
  4880. SUN-378 Unilateral Primary Aldosteronism as an Independent Risk Factor for Vertebral Fracture
  4881. OR34-01 11C Metomidate PET-CT Identifies More Unilateral Primary Aldosteronism Than Adrenal Vein Sampling
  4882. Duplicate inferior vena cava complicating the evaluation of primary aldosteronism
  4883. Becoming of patients with primary aldosteronism according to their treatment
  4884. The Diagnostic Value of Captopril Challenge Test for Primary Aldosteronism
  4885. SUN-189 A Case of Delayed Hypoaldosteronism Following Unilateral Adrenalectomy for Primary Aldosteronism
  4886. โ€ฆ PRESSURE OUTCOME OF PATIENTS WITH ADRENAL VENOUS SAMPLING-PROVEN UNILATERAL PRIMARY ALDOSTERONISM: A RETROSPECTIVE STUDY โ€ฆ
  4887. OR34-04 Efficiency of Adrenal Venous Sampling in the Treatment Choice of Primary Aldosteronism (AVSTAT Study)
  4888. Aldosteroneย measurement in the Diagnosis of primary aldosteronism-comparison between two automated immunoassays and two liquid chromatography tandem โ€ฆ
  4889. โ€ฆ ON THEย Aldosterone/RENIN RATIO ANDย Aldosterone/ANGIOTENSIN II RATIO IN PATIENTS WITH PRIMARY ALDOSTERONISM: A PILOT STUDY
  4890. SAT-LB76 Impact of Glucocorticoid Cosecretion in Primary Aldosteronism on Thyroid Autoantibody Titers During the Course of Disease
  4891. Cardiovascular, cerebrovascular and metabolic risk in primary aldosteronismโ€“beyondย hypertension.
  4892. Non-sequential and non-stimulated bilateral adrenal vein sampling utility in primary aldosteronism: Case inform
  4893. SUN-175 Repeat Unstimulated AVS with Aid of Plasma Metanephrines Identifies Unilateral Primary Aldosteronism When Initial AVS and Metomidate PET-CT Fails To
  4894. Primary Aldosteronism
  4895. Cellular and Functional Defects in Aldosteronism-linked Cytosolic Domain Mutations in GIRK4 (KCNJ5)
  4896. SUN-161 Primary Aldosteronism and Klinefelterโ€™s Syndrome: Two Cases
  4897. SAT-558 A Dedicated Endocrineย hypertensionย Service Increases the Timely Diagnosis of Primary Aldosteronism
  4898. SAT-177 Relationship Between Visceral Fat and the Position of Adrenal Glands in Cranial-Caudal Direction in Patients with Primary Aldosteronism
  4899. Surgical treatment ofย hypertension: Preoperative work-up and surgical treatment of primary aldosteronism in current daily practice
  4900. Corrigendum: IRB Approval Number Correction. Cardiac Dysfunction in Association with Increased Inflammatory Markers in Primary Aldosteronism
  4901. Clinical characteristics of primary aldosteronism with concurrent adrenal Cushingโ€™s syndrome
  4902. Primary aldosteronism: Study of 09 cases
  4903. SAT-543 Human Hairย Aldosteroneย Measurements for Evaluation of Primary Aldosteronism
  4904. Atrial Fibrillation is an Independent Predictor for Cardiovascular Events in Hypertensive Patients Due to Primary Aldosteronism
  4905. SUN-191 The Creatinine, the Crib and the Manometer-Navigating the Labyrinth of Primary Aldosteronism
  4906. Supplemental Data and Methods: Subtyping of Primary Aldosteronism in the AVIS-2 Study: Assessment of Selectivity and Lateralisation
  4907. Abstract P234: Pre-And Post-treatment Analysis Of Pendrin In The Urinary Exosome In Primary Aldosteronism
  4908. SAT-548 Significance of Adrenal Veinย Aldosteroneย Gradient in the Diagnosis of Unilateral Subtype of Primary Aldosteronism
  4909. Primary Aldosteronism Complicated by Hypokalemic Rhabdomyolysis. A Clinical Case
  4910. Characterization and gene expression analysis of serum-derived extracellular vesicles in primary aldosteronism 2
  4911. SAT-551 Sparing Confirmatory Tests in Primary Aldosteronism
  4912. Reply to: Assessing outcomes after adrenalectomy for unliateral primary aldosteronism
  4913. Primary Aldosteronism due to a Sub Centimeter Unilateral Adrenal Adenoma.โ€. Endocrinology and Surgical Endocrinology, 1 (1); DOI: http
  4914. SAT-544 Primary Aldosteronism in Intracerebral Hemorrhage. Not Intracerebral Hemorrhage in Primary Aldosteronism
  4915. Normotensive primary aldosteronism in a young woman taking-minipillโ€“case report
  4916. MON-207 Validating and Optimizing the Guideline Criterion for Skipping Confirmatory Tests of Primary Aldosteronism
  4917. SUN-LB36 Primary Aldosteronism Due Tosimultaneous Occurrence of Aldosteronoma in the Left Adrenal Gland and Ectopicaldosteronoma in the Liver: A Case โ€ฆ
  4918. Predictors of bilateral and unilateral primary aldosteronism: a retrospective observational study
  4919. ONLINE SUPPLEMENT Effect of Cosyntropin during Adrenal Venous Sampling on Subtype of Primary Aldosteronism: Analysis of Surgical Outcome
  4920. MON-200 Clinical Characterizations ofย Aldosterone-and Cortisol-Producing Adrenal Tumors in Primary Aldosteronism
  4921. Regression of left ventricular hypertrophy in primary aldosteronism after adrenalectomy: a meta-analysis of echocardiographic studies.
  4922. Application ofย Aldosterone/direct renin ratio before drug washout in the screening of primary aldosteronism
  4923. The effectiveness of treatment for primary aldosteronism in Iceland 2007โ€“2016
  4924. Primary Aldosteronism is Under-Diagnosed, Partially Due to Insufficient Screening
  4925. Radiofrequency ablation for adenoma in patients with primary aldosteronism andย hypertension: ADERADHTA, a pilot study.
  4926. Development of radiofluorinated CYP11B2-Inhibitors for the differential diagnosis of primary aldosteronism
  4927. โ€ฆ : Dilated Cardiomyopathy With Electrocardiographic Changes And Coronary-Pulmonary Fistula: An Uncommon Presentation Of Primary Aldosteronism In The Covid โ€ฆ
  4928. Hypokalaemic cardiac arrest-a rare presentation of primary aldosteronism
  4929. Clinical Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism
  4930. EFFECTIVENESS OF RENAL DENERVATION IN SECONDARY ALDOSTERONISM RELATEDย hypertensionย FROM TAIWAN MULTICENTER EXPERIENCE
  4931. Primary aldosteronism (PA)-clinical and hormonal characteristics of a series of patients
  4932. Obstructive sleep apnea in primary aldosteronism is associated with cortisol cosecretion
  4933. Confirmatory testing of primary aldosteronism with saline infusion test and LC-MS/MS
  4934. Steroid profiling as an additional tool to confirm one-sided hormone overproduction in primary aldosteronism
  4935. Clinical and histopathologic phenotype of a single-center patient cohort operated for unilateral primary aldosteronism
  4936. Histopathological, biochemical and genetic characterization of different types of primary aldosteronism, including validation of a new angiotensin assay
  4937. Immunohistochemical characteristics of adrenal tumors in patients with primary aldosteronism
  4938. Intraoperative hypertensive crisis in a patient with normotensive primary aldosteronism. Lessons from a clinical case
  4939. The diagnostic accuracy of adjusted unconventional indices for adrenal vein sampling in the diagnosis of primary aldosteronism subtypes.
  4940. Analysis of circulating microRNAs in primary aldosteronism
  4941. Assessment of serum adropin concentrations in primary aldosteronism
  4942. A CASE OF PERSISTENT HYPOKALEMIA IN A NORMOTENSIVE PATIENT WITH PRIMARY ALDOSTERONISM
  4943. Evaluation of angiotensin II in primary aldosteronism and other forms ofย hypertension-a preliminary study
  4944. A Case of Giant Adrenal Adenoma Presenting Primary Aldosteronism
  4945. TARGET TREATMENT OF PRIMARY ALDOSTERONISM AFFECTS CARDIAC WORK AND BIOENERGETICS
  4946. Adrenal androgen measurement for assessing the selectivity of adrenal venous sampling in primary aldosteronism
  4947. Moderators of the psychotropic effect ofย Aldosteroneย in primary aldosteronism
  4948. Expression of CYP11B2 and CYP11B1 immunostaining in primary aldosteronism
  4949. Primary Aldosteronism due to a Sub Centimeter Unilateral Adrenal Adenoma
  4950. MON-LB062 A Preemptive Strike at Suspected Primary Aldosteronism in a Medically Underserved Patient
  4951. Measurement of metanephrine in adrenal venous sampling may help subtyping primary aldosteronism
  4952. SAT-LB41 Surgery Outcomes for Patients With Primary Aldosteronism Who Show Normal-Appearing Adrenals on Computed Tomography but Unilateral Disease on โ€ฆ
  4953. EHR-Based Modeling Specifically Identifies Patients With Primary Aldosteronism
  4954. High sensitive CRP and copeptin levels in patients with primary aldosteronism compared to hypertensive subjects: Data from the German Connโ€™s registry and the โ€ฆ
  4955. Cardiac Dysfunction in Association with Increased Inflammatory Markers in Primary Aldosteronism
  4956. Intact endothelial epoxyeicosatrienoic acids pathway in primary aldosteronismโ€“the route to new treatment strategies?
  4957. Adrenocortical hypofunction with simultaneous primary aldosteronism: A case report
  4958. Primary aldosteronism with anย Aldosterone-producing adenoma and contralateral adrenal hyperplasia: A case report
  4959. Plasma metanephrines and normetanephrines: Alternative indices of avs in a patient with primary aldosteronism and endogenous hypercortisolemia
  4960. Impact of daily salt intake on the consistency between catopril challenge test and saline infusion test in patients with primary aldosteronism
  4961. Clinical presentation and management of primary aldosteronism in late childhood and adolescence: Experience in an outpatientย hypertensionย clinic
  4962. Abstract P2025: Primary Aldosteronism Decreases Insulin Secretion and Increases Insulin Clearance in Humans
  4963. Partially successful adrenal vein sampling can in some cases reveal the etiology of primary aldosteronism
  4964. Theย Aldosterone/renin ratio predicts cardiometabolic disorders in subjects without classic primary aldosteronism
  4965. Heparin-induced hypo-aldosteronism and hyperkalemia
  4966. ASSOCIATION OF LOW SODIUM-POTASSIUM RATIO WITH ATRIAL FIBRILLATION IN PATIENTS WITH PRIMARY ALDOSTERONISM
  4967. Possible protective influence of KCNJ5 and CACNA1D gene polymorphisms on lipid profile in primary aldosteronism and essential hypertensive patients
  4968. 11C-Metomidate PET/CT Identifies Unilateral Primary Aldosteronism in a Multi-ethnic Cohort
  4969. Biochemical and clinical cure of primary aldosteronism by ultrasound-guided endoscopic radiofrequency ablation
  4970. ANGIOTENSIN II TYPE 1 RECEPTOR AUTOANTIBODIES: CAUSE OR CONSEQUENCE OF HUMAN PRIMARY ALDOSTERONISM?
  4971. Diagnostic accuracy of captopril challenge test and saline infusion test in patients at high risk for primary aldosteronism
  4972. โ€ฆ OF SEVERE LEFT VENTRICLE HYPERTROPHY AFTER MEDICAL TREATMENT OF GLUCOCORTICOID-SUPPRESSIBLE PRIMARY ALDOSTERONISM
  4973. โ€ฆ imaging techniques, immunohistochemistry and genetic analysis to investigate the suitability of laparoscopic partial adrenalectomy in primary aldosteronism
  4974. Authorโ€™s Reply: Primary Aldosteronism: Does Underlying Pathology Impact Clinical Presentation and Outcomes Following Unilateral Adrenalectomy?
  4975. โ€ฆ RATIO AND LATERALIZATION INDEX ARE ASSOCIATED WITH ADVERSE RENAL OUTCOMES IN PRIMARY ALDOSTERONISM PATIENTS WHO UNDERWENT โ€ฆ
  4976. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) as an alternative to left sided adrenalectomy in the treatment of primary aldosteronism
  4977. Evaluation of clinical and biochemical cure and adrenal CYP11B2 and CYP11B1 immunostaining in primary aldosteronism operated after adrenal venous sampling
  4978. SUN-367 Artificial Intelligence Systems for Predicting Primary Aldosteronism Subtype
  4979. Abstract MP11:ย Aldosteroneย Synthase Structure With Cushingโ€™s Disease Drug Osilodrostat Provides Clues For Treatment Of Primary Aldosteronism
  4980. Somatic transmembrane domain mutations of a cell adhesion molecule, CADM1, cause primary aldosteronism by preventing gap junction communication between โ€ฆ
  4981. SAT-012 Urinaryย Aldosteroneย Assay Using LC-MS/MS Could Improve Primary Aldosteronism Screening
  4982. SUN-058 Concurrent Hypercortisolism in Primary Aldosteronism Patients at a Tertiary Care Center: 2007-2017
  4983. MP69-03 IMPACT OF LAPAROSCOPIC ADRENALECTOMY ON CARDIAC FUNCTION IN PATIENTS WITH PRIMARY ALDOSTERONISM
  4984. MON-211 Prevalence, Characteristics and Outcomes of Primary Aldosteronism in Newly Diagnosed Hypertensives in China (Pa China)
  4985. SAT-016 The Influence ofย Aldosteroneย Values in the Tributary Veins of Unresected Adrenal Gland on Primary Aldosteronism Surgical Outcomes
  4986. MON-215 Clinical Factors Associated with Insulin Secretion and Sensitivity in Patients with Primary Aldosteronism
  4987. MON-198 Cosyntropin Stimulation on Adrenal Venous Sampling Obscure Surgically Curable Primary Aldosteronism
  4988. MON-213 Cardiac Damage and Related Risk Factors in Patients with Primary Aldosteronism
  4989. MON-193 Glucocorticoid Excess and Its Association with Metabolic and Cardiovascular Complications in Primary Aldosteronism
  4990. SUN-366 The Optimal Cutoff Value for Basal Plasmaย Aldosteroneย Concentration Suspected as Primary Aldosteronism Distributed According toย Aldosterone-Renin โ€ฆ
  4991. SAT-059 Treatment Of Primary Aldosteronism With The mTORC1 Inhibitor Everolimus
  4992. SAT-563 The Unsuppressed Plasma Renin Activity May Not Enough for Management of Non-Surgically Treated Primary Aldosteronism
  4993. SUN-365 Characteristics of Primary Aldosteronism without Suppression of Plasma Renin Activity
  4994. SUN-144 High Prevalence of Diabetes in Patients with Primary Aldosteronism (PA) Associated with Subclinical Hypercortisolism and Prediabetes More Prevalent in โ€ฆ
  4995. SAT-060 Analysis of over 24,000ย Aldosteroneย to Renin Ratio for Screening Hypertensive Patients for Primary Aldosteronism
  4996. PD31-03 FACTORS ASSOCIATED WITH RENAL FUNCTION DECLINE AFTER UNILATERAL ADRENALECTOMY IN PATIENTS WITH PRIMARY ALDOSTERONISM
  4997. SAT-075 Introduction of a Single Radiologist Improves the Performance of Adrenal Vein Sampling for Primary Aldosteronism, but Does Not Ameliorate Suboptimal โ€ฆ
  4998. SAT-058 Histopathological Analysis of Kidneys and Adrenal Glands in the Same Primary Aldosteronism (PA) Patients: Exploring the Mechanisms ofย Aldosteroneย โ€ฆ
  4999. OR02-3 Endocrinological Crosstalk between Calcium Metabolism and Steroidogenesis in Primary Aldosteronism
  5000. โ€ฆ TO PREDICT RENAL DAMAGE AFTER LAPAROSCOPIC ADRENALECTOMY IN PATIENTS WITH PRIMARY ALDOSTERONISM: MANAGEMENT OF UNMASKED โ€ฆ
  5001. SUN-364 In Search of Predictors of Concordance between Imaging and Adrenal Vein Sampling in Unilateral Primary Aldosteronism
  5002. OR31-6 Insulin Sensitivity and Pancreatic Beta-Cell Function in Patients with Primary Aldosteronism
  5003. MP69-01 VALIDATION OF PRIMARY ALDOSTERONISM (PA) DISCRIMINATION SCORE FOR CONFIRMATORY TESTS OF PA
  5004. SAT-067 Insights into Paradoxical Bilateralย Aldosteroneย Suppression in the Adrenal Veins of Patients with Primary Aldosteronism
  5005. SAT-056 Primary Aldosteronism Has a Distinctive Twenty-four Hour Blood Pressure Profile
  5006. SAT-002 Measurement of Visceral Fat Using Computed Tomography in Two Subtypes of Primary Aldosteronism
  5007. SAT-061 Determinants of Cosyntropin Effect on Adrenal Vein Sampling Lateralization in Primary Aldosteronism
  5008. SAT-070 Clinical and Imaging Characteristics of Primary Unilateral Adrenal Hyperplasia in Primary Aldosteronism
  5009. 2445-PUB: Impact of Primary Aldosteronism on Renal Function in Type 2 Diabetes Patients
  5010. PD31-04 IMPACT OF NOCTURIA ON DETERIORATED RENAL FUNCTION AFTER ADRENALECTOMY IN PATIENTS WITH PRIMARY ALDOSTERONISM
  5011. SAT-076 The Effect of Body Mass Index on Diagnosis of Primary Aldosteronism
  5012. SAT-055 Theย Aldosterone-Renin Ratio Predicts Cardiometabolic Disorders in Subjects without Classic Primary Aldosteronism
  5013. SAT-062 National PA Registry as a Platform for Standardized Clinical Practice of Primary Aldosteronism in Japan
  5014. โ€ฆ OF PRE-OPERATIVE MODELS FOR PREDICTING PATHOLOGY OF PRIMARY ALDOSTERONISM-A JAPAN PRIMARY ALDOSTERONISM STUDY/JAPAN RARE โ€ฆ
  5015. SAT-052 Comparison of Echocardiographic Parameters between Pre-and Post-Adrenalectomy in Patients with Primary Aldosteronism
  5016. SAT-071 Usefulness of NP-59 SPECT/CT for Lateralization in Primary Aldosteronism
  5017. SAT-074 Using Ipsilateral and Contralateral Ratios from Adrenal Vein Samples to Identify Functioning Adrenal Adenoma in Patients with Primary Aldosteronism
Related Posts

Alzheimerโ€™s, Dementia, Parkinsonโ€™s

Myostatin Inhibition Preserves Muscle

Reduces Cocaine Self-administration

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping